Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" NA NA "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 15.0 35.1 13.4 22.0 16.6 19.9 16.5 19.2 18.4 17.6 16.4 22.6 20.9 15.4 19.3 26.1 18.2 25.3 19.4 20.7 13.2 11.8 20.4 26.0 13.4 23.4 19.3 10.1 19.7 27.3 33.1 27.3 23.6 15.8 17.3 19.3 21.5 22.8 18.5 19.7 22.2 17.5 21.2 16.4 22.0 19.1 26.6 19.5 39.1 19.5 24.6 24.4 17.2 16.9 15.3 17.2 8.2 14.7 10.0 16.7 10.1 10.3 31.5 24.6 15.1 11.7 14.2 15.8 11.8 12.8 29.8 17.2 21.4 22.0 24.8 20.4 15.0 16.9 15.1 42.9 31.5 17.6 15.7 27.7 20.2 13.9 21.5 11.9 17.8 15.3 13.6 15.9 19.7 19.2 16.2 23.4 21.3 26.7 28.8 14.4 33.5 28.0 18.5 16.9 12.2 22.0 27.5 16.4 27.8 21.1 8.5 13.2 16.9 8.7 19.7 9.1 16.4 25.3 15.6 10.6 14.2 21.5 11.3 12.5 12.9 16.3 22.6 11.4 15.5 16.3 1.2 12.1 8.2 13.7 14.0 16.5 15.2 12.3 12.6 13.7 15.3 16.7 16.2 1.1 10.0 14.7 17.2 12.6 10.1 13.4 16.6 19.2 18.4 13.2 11.8 19.3 10.1 15.8 19.5 11.9 5.6 10.4 16.1 6.5 11.3 5.9 15.3 6.7 7.9 14.0 15.7 53.6 11.6 17.4 11.4 9.1 9.8 23.3 16.1 43.4 12.2 8.6 8.1 11.5 25.1 1.6 8.1 10.4 9.1 18.3 16.4 10.8 10.1 10.8 11.5 17.4 9.4 13.5 12.0 15.4 14.7 19.4 11.3 26.5 45.3 6.5 30.6 10.2 16.2 8.0 AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 11.2 13.5 16.2 9.9 20.5 9.1 13.7 20.5 25.2 13.2 10.5 11.9 14.3 8.3 15.6 14.8 12.6 13.9 12.7 21.7 14.8 15.7 13.6 16.0 8.0 10.2 14.1 21.7 18.2 29.6 16.7 12.4 9.5 19.2 12.5 11.7 13.1 16.6 13.0 41.1 10.1 8.1 15.6 11.1 9.7 11.3 58.4 9.5 8.8 14.4 20.6 14.4 10.0 10.0 17.2 18.4 2.3 15.1 14.5 16.3 9.2 14.3 19.8 15.4 15.3 18.7 18.0 11.7 15.7 13.2 18.3 12.2 17.2 12.1 39.0 0.7 16.3 11.2 12.3 21.2 23.6 21.0 13.0 16.7 15.3 21.4 9.1 24.7 30.3 8.6 16.3 12.8 12.6 32.1 12.6 14.7 17.7 27.9 8.3 17.3 8.2 30.0 21.4 10.6 19.9 9.9 19.7 31.5 40.0 18.0 13.6 19.9 12.4 7.5 7.8 19.9 17.4 21.1 25.2 13.8 18.8 17.0 9.6 21.7 13.1 16.6 24.1 12.5 18.7 20.1 2.3 10.6 0.8 12.3 15.1 16.2 15.4 12.9 14.6 17.1 17.2 16.3 15.7 0.3 14.5 12.6 18.4 12.2 9.2 16.2 20.5 20.5 25.2 14.8 15.7 14.1 21.7 19.2 9.5 11.9 8.0 23.8 7.0 7.3 22.2 0.6 5.1 12.0 14.8 14.0 31.4 7.6 3.3 6.7 55.5 6.7 5.4 0.0 5.2 7.8 8.8 6.4 4.7 3.4 4.6 14.3 11.5 5.5 3.8 15.9 12.0 5.2 3.3 5.4 4.9 6.0 3.4 5.8 10.3 4.1 16.1 0.0 9.5 39.6 21.5 4.0 2.3 11.5 9.3 6.3 ABHD18 "C4orf29, FLJ21106" ENSG00000164074 "Abhydrolase domain containing 18" Q0P651 4 127965306-128039927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050168, HPA051676" Approved Approved "Nuclear membrane" "Intracellular and membrane" NA NA "Nuclear membrane" "HPA050168: AB_2681040, HPA051676: AB_2681571" "unprognostic (1.91e-1)" "unprognostic (8.66e-2)" "prognostic favorable (5.35e-4)" "unprognostic (1.74e-2)" "unprognostic (4.99e-2)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (5.60e-2)" "unprognostic (3.34e-1)" "unprognostic (1.14e-2)" "unprognostic (1.76e-3)" "unprognostic (2.17e-3)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" "unprognostic (7.32e-2)" "prognostic favorable (9.13e-4)" 7.6 8.2 7.4 13.2 10.5 9.9 8.4 14.1 7.9 7.1 13.6 8.6 8.3 13.7 9.2 9.8 7.2 7.8 9.6 25.1 7.0 7.5 9.1 15.7 9.2 12.0 7.2 5.2 10.8 24.5 8.0 16.3 7.0 8.4 6.8 10.2 7.5 8.9 11.1 18.7 10.6 19.0 9.8 9.7 10.0 8.2 4.0 8.1 18.2 9.2 10.9 10.5 8.4 7.5 10.2 8.8 14.2 7.1 5.2 8.8 3.5 3.5 2.9 3.7 4.5 2.9 4.1 5.5 3.6 2.9 3.2 4.2 6.8 6.3 9.7 5.9 1.4 2.9 3.5 7.7 4.2 3.5 8.0 2.5 7.1 4.7 5.4 4.1 12.0 9.0 3.4 2.9 3.4 2.2 3.8 5.6 7.4 11.7 7.1 2.9 6.4 15.7 5.7 3.8 7.6 2.9 8.8 1.3 6.2 4.7 3.7 8.5 3.1 3.4 6.1 3.7 5.5 5.2 5.0 4.8 2.0 2.7 5.2 3.4 12.7 12.6 11.5 3.5 13.0 3.3 11.1 7.1 9.5 6.3 5.9 4.6 6.8 8.0 7.3 5.7 10.2 8.7 8.8 14.2 5.2 4.2 8.8 8.2 3.5 7.4 10.5 14.1 7.9 7.0 7.5 7.2 5.2 8.4 8.1 6.0 12.5 5.3 8.0 0.0 13.0 0.0 5.1 6.7 10.3 7.0 19.6 4.5 0.0 4.0 2.8 3.0 8.5 0.0 6.4 3.9 2.1 10.7 1.1 20.2 6.7 17.5 5.8 9.2 17.0 0.9 5.8 10.9 0.0 3.6 11.7 6.5 6.5 3.5 5.3 6.2 17.4 12.9 0.0 5.5 3.6 0.0 7.7 5.0 10.1 7.8 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010422.5 ENSG00000269590 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in single" 33 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 14.1;RT4: 7.4;U-138 MG: 5.3" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA065685: AB_2685531" 4.5 8.7 3.7 5.1 3.8 3.1 7.5 5.1 8.3 5.6 5.8 3.6 5.9 11.3 4.5 6.7 6.9 5.4 7.8 5.5 4.2 4.1 6.0 8.3 8.0 13.1 3.5 2.4 6.4 13.2 2.3 3.8 7.5 2.2 6.9 2.8 3.3 8.2 6.2 10.9 6.0 5.9 4.6 3.7 4.1 3.8 4.5 2.6 2.7 10.4 6.9 3.9 4.7 7.1 1.2 0.0 6.7 0.2 0.0 0.2 0.5 2.1 0.0 0.0 3.3 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 2.3 0.0 0.4 1.3 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.4 1.3 0.2 0.0 0.0 0.1 0.3 3.8 0.0 14.1 3.5 0.4 0.9 0.0 0.0 1.4 0.0 0.0 1.1 7.4 2.1 1.9 0.0 1.7 0.3 0.0 2.4 0.7 0.0 5.3 0.1 1.9 2.2 2.3 3.1 1.4 4.7 0.8 2.1 2.0 0.2 1.8 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.8 0.0 0.1 6.7 0.0 0.2 0.0 0.1 0.5 3.7 3.8 5.1 4.4 4.2 4.1 3.5 2.4 2.2 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 7.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.5 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.1 3.3 0.0 4.7 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.8 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.2 0.7 0.0 0.3 0.8 0.4 1.1 0.1 0.1 0.3 1.7 0.1 2.5 0.5 3.2 0.1 0.1 0.0 1.1 0.1 0.1 0.1 0.2 5.6 0.1 0.2 0.1 3.2 4.8 8.9 2.1 0.5 0.2 0.1 4.6 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB001701: , HPA036961: AB_2675405" "prognostic favorable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 14.3 8.5 2.3 10.9 4.6 2.5 14.8 1.2 2.4 7.1 6.2 4.7 14.6 1.9 7.9 6.2 5.0 5.4 6.6 8.4 2.3 2.4 5.1 5.5 17.4 18.9 3.7 2.7 3.6 11.9 8.1 2.8 23.0 4.0 6.3 3.9 6.8 6.5 14.5 19.7 3.1 6.4 8.8 4.7 13.6 5.1 4.1 3.6 5.3 7.4 5.8 12.0 7.1 6.9 8.2 8.0 13.3 13.0 3.4 9.6 4.9 1.6 2.0 0.5 0.0 1.7 1.9 0.0 1.4 0.3 1.2 1.6 0.6 1.3 0.4 0.6 2.1 0.0 0.1 1.4 0.0 1.2 16.0 0.1 11.5 0.2 0.0 2.8 0.0 13.0 2.8 0.0 0.6 0.0 0.5 5.0 0.0 1.0 17.6 7.6 0.5 0.0 2.7 4.8 0.1 4.0 0.0 5.7 0.7 0.7 0.6 0.3 0.0 0.0 0.1 4.3 0.7 3.1 7.2 4.1 0.0 0.8 3.2 0.3 17.2 3.8 0.0 2.1 0.0 3.1 7.8 13.0 13.3 0.6 12.0 0.6 8.2 1.4 1.3 8.0 4.9 0.2 0.6 0.4 3.4 9.2 7.0 9.6 4.9 2.3 4.6 1.2 2.4 2.3 2.4 3.7 2.7 4.0 3.6 8.9 7.5 4.5 0.7 0.7 0.6 4.1 2.5 2.7 4.5 3.5 3.9 4.8 1.7 2.2 0.8 8.4 0.0 0.0 2.9 3.2 1.1 0.9 10.4 1.3 8.4 0.0 0.0 5.5 9.4 0.4 0.3 10.6 1.7 7.2 0.1 0.8 2.4 0.0 2.8 0.8 4.6 0.0 2.9 0.5 0.2 0.6 9.8 1.3 0.0 0.1 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AHCTF1 ELYS ENSG00000153207 "AT-hook containing transcription factor 1" Q8WYP5 1 246839098-246931978 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 114.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.4" "Group enriched" "Detected in many" 5 "B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031658 Uncertain Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA031658: AB_10601968" "unprognostic (3.10e-1)" "unprognostic (1.10e-2)" "unprognostic (2.20e-1)" "unprognostic (6.11e-2)" "unprognostic (7.96e-2)" "unprognostic (2.42e-1)" "unprognostic (3.12e-2)" "unprognostic (8.50e-2)" "unprognostic (2.06e-3)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.49e-8)" "unprognostic (7.65e-2)" "unprognostic (1.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.52e-2)" 20.2 13.7 10.4 11.0 17.4 17.3 14.3 23.3 12.9 12.2 12.6 7.5 10.3 8.3 13.8 8.2 10.7 14.7 8.9 14.9 10.1 6.8 13.4 13.1 9.7 9.5 11.6 8.3 23.3 12.3 19.2 17.6 10.7 10.9 10.1 8.1 7.4 10.7 11.5 15.6 11.3 10.3 10.1 11.4 12.5 12.7 33.9 11.3 17.9 15.3 8.8 9.7 14.5 20.9 5.0 1.1 8.4 0.9 0.7 2.9 0.7 23.9 12.2 10.8 9.5 10.7 10.7 22.9 17.4 8.5 12.7 10.5 11.9 9.1 23.7 19.0 9.0 7.5 20.7 17.2 8.9 21.5 16.8 7.2 15.0 13.3 10.4 8.0 21.7 11.8 10.2 7.9 16.4 16.8 5.9 9.2 8.9 41.6 11.6 12.1 5.5 16.1 9.8 25.1 14.4 13.3 19.8 17.5 18.4 7.8 12.1 13.6 19.8 22.8 8.7 9.3 8.3 11.1 13.5 12.0 13.1 15.1 18.4 32.7 21.1 29.5 26.5 10.6 13.8 12.7 0.7 0.6 1.7 1.7 0.3 1.3 5.0 1.9 1.6 0.8 1.3 2.9 1.5 8.4 0.7 0.9 1.1 2.9 0.7 10.4 17.4 23.3 12.9 10.1 6.8 11.6 8.3 10.9 11.3 32.8 25.4 17.3 13.4 26.7 19.8 17.1 7.6 21.4 27.3 5.2 7.9 12.0 3.3 11.2 54.5 16.3 12.2 0.0 10.5 9.1 14.6 17.6 11.5 12.5 8.0 17.5 20.7 19.0 15.5 17.5 33.4 16.8 3.3 11.8 12.5 8.9 13.9 10.5 36.7 7.6 15.4 32.3 23.7 114.9 37.5 26.8 11.3 13.8 11.2 22.6 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 165.9;Spermatocytes: 116.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 4.6 4.7 7.7 5.6 8.4 4.7 8.3 13.5 8.7 5.0 6.5 8.5 4.1 5.0 6.3 11.1 6.2 11.3 5.2 6.9 9.1 10.3 7.6 4.5 6.7 5.5 9.4 4.9 6.7 4.6 15.4 33.3 4.4 11.5 5.9 6.7 3.7 7.0 6.3 6.1 5.5 6.2 5.7 11.7 6.5 6.1 22.0 7.7 20.5 11.4 4.1 5.0 5.9 4.4 11.2 2.9 15.1 4.1 4.9 6.4 1.6 2.5 1.8 7.6 13.5 7.1 4.5 5.7 4.0 5.0 4.2 5.7 2.9 5.3 5.5 2.1 3.7 9.2 4.5 2.2 4.3 8.9 11.7 4.7 4.2 4.4 2.9 5.8 5.3 2.6 3.6 8.4 7.7 10.1 10.3 5.5 8.4 3.9 4.6 3.1 5.2 4.6 3.5 1.7 5.8 2.9 6.1 4.2 5.1 6.1 5.0 9.2 7.9 4.8 4.6 6.6 4.5 6.0 6.4 5.8 4.0 2.7 5.8 2.6 2.4 2.1 3.2 8.1 6.7 2.2 15.1 2.8 6.5 5.1 1.5 4.4 10.5 5.1 6.1 2.0 11.2 6.4 5.5 5.4 4.9 4.1 2.9 3.6 1.6 7.7 8.4 13.5 8.7 9.1 10.3 9.4 4.9 11.5 7.7 26.8 18.8 6.6 7.7 2.4 14.6 16.1 2.5 165.9 18.2 8.7 13.7 3.3 0.0 7.0 55.8 11.3 10.5 0.0 3.9 1.2 3.5 4.8 20.9 1.8 3.0 19.1 19.0 5.5 4.6 32.1 6.9 5.3 5.0 1.8 14.3 15.2 6.1 7.8 6.0 5.6 48.9 25.8 5.2 116.9 28.5 2.3 4.7 12.8 9.9 7.5 AKIRIN1 "C1orf108, FLJ12666" ENSG00000174574 "Akirin 1" Q9H9L7 1 38991223-39006059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 1447.5;Late spermatids: 943.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051871 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA051871: AB_2681646" "unprognostic (1.16e-1)" "unprognostic (2.13e-2)" "unprognostic (1.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.40e-1)" "unprognostic (1.39e-3)" "prognostic unfavorable (5.39e-7)" "unprognostic (3.53e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-2)" "unprognostic (9.49e-3)" "unprognostic (1.47e-2)" "unprognostic (3.89e-2)" "unprognostic (1.22e-1)" "unprognostic (7.13e-2)" "unprognostic (3.77e-3)" "unprognostic (5.17e-2)" 30.2 20.8 28.3 21.1 29.4 43.1 16.8 17.6 30.3 16.2 23.3 35.0 20.4 15.9 20.6 29.5 19.8 19.5 28.6 40.8 30.1 34.0 29.2 35.0 19.8 25.5 32.1 21.0 17.0 18.2 25.9 34.5 19.5 31.3 25.5 25.0 20.3 18.2 25.7 20.7 12.0 19.2 28.2 41.8 20.5 24.3 68.0 23.6 25.6 24.5 11.2 27.1 22.6 22.4 14.8 22.7 43.1 15.8 29.3 28.6 20.1 16.4 7.7 33.2 27.0 16.2 19.3 23.5 19.4 20.4 19.6 20.1 19.6 13.8 13.1 18.1 18.4 14.1 11.6 32.0 17.4 31.7 19.5 16.0 38.8 11.7 24.9 21.5 36.8 21.3 19.8 22.8 25.5 21.1 17.6 18.1 17.2 26.3 13.1 24.5 6.7 15.6 15.9 69.9 12.5 12.9 25.0 24.1 13.0 21.8 20.3 22.9 15.7 21.5 11.4 42.0 54.3 10.6 19.1 16.0 12.0 19.5 13.0 19.6 19.0 24.4 28.1 20.7 21.9 20.4 12.2 15.8 33.2 14.6 13.5 22.4 14.8 24.1 22.6 22.7 13.0 28.6 18.3 43.1 29.3 15.0 17.1 21.7 20.1 28.3 29.4 17.6 30.3 30.1 34.0 32.1 21.0 31.3 23.6 59.6 44.0 57.9 73.6 122.5 43.4 42.7 28.1 25.4 40.9 36.6 45.2 66.3 79.6 41.6 1447.5 35.9 34.6 46.7 35.5 58.5 56.4 57.9 47.3 31.4 40.1 52.4 90.8 28.8 40.3 943.7 40.9 47.8 40.5 101.0 32.3 47.2 39.9 31.7 42.8 28.4 42.1 51.8 47.4 71.1 89.7 121.1 140.1 47.3 28.1 70.7 AMPD3 ENSG00000133805 "Adenosine monophosphate deaminase 3" Q01432 11 10308313-10507579 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.2;skeletal muscle: 61.0" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.7;CAPAN-2: 19.3;HMC-1: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038662, HPA047408" Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA038662: AB_2676136, HPA047408: AB_2680034" "unprognostic (2.24e-1)" "unprognostic (3.88e-3)" "unprognostic (1.44e-2)" "prognostic favorable (2.37e-4)" "unprognostic (1.89e-2)" "unprognostic (1.71e-3)" "unprognostic (2.91e-3)" "unprognostic (1.25e-1)" "unprognostic (7.83e-2)" "unprognostic (2.26e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-1)" "unprognostic (3.06e-2)" "unprognostic (7.07e-2)" "unprognostic (4.42e-2)" "unprognostic (2.98e-1)" "unprognostic (2.12e-2)" 2.9 13.7 5.3 13.8 14.0 39.2 2.3 2.3 7.8 3.3 3.4 19.6 0.7 4.7 3.1 4.2 5.2 8.0 4.6 2.1 7.4 7.1 4.2 1.5 4.5 12.7 15.2 5.7 2.3 2.5 24.9 14.5 3.7 11.2 5.5 4.9 4.3 4.7 2.8 61.0 10.8 5.0 3.1 12.8 8.3 4.6 1.4 12.6 14.8 2.7 7.6 14.2 6.1 5.1 7.6 3.9 17.0 6.0 3.3 5.3 2.3 7.6 1.1 0.3 0.1 4.1 2.9 0.4 6.9 24.7 1.7 1.8 3.8 19.3 2.8 0.7 3.1 6.8 4.8 0.1 6.5 5.1 6.9 0.2 6.8 1.0 0.5 1.4 9.2 20.5 10.8 10.2 3.4 4.4 4.3 0.7 4.6 10.3 3.0 5.6 0.2 5.4 12.1 0.9 0.6 6.8 2.0 9.0 9.9 0.3 6.5 2.9 1.5 1.5 0.2 0.4 0.6 0.2 3.1 1.9 7.9 0.1 5.4 0.2 2.7 1.5 3.0 9.0 9.2 0.2 6.6 6.0 17.0 2.3 3.8 5.3 7.6 3.3 2.5 3.9 5.8 3.7 2.5 8.3 3.3 1.6 2.5 1.9 2.3 5.3 14.0 2.3 7.8 7.4 7.1 15.2 5.7 11.2 12.6 0.0 4.6 5.2 8.9 11.1 20.7 5.6 7.6 12.0 7.9 14.0 2.0 0.7 14.9 2.4 7.0 1.0 1.7 46.7 1.4 1.1 1.4 17.1 11.5 0.6 13.4 0.0 9.8 1.8 14.3 14.2 0.9 9.1 3.3 13.6 3.2 6.8 3.9 2.9 0.0 1.0 1.3 0.0 1.7 0.2 0.5 10.9 1.0 2.9 2.2 16.1 ANKRD17 "FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16" ENSG00000132466 "Ankyrin repeat domain 17" O75179 4 73073376-73258798 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045024, HPA063731" Approved Supported "Nucleoplasm,Nuclear membrane" No No Nucleoplasm "Nuclear membrane" "HPA045024: AB_10964778, HPA063731: AB_2685106" "unprognostic (3.86e-3)" "unprognostic (3.59e-2)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-3)" "unprognostic (3.29e-2)" "unprognostic (3.10e-2)" "unprognostic (1.78e-1)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (3.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.13e-1)" "unprognostic (4.00e-2)" "unprognostic (4.07e-1)" 19.6 20.2 28.9 23.2 32.4 10.3 24.8 41.2 29.9 22.8 19.4 21.2 19.5 18.2 19.3 24.2 22.2 23.5 18.8 20.4 23.4 21.6 25.3 25.3 18.0 17.4 22.3 19.4 23.4 22.8 40.2 34.6 23.2 31.8 19.7 24.2 21.5 23.1 23.1 32.7 22.2 18.5 20.7 18.0 17.7 19.2 13.5 25.1 22.3 22.7 15.9 21.1 21.1 18.9 4.5 7.6 3.2 2.8 9.3 5.3 1.7 12.3 13.6 21.7 17.1 24.5 21.6 11.9 18.2 21.5 16.4 15.9 16.5 16.3 33.6 15.2 18.6 8.7 10.4 27.1 16.1 22.8 13.0 11.5 22.8 14.8 23.9 13.1 29.8 14.1 18.2 17.6 23.5 18.8 17.1 21.8 13.8 31.9 12.4 19.6 11.4 24.4 10.6 14.1 16.0 13.8 19.5 23.9 13.9 17.5 18.7 21.1 14.3 17.6 19.9 9.5 17.7 10.7 11.8 26.2 17.4 16.7 15.5 14.2 10.4 5.2 25.7 14.1 13.1 17.7 2.3 2.8 3.0 5.3 1.8 2.7 3.0 3.3 3.6 2.3 4.5 3.2 3.6 3.2 9.3 2.1 7.6 2.0 1.7 28.9 32.4 41.2 29.9 23.4 21.6 22.3 19.4 31.8 25.1 44.7 48.2 16.6 32.2 67.7 55.9 71.9 33.1 22.7 48.9 38.4 115.8 24.2 6.6 26.7 4.0 47.7 39.9 0.0 25.0 20.0 36.8 36.1 30.1 45.3 23.8 65.2 43.4 40.5 26.7 4.2 32.5 26.4 27.0 22.6 40.3 32.1 25.1 17.3 35.3 19.8 77.0 19.4 28.2 24.7 28.7 71.0 28.3 24.9 41.9 42.2 ANXA5 "ANX5, ENX2" ENSG00000164111 "Annexin A5" P08758 4 121667955-121697113 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 989.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003677, HPA035330" Approved Approved "Nuclear membrane" NA NA 6100000 "Nuclear membrane" "CAB003677: AB_425305, HPA035330: AB_2674574" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (9.70e-2)" "prognostic favorable (3.64e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.01e-5)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.33e-3)" "unprognostic (3.09e-1)" "unprognostic (6.04e-2)" "unprognostic (6.49e-3)" "unprognostic (4.54e-1)" "prognostic unfavorable (9.29e-7)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.26e-4)" 130.1 65.6 24.6 43.2 26.1 15.3 151.3 10.0 17.9 85.9 35.6 33.8 45.1 17.5 64.4 45.9 42.8 42.4 54.7 46.8 22.5 25.1 62.2 73.1 68.0 49.3 37.8 16.4 62.6 52.1 25.7 55.3 135.8 40.8 57.1 29.8 56.1 83.7 49.8 23.1 28.0 30.1 68.3 51.5 67.9 39.4 33.3 27.8 15.9 61.8 32.5 31.2 57.3 69.8 13.9 80.0 37.2 87.3 4.8 29.9 64.7 30.9 23.0 31.3 17.3 151.1 115.4 34.2 110.1 98.2 57.1 51.2 16.7 13.5 2.3 19.9 151.0 40.0 11.0 19.9 48.7 53.7 22.1 11.4 6.9 21.7 45.4 86.6 14.9 12.0 66.5 23.7 48.6 48.0 65.3 75.3 1.6 6.8 18.7 144.2 20.5 15.1 5.1 16.1 28.0 48.2 0.5 71.7 4.7 95.9 4.6 8.0 9.7 39.7 15.5 100.2 64.9 13.6 17.9 55.6 91.0 44.5 65.0 32.7 16.8 20.3 5.2 58.2 8.1 106.9 9.2 74.0 37.2 11.9 87.3 15.5 13.9 18.2 14.8 80.0 8.8 6.1 8.8 17.1 4.8 79.7 9.7 29.9 64.7 24.6 26.1 10.0 17.9 22.5 25.1 37.8 16.4 40.8 27.8 226.3 227.0 73.7 202.4 177.1 4.9 75.9 209.0 279.7 232.0 125.6 23.6 989.9 252.0 588.9 12.3 263.9 14.2 0.0 297.2 883.6 492.7 311.2 142.3 46.9 681.5 12.7 46.7 191.5 406.3 27.8 351.8 564.0 334.0 369.7 81.0 152.9 380.8 32.0 344.4 128.7 28.3 291.1 342.1 9.5 14.1 123.1 954.0 91.3 35.2 131.9 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289793 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Supported "Nuclear membrane,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "Nuclear membrane" "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favorable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.3 13.8 17.8 16.7 21.8 12.4 10.4 29.2 28.9 16.0 16.6 27.1 15.3 14.8 17.3 17.9 13.4 16.0 20.0 14.3 17.5 17.2 13.7 14.8 13.1 16.6 26.0 19.9 16.7 32.8 13.7 40.9 17.9 19.2 16.2 11.7 20.1 21.3 18.1 10.4 21.9 15.7 14.8 15.9 17.2 21.1 19.9 22.7 11.2 15.0 10.3 15.5 16.0 11.9 7.4 8.2 8.3 12.6 6.6 9.9 7.0 11.2 21.4 9.3 11.1 11.2 12.7 18.3 16.5 13.6 33.6 16.9 50.9 12.6 8.6 15.1 19.8 15.3 15.6 8.5 26.6 10.4 5.6 9.4 6.6 20.7 42.9 17.2 9.9 13.9 10.9 17.2 16.2 9.1 11.9 11.8 9.1 12.0 10.0 9.0 18.5 17.9 9.4 12.4 11.9 18.5 10.1 13.5 8.3 8.3 13.8 10.0 11.0 19.7 21.1 20.6 7.9 15.5 12.8 15.3 20.5 27.9 12.4 13.0 10.2 6.6 9.3 20.8 7.0 12.7 6.9 7.6 8.3 8.8 10.5 9.9 4.8 4.8 8.0 8.2 7.4 4.9 4.6 3.6 6.6 12.6 6.2 5.9 7.0 17.8 21.8 29.2 28.9 17.5 17.2 26.0 19.9 19.2 22.7 20.8 30.7 9.0 5.8 9.0 25.4 10.6 10.2 14.7 13.6 12.2 31.4 9.8 8.3 10.5 10.4 9.5 21.3 23.3 13.4 20.9 14.6 11.1 16.1 19.2 13.1 20.6 23.5 17.8 17.2 16.3 11.5 10.5 11.8 10.8 27.0 11.5 20.5 12.7 9.2 10.2 19.1 6.5 9.2 9.5 7.0 7.4 12.7 10.7 15.8 5.8 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.8 4.0 2.2 4.5 16.7 22.8 22.7 13.7 11.4 8.8 6.9 10.3 5.7 0.0 2.3 11.6 7.4 4.9 7.9 11.2 10.7 5.4 5.3 3.3 3.1 0.3 25.8 3.3 4.0 11.8 8.8 11.0 9.4 11.2 10.6 2.9 0.5 18.7 15.7 12.0 2.0 0.0 2.0 6.6 2.0 3.8 6.2 11.5 6.1 9.1 5.3 2.5 3.6 14.4 3.8 9.8 1.8 0.3 10.6 8.3 6.4 5.0 6.5 7.0 0.8 0.0 12.7 0.4 7.3 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 3.0 2.6 0.0 6.9 12.8 3.8 58.3 5.1 0.0 2.3 1.8 41.2 24.2 0.0 4.2 7.8 9.0 0.0 0.0 13.5 41.5 17.5 3.3 1.1 11.3 20.5 3.2 0.0 6.2 3.9 6.2 127.4 12.8 5.0 96.4 0.0 7.7 14.2 0.0 113.8 11.7 129.8 142.3 59.0 3.9 16.1 8.9 10.6 12.5 1.1 2.4 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152761253 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.7;eosinophil: 45.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 50.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 6.1 5.1 8.4 4.2 10.1 14.5 9.4 6.6 11.4 4.7 5.7 10.1 7.9 6.5 5.6 2.5 7.8 5.1 5.6 3.2 11.4 4.9 3.3 2.3 7.2 7.2 15.9 7.4 6.9 3.3 2.6 8.3 10.2 12.9 4.6 4.1 3.4 4.9 4.8 9.7 8.2 6.1 4.7 12.4 8.7 6.0 7.3 13.5 2.5 4.1 4.6 5.4 6.3 18.9 5.7 7.4 50.7 3.5 2.6 5.6 3.6 8.3 5.1 12.5 3.5 3.1 3.8 19.4 10.2 4.1 8.6 10.8 13.5 12.2 14.7 10.3 4.3 4.1 9.6 6.6 4.5 8.9 23.0 14.0 12.0 5.1 12.0 4.2 9.9 11.3 2.8 5.3 9.3 7.5 3.3 6.4 11.0 13.3 9.5 6.6 6.0 10.2 10.7 12.1 2.6 11.6 11.8 12.4 11.8 3.6 6.2 11.0 11.8 9.3 0.9 8.1 4.5 4.2 7.5 8.8 13.7 9.3 9.5 8.9 9.1 9.1 11.9 6.6 8.5 11.2 50.7 2.8 45.4 4.1 3.0 4.2 5.7 4.2 4.1 3.2 4.9 4.3 3.7 7.5 2.6 3.5 7.4 5.6 3.6 8.4 10.1 6.6 11.4 11.4 4.9 15.9 7.4 12.9 13.5 14.9 10.6 31.2 40.7 94.6 5.6 3.9 20.4 17.4 15.9 10.4 3.9 127.9 14.9 23.8 9.4 27.2 12.3 0.0 16.4 114.2 39.0 25.6 26.5 4.7 35.6 7.9 13.3 21.5 27.9 14.2 18.1 34.9 43.9 56.9 21.6 17.2 18.4 17.5 15.9 7.7 14.7 32.3 26.0 21.3 24.3 93.2 90.6 45.0 22.6 48.9 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Group enriched" "Detected in some" 9 "BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.4 0.8 1.7 2.0 13.8 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.8 0.0 12.7 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 31.3 0.0 1.8 0.3 0.0 0.3 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 1.8 0.1 0.8 0.4 0.0 1.4 1.2 0.0 7.9 143.1 41.4 0.0 0.6 0.6 0.0 0.0 0.5 41.7 0.7 0.7 0.0 0.0 10.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.3 0.5 0.0 1.1 0.0 3.4 0.0 0.3 0.4 1.3 0.4 54.2 0.0 0.0 0.6 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2, apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7" "Group enriched" "Detected in many" 8 "B-cells: 5.2;T-cells: 7.6" "Cell line enhanced" "Detected in many" "Karpas-707: 22.8;U-266/70: 79.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 3.0 10.1 15.7 9.4 5.3 24.6 4.7 8.4 14.8 7.8 7.4 9.1 5.0 17.1 9.3 4.7 12.2 9.2 6.5 10.0 8.1 8.5 2.3 5.0 14.6 10.8 5.6 18.2 2.9 19.6 7.0 22.4 9.2 8.4 5.9 10.8 5.4 15.7 20.0 6.3 10.5 8.6 9.3 17.8 5.4 3.5 10.5 21.0 35.6 2.9 13.4 7.9 16.4 5.2 0.3 0.7 0.2 0.7 7.6 1.9 0.5 0.1 2.3 1.8 2.8 0.4 0.8 0.2 0.2 0.8 0.5 1.1 0.1 0.0 0.4 0.2 1.5 0.1 2.1 0.3 0.4 13.6 0.4 0.1 0.6 0.2 0.5 12.4 1.8 0.5 0.2 0.9 1.9 0.3 0.2 1.4 0.2 22.8 0.4 0.4 2.6 5.4 0.5 0.2 0.4 11.7 0.5 8.8 3.9 1.9 1.9 1.8 0.0 0.0 2.8 0.5 0.1 10.5 0.1 3.0 1.0 0.3 1.5 79.4 10.4 0.9 0.5 8.8 1.7 0.7 0.0 0.0 2.3 0.0 7.6 5.2 6.3 3.8 0.1 4.1 5.1 4.5 0.1 0.7 0.2 0.3 6.7 1.9 10.1 9.4 4.7 8.4 10.0 8.1 10.8 5.6 9.2 10.5 0.0 0.6 41.9 30.2 17.3 1.0 15.4 17.8 0.0 3.4 7.0 0.0 8.5 13.3 2.5 0.2 3.5 0.8 0.0 0.0 0.9 10.3 31.5 15.1 1.5 8.3 0.0 5.2 3.7 10.4 2.1 8.1 16.9 43.9 29.7 9.9 18.9 0.3 0.0 13.1 13.5 0.5 25.8 10.8 0.3 0.6 15.4 41.1 28.7 10.6 39.2 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685986 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.9" "Group enriched" "Detected in many" 5 "Early spermatids: 224.1;Late spermatids: 273.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: AB_2683827" "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 9.8 9.9 9.8 7.2 11.6 26.5 9.6 10.0 12.8 8.3 9.3 10.0 8.0 8.6 10.1 7.0 9.4 8.4 7.3 8.8 8.6 8.7 8.4 9.3 7.9 9.7 9.2 8.5 9.7 7.8 9.4 10.4 9.8 12.0 8.3 9.0 6.7 8.9 9.7 19.1 12.7 9.3 9.1 11.1 9.6 7.9 55.9 10.1 12.4 9.5 5.6 10.4 10.2 11.8 12.7 11.7 25.7 13.5 16.6 18.5 11.6 9.9 14.6 12.0 13.7 12.8 10.8 20.0 13.9 11.7 16.2 12.5 19.6 6.9 19.1 8.4 13.1 9.2 12.2 16.7 11.4 17.4 12.2 10.8 23.6 9.1 13.1 16.2 20.7 16.0 12.2 16.2 14.0 22.8 14.0 14.0 13.3 24.5 6.3 13.3 12.5 17.2 20.0 16.1 10.5 15.4 16.0 13.0 17.0 10.7 20.9 14.9 11.0 16.3 13.9 13.6 14.4 15.3 13.2 12.9 10.4 9.7 9.4 9.8 16.1 20.3 21.1 9.9 11.5 11.4 16.1 13.0 24.0 14.7 13.5 14.3 12.7 15.4 14.7 11.7 12.5 14.6 14.8 25.7 16.6 10.6 8.4 18.5 11.6 9.8 11.6 10.0 12.8 8.6 8.7 9.2 8.5 12.0 10.1 20.8 9.1 7.5 8.2 10.0 8.1 10.6 17.8 13.4 10.3 10.4 27.5 11.4 5.0 11.0 224.1 9.3 12.8 0.0 6.6 12.6 8.5 9.9 8.1 7.9 9.3 3.2 9.2 8.6 6.4 273.6 12.4 11.3 3.3 20.8 10.6 7.8 11.8 10.5 12.7 11.9 11.5 6.5 10.7 49.2 33.7 11.0 18.8 10.1 9.3 11.2 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61681266-61863521 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Group enriched" "Detected in many" 11 "Early spermatids: 136.2;Late spermatids: 148.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 1.0 0.9 0.7 6.3 3.5 9.1 1.1 0.6 1.4 1.4 2.6 0.2 0.6 2.8 1.5 1.2 3.7 0.8 1.8 0.4 0.5 0.5 0.6 2.3 1.3 4.0 0.5 0.9 2.1 1.3 0.1 0.4 1.7 0.7 1.0 2.8 0.4 1.4 0.0 0.4 2.7 5.5 1.0 0.5 2.3 1.3 10.8 0.4 30.1 0.4 2.0 6.6 1.3 1.7 2.2 0.5 2.1 0.3 0.6 3.7 0.5 12.5 4.3 12.4 7.1 0.4 1.1 2.7 11.6 6.8 12.4 16.1 4.4 4.0 7.5 2.7 2.4 3.6 4.5 6.4 2.4 16.8 1.9 7.8 7.6 6.8 5.4 0.1 9.8 4.5 0.2 0.1 9.9 2.6 1.7 2.7 7.4 5.3 5.1 7.8 42.2 15.5 3.4 2.7 3.0 3.7 9.7 23.9 3.6 1.7 5.7 5.0 12.9 4.5 1.6 1.8 4.9 4.2 3.8 2.3 18.3 13.4 6.7 13.3 3.2 6.1 8.0 3.7 4.7 4.5 2.1 0.3 1.5 0.5 0.2 0.6 2.2 1.2 0.6 0.4 1.8 1.8 0.9 1.0 0.6 0.2 0.5 3.7 0.5 0.7 3.5 0.6 1.4 0.5 0.5 0.5 0.9 0.7 0.4 0.0 0.3 1.5 1.3 2.1 0.1 0.5 0.0 1.4 6.8 0.0 0.0 0.7 0.0 0.3 136.2 0.3 0.9 0.0 0.2 2.5 0.6 0.1 0.0 3.0 1.4 0.0 0.0 0.6 0.3 148.4 1.1 0.4 3.3 1.0 1.5 0.3 0.5 0.0 1.1 0.0 0.2 0.0 0.9 13.3 4.5 0.4 0.2 0.8 2.5 0.3 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 138.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Group enriched" "Detected in some" 4 "OE19: 7.5;U-698: 28.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.2 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.9 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.7 0.3 0.0 0.1 0.1 0.1 0.1 7.5 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.1 4.4 0.1 0.0 0.2 0.1 28.3 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 0.0 6.7 3.0 0.6 2.1 0.4 27.4 0.0 4.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 29.2 0.0 0.0 0.2 0.1 0.2 0.3 1.1 0.4 0.1 0.0 4.1 138.7 12.7 1.1 2.0 1.0 3.3 0.0 4.0 0.2 0.1 0.0 0.4 0.0 0.3 12.9 2.1 4.3 11.1 1.9 0.1 0.5 1.1 0.6 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205566-6211132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 27.9" "Group enriched" "Detected in some" 136 "Early spermatids: 149.9;Late spermatids: 529.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HeLa: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.0 1.2 0.1 0.2 0.1 0.1 1.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.3 27.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.5 2.5 0.4 1.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.8 0.6 0.1 0.0 0.3 1.9 0.0 0.0 0.0 0.6 4.2 0.0 4.8 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.9 0.4 0.0 0.8 0.9 0.4 1.5 0.3 1.3 0.8 1.2 0.2 0.0 0.4 1.2 0.3 0.2 1.1 0.5 0.6 0.4 0.9 0.4 1.0 0.4 2.0 0.3 0.5 1.1 0.4 0.7 1.8 0.4 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986310-105074197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 82.3" "Lineage enriched" "Detected in all" 13 "dendritic cells: 82.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 12.1 11.4 14.1 14.4 14.4 15.9 10.8 6.5 15.4 9.0 13.6 9.4 12.4 14.9 9.6 10.0 11.1 7.3 7.1 9.2 12.3 11.5 8.0 18.8 7.7 14.6 11.4 11.0 10.2 35.3 2.7 10.8 7.9 16.0 10.3 11.7 7.5 21.6 13.8 7.7 10.6 10.6 9.7 9.6 12.3 14.1 8.1 9.7 11.0 12.1 8.5 15.4 9.0 11.1 5.9 82.3 1.2 6.2 4.7 5.5 3.5 9.4 13.5 6.5 16.6 5.5 5.6 30.2 8.5 2.1 5.2 2.9 13.5 4.8 18.1 8.6 3.8 13.1 6.3 5.4 12.9 5.8 5.1 9.7 12.0 6.9 18.5 8.1 17.9 9.5 8.3 5.5 7.8 8.5 8.7 8.4 15.2 10.0 4.7 5.0 15.8 11.8 30.7 12.7 14.2 19.6 15.9 7.9 40.8 7.0 12.4 8.4 6.1 8.2 17.7 12.7 12.4 14.7 7.3 4.0 13.1 8.5 11.1 12.9 9.9 11.2 19.1 6.1 12.6 12.3 1.2 6.2 0.1 2.6 5.2 3.2 5.9 3.5 3.2 18.7 4.4 3.6 3.4 0.7 4.7 2.9 82.3 5.5 3.5 14.1 14.4 6.5 15.4 12.3 11.5 11.4 11.0 16.0 9.7 6.0 33.1 19.3 31.8 34.7 9.6 34.4 28.1 25.4 31.8 31.4 23.6 29.8 23.2 25.1 16.4 17.7 9.1 0.0 47.4 53.7 16.7 19.3 19.7 42.3 33.7 3.2 12.0 10.4 20.2 8.5 14.1 56.0 37.1 52.3 18.7 15.6 38.0 18.4 9.6 32.1 11.1 0.0 28.3 17.2 30.2 28.5 18.4 20.8 25.3 32.5 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Group enriched" "Detected in some" 15 "Early spermatids: 55.4;Late spermatids: 34.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Not detected" "Not detected" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.9 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.0 0.0 0.0 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.6 8.1 13.3 10.0 13.7 6.8 9.0 4.0 5.3 6.7 8.9 7.3 10.6 11.8 6.1 7.3 6.2 9.6 7.3 8.0 7.2 6.2 15.3 20.2 11.9 7.6 11.3 10.8 10.7 10.4 9.3 5.0 13.3 9.7 10.9 13.2 10.2 13.3 6.4 9.9 12.3 10.6 6.4 10.6 7.0 13.8 25.4 11.6 8.6 9.2 17.1 12.3 6.2 8.3 8.0 8.2 9.4 5.5 6.4 4.8 13.3 5.4 3.8 17.2 12.0 11.0 7.1 11.0 5.8 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 59.6 76.5 21.4 16.8 5.3 17.5 9.3 38.2 25.4 34.2 33.2 33.4 38.5 14.9 14.0 3.3 9.0 23.5 0.0 17.1 14.2 11.3 12.3 32.5 19.2 20.3 23.8 18.5 19.0 31.3 7.0 22.5 24.2 13.5 14.4 15.8 10.8 17.3 10.5 12.7 19.2 23.7 19.4 7.6 37.2 20.6 8.5 20.8 28.0 16.8 17.6 C2orf70 LOC339778 ENSG00000173557 "Chromosome 2 open reading frame 70" A6NJV1 2 26562582-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.5;testis: 44.9" "Group enriched" "Detected in some" 16 "Early spermatids: 140.3;Late spermatids: 288.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.3 1.1 0.3 2.2 0.0 0.3 0.1 0.8 0.5 1.0 3.1 2.3 0.3 0.4 5.2 0.2 11.5 0.6 1.4 1.1 2.7 0.7 0.1 1.0 0.1 0.8 0.7 2.7 4.5 0.0 1.2 0.1 4.4 0.4 0.6 0.0 3.1 1.7 0.2 0.1 0.2 0.1 0.7 0.1 7.6 44.9 0.5 0.0 3.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 3.8 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.1 0.8 1.1 2.7 0.8 0.7 4.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 13.4 0.0 0.0 0.0 0.0 1.7 0.6 140.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 2.3 0.0 0.0 0.0 2.9 0.0 0.0 288.4 1.7 0.0 0.0 0.0 1.3 0.0 0.3 0.0 1.8 0.5 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 C5orf22 FLJ11193 ENSG00000082213 "Chromosome 5 open reading frame 22" Q49AR2 5 31532266-31555058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 17.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043062 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA043062: AB_10795766" "unprognostic (2.58e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.50e-1)" "unprognostic (2.91e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.65e-1)" "unprognostic (7.30e-2)" "unprognostic (8.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (4.44e-2)" "unprognostic (1.08e-1)" "unprognostic (3.22e-1)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" 8.8 9.3 8.6 7.7 16.8 7.4 9.5 12.5 24.1 9.5 9.8 9.0 6.9 6.4 10.8 5.8 10.1 9.2 8.5 15.1 8.9 10.8 11.2 10.0 9.5 10.1 8.3 10.7 6.8 15.0 14.9 8.1 10.9 14.8 9.2 11.5 8.7 10.1 8.4 29.0 8.4 8.4 12.2 7.9 7.6 9.5 5.3 5.9 11.9 9.8 7.2 12.4 11.4 7.1 2.7 2.7 17.3 5.3 3.1 3.9 1.8 5.1 4.4 9.8 13.8 7.9 6.2 11.2 7.9 6.7 10.1 7.9 5.2 5.6 4.2 11.9 7.8 8.7 3.9 12.4 7.2 10.9 6.3 6.1 8.4 14.3 6.7 11.7 12.4 29.4 8.9 9.2 6.9 10.9 3.9 8.3 6.0 11.3 7.3 11.4 5.5 6.3 3.1 5.7 4.9 5.7 5.8 16.8 5.7 7.4 8.6 6.6 9.8 25.5 11.0 17.9 6.5 8.4 8.9 7.1 7.5 8.8 9.2 8.6 4.3 9.5 8.0 4.3 22.4 10.9 17.3 2.5 1.9 3.0 2.9 2.9 2.7 3.6 2.8 2.7 2.7 3.9 3.6 1.4 3.1 5.3 1.2 2.4 1.8 8.6 16.8 12.5 24.1 8.9 10.8 8.3 10.7 14.8 5.9 3.0 4.0 6.8 2.6 3.9 3.7 21.8 5.1 9.4 5.7 12.2 0.0 4.8 1.7 3.8 2.1 4.5 6.4 0.0 5.3 5.1 3.4 4.2 7.0 9.0 5.6 6.4 6.4 7.4 11.3 1.6 4.4 3.8 8.5 8.2 8.2 4.9 5.5 5.8 3.2 6.1 4.5 6.5 3.3 3.9 7.0 3.4 4.5 7.2 6.6 4.1 C6orf141 MGC46457 ENSG00000197261 "Chromosome 6 open reading frame 141" Q5SZD1 6 49550646-49561907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;gallbladder: 18.9" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "basal ganglia: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5" HPA036199 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA036199: AB_2675002" "prognostic favorable (3.92e-6)" "unprognostic (1.58e-1)" "unprognostic (9.87e-2)" "prognostic favorable (1.15e-4)" "unprognostic (4.95e-2)" "unprognostic (2.15e-2)" "unprognostic (1.39e-3)" "unprognostic (8.13e-2)" "unprognostic (7.02e-2)" "unprognostic (2.85e-2)" "unprognostic (6.37e-3)" "unprognostic (1.41e-1)" "unprognostic (1.89e-8)" "unprognostic (2.33e-2)" "unprognostic (5.81e-1)" "unprognostic (3.77e-1)" "unprognostic (4.43e-1)" 4.7 0.2 1.0 3.0 30.6 0.0 4.9 3.1 1.8 3.7 2.1 0.3 4.4 10.5 4.4 3.6 2.9 1.9 18.9 0.4 0.3 0.4 0.3 1.1 0.6 0.6 0.5 0.1 0.5 3.3 0.0 2.0 0.2 2.8 1.1 1.4 0.0 2.2 0.9 1.2 4.6 1.4 1.4 0.3 0.1 9.1 3.1 2.9 0.0 1.1 0.4 0.8 1.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 1.6 0.8 0.9 0.0 0.0 0.2 3.3 0.0 0.5 1.5 8.0 8.8 1.0 2.3 0.0 0.0 5.6 0.0 7.0 0.0 0.3 0.0 0.0 0.3 6.9 0.0 5.0 2.7 1.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.3 1.2 12.0 0.0 0.0 0.0 1.6 5.2 0.2 0.0 2.2 0.0 0.0 0.4 7.5 0.0 2.7 0.4 0.0 0.0 5.7 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 30.6 3.1 1.3 0.3 0.4 0.5 0.1 2.8 2.9 0.0 1.9 0.0 22.6 36.7 0.0 2.0 7.6 5.3 12.5 0.0 0.0 2.9 0.0 32.6 0.2 8.8 2.0 0.0 8.1 15.4 0.9 2.7 0.0 0.0 0.8 0.0 102.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 7.8 7.0 0.4 0.0 0.0 0.0 0.9 0.5 0.5 31.5 1.7 0.0 1.7 13.2 CACNA1D "CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2" ENSG00000157388 "Calcium voltage-gated channel subunit alpha1 D" Q01668 3 53328963-53813733 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 7.2" "Lineage enriched" "Detected in single" 20 "granulocytes: 7.2" "Cell line enhanced" "Detected in some" "HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020215 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA020215: AB_1845860" "unprognostic (5.85e-2)" "unprognostic (4.90e-3)" "unprognostic (5.09e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (2.32e-2)" "unprognostic (2.95e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-3)" "unprognostic (1.53e-1)" "prognostic favorable (8.34e-8)" "unprognostic (1.14e-1)" "unprognostic (3.05e-2)" "unprognostic (8.09e-3)" "unprognostic (6.70e-3)" 0.6 13.4 10.0 0.8 12.6 1.4 3.6 12.2 16.5 11.2 2.8 3.7 0.1 3.3 6.8 13.2 1.2 14.9 6.2 1.8 5.3 3.5 4.2 3.0 9.0 0.5 2.5 9.6 1.2 5.3 3.0 13.6 1.4 8.7 5.7 3.1 10.1 1.1 3.5 0.6 1.5 4.2 1.7 2.2 4.4 1.8 3.0 1.6 0.0 5.2 0.0 0.6 2.3 0.6 0.1 0.3 7.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.1 33.6 0.3 2.2 3.1 1.3 0.2 6.3 0.7 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 7.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.0 12.6 12.2 16.5 5.3 3.5 2.5 9.6 8.7 1.6 3.0 45.9 0.0 0.6 0.8 23.0 1.2 12.7 14.7 14.8 1.8 33.4 0.6 0.0 5.5 3.6 0.5 3.3 0.0 2.0 0.1 1.0 2.6 11.6 2.4 0.2 7.9 57.1 0.0 1.0 4.9 4.0 0.3 5.0 0.0 2.7 2.5 2.6 3.5 25.5 1.6 13.0 0.0 2.8 1.1 2.5 0.9 0.2 1.3 4.5 0.6 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.9;Proximal tubular cells: 22.7" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Cell line enriched" "Detected in many" 5 "WM-115: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.8 2.5 13.7 17.9 0.0 0.3 0.7 0.4 0.7 1.2 1.9 3.8 1.5 0.0 3.3 0.1 0.7 2.1 3.0 1.8 1.5 0.1 2.4 0.0 0.6 5.6 1.6 0.0 1.4 0.5 4.0 6.6 0.2 6.5 0.8 0.8 0.9 0.1 0.1 1.3 1.3 0.1 1.5 1.8 0.9 7.1 0.1 0.8 1.8 1.8 1.6 8.8 0.9 2.7 3.5 2.1 2.0 0.4 0.3 0.1 21.2 0.1 0.8 1.3 0.8 0.0 1.0 0.1 112.4 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 0.0 1.7 0.0 17.0 4.4 16.4 2.8 5.1 1.4 1.2 7.0 2.0 0.2 5.0 10.4 17.6 1.9 0.0 0.0 2.7 0.1 1.1 19.9 0.0 2.6 0.4 19.1 0.0 4.3 0.0 14.7 0.3 0.0 13.5 0.0 0.3 15.4 4.2 0.0 1.4 22.7 3.7 0.0 4.7 0.5 0.8 7.4 0.0 0.5 1.0 12.8 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "OE19: 51.0;RT4: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 51.0 1.6 0.0 0.0 0.0 0.6 30.2 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 26.8 123.4 0.0 6.0 0.1 0.0 2.2 15.3 24.1 94.4 24.4 0.0 0.1 0.0 0.4 1.4 0.0 30.0 0.0 19.7 0.0 0.0 3.3 10.4 0.0 0.5 0.0 2.9 0.0 0.0 3.5 1.7 0.4 0.0 0.0 49.6 0.0 21.9 16.9 3.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 13.2 15.4 CASC3 "BTZ, MLN51" ENSG00000108349 "Cancer susceptibility 3" O15234 17 40140318-40172183 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024592, HPA050262" Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA024592: AB_1846034, HPA050262: AB_2681067" "unprognostic (3.76e-2)" "unprognostic (3.18e-1)" "unprognostic (2.00e-1)" "unprognostic (1.00e-1)" "unprognostic (1.98e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-3)" "unprognostic (3.40e-3)" "unprognostic (3.38e-1)" "unprognostic (1.16e-2)" "unprognostic (3.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.48e-2)" 27.4 21.0 37.8 20.4 34.8 22.6 26.8 30.0 36.5 30.1 27.3 40.7 19.3 16.4 35.9 26.8 22.2 35.1 21.7 17.8 36.6 32.7 21.6 14.7 23.2 21.8 39.9 27.7 42.1 22.7 31.8 32.6 21.4 29.4 27.4 23.4 25.7 22.5 36.6 50.9 23.0 19.6 35.0 40.7 23.2 22.7 59.7 31.0 19.6 29.4 18.1 25.5 34.1 29.7 6.5 7.2 26.1 11.5 6.8 9.2 5.6 13.5 13.9 17.9 20.1 14.5 15.3 11.5 13.8 12.3 19.0 16.5 15.1 11.8 25.4 22.1 17.3 15.6 24.4 21.8 14.6 26.0 17.3 19.3 18.3 17.3 15.1 13.2 22.3 12.4 15.8 13.5 18.5 29.1 14.7 23.5 14.0 19.6 19.0 15.5 7.8 32.7 12.6 14.1 11.9 8.5 20.5 23.9 26.0 9.8 11.9 28.1 16.1 20.5 74.3 18.1 29.6 24.4 17.6 15.6 16.6 17.3 15.6 21.7 18.2 16.8 25.7 15.8 12.2 17.9 5.8 5.9 8.6 9.2 8.0 8.3 6.5 6.9 8.3 7.2 6.5 7.9 7.4 26.1 6.8 11.5 3.9 6.4 5.6 37.8 34.8 30.0 36.5 36.6 32.7 39.9 27.7 29.4 31.0 17.9 30.8 20.6 20.1 17.5 38.5 23.6 17.8 29.4 45.5 22.7 21.6 17.0 18.3 15.8 11.3 31.6 14.4 0.0 20.7 17.2 23.3 22.2 15.1 19.7 14.8 28.6 30.0 17.2 20.4 18.4 33.4 25.7 33.7 16.2 19.3 20.8 18.6 14.4 28.0 14.3 40.4 12.9 35.0 52.8 63.8 17.3 22.7 21.7 18.8 22.6 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Cell line enhanced" "Detected in many" "T-47d: 19.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.6 0.7 10.1 1.2 0.7 13.0 1.3 1.9 0.9 0.5 3.2 10.9 3.9 7.6 1.4 0.8 2.8 7.4 3.8 0.8 13.6 5.9 2.5 5.8 6.1 3.1 2.6 1.4 4.2 1.9 4.2 1.3 2.1 1.4 4.7 7.2 1.7 0.7 8.7 3.4 4.3 0.1 2.8 2.3 5.0 0.0 5.3 5.0 2.5 4.2 2.7 2.6 5.9 1.9 0.1 19.4 2.8 1.7 0.8 1.5 2.5 2.0 7.9 12.1 1.5 2.6 14.5 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 23.8 14.8 4.2 3.6 0.9 4.4 5.5 5.1 87.0 19.4 1.8 2.0 26.8 5.0 10.6 0.8 2.9 9.3 0.0 10.4 6.6 1.3 8.6 15.1 15.3 5.4 3.2 1.2 1.8 4.5 1.5 2.0 3.9 1.7 8.2 12.3 5.4 7.8 13.5 2.1 6.9 7.4 0.0 1.4 1.4 2.3 0.9 10.4 3.1 7.4 4.6 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363868 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.5" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 280.3;Spermatocytes: 327.2;Spermatogonia: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 37.6;U-266/70: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 2.7 4.7 9.3 6.8 17.1 8.3 8.4 3.8 11.7 4.2 6.6 2.1 3.8 7.9 4.1 8.6 5.9 9.7 4.0 3.2 9.0 7.5 4.1 3.4 2.8 4.3 5.6 6.2 7.7 4.8 7.2 12.5 3.9 11.1 5.4 7.4 3.3 3.6 3.8 2.8 4.7 6.3 2.8 4.5 3.3 6.9 31.5 4.4 14.8 6.7 5.3 6.0 3.3 3.9 4.8 2.4 0.4 3.6 4.1 7.1 1.3 10.2 11.8 10.1 10.1 1.9 4.1 7.2 6.5 2.6 7.5 7.3 6.6 2.0 11.5 4.7 3.7 10.5 9.5 9.8 4.3 13.4 4.4 14.2 9.0 15.0 16.5 0.9 8.9 3.5 1.4 3.1 6.2 2.8 3.1 5.3 16.4 9.1 3.8 7.5 7.4 17.2 14.2 10.6 7.0 10.8 17.5 37.6 1.6 2.8 3.3 7.7 10.2 10.4 4.6 4.5 5.7 12.3 4.8 2.6 11.3 10.6 21.4 15.5 37.5 34.0 8.1 10.5 0.4 9.6 0.0 0.2 0.4 3.6 1.0 4.5 3.5 4.5 4.8 1.0 4.8 5.4 3.3 0.0 4.1 3.6 2.4 7.1 1.3 9.3 17.1 3.8 11.7 9.0 7.5 5.6 6.2 11.1 4.4 0.0 1.7 5.2 22.4 20.3 10.0 8.1 35.7 119.1 23.9 22.7 11.8 26.0 16.6 12.7 280.3 10.6 8.9 93.5 10.8 18.1 15.8 12.5 6.9 14.9 18.8 3.2 20.7 8.0 10.5 39.6 19.8 8.4 13.5 6.4 32.6 21.5 5.5 7.0 19.4 11.2 19.5 6.5 4.7 327.2 197.3 18.1 13.5 8.7 69.8 7.8 CCDC71 FLJ12800 ENSG00000177352 "Coiled-coil domain containing 71" Q8IV32 3 49162535-49166321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047547 Uncertain Approved "Nuclear membrane" No No "Nuclear membrane" "HPA047547: AB_2680083" "unprognostic (1.06e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-3)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (3.68e-2)" "unprognostic (6.71e-3)" "unprognostic (7.20e-3)" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (9.03e-3)" "unprognostic (7.20e-2)" "prognostic favorable (9.65e-9)" "unprognostic (3.53e-2)" "unprognostic (1.53e-1)" "unprognostic (2.00e-2)" "unprognostic (7.14e-2)" 15.5 20.2 7.9 11.2 14.4 7.9 18.0 10.8 19.2 17.6 12.3 15.7 14.7 10.1 19.9 17.3 17.4 21.3 17.5 14.8 8.9 8.5 16.2 20.3 13.7 15.2 9.6 9.9 24.1 12.3 12.2 13.1 18.7 10.6 15.3 9.6 16.3 15.8 15.7 17.2 15.8 16.3 12.8 7.3 20.4 13.2 18.1 8.8 33.2 21.5 12.1 19.4 18.3 14.9 3.2 1.9 1.9 3.5 7.8 3.2 1.3 7.9 11.0 12.9 12.3 14.8 10.9 12.4 9.9 14.4 17.4 15.4 11.3 13.0 7.1 8.7 16.9 14.0 8.5 12.7 26.5 6.2 15.8 9.2 14.5 14.3 11.3 17.6 11.6 11.0 18.3 20.9 20.6 15.9 13.0 17.0 17.5 14.5 3.1 13.8 17.1 19.9 7.1 19.9 12.0 11.9 7.3 7.1 6.6 16.4 15.5 6.6 14.2 10.1 10.8 11.8 10.9 14.3 19.4 11.1 12.3 13.1 12.1 12.8 11.7 5.0 9.8 8.9 11.0 13.6 0.0 2.0 0.8 2.0 3.5 3.2 1.2 1.7 2.5 1.9 3.2 2.7 1.7 1.9 7.8 2.6 0.7 1.9 1.3 7.9 14.4 10.8 19.2 8.9 8.5 9.6 9.9 10.6 8.8 6.0 1.0 4.4 10.6 2.4 1.2 1.1 7.6 2.7 0.0 7.0 0.0 19.5 21.6 16.8 6.7 6.3 6.3 0.0 10.3 15.3 6.0 8.9 2.3 8.7 17.4 0.0 8.1 19.0 3.7 8.2 10.9 5.6 5.0 9.0 8.3 4.5 13.7 8.6 12.7 11.9 1.3 12.9 5.2 9.1 15.6 2.4 18.8 2.9 9.7 9.9 CCDC77 MGC13183 ENSG00000120647 "Coiled-coil domain containing 77" Q9BR77 12 389273-442645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038854 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA038854: AB_10673121" "unprognostic (3.25e-1)" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (7.26e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (8.11e-7)" "unprognostic (2.54e-2)" "unprognostic (3.41e-3)" "unprognostic (2.89e-1)" "unprognostic (3.82e-1)" "unprognostic (2.62e-1)" "unprognostic (4.11e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-1)" "unprognostic (3.19e-2)" "unprognostic (4.41e-3)" 7.5 9.8 9.7 9.9 19.2 7.1 7.8 13.8 12.3 6.3 7.0 13.2 3.2 7.9 8.7 5.4 7.8 6.7 5.4 5.1 8.6 6.2 6.6 5.9 6.7 10.6 11.2 8.6 9.3 5.6 5.3 9.4 6.1 10.4 6.4 8.3 6.1 5.6 4.8 8.2 8.8 6.2 6.0 12.0 8.9 5.5 20.2 12.5 16.2 7.0 4.5 10.1 6.1 6.5 11.4 8.0 5.9 10.8 8.6 8.3 4.4 4.8 6.5 14.4 9.5 4.8 4.3 14.9 12.6 5.8 11.8 19.1 6.6 8.6 11.5 3.0 4.8 6.8 6.8 10.2 3.6 12.7 25.2 10.1 13.1 12.6 8.6 2.8 10.7 6.6 3.3 2.2 11.0 6.9 7.2 7.8 11.3 10.7 12.2 12.0 2.8 10.3 7.5 28.6 6.7 4.8 11.9 26.2 7.2 4.4 3.6 4.1 10.7 12.3 4.7 6.2 22.5 3.8 8.0 7.4 5.9 11.6 10.3 14.2 3.4 6.6 14.6 8.1 10.7 10.2 3.8 7.0 5.9 7.7 10.1 8.0 9.2 7.1 8.3 7.4 11.4 5.1 7.4 5.6 8.6 10.8 8.0 5.0 4.4 9.7 19.2 13.8 12.3 8.6 6.2 11.2 8.6 10.4 12.5 0.0 3.8 6.9 3.3 3.7 2.7 3.4 2.5 5.3 5.7 3.5 5.9 5.1 6.6 2.5 19.3 2.9 2.1 0.0 1.7 6.4 3.5 2.1 6.9 1.8 4.8 1.6 2.4 3.7 7.0 12.0 3.7 5.0 1.7 2.8 3.7 5.6 1.7 5.8 4.2 2.6 5.2 6.5 3.1 17.1 16.0 3.3 4.7 5.3 3.1 1.6 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.5 27.3 7.7 15.4 42.0 29.1 22.8 22.1 24.8 15.7 15.7 15.9 24.2 8.4 41.9 25.4 13.9 19.8 12.4 14.3 7.2 21.1 25.0 6.0 20.4 23.2 29.3 8.9 15.7 49.2 25.2 21.1 9.7 24.9 19.6 16.1 9.0 21.9 14.1 40.1 12.1 17.7 18.3 13.2 20.3 23.7 9.6 24.5 20.7 12.1 31.7 17.8 11.7 24.9 17.4 14.1 18.6 24.4 17.0 23.3 7.4 18.9 11.3 16.3 18.4 6.0 25.4 14.5 14.0 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 23.8 21.2 20.5 35.7 36.7 46.6 49.2 30.6 18.7 10.3 43.6 43.2 92.1 34.9 59.1 22.5 43.2 44.6 46.7 62.9 107.9 45.5 34.0 13.8 36.5 56.9 55.6 35.8 33.2 37.3 11.0 71.1 25.7 21.9 47.7 34.8 54.4 41.4 37.1 58.0 30.1 42.9 45.3 43.2 8.6 14.0 44.4 61.2 40.6 37.0 35.3 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 32.2 43.1 13.8 22.2 15.7 24.0 45.0 13.1 17.9 36.3 28.2 20.1 22.8 15.2 51.4 28.1 29.9 31.0 32.3 27.4 14.5 12.1 24.0 36.9 26.8 26.4 18.3 13.7 61.4 54.4 18.9 34.2 25.0 16.0 37.2 26.9 26.2 29.3 24.1 27.8 25.6 20.7 34.1 13.5 27.2 23.9 24.6 17.5 29.2 54.3 32.1 27.5 33.6 30.9 29.6 25.5 2.6 19.9 15.8 32.1 22.2 9.5 11.1 14.6 13.0 13.4 11.8 9.8 5.5 18.0 24.4 20.2 15.8 9.1 13.9 10.0 8.6 14.4 7.4 20.2 128.1 18.5 6.8 9.3 13.0 7.5 11.1 15.7 14.7 9.0 11.6 9.4 14.9 17.2 16.6 15.6 13.3 13.8 12.0 141.4 13.9 14.1 12.0 17.2 10.0 11.2 12.6 445.0 12.9 7.6 15.1 13.3 12.4 9.8 7.4 14.7 10.5 9.8 17.9 7.1 11.4 10.8 12.9 11.1 6.0 9.7 21.4 10.5 13.7 13.7 1.7 14.3 2.6 26.2 19.9 27.0 29.6 23.1 23.7 21.0 28.1 32.1 28.5 1.2 15.8 12.0 25.5 16.6 22.2 13.8 15.7 13.1 17.9 14.5 12.1 18.3 13.7 16.0 17.5 20.8 25.0 32.0 62.9 79.7 15.3 0.5 48.4 4.0 23.9 45.4 9.8 64.6 59.7 71.7 10.1 44.2 11.3 23.3 53.6 108.9 77.4 41.8 68.1 32.1 111.7 17.5 43.8 34.4 23.2 6.8 59.2 34.0 50.6 54.1 33.5 51.3 55.4 7.0 59.4 66.3 15.3 32.3 54.2 25.9 40.3 75.3 39.1 34.1 78.3 32.5 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.4 0.2 0.6 0.1 0.0 0.0 12.0 0.0 0.1 0.3 0.2 4.8 20.5 0.0 0.9 0.0 2.4 12.1 3.7 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.6 0.0 3.7 0.4 0.0 0.7 0.0 0.0 0.0 8.1 0.1 0.0 1.7 19.7 0.8 0.0 0.0 2.4 5.7 8.7 4.8 0.1 1.3 27.8 0.0 2.3 8.5 0.2 0.0 0.0 0.6 1.2 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 14.9 36.5 0.5 24.3 25.8 16.5 1.6 17.8 105.7 27.3 38.4 9.8 49.0 3.3 23.6 5.9 2.1 44.6 0.0 20.1 9.6 1.5 29.0 0.0 0.0 10.4 20.6 21.5 1.8 2.2 3.1 0.6 5.6 0.0 1.0 45.1 28.4 30.8 31.6 0.4 14.7 28.1 0.0 1.3 2.3 3.8 47.3 47.9 0.0 47.2 32.3 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027262, HPA078737" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717, HPA078737: " "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.5 28.0 23.6 50.6 70.5 43.3 17.7 26.1 38.4 49.9 34.3 29.3 45.3 22.5 43.7 41.1 31.2 29.2 32.7 27.9 41.0 30.5 26.7 31.0 19.6 35.4 51.0 35.2 38.4 39.4 36.0 44.0 54.9 60.5 31.1 32.5 33.2 51.5 62.2 38.5 23.0 20.3 36.1 85.2 50.0 26.3 16.0 35.8 54.0 21.7 21.8 34.0 28.8 51.3 29.9 30.7 61.0 53.4 24.1 36.1 16.3 32.6 46.0 33.4 37.5 141.2 40.6 15.1 36.6 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 62.5 51.6 17.2 31.4 21.4 7.0 2.2 101.9 21.4 14.8 50.6 3.9 65.8 11.6 88.6 6.4 42.6 55.1 0.0 80.3 35.9 56.4 34.0 35.8 187.2 49.9 3.2 23.6 32.5 43.8 3.8 52.0 30.4 35.4 20.8 32.1 25.3 90.5 30.8 37.8 65.4 8.2 38.8 25.5 11.8 5.2 13.7 45.3 37.6 28.9 27.6 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961237-66975148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8;liver: 26.7" "Group enriched" "Detected in many" 5 "Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6" "Not detected" "Not detected" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" NA NA 1200000 "Nuclear membrane, Endoplasmic reticulum" "HPA041008: AB_2677247, HPA041307: AB_2677400" "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favorable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.5 0.1 0.8 13.3 1.3 0.2 1.0 1.6 1.3 0.6 40.7 0.7 1.4 16.8 0.4 0.7 2.2 1.5 3.0 0.7 1.5 1.0 6.8 26.7 0.9 0.2 0.8 1.1 0.5 7.8 0.0 1.1 0.4 2.2 0.4 17.9 1.1 5.9 0.6 12.9 0.5 41.8 0.5 0.9 0.2 4.6 0.9 0.6 0.5 0.4 2.4 0.5 0.4 0.3 0.7 0.6 2.7 0.6 0.3 0.9 0.2 0.4 3.2 0.4 8.1 0.3 0.2 1.3 0.3 0.2 0.4 0.5 0.5 4.0 8.9 2.7 0.0 0.2 0.7 1.2 0.6 0.1 1.5 6.0 4.4 1.3 2.6 0.1 1.0 0.7 0.3 1.0 0.9 0.2 0.3 0.0 14.6 2.8 1.9 0.3 1.2 1.5 1.6 1.4 2.7 0.5 1.4 0.7 1.4 0.1 0.5 0.4 0.9 0.2 6.1 0.2 0.7 5.4 6.8 0.4 0.4 2.6 0.7 0.2 1.0 3.6 1.3 0.3 7.6 0.2 0.6 0.6 2.7 0.3 0.3 0.5 0.5 0.6 0.4 0.6 0.7 0.9 0.6 2.0 0.3 0.4 0.3 0.9 0.2 0.8 1.3 1.6 1.3 1.5 1.0 0.8 1.1 2.2 0.6 3.0 7.0 0.8 0.0 0.5 0.0 1.0 5.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 66.2 0.0 0.8 0.0 0.0 0.2 1.1 40.9 0.2 0.0 18.9 0.0 3.2 2.6 0.0 1.4 0.0 0.0 31.1 0.2 1.0 60.4 1.1 8.2 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 31.9 0.1 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: AB_2684753" "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.28e-4)" 26.3 55.1 27.8 30.5 43.4 97.6 40.2 40.1 40.7 42.2 23.0 19.9 39.1 12.9 29.1 34.5 26.3 19.1 35.8 26.7 31.0 21.9 21.8 35.3 28.2 30.1 56.0 23.1 48.1 20.9 36.6 41.5 40.0 34.4 34.3 16.5 13.7 25.6 37.1 27.3 32.1 14.9 36.8 55.2 32.4 15.1 12.4 52.6 25.0 30.4 20.2 25.6 51.2 71.8 13.2 9.8 26.2 6.2 6.5 14.4 7.4 8.2 6.2 10.4 3.2 11.9 13.1 8.2 9.0 12.8 9.1 12.2 11.6 5.4 2.8 6.1 5.6 5.3 8.9 13.1 4.1 18.7 12.5 11.6 8.5 15.7 14.3 7.1 8.8 14.4 6.0 18.9 11.4 20.2 10.9 5.3 4.5 10.2 37.3 12.9 5.6 10.4 26.8 6.6 5.2 14.2 10.6 12.4 14.8 6.3 5.4 10.5 8.3 7.8 2.9 13.0 6.5 2.4 6.1 8.1 10.2 7.0 9.8 9.8 22.0 9.1 6.5 6.5 7.2 6.9 26.2 6.2 13.3 13.6 4.4 13.1 13.2 12.8 12.1 4.1 10.1 14.4 11.4 12.7 6.5 4.2 9.8 13.0 7.4 27.8 43.4 40.1 40.7 31.0 21.9 56.0 23.1 34.4 52.6 41.7 97.6 120.6 205.3 149.9 55.8 85.6 28.1 76.3 79.6 26.2 94.2 37.9 16.6 25.9 1.9 110.1 100.8 23.3 23.3 39.1 151.1 171.5 133.9 37.6 51.4 49.3 128.8 78.0 91.9 5.1 86.0 167.5 146.8 47.7 56.3 46.1 27.4 66.6 71.1 11.1 91.9 109.9 142.2 31.2 22.0 132.6 75.5 146.6 44.8 153.2 CLPTM1 ENSG00000104853 "CLPTM1, transmembrane protein" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068702, HPA068767" Approved Approved "Nuclear membrane,Centriolar satellite" NA NA "Nuclear membrane, Centriolar satellite" "HPA068702: AB_2686020, HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 29.7 53.4 39.4 20.3 56.2 14.7 20.2 26.7 66.4 25.8 26.6 36.8 17.3 31.5 20.3 24.0 23.7 25.6 22.1 32.2 35.7 35.7 40.6 62.5 23.1 19.1 36.0 33.7 26.9 36.2 53.8 21.1 34.3 37.7 27.1 21.3 30.2 38.0 29.6 37.6 32.9 27.6 23.7 27.2 22.6 25.1 26.7 30.7 13.9 27.3 16.1 26.3 19.5 18.6 18.4 24.1 25.5 28.8 12.5 24.4 11.8 26.5 60.1 14.0 27.7 46.7 18.8 14.9 26.3 29.0 31.1 33.5 26.0 26.9 26.5 29.4 34.8 22.9 31.4 24.9 23.8 21.1 19.4 34.4 20.5 22.7 21.8 33.0 16.3 24.1 29.4 25.3 29.7 19.3 22.2 21.6 15.5 21.3 37.1 27.4 24.0 17.1 9.6 12.6 38.7 20.0 17.8 15.2 25.6 28.9 37.3 16.5 18.2 32.6 48.4 14.2 13.0 26.5 13.1 20.0 35.0 21.8 18.3 32.6 26.1 56.9 20.6 28.9 16.2 32.0 10.4 16.7 25.5 17.0 23.6 14.3 17.5 18.3 24.4 15.4 18.4 14.5 12.2 15.7 12.5 28.8 24.1 15.1 11.8 39.4 56.2 26.7 66.4 35.7 35.7 36.0 33.7 37.7 30.7 6.0 5.6 29.8 29.5 32.5 35.2 10.1 33.1 6.7 10.3 34.9 37.3 80.2 11.6 67.1 41.8 27.0 90.3 0.0 64.6 70.4 35.2 31.5 10.4 43.3 66.9 41.3 39.0 25.8 23.2 42.5 27.9 27.2 32.1 141.5 38.2 56.2 55.1 50.4 28.3 50.1 26.9 25.8 28.3 31.6 29.4 38.5 100.3 22.9 40.1 31.7 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog (yeast)" Q9BQ75 3 99817834-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavorable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 21.4 34.1 23.7 15.1 24.5 17.7 20.6 24.1 27.4 13.4 12.9 9.4 8.2 8.3 19.6 10.7 12.0 13.3 10.5 16.6 24.0 22.2 17.1 17.5 10.8 15.8 15.3 22.3 21.1 26.4 20.7 25.9 11.7 19.2 15.1 12.4 9.3 12.4 14.5 58.2 11.5 9.3 13.8 15.7 12.9 11.0 28.1 13.5 13.6 14.9 14.4 14.7 18.8 15.7 23.5 26.1 1.6 10.9 11.2 19.0 7.9 28.9 13.1 13.0 18.7 9.2 10.9 13.4 13.5 7.3 24.3 20.3 16.3 9.7 31.4 23.7 7.2 21.5 17.5 18.0 15.3 32.2 16.2 17.2 24.7 9.3 13.2 16.6 33.8 13.6 7.4 14.9 18.1 30.3 7.7 16.8 25.4 15.2 20.4 17.6 20.0 27.0 31.5 19.0 27.6 32.9 12.2 21.0 33.6 15.0 7.1 36.7 15.4 13.5 11.0 30.7 13.0 13.3 21.2 4.8 19.3 54.8 11.2 27.4 14.6 29.0 61.0 12.5 37.4 32.2 0.3 4.7 0.8 10.0 10.9 14.2 23.2 14.8 13.5 9.9 23.5 18.7 19.0 1.6 11.2 9.7 26.1 13.7 7.9 23.7 24.5 24.1 27.4 24.0 22.2 15.3 22.3 19.2 13.5 6.0 14.2 29.8 33.2 55.3 30.0 40.3 43.3 29.4 23.9 59.3 17.7 34.3 82.9 17.0 137.8 37.9 1.1 0.0 40.8 46.0 41.2 21.8 61.1 44.9 24.7 120.8 14.5 19.0 5.8 151.1 46.9 25.2 35.4 14.4 13.3 17.6 29.9 0.0 55.2 66.2 21.4 25.8 64.6 105.9 127.7 57.7 18.3 28.7 20.7 22.0 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" NA NA 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: AB_2681953, HPA055465: AB_2682823" "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.2 18.7 16.2 16.7 16.9 32.2 5.8 16.9 24.8 11.7 14.5 21.9 7.9 1.5 21.6 19.4 14.9 8.8 10.5 21.4 19.9 5.8 15.0 3.5 11.5 13.5 20.6 22.7 9.2 57.4 9.6 15.0 14.6 19.6 23.8 5.3 6.7 18.1 9.4 2.4 7.3 6.2 4.5 28.2 4.3 7.0 18.8 4.7 22.0 14.0 4.1 10.3 20.2 17.5 8.8 19.8 16.5 15.8 28.3 11.7 7.7 18.2 16.1 7.3 15.2 5.2 15.0 14.9 9.9 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 29.8 19.2 7.5 28.1 19.6 23.1 10.4 178.3 18.7 27.3 27.9 43.2 20.5 1.7 21.2 75.9 48.4 31.6 0.0 21.4 9.1 26.2 58.6 24.2 67.2 14.9 44.5 31.0 51.0 34.9 41.5 15.5 20.5 28.7 10.0 69.1 11.1 30.2 20.1 15.2 17.7 35.0 0.0 22.6 15.6 24.2 16.3 20.1 20.8 31.5 38.6 CPNE1 CPN1 ENSG00000214078 "Copine 1" Q99829 20 35626031-35664956 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047259, HPA072634" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 160000 "Nucleoplasm, Nuclear membrane" "HPA047259: AB_2680004, HPA072634: AB_2686541" "unprognostic (5.94e-2)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.74e-10)" "unprognostic (3.10e-1)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" 32.0 25.3 23.1 32.9 25.6 36.5 31.8 34.0 24.7 35.5 31.5 23.9 26.3 18.4 38.8 35.1 30.8 34.3 27.8 22.1 22.1 16.0 25.4 23.2 33.3 28.7 22.0 24.8 41.6 27.5 21.5 33.3 39.3 19.4 30.0 27.6 27.4 27.9 25.9 23.9 32.9 31.9 40.5 19.2 42.4 26.3 25.6 23.1 64.8 36.3 27.1 44.4 34.9 33.7 39.4 43.9 52.1 31.0 60.1 53.8 44.7 41.5 32.9 18.7 7.8 2.4 3.2 14.2 20.1 36.0 49.0 32.4 98.9 18.3 29.3 19.4 29.9 42.5 16.1 14.4 38.1 30.4 5.4 11.0 73.8 25.9 71.5 22.6 23.9 10.3 20.9 39.2 19.7 23.5 29.8 30.9 30.0 9.6 15.0 23.7 22.9 35.4 32.1 4.6 42.3 31.8 25.3 56.0 19.9 19.9 30.0 13.2 14.7 45.5 21.7 30.8 5.3 22.5 23.9 20.1 52.0 9.5 16.9 21.2 10.1 10.3 20.2 37.4 13.2 11.5 13.6 31.0 52.1 39.6 30.4 53.8 39.4 38.0 36.6 43.9 37.0 37.7 37.4 42.9 60.1 28.9 24.0 46.0 44.7 23.1 25.6 34.0 24.7 22.1 16.0 22.0 24.8 19.4 23.1 17.9 34.1 35.8 60.3 48.9 31.5 13.2 28.1 29.4 40.9 24.4 19.6 114.0 21.6 56.4 30.6 49.6 28.4 0.0 33.1 69.7 50.3 49.5 47.3 20.2 56.7 20.6 32.2 27.6 34.4 9.4 50.6 44.1 45.5 117.2 29.0 24.1 43.3 37.0 58.0 24.9 17.1 45.3 60.4 11.7 24.0 42.9 88.9 76.2 38.1 60.3 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094810-129111189 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6;testis: 71.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 149.6;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 13000 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favorable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 11.6 13.4 8.4 4.6 9.2 5.9 10.7 7.5 15.9 8.3 15.4 8.6 6.2 24.3 6.5 9.5 9.4 5.4 10.0 17.3 7.7 7.9 12.9 50.0 4.2 3.1 8.3 9.1 7.3 33.1 16.8 3.2 7.9 9.3 10.5 4.4 8.1 14.7 7.9 98.6 7.0 22.8 8.3 5.2 4.6 8.1 71.7 4.4 2.4 8.0 20.2 4.4 9.3 6.8 2.6 11.3 6.0 11.3 6.0 10.0 8.1 0.1 18.3 6.4 13.1 12.0 16.1 9.3 7.8 8.7 9.5 6.0 3.8 7.4 0.7 4.7 13.1 12.7 3.3 1.7 2.8 3.4 11.8 0.4 3.6 9.2 14.7 17.1 0.1 14.0 14.7 0.0 8.0 0.2 12.1 12.4 3.5 1.6 3.8 9.7 3.6 0.3 8.1 1.5 19.8 8.2 9.1 12.3 6.0 9.2 0.3 2.1 6.6 0.0 4.1 2.7 2.1 26.6 4.0 11.1 14.3 1.0 17.9 7.7 13.0 11.0 0.0 16.9 2.2 9.1 2.5 11.3 6.0 5.0 7.4 10.0 2.4 6.9 6.6 11.3 2.6 4.3 4.7 2.9 6.0 7.3 5.3 6.4 8.1 8.4 9.2 7.5 15.9 7.7 7.9 8.3 9.1 9.3 4.4 6.0 3.0 5.4 4.5 2.9 1.4 52.0 20.4 1.4 3.4 3.5 2.0 38.4 14.9 16.6 149.6 12.6 94.4 0.0 19.6 46.4 21.8 14.9 6.9 58.6 18.0 1.6 14.9 14.1 8.1 410.0 20.4 8.8 5.0 9.0 16.9 13.4 12.1 38.6 23.0 41.0 1.4 6.5 14.6 94.3 6.9 4.0 42.1 10.7 22.1 9.9 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 54.0;Mucus-secreting cells: 48.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.3 3.3 3.1 3.4 2.2 3.3 7.8 1.9 2.2 2.6 2.3 1.5 9.7 4.2 10.1 0.8 2.0 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.6 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.4 2.3 5.1 2.4 5.3 1.2 24.9 2.7 1.1 2.1 25.3 4.0 6.2 3.2 7.8 2.8 1.6 5.9 6.3 2.0 55.0 5.2 4.2 44.1 4.5 1.4 0.8 2.4 1.6 1.5 10.0 5.1 3.1 1.7 2.6 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 6.0 12.5 2.0 15.5 2.6 4.7 1.7 10.2 18.7 12.5 1.8 2.0 11.1 8.3 11.1 0.0 4.9 3.2 0.0 11.8 13.3 3.3 54.0 5.7 12.3 4.8 0.0 8.6 3.1 7.9 0.0 6.6 2.2 5.0 1.8 48.0 6.0 7.4 3.5 2.1 3.6 7.5 19.4 3.3 3.6 8.7 2.6 3.5 4.4 11.8 3.5 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093829 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" NA NA "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 12.2 12.2 8.7 8.5 12.6 9.5 18.3 29.2 10.3 12.4 14.3 12.4 5.0 10.7 14.3 12.9 10.7 15.8 16.3 12.2 10.5 8.7 16.0 13.7 18.0 5.0 17.4 7.3 10.7 12.9 8.6 10.0 13.4 13.1 11.2 8.3 8.7 9.4 11.8 10.8 8.7 17.6 15.9 15.4 10.1 14.6 37.6 15.1 26.5 20.1 6.2 7.5 9.5 18.4 1.7 3.5 6.8 6.4 4.7 13.9 4.7 8.6 8.9 10.9 12.0 7.8 4.9 19.5 9.3 9.9 19.1 12.9 10.1 5.3 0.0 5.9 8.6 12.2 6.0 14.0 4.7 20.9 8.7 8.7 8.5 7.9 7.1 10.1 8.7 7.5 4.6 5.0 14.0 13.3 9.5 15.8 16.3 9.6 7.7 11.7 6.1 19.5 9.9 13.3 8.4 13.0 17.5 27.6 3.1 13.3 10.2 19.8 10.2 17.6 11.5 5.5 11.2 8.1 4.9 7.0 11.2 12.0 7.6 8.3 14.2 13.2 4.0 5.4 8.3 9.1 6.8 2.5 4.4 11.2 3.8 13.9 1.6 8.5 7.0 3.5 1.7 8.0 7.8 1.1 4.7 6.4 2.3 11.0 4.7 8.7 12.6 29.2 10.3 10.5 8.7 17.4 7.3 13.1 15.1 14.9 14.4 5.1 37.9 61.5 15.5 9.3 10.2 17.4 5.7 10.4 19.6 7.7 14.9 9.5 8.6 13.1 8.8 0.0 14.4 10.4 26.7 29.3 4.7 18.5 5.5 25.4 18.8 12.3 5.4 2.7 10.6 7.7 15.1 21.6 6.8 21.9 15.1 3.6 16.3 13.9 11.9 6.5 11.3 107.6 21.1 51.9 12.6 12.9 5.2 23.3 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell type enhanced" "Detected in some" 12 "Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Cell line enhanced" "Detected in some" "HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 34.2 0.0 0.0 1.7 0.0 0.0 0.0 83.4 0.1 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 5.2 0.0 0.0 0.0 11.7 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 20.2 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 0.0 0.3 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.1 15.8 0.5 9.2 0.0 12.7 0.0 0.0 1.3 0.0 0.0 0.0 5.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.5 0.0 0.0 0.6 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641392-23677455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: AB_2685101" "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 16.9 16.4 26.6 17.5 38.8 36.9 15.9 19.0 47.1 15.3 19.3 26.9 13.3 20.9 19.2 13.1 30.4 14.6 14.7 17.3 19.4 17.2 22.0 15.4 17.4 20.7 19.1 23.8 14.7 18.6 23.2 17.6 21.1 29.0 18.4 26.1 17.4 19.7 15.5 21.0 23.8 22.2 22.3 19.7 21.5 19.4 20.1 19.9 16.2 19.6 10.5 31.6 20.9 18.7 14.5 17.0 19.0 19.3 20.2 17.9 16.0 12.0 24.0 23.5 19.5 16.8 12.5 16.5 21.4 13.3 13.8 16.7 26.8 16.7 16.9 17.4 22.3 14.5 12.6 38.7 20.6 17.2 19.3 15.3 20.9 28.8 37.8 11.4 25.4 16.2 10.4 14.9 17.0 18.2 15.4 21.8 21.3 39.8 13.1 22.1 33.3 19.5 7.3 27.7 17.5 10.6 23.9 20.3 18.4 11.2 25.5 19.7 20.5 18.7 15.3 12.7 21.6 21.3 21.6 29.4 18.7 8.5 14.6 14.9 17.9 26.8 27.2 17.8 12.7 20.2 11.2 16.1 19.0 16.2 13.5 17.9 14.5 15.0 17.5 17.0 11.2 12.8 15.1 7.0 20.2 19.3 11.8 17.3 16.0 26.6 38.8 19.0 47.1 19.4 17.2 19.1 23.8 29.0 19.9 14.9 25.8 16.2 11.1 13.1 49.6 23.4 15.3 13.4 15.9 19.2 86.4 26.9 10.0 21.9 17.5 19.4 27.4 23.3 22.1 30.2 15.6 13.0 26.6 12.1 24.5 49.3 21.2 18.4 18.6 20.3 12.0 15.7 6.8 34.3 20.1 24.4 33.6 14.0 17.0 18.9 42.0 12.9 10.5 64.6 15.5 12.4 40.3 18.1 20.8 15.3 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953586-23969279 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 15.8 18.5 8.3 10.3 13.7 5.9 15.4 4.4 9.6 11.0 22.2 10.2 12.1 30.3 13.7 11.7 17.2 8.3 16.3 16.3 9.0 6.6 65.8 40.3 12.6 13.6 14.0 7.7 12.6 20.6 7.3 9.7 8.9 9.3 17.0 12.4 12.0 17.5 14.4 25.3 16.6 35.2 14.4 9.6 12.4 12.9 13.5 12.6 6.9 17.1 16.1 11.1 10.0 14.8 9.7 22.0 2.6 25.5 7.9 10.6 14.9 7.7 15.7 5.4 8.8 8.6 9.6 0.1 14.6 7.7 5.8 4.6 3.3 8.3 6.6 7.8 7.2 4.0 9.2 4.3 6.0 5.2 17.8 8.9 4.0 13.2 18.3 5.2 5.7 24.6 9.5 7.5 4.8 10.6 6.6 7.2 9.9 5.9 15.8 7.9 26.3 10.4 5.4 5.3 9.0 15.8 16.9 9.5 21.8 6.0 9.0 10.5 8.8 14.0 9.1 6.9 3.6 8.4 7.7 13.4 7.2 7.6 7.4 4.7 12.1 11.2 1.8 6.3 6.5 7.2 2.4 25.5 2.6 8.9 21.0 10.6 9.7 10.1 8.9 22.0 8.3 10.3 9.9 1.1 7.9 11.1 18.5 8.6 14.9 8.3 13.7 4.4 9.6 9.0 6.6 14.0 7.7 9.3 12.6 14.9 26.2 4.7 9.5 11.1 4.7 30.1 7.6 32.1 31.8 14.0 0.0 8.3 66.3 5.2 39.4 10.8 35.9 0.0 8.6 4.2 11.6 9.3 12.8 64.8 26.6 6.4 18.5 16.0 34.4 43.6 10.3 34.4 5.0 3.6 41.8 12.8 6.6 7.0 16.3 63.7 1.6 6.5 11.3 27.0 2.0 11.7 3.2 14.1 63.5 9.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Hepatocytes: 186.0;Proximal tubular cells: 502.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 6.3 11.2 6.9 12.8 7.9 3.0 11.4 14.6 9.6 7.2 9.9 3.4 2.6 12.1 5.6 10.4 25.5 5.4 4.3 8.9 5.0 4.1 42.0 33.0 16.7 7.2 4.6 2.4 7.1 28.4 6.0 5.2 3.1 7.6 8.3 9.5 5.4 14.2 10.9 18.7 9.8 14.9 6.4 5.6 8.1 7.1 28.2 4.5 13.8 5.9 32.8 14.5 5.3 7.1 10.4 22.3 3.2 27.2 7.9 11.5 14.7 8.5 12.9 2.2 11.0 21.4 22.4 0.2 7.7 15.3 11.3 8.4 3.7 10.1 5.6 5.3 15.5 7.3 9.3 9.9 12.9 9.4 18.2 6.0 1.3 11.2 23.0 15.8 7.1 22.2 23.1 16.4 7.3 10.8 7.8 13.2 17.3 4.3 19.9 12.1 26.9 17.7 7.4 4.4 20.1 14.3 28.0 9.1 17.4 16.2 11.3 12.0 7.2 10.6 9.8 6.4 4.9 11.8 10.7 9.3 6.0 6.2 7.0 3.9 11.6 9.2 1.6 5.2 10.3 8.5 2.3 27.2 3.2 10.1 22.5 10.4 10.4 10.8 11.5 22.3 8.2 11.1 10.1 1.3 7.9 13.2 18.3 10.3 14.7 6.9 7.9 14.6 9.6 5.0 4.1 4.6 2.4 7.6 4.5 14.9 23.5 21.4 38.6 24.6 9.7 15.1 17.8 32.1 23.9 24.4 2.0 16.3 107.8 33.6 16.0 33.7 49.1 23.3 48.9 6.2 41.2 29.1 17.3 186.0 120.7 11.1 35.8 45.4 59.2 31.0 40.6 42.6 49.0 45.9 56.0 58.7 33.6 63.1 35.0 502.2 6.9 32.3 38.1 8.9 1.4 35.1 10.9 27.3 69.8 32.0 DHX37 "DDX37, Dhr1, KIAA1517, MGC2695, MGC4322" ENSG00000150990 "DEAH-box helicase 37" Q8IY37 12 124946825-124989122 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047607 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA047607: AB_2680101" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.54e-10)" "unprognostic (2.38e-2)" "unprognostic (5.14e-2)" "unprognostic (2.90e-2)" "unprognostic (2.07e-1)" "unprognostic (3.16e-2)" "unprognostic (8.28e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (2.85e-2)" "unprognostic (2.73e-1)" 9.5 9.2 8.6 12.7 12.1 29.6 9.3 5.7 12.1 8.9 7.9 11.8 6.0 10.2 11.6 6.5 11.2 9.8 10.7 12.4 7.3 5.4 7.4 10.7 8.2 13.3 11.6 7.4 12.7 14.4 4.7 5.7 6.7 10.5 8.7 5.7 5.6 9.1 7.3 22.7 15.8 9.5 7.7 7.5 12.2 9.1 6.8 11.1 7.8 8.9 9.7 11.5 9.7 13.6 4.3 1.6 0.2 2.5 1.4 2.5 1.4 7.4 21.5 3.8 11.8 3.8 4.3 9.7 2.6 3.9 8.6 6.9 27.1 5.2 18.3 10.0 3.1 11.5 10.4 9.9 5.8 3.1 15.8 18.4 9.0 12.2 10.7 5.4 11.8 16.3 4.0 6.6 14.9 2.4 3.4 5.0 9.3 18.9 5.1 5.1 11.0 16.7 12.4 13.8 8.0 13.0 12.3 3.7 9.1 3.7 17.0 6.7 3.3 7.0 7.6 5.7 2.7 8.5 10.5 5.9 10.0 7.5 14.2 17.3 11.7 14.7 18.1 6.6 6.9 12.5 0.0 0.6 0.0 1.5 2.0 2.2 4.3 1.8 2.5 1.6 0.2 0.9 0.8 0.2 1.4 2.5 1.2 0.9 1.4 8.6 12.1 5.7 12.1 7.3 5.4 11.6 7.4 10.5 11.1 3.0 6.9 8.2 2.2 3.8 2.6 3.2 0.0 2.7 4.5 0.0 0.0 3.7 3.3 4.3 1.5 3.6 3.3 0.0 5.3 4.8 3.5 3.1 5.8 6.0 4.6 12.7 8.6 1.8 6.9 1.5 4.9 4.5 0.0 6.4 6.7 2.0 7.2 0.0 2.5 3.9 1.8 6.5 2.7 1.4 5.6 3.4 2.4 4.4 7.3 2.8 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045896-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 33.2;pituitary gland: 35.2" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 49.9" "Group enriched" "Detected in some" 18 "plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 20 "dendritic cells: 2.1;T-cells: 1.8" "Cell line enhanced" "Detected in some" "HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.0 10.2 2.0 0.2 49.9 0.0 2.4 0.9 2.9 2.3 1.6 1.0 0.0 3.4 1.2 5.4 1.3 1.3 5.9 5.7 1.3 8.7 3.2 4.5 2.3 0.0 1.3 1.1 33.2 9.9 8.8 35.2 0.0 17.3 2.3 0.1 2.4 1.3 1.1 1.0 1.1 1.2 0.3 1.7 1.2 1.9 2.4 0.5 0.0 1.6 0.3 0.1 1.2 1.9 0.0 2.1 0.0 0.0 0.0 1.8 0.0 0.0 1.3 1.4 0.0 4.8 3.6 0.5 4.0 1.4 0.3 1.1 0.0 0.7 0.0 0.2 4.2 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 7.5 0.0 0.0 15.7 0.1 0.6 0.0 0.0 0.9 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 9.7 0.0 0.4 0.2 7.9 2.5 0.0 0.0 15.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 2.0 49.9 0.9 2.9 1.3 8.7 1.3 1.1 17.3 0.5 0.0 2.6 0.0 16.7 2.9 0.6 4.8 10.2 1.4 3.4 3.5 9.8 0.7 54.7 2.0 0.0 0.6 0.0 0.0 17.0 0.1 10.6 3.2 0.0 2.6 0.1 0.0 15.5 1.8 0.0 0.0 6.4 0.2 5.0 0.0 0.3 0.7 3.6 0.0 1.4 5.0 5.6 0.0 2.6 0.0 0.2 2.5 0.3 0.0 0.6 2.1 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 6.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 87.0;Early spermatids: 28.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.2;hTEC/SVTERT24-B: 1.4;U-698: 1.2" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.5 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.0 1.2 0.1 0.4 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.6 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.0 1.6 0.0 87.0 9.1 0.0 0.0 0.2 0.0 0.0 28.8 0.3 0.9 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.3 0.5 0.0 0.0 1.9 0.1 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355230 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 160.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.9 31.7 18.6 20.1 20.6 27.2 32.6 24.0 28.3 24.1 21.8 29.9 26.4 25.0 26.8 31.0 23.8 21.1 28.7 25.3 18.0 17.3 25.6 34.3 26.8 27.5 19.9 19.4 25.4 33.1 38.4 26.2 36.0 20.2 24.5 17.5 27.5 32.4 44.8 40.3 28.6 27.4 22.8 22.3 26.9 24.3 29.2 18.2 20.8 25.5 25.8 23.5 21.1 21.2 7.6 15.5 23.3 19.8 8.3 8.7 9.9 15.6 16.3 10.3 17.2 13.5 13.8 13.0 15.8 27.4 21.8 20.3 19.1 27.4 11.6 12.8 19.0 13.6 26.4 9.5 14.2 11.5 12.6 13.0 6.2 9.7 12.3 29.8 12.6 23.8 17.7 29.5 19.2 24.4 19.7 15.1 11.2 9.7 17.5 18.0 15.2 10.7 10.7 4.8 12.0 4.8 9.9 7.8 8.0 16.0 9.2 7.1 10.2 8.6 32.0 15.4 5.8 12.2 14.4 16.9 10.9 15.0 12.2 19.8 14.8 11.0 6.8 18.0 13.9 7.4 9.1 18.1 11.0 8.7 19.8 7.8 7.6 8.6 6.5 15.5 7.3 7.2 7.1 23.3 8.3 16.8 10.5 8.7 9.9 18.6 20.6 24.0 28.3 18.0 17.3 19.9 19.4 20.2 18.2 26.8 27.7 36.1 25.5 11.8 32.1 20.2 53.5 20.1 22.7 22.7 21.6 34.5 10.0 30.2 95.9 21.5 37.6 46.7 56.5 35.4 21.6 25.1 39.3 26.0 34.3 28.6 28.3 17.8 36.2 160.7 33.6 33.3 10.1 33.3 24.0 31.9 29.4 31.7 32.9 30.0 34.0 51.8 25.0 20.2 9.0 13.6 56.9 20.3 21.7 29.8 DNAJB2 "CMT2T, HSJ1, HSPF3" ENSG00000135924 "DnaJ heat shock protein family (Hsp40) member B2" P25686 2 219279267-219286900 "Disease related genes, Predicted intracellular proteins" Chaperone Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036268 Approved Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA036268: AB_10670793" "unprognostic (2.02e-2)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.53e-2)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.45e-3)" "unprognostic (5.11e-2)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-3)" "unprognostic (7.03e-2)" "unprognostic (4.09e-2)" "unprognostic (4.64e-2)" "unprognostic (1.96e-2)" "unprognostic (5.98e-2)" "unprognostic (5.62e-3)" 19.9 34.1 48.9 10.1 51.3 14.0 20.9 43.1 62.6 18.4 14.9 51.6 19.8 13.9 13.7 29.0 15.7 25.6 16.3 26.9 52.6 46.8 23.2 16.6 19.4 13.8 65.7 43.4 26.2 41.3 27.8 28.7 16.4 50.0 24.3 10.2 17.2 36.1 23.7 57.5 37.7 14.3 10.3 71.3 14.6 20.7 24.1 54.0 5.2 27.4 10.9 12.1 13.4 41.2 3.8 1.8 5.2 2.9 3.5 2.6 1.1 13.1 5.4 8.7 8.1 18.5 8.9 11.6 12.7 10.7 11.5 9.7 25.3 8.2 8.1 15.5 12.1 26.1 19.0 11.0 14.1 6.5 17.1 4.6 15.9 9.6 12.0 12.3 2.6 14.5 8.6 40.9 12.4 15.3 20.5 5.0 9.1 2.7 9.3 8.4 6.8 4.3 3.2 5.1 11.5 10.2 5.1 7.1 4.8 12.5 9.4 8.0 9.3 14.7 15.1 24.2 24.0 11.2 5.3 6.5 16.6 32.5 4.7 10.9 10.4 3.0 13.3 16.6 2.5 12.1 0.0 1.1 5.2 2.2 1.0 1.7 1.7 2.1 1.9 0.7 3.8 2.6 2.6 1.2 3.5 2.9 1.8 2.2 1.1 48.9 51.3 43.1 51.0 52.6 46.8 65.7 43.4 50.0 54.0 17.9 32.7 22.5 39.8 25.3 96.5 55.2 25.5 32.1 17.0 36.6 53.0 32.3 66.3 51.1 34.5 19.9 30.4 93.5 29.1 27.6 27.7 53.0 25.3 16.3 24.5 76.3 51.5 19.6 16.2 53.9 33.6 17.5 30.4 30.7 37.8 72.2 54.1 23.0 36.7 38.4 79.6 19.4 26.9 45.0 19.3 44.2 57.7 26.6 18.3 19.2 DOCK11 "ACG, FLJ32122, FLJ43653, ZIZ2" ENSG00000147251 "Dedicator of cytokinesis 11" Q5JSL3 X 118495898-118686163 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 43.8;Kupffer cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.8;HMC-1: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059695 Uncertain Approved "Nuclear membrane,Nucleoli" NA NA Nucleoli "Nuclear membrane" "HPA059695: AB_2684104" "unprognostic (4.09e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.56e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.50e-1)" "unprognostic (5.56e-2)" "unprognostic (1.76e-1)" "unprognostic (6.37e-3)" "unprognostic (3.06e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.11e-2)" "unprognostic (8.16e-3)" 27.3 6.9 5.0 15.9 15.0 23.5 30.6 1.4 3.1 7.6 11.6 1.5 4.2 2.5 7.9 8.2 7.8 7.0 7.3 6.7 4.4 3.3 7.4 2.6 11.7 27.5 5.4 2.0 3.5 1.7 2.4 15.9 10.0 3.9 6.0 4.8 1.4 4.4 4.1 2.5 4.4 9.7 9.6 7.8 13.8 7.3 3.7 5.3 19.7 9.4 3.6 13.8 9.3 13.3 5.2 4.6 13.1 7.3 7.6 11.3 2.1 0.0 2.4 2.0 1.9 27.8 11.9 5.4 2.8 6.1 2.3 6.2 0.3 0.0 7.5 0.2 10.2 2.8 0.1 3.6 0.0 2.1 9.3 3.1 16.5 2.7 0.0 9.0 9.9 39.9 8.3 0.1 2.5 2.8 1.6 0.1 6.6 5.0 13.7 1.4 1.6 5.9 13.2 2.1 2.2 3.9 4.0 5.3 0.2 0.0 0.5 0.7 4.9 8.5 7.9 2.7 1.6 0.9 8.4 0.1 1.9 0.6 10.9 1.2 4.2 6.3 7.0 4.1 15.9 1.0 6.3 4.2 7.5 8.8 6.1 5.5 4.9 7.4 7.0 4.6 5.2 6.7 8.3 13.1 7.6 7.3 3.7 11.3 2.1 5.0 15.0 1.4 3.1 4.4 3.3 5.4 2.0 3.9 5.3 26.8 3.0 16.0 0.1 2.6 0.4 1.1 0.0 1.4 13.6 7.0 0.0 3.2 0.0 0.1 0.3 2.1 0.7 0.0 0.0 2.6 8.0 0.4 43.8 0.8 17.4 0.0 4.1 3.7 50.0 0.2 11.2 27.1 8.5 10.8 3.7 0.2 0.5 0.8 4.6 4.8 0.3 25.8 9.1 0.7 3.0 1.6 5.7 23.8 0.8 0.1 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 28.3;CAPAN-2: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.9 28.3 4.2 6.2 2.4 2.3 9.1 2.8 2.4 3.1 4.3 7.9 46.8 4.0 2.0 2.8 16.4 9.7 2.2 13.4 1.9 9.0 4.8 2.3 5.8 6.9 3.2 3.3 5.8 4.2 8.2 8.0 4.3 2.4 2.3 7.2 7.0 6.1 3.7 6.3 5.1 11.6 6.1 9.8 4.3 5.6 3.9 7.2 1.4 10.1 1.7 3.5 4.5 7.8 3.8 3.9 7.8 8.9 2.4 17.5 8.4 5.9 11.2 4.6 5.4 4.6 3.8 3.6 9.0 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 6.0 5.3 7.3 17.3 30.1 2.6 1.7 5.1 29.4 18.2 7.0 7.9 16.0 3.3 16.6 13.7 4.7 27.5 0.0 9.5 11.1 6.0 16.5 3.5 3.2 18.8 3.2 8.7 9.2 11.1 6.7 5.2 11.6 6.8 9.0 26.8 5.0 19.5 35.3 4.6 2.9 8.7 6.5 4.1 9.2 10.1 30.9 31.5 8.3 21.7 51.5 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143166-96145440 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 151.1" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 136.7;T-cells: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 46.1" "Group enriched" "Detected in all" 10 "NK-cells: 29.6;T-cells: 46.1" "Cell line enhanced" "Detected in many" "Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071920 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA071920: AB_2686472" "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 6.4 3.1 2.0 13.1 4.3 51.3 2.9 1.3 4.3 4.8 3.9 1.9 7.9 0.8 4.3 18.3 4.1 3.0 8.8 7.4 3.0 1.4 5.5 3.4 15.9 19.0 1.8 0.8 3.0 1.7 0.4 14.6 0.6 2.0 10.7 1.1 2.8 2.0 151.1 1.8 9.8 4.7 3.7 1.6 16.4 2.1 3.3 0.7 43.4 2.4 2.6 12.2 24.6 14.1 3.9 2.3 1.4 2.2 29.6 46.1 7.5 1.5 0.0 0.1 0.1 0.2 0.3 2.3 1.9 0.0 2.8 2.7 4.4 0.3 15.3 5.6 2.1 0.0 1.1 3.8 0.0 0.5 0.2 0.0 0.3 13.9 0.0 1.0 6.3 1.3 0.5 1.0 0.4 0.0 0.0 0.0 14.2 0.0 17.5 0.1 2.6 12.5 14.5 3.4 0.4 5.4 0.0 0.2 12.1 0.1 17.4 15.5 0.8 0.7 0.2 2.8 0.0 1.0 7.2 0.0 0.0 4.1 0.0 0.9 1.2 1.8 21.0 0.0 6.9 0.1 0.5 0.9 0.2 46.1 2.2 22.6 3.9 11.4 41.4 2.3 2.6 7.8 23.9 1.4 29.6 1.8 0.6 3.4 7.5 2.0 4.3 1.3 4.3 3.0 1.4 1.8 0.8 2.0 0.7 0.0 10.6 47.7 90.1 86.0 22.1 33.5 2.5 0.0 1.2 8.7 21.6 0.8 1.7 0.9 0.7 8.2 3.3 0.0 1.2 1.1 24.2 63.5 105.8 2.8 75.6 0.0 84.2 8.6 27.5 0.7 1.7 90.7 136.7 0.0 12.3 1.3 0.9 2.9 1.8 1.0 2.5 0.0 35.3 0.5 4.3 95.9 1.4 346.4 21.8 28.5 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 EIF2B4 "DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta" ENSG00000115211 "Eukaryotic translation initiation factor 2B subunit delta" Q9UI10 2 27364352-27370486 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 158.7;Late spermatids: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032234, HPA039993" Uncertain Approved "Nuclear membrane,Actin filaments" NA NA "Nuclear membrane" "Actin filaments" "CAB032234: AB_668909, HPA039993: AB_2676790" "unprognostic (2.26e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" "unprognostic (7.55e-2)" "unprognostic (2.37e-1)" "unprognostic (4.63e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (3.64e-2)" "unprognostic (2.18e-1)" "unprognostic (3.56e-3)" "unprognostic (1.11e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (5.46e-8)" "unprognostic (1.79e-1)" "unprognostic (1.70e-1)" "unprognostic (8.76e-2)" "unprognostic (1.67e-2)" 18.5 20.6 22.0 18.0 21.6 9.1 18.8 21.8 20.6 19.7 23.8 17.4 20.0 13.6 20.3 16.4 25.5 17.6 14.0 29.2 20.4 14.4 20.3 24.1 15.0 14.2 19.0 17.8 17.5 27.4 21.1 21.0 18.1 19.3 23.3 17.9 16.3 25.8 22.1 52.7 27.1 14.6 22.5 19.6 15.7 20.1 28.5 19.9 14.0 15.8 13.7 21.2 20.6 24.1 17.7 28.3 22.7 29.7 15.1 25.4 21.1 15.7 24.0 18.7 14.1 25.8 19.2 20.5 17.3 18.7 24.1 16.4 36.8 6.5 20.0 16.0 20.6 20.5 10.0 26.8 21.5 16.1 15.4 17.4 25.6 15.4 40.3 22.4 23.7 9.3 18.0 22.3 30.1 22.6 17.4 22.8 15.7 23.4 9.5 22.9 13.9 11.2 21.9 19.6 24.8 16.6 20.4 29.8 17.0 21.5 12.4 14.2 15.3 13.6 20.1 16.6 17.7 12.2 8.6 21.3 16.6 20.1 14.3 18.9 20.8 25.8 30.2 13.9 19.5 15.3 22.7 29.7 20.4 18.2 25.7 25.4 17.7 18.3 18.4 28.3 14.5 17.5 19.3 4.4 15.1 25.4 20.9 22.4 21.1 22.0 21.6 21.8 20.6 20.4 14.4 19.0 17.8 19.3 19.9 11.9 15.0 22.0 15.8 31.9 21.9 29.1 17.8 26.8 18.2 21.0 62.8 36.2 16.6 27.0 158.7 20.7 20.0 0.0 29.1 20.9 23.9 17.2 30.1 30.7 21.5 9.5 23.1 22.7 22.4 199.6 21.6 20.4 21.9 33.3 19.7 23.3 24.3 17.8 23.3 22.6 56.8 19.4 34.4 51.6 36.2 30.5 38.6 25.5 16.9 12.9 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 520000 "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 30.6 11.6 8.0 8.8 7.3 14.6 14.4 15.1 16.2 19.3 20.3 10.3 6.0 24.4 23.0 15.5 40.7 17.1 15.3 18.7 8.2 14.3 33.4 11.4 17.0 6.0 19.8 11.0 12.6 12.8 14.9 17.2 21.5 13.0 13.4 10.4 9.4 10.5 13.1 13.0 19.2 20.2 13.4 17.9 36.2 16.0 12.0 23.3 10.4 5.9 10.2 12.6 7.8 13.1 18.4 8.1 9.2 8.3 12.1 9.6 18.3 21.6 21.6 34.4 25.5 44.0 11.7 18.6 10.4 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 29.8 39.9 28.9 65.6 63.7 31.2 18.5 30.6 20.1 30.7 26.2 11.8 50.6 59.7 39.0 13.8 27.2 18.0 0.0 47.4 56.3 49.5 56.7 53.2 33.5 46.5 28.6 23.0 27.0 17.1 11.2 37.7 46.4 64.1 59.5 33.9 40.7 39.0 28.8 42.1 35.0 29.9 25.8 51.0 10.7 34.1 67.2 104.6 47.8 27.5 59.3 ENDOD1 KIAA0830 ENSG00000149218 "Endonuclease domain containing 1" O94919 11 95089810-95132645 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008932, HPA010517" Enhanced Approved "Nuclear membrane" "Secreted - unknown location" NA NA 19000000 "Nuclear membrane" "HPA008932: AB_2262252, HPA010517: AB_1852351" "unprognostic (8.81e-3)" "unprognostic (1.92e-2)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (2.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (2.84e-1)" "prognostic favorable (6.64e-7)" "unprognostic (5.92e-2)" "unprognostic (2.35e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (3.27e-4)" 14.9 13.8 20.3 7.9 27.9 4.1 15.0 14.3 31.0 17.6 25.4 52.6 9.7 8.4 13.7 12.2 19.0 13.1 12.2 14.4 24.0 22.3 18.9 4.9 10.6 7.3 33.5 20.1 12.0 4.7 48.8 11.8 12.1 40.6 36.5 29.4 15.5 12.5 22.9 34.4 20.6 14.5 16.2 40.4 22.9 8.3 9.3 25.5 0.5 12.6 12.3 6.7 9.0 16.5 7.3 2.9 1.3 5.4 3.1 5.9 6.1 1.1 1.7 2.2 1.3 62.5 20.0 9.2 8.3 1.8 2.2 2.3 8.6 15.1 8.0 10.3 6.6 5.0 11.1 2.1 11.4 0.8 6.3 1.6 17.3 0.8 3.6 6.8 3.1 22.4 18.1 14.9 1.3 4.2 15.3 7.7 7.7 3.5 5.2 8.3 2.9 1.3 0.1 0.5 12.4 5.6 5.8 0.0 3.3 6.6 9.3 1.1 0.9 3.5 3.5 6.2 3.1 3.6 0.9 5.5 12.2 3.6 8.1 3.5 4.3 3.2 0.6 3.7 1.7 27.2 1.3 1.3 0.9 5.9 3.2 5.5 7.2 3.9 5.0 2.9 7.3 3.2 3.8 0.6 3.1 5.4 1.3 2.2 6.1 20.3 27.9 14.3 31.0 24.0 22.3 33.5 20.1 40.6 25.5 8.9 14.2 11.5 14.8 7.1 2.1 4.4 17.8 1.4 11.4 10.4 0.0 4.6 1.7 4.5 2.5 22.4 35.5 23.3 7.7 6.5 8.6 20.7 13.9 2.9 2.9 0.0 15.5 38.1 4.3 2.6 9.5 5.5 27.0 1.0 22.5 1.9 6.1 40.2 14.2 9.3 0.6 38.8 19.1 0.3 3.6 10.9 10.4 5.1 18.4 8.6 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.2 2.8 5.4 6.6 7.7 15.2 4.0 11.2 13.7 7.1 9.4 3.7 4.7 0.4 1.7 12.1 6.1 2.7 3.7 14.6 9.0 26.7 2.6 8.6 6.3 5.3 8.6 4.8 3.6 12.6 12.4 9.2 11.7 8.7 39.1 0.3 2.3 5.1 23.8 2.1 0.7 1.5 6.3 2.7 1.3 0.3 5.7 3.5 6.1 19.0 0.5 3.0 12.9 1.0 10.1 6.0 2.8 6.6 20.7 20.1 6.1 2.3 10.8 2.6 8.4 4.0 8.0 7.5 11.2 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 11.9 10.1 1.5 10.1 6.4 2.2 13.7 7.6 8.1 14.8 1.8 15.7 0.8 0.0 4.0 13.9 15.0 2.5 0.0 7.0 3.8 7.5 7.5 0.0 3.8 5.9 0.0 5.8 21.5 5.1 12.0 2.8 7.7 8.5 9.0 3.4 1.3 9.0 2.9 38.2 1.5 4.8 0.0 23.8 1.1 2.4 4.0 0.7 4.4 2.5 5.8 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Group enriched" "Detected in some" 5 "Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 66.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.6 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 0.0 0.0 0.0 0.3 0.5 1.5 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.1 12.2 0.1 0.0 0.0 0.1 19.1 0.0 0.6 0.0 1.3 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 7.8 0.0 16.9 6.5 20.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.2;stomach 1: 45.5" "Cell type enhanced" "Detected in many" 20 "Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 24 "B-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA056614: AB_2683191, HPA077840: AB_2686858" "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favorable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.7 0.7 11.8 3.4 27.7 0.7 2.6 2.8 25.3 2.0 16.2 62.4 0.0 8.1 0.7 2.2 3.7 1.8 14.3 0.7 22.3 11.0 3.7 0.7 1.5 0.9 40.5 16.5 0.6 6.8 7.1 0.8 1.0 28.5 1.9 15.4 0.0 8.4 1.0 0.6 3.5 11.3 1.4 78.2 0.8 45.5 2.4 44.6 2.6 2.0 0.0 4.7 3.8 1.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 16.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 8.7 8.9 0.0 0.0 0.0 0.9 1.5 20.7 0.2 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 6.3 0.3 0.0 0.4 25.5 1.0 0.0 0.0 0.7 10.1 6.5 2.8 0.0 0.0 12.3 0.0 0.5 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 27.7 2.8 16.1 22.3 11.0 40.5 16.5 28.5 44.6 0.0 2.2 0.0 4.2 0.5 0.0 0.3 10.2 4.0 2.3 0.0 0.0 0.2 6.6 11.5 6.3 0.0 25.4 0.0 12.9 0.1 0.0 20.7 0.0 0.0 0.1 0.0 6.4 0.0 0.0 2.7 0.0 0.0 3.3 0.0 34.0 0.0 26.4 56.1 0.4 0.0 0.0 0.0 0.1 0.5 2.1 0.6 0.1 0.0 16.8 163.9 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "RH-30: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 14.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 0.0 0.0 0.0 0.0 0.0 27.7 1.1 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 22.0 1.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Group enriched" "Detected in many" 5 "Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.1 4.6 3.3 4.4 0.0 0.0 22.8 0.7 1.7 3.5 3.5 2.1 3.4 0.0 2.3 0.0 9.4 3.7 6.8 10.3 3.6 3.8 7.8 1.4 0.8 15.5 0.1 0.0 0.0 0.1 10.9 0.8 5.1 0.5 0.0 5.0 0.0 0.0 2.0 1.5 4.9 0.0 8.2 1.4 2.5 7.1 2.1 0.3 3.2 8.2 2.0 2.7 8.6 3.9 0.6 15.6 3.7 1.0 0.0 0.2 3.3 0.0 3.7 12.6 11.7 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 0.0 0.0 0.9 4.9 0.2 120.0 1.2 0.0 2.7 3.4 47.1 133.5 4.4 3.3 1.6 12.3 0.6 1.3 0.0 0.0 0.4 0.4 6.7 1.1 2.9 0.4 81.0 3.4 0.0 0.6 22.2 4.6 0.0 1.7 1.0 1.2 163.2 2.0 0.0 3.9 2.0 163.5 0.0 0.3 18.9 10.7 0.1 0.2 5.1 0.6 3.4 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.1 0.1 1.2 0.0 0.2 0.1 0.0 0.0 0.2 6.7 1.0 3.6 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.1 3.5 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 0.0 0.0 0.0 0.2 0.2 0.2 2.7 0.0 0.0 0.0 5.2 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 18.0 0.0 0.0 0.4 0.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 FOLR1 FOLR ENSG00000110195 "Folate receptor 1" P15328 11 72189558-72196323 "Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 157.6;salivary gland: 101.2" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Region enriched" "Detected in many" 20 "pons and medulla: 157.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HeLa: 83.6;RPTEC TERT1: 88.8" "Group enriched" "Detected in many" 5 "basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" NA NA 81000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.0 0.7 1.3 0.2 1.7 0.0 6.6 0.6 3.5 31.4 0.1 21.4 2.8 0.0 1.0 3.5 1.6 46.7 1.0 0.2 7.9 1.8 38.8 0.2 47.0 0.0 0.8 0.4 8.9 1.8 0.4 3.5 24.5 157.6 1.5 0.0 17.0 101.2 4.0 0.1 0.9 0.1 0.0 0.7 0.0 7.4 0.4 0.2 0.0 12.7 2.6 3.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 7.8 7.9 0.0 8.1 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.2 0.1 83.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.0 88.8 0.0 0.0 0.5 0.2 1.2 0.0 7.3 11.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 1.7 0.6 3.5 7.9 1.8 0.8 0.4 157.6 0.2 461.6 156.4 0.0 7.8 0.8 0.0 0.3 35.7 178.0 316.2 301.8 0.0 307.8 112.7 15.6 0.0 0.0 0.0 0.0 1.2 101.0 3.8 4.7 4.7 0.0 26.1 0.0 1.7 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.4 4.1 0.0 0.0 286.0 0.0 0.0 0.1 0.0 0.1 0.1 216.6 0.0 0.0 8.6 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" NA NA Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.4 7.6 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.8 0.9 0.3 6.2 0.0 0.8 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.4 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.2 0.0 0.3 3.4 4.0 0.0 7.2 0.8 0.3 8.2 7.8 0.8 0.3 0.7 7.7 0.0 8.4 33.1 0.7 1.7 1.4 0.1 7.8 2.8 0.3 0.2 0.3 1.4 0.4 0.2 11.9 11.8 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 0.0 1.9 0.0 1.7 1.4 10.3 7.3 0.0 6.7 7.9 0.0 13.7 0.3 0.0 0.2 31.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 8.6 0.0 0.0 13.9 0.3 0.0 10.1 0.0 0.0 3.3 0.8 0.0 0.7 2.3 2.4 6.5 0.0 0.4 0.6 1.4 0.0 0.0 0.0 2.6 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772291-73780251 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 147.9;Late spermatids: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 840000 "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavorable (6.78e-4)" "prognostic unfavorable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 16.2 9.5 8.9 9.0 9.2 7.8 13.9 7.9 11.8 13.8 7.0 8.2 9.8 4.4 12.5 7.8 14.6 9.0 12.8 14.5 7.3 6.3 9.2 7.4 16.1 18.2 10.4 7.2 13.4 7.9 8.9 7.7 24.0 9.7 9.7 5.6 9.7 9.1 9.8 7.5 6.9 7.9 11.9 8.7 14.2 6.9 18.8 7.4 4.5 10.0 6.8 8.6 10.8 11.1 1.7 2.6 3.9 1.3 7.8 16.0 4.4 13.6 7.5 5.4 11.1 10.7 12.4 1.6 7.0 16.9 8.9 17.5 2.5 7.4 3.1 5.1 11.4 3.0 5.8 2.8 7.0 9.9 7.5 5.8 4.2 6.1 3.9 4.2 5.9 13.4 8.2 1.6 8.5 8.7 27.6 16.2 1.5 4.1 5.7 8.8 1.6 1.0 3.1 2.5 1.3 18.9 1.4 3.3 3.7 3.2 2.5 1.6 5.2 6.1 6.5 3.9 4.8 4.4 2.6 16.5 11.6 5.0 5.7 8.6 7.5 2.6 0.7 16.3 5.3 3.8 3.9 1.0 1.0 16.0 1.2 11.4 1.7 4.8 11.2 1.3 1.5 3.5 7.4 0.2 7.8 1.3 2.6 1.9 4.4 8.9 9.2 7.9 11.8 7.3 6.3 10.4 7.2 9.7 7.4 14.9 13.3 5.6 4.8 12.0 14.0 10.7 10.2 8.1 5.7 10.4 13.7 9.0 0.0 10.7 147.9 29.2 2.6 0.0 5.9 14.6 15.3 6.2 13.9 5.0 10.8 19.1 4.6 40.5 17.8 165.7 15.0 9.5 16.9 6.4 4.2 10.8 8.2 4.8 13.8 3.3 13.8 6.5 12.1 22.8 15.3 10.0 8.1 15.2 3.1 4.8 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 82.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 9.8;RPTEC TERT1: 11.2" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 2.8 2.7 7.4 1.8 12.4 1.8 2.7 4.2 22.2 6.0 4.5 7.9 1.4 1.8 11.4 5.2 2.5 3.9 6.6 3.0 4.8 2.9 23.0 2.8 3.1 2.1 2.5 16.5 10.2 9.6 2.4 4.2 2.5 4.6 9.4 2.0 2.2 19.5 2.2 2.9 2.5 3.0 13.7 2.5 4.2 2.9 3.6 4.3 0.0 2.9 0.5 2.3 10.1 2.8 0.0 0.5 0.0 1.1 0.8 1.3 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 9.8 0.0 0.7 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 0.4 0.3 0.0 0.8 0.0 0.5 0.0 0.7 7.4 12.4 4.2 22.2 4.8 2.9 2.5 16.5 4.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 10.4 0.0 0.0 82.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 9.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506273-3538330 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.7;Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 10.3 16.9 15.4 12.0 19.9 37.2 10.6 39.1 23.1 13.3 13.8 17.7 11.0 29.0 14.6 10.1 14.6 12.3 14.5 10.3 13.0 16.6 12.0 13.8 10.7 12.6 11.7 14.3 16.4 20.6 13.2 22.5 15.4 16.1 12.3 5.0 14.9 24.6 15.1 18.1 15.7 18.0 12.0 10.7 15.3 16.3 29.7 14.1 18.9 15.6 9.3 15.8 10.6 12.9 3.0 1.7 5.7 2.1 3.3 3.5 1.5 23.2 14.2 12.1 11.8 3.4 5.6 10.5 14.8 7.6 14.3 11.3 14.3 11.5 12.9 7.6 9.5 7.8 13.9 6.7 12.3 2.9 17.6 13.1 6.2 10.0 14.0 7.5 11.1 13.1 5.0 6.5 8.8 5.1 5.4 9.2 12.5 11.1 20.8 7.7 12.2 19.6 7.9 11.3 7.2 11.1 14.6 11.6 12.6 7.3 11.8 11.6 14.0 13.1 9.3 7.2 2.8 9.7 8.8 13.9 9.8 12.2 23.7 25.2 24.1 5.6 9.9 13.4 21.7 11.9 3.5 1.9 5.7 3.5 2.1 2.0 3.0 3.4 2.4 1.7 2.6 1.8 2.7 3.7 3.3 1.5 1.4 2.4 1.5 15.4 19.9 39.1 23.1 13.0 16.6 11.7 14.3 16.1 14.1 0.0 5.3 15.1 31.9 15.9 20.9 2.9 2.5 1.4 3.4 12.2 9.8 18.6 5.0 14.2 78.7 8.5 17.3 46.7 13.0 11.5 11.2 17.6 3.5 14.7 14.4 28.6 20.7 7.4 6.5 132.8 11.8 11.0 11.8 25.2 14.5 8.3 21.4 17.3 8.9 10.8 14.3 6.5 9.9 25.7 16.2 19.7 38.0 9.6 12.2 24.3 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" No No 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavorable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 188.4 332.6 95.9 149.5 93.6 154.4 209.1 143.2 204.0 209.6 218.8 234.7 129.4 220.4 28.3 168.8 159.1 107.3 89.1 332.2 145.5 193.2 96.8 121.9 208.7 199.3 126.2 197.0 98.1 129.1 108.5 206.0 232.8 501.3 230.7 161.2 65.4 46.4 238.1 376.0 224.4 103.7 354.5 226.1 110.8 182.6 170.9 104.9 238.5 230.6 68.0 109.1 126.4 329.8 190.3 285.1 51.5 139.2 143.9 163.6 197.8 84.4 247.4 105.5 76.7 284.0 346.8 124.9 256.0 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 220.3 245.0 821.1 1485.4 1615.7 992.1 33.2 1355.4 275.7 444.7 970.1 392.7 4082.4 2934.5 4447.1 583.7 1564.4 2836.9 443.9 3299.5 7140.5 1484.6 1124.2 551.6 1346.2 3470.6 2218.3 1273.2 1144.2 2599.6 1556.8 823.5 2367.4 4003.5 3613.2 2061.2 5234.8 4742.6 2687.7 965.3 5345.0 1026.0 1131.8 2133.1 429.6 390.5 1399.2 3925.6 1271.1 3009.6 2464.1 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 82.5;Intestinal endocrine cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.8 0.0 1.2 0.8 2.2 0.9 0.6 13.3 3.3 0.1 1.8 2.0 5.7 0.9 0.0 5.2 5.0 0.3 0.2 1.9 5.7 0.0 1.2 1.4 1.6 1.9 0.0 0.0 0.4 9.1 0.8 0.0 0.0 6.8 7.2 0.2 1.1 2.9 4.5 5.9 1.4 0.0 1.7 2.8 5.9 29.7 2.5 1.5 0.7 0.3 5.7 1.6 0.2 0.1 2.0 3.7 2.3 5.7 4.3 3.2 2.5 4.6 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 3.0 4.5 8.1 28.1 66.2 0.0 3.3 5.1 2.7 7.9 5.2 2.0 1.8 6.6 8.3 0.4 11.7 16.0 23.3 8.1 40.5 8.2 17.3 0.0 82.5 5.6 0.0 203.8 6.2 24.0 0.6 0.3 13.3 10.1 6.4 15.2 0.3 9.8 14.0 4.6 38.4 0.2 0.0 15.5 1.1 4.7 66.6 3.5 22.3 8.9 32.9 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1, RNA export mediator" Q53GS7 9 128504700-128542288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 12.5 17.0 11.1 13.5 13.2 12.2 14.7 22.1 13.8 13.1 15.7 16.5 17.6 14.6 13.8 11.4 18.5 13.5 12.6 13.2 10.5 8.9 13.1 20.4 11.3 23.0 11.2 9.9 15.7 21.1 20.8 16.3 16.4 10.6 13.4 17.2 13.1 13.6 16.7 23.3 18.3 14.9 12.0 9.8 17.5 12.1 42.8 11.8 27.2 12.4 14.6 20.0 14.3 13.5 16.0 19.2 26.2 22.5 22.6 20.5 15.8 10.8 20.4 10.0 17.1 9.9 10.1 13.3 11.0 9.4 15.5 11.0 13.7 7.6 22.0 8.9 12.3 14.9 38.3 17.3 15.7 13.4 20.9 11.3 11.3 22.5 12.7 11.2 18.2 14.9 7.1 15.3 17.5 18.8 8.6 8.7 20.7 16.1 19.5 17.7 25.2 17.9 12.9 8.5 29.2 17.7 18.3 24.6 29.1 10.4 9.7 11.9 8.9 26.8 16.3 9.6 8.5 30.0 12.9 6.3 16.5 11.0 19.2 15.2 19.6 47.1 17.2 15.4 13.9 17.7 26.2 18.1 20.3 20.5 22.5 16.7 12.0 16.0 18.1 19.2 16.0 14.4 16.6 15.4 22.6 22.0 11.4 18.3 15.8 11.1 13.2 22.1 13.8 10.5 8.9 11.2 9.9 10.6 11.8 8.9 7.0 10.2 6.2 5.8 6.6 10.9 0.0 9.4 4.5 7.0 7.9 14.2 5.0 9.6 55.3 3.1 11.4 0.0 5.4 9.5 5.1 4.8 9.2 10.5 13.4 9.5 5.2 3.7 12.6 44.8 9.5 9.9 3.3 20.8 13.4 8.4 7.6 5.8 6.0 11.1 8.2 12.9 5.1 45.3 28.1 5.9 11.1 11.5 13.9 4.3 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294530-99307405 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.7" "Cell type enhanced" "Detected in many" 15 "B-cells: 189.0;Macrophages: 550.4;monocytes: 424.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 22 "HDLM-2: 53.8;HL-60: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028847, CAB033690, HPA075590" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "CAB033690: AB_2114269, HPA028847: AB_10603672, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 27.0 5.5 3.1 33.8 5.0 40.8 7.6 1.1 2.9 5.9 11.2 7.5 4.5 3.2 3.8 9.2 9.3 6.4 17.3 11.7 4.8 6.1 5.4 7.2 26.5 53.7 7.5 2.6 4.4 2.1 2.1 4.8 11.1 9.3 7.4 9.2 4.8 6.6 2.0 4.1 5.3 19.2 9.0 31.3 46.5 6.0 3.7 7.4 13.2 6.5 8.3 38.9 34.9 5.2 46.8 30.6 101.7 1.2 55.0 60.2 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 53.8 0.0 0.4 0.1 0.0 0.0 36.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 101.7 1.2 46.1 5.7 0.4 34.0 46.8 60.2 30.9 9.3 19.1 38.1 5.2 1.2 55.0 0.4 30.6 47.3 27.8 3.1 5.0 1.1 2.9 4.8 6.1 7.5 2.6 9.3 7.4 14.9 41.9 189.0 0.4 54.7 0.2 1.8 0.0 6.7 10.3 0.0 5.9 0.9 1.7 0.1 0.6 2.3 0.0 0.0 2.5 1.3 21.6 0.4 60.0 0.5 114.3 0.0 0.0 0.6 92.9 1.3 0.3 550.4 138.3 424.8 0.0 0.1 0.7 0.0 0.0 0.3 0.8 6.5 3.6 0.5 0.2 46.7 1.5 126.8 0.0 0.3 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell type enriched" "Detected in many" 36 "Muller glia cells: 779.4" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 48000 "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 22.0 0.3 0.2 2.8 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.8 0.0 0.1 0.0 4.5 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.4 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 10.6 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 0.0 0.0 0.0 0.3 4.0 21.7 0.4 2.5 0.0 0.0 1.8 5.9 7.1 0.0 4.3 0.2 0.5 0.0 0.0 0.5 15.1 2.7 2.1 0.0 21.5 1.0 17.5 0.0 0.0 0.3 0.9 2.6 0.0 3.3 1.0 0.4 779.4 0.4 0.0 0.7 0.0 12.5 0.0 0.9 0.6 0.7 8.9 2.5 0.0 0.0 0.1 GRK5 GPRK5 ENSG00000198873 "G protein-coupled receptor kinase 5" P34947 10 119207589-119459742 "Enzymes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Sertoli cells: 58.2;Smooth muscle cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.6;HUVEC TERT2: 28.2;OE19: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025579, HPA046838" Approved Supported "Nuclear membrane,Nuclear speckles,Plasma membrane" NA NA "Nuclear membrane, Nuclear speckles" "Plasma membrane" "CAB025579: , HPA046838: AB_2679833" "unprognostic (1.09e-1)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.02e-2)" "unprognostic (6.56e-2)" "unprognostic (3.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.69e-1)" "unprognostic (4.11e-1)" "unprognostic (1.06e-1)" "unprognostic (3.70e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" 15.9 8.3 3.4 16.8 7.8 2.7 10.2 6.5 5.0 12.5 18.8 3.9 4.5 12.4 13.4 12.2 8.1 7.7 19.5 45.4 4.2 4.2 4.3 5.7 27.6 8.8 3.7 2.5 16.5 3.5 26.2 6.3 24.0 4.5 7.5 6.4 5.6 5.0 6.7 12.8 4.7 10.4 10.8 4.8 17.0 13.9 3.5 4.7 9.8 8.9 10.7 8.6 9.5 13.6 9.3 2.2 6.5 3.7 0.2 11.3 4.2 3.9 2.3 5.9 6.0 13.5 13.0 1.7 7.6 35.6 4.7 2.7 1.9 5.7 4.2 1.8 11.9 8.3 0.9 2.5 8.4 3.1 16.7 2.1 0.7 4.9 7.5 9.3 0.2 2.1 1.8 1.2 9.6 1.4 5.7 28.2 2.6 0.4 4.1 1.7 0.6 3.9 3.8 0.8 27.1 5.9 1.4 0.8 1.0 0.7 1.6 1.9 5.4 2.6 1.2 7.3 3.6 0.1 1.0 8.5 2.6 1.8 15.5 3.0 0.9 4.5 2.6 5.4 4.7 2.4 0.9 3.7 6.5 5.3 3.2 0.4 9.3 7.7 3.8 2.2 9.1 11.3 5.0 5.0 0.2 0.9 0.0 9.2 4.2 3.4 7.8 6.5 5.0 4.2 4.2 3.7 2.5 4.5 4.7 53.6 5.9 13.7 0.5 1.4 3.4 14.6 0.0 1.4 2.3 3.5 0.0 2.4 0.0 1.0 11.8 24.8 0.9 0.0 2.7 13.7 12.4 0.6 4.6 1.7 3.6 1.6 4.6 21.5 10.4 2.9 4.0 5.1 6.8 0.0 0.7 0.0 1.7 0.2 4.2 0.4 0.7 58.2 37.3 1.4 1.7 2.0 11.0 10.2 0.3 0.9 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763032-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 19.3 20.3 14.9 14.3 20.0 34.6 23.4 17.3 21.2 17.3 15.3 16.3 14.1 13.1 19.7 18.7 18.1 17.5 21.5 16.1 12.6 11.7 16.2 16.6 15.1 20.0 20.9 16.4 20.3 23.5 21.5 30.8 20.4 23.4 17.2 18.3 11.8 17.7 15.0 22.6 23.9 20.1 18.3 22.3 19.4 18.0 17.5 20.3 29.8 18.6 19.1 18.7 19.5 25.4 14.3 11.8 16.3 15.0 12.6 14.3 7.4 11.0 11.9 21.4 16.2 10.4 14.3 23.7 18.4 12.4 18.4 17.5 26.1 17.4 22.8 14.4 11.7 22.8 16.1 21.4 17.9 23.7 25.8 20.3 28.7 33.3 23.8 17.9 24.8 21.9 19.9 18.7 15.4 21.0 19.6 17.4 22.8 32.5 33.3 10.0 20.3 24.5 20.3 13.9 13.1 22.0 19.9 17.7 15.6 13.8 26.5 15.8 16.9 14.3 11.8 15.3 33.4 11.1 18.9 15.1 15.8 13.1 12.6 16.4 20.3 24.7 16.8 17.7 18.4 14.5 16.3 11.0 10.8 11.2 10.5 13.4 12.6 11.5 12.2 11.8 14.3 14.3 12.9 7.1 12.6 15.0 10.4 12.4 7.4 14.9 20.0 17.3 21.2 12.6 11.7 20.9 16.4 23.4 20.3 20.8 13.6 6.8 10.9 3.5 18.1 30.2 2.5 41.5 21.6 14.0 17.7 12.7 11.6 11.2 3.0 12.8 8.4 0.0 10.8 10.4 8.9 7.4 13.9 6.8 11.6 0.0 12.0 14.1 10.5 3.8 12.4 10.3 6.8 23.4 9.0 12.6 13.5 7.0 10.3 8.1 14.9 6.5 7.8 43.3 19.0 4.8 13.2 10.2 10.3 6.8 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988019-1019936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 19.0 24.6 11.3 13.9 14.9 24.8 14.2 11.6 15.0 11.0 10.5 12.2 10.3 9.6 14.8 10.1 12.2 15.8 8.9 11.9 14.1 11.8 11.8 14.0 9.5 13.8 14.0 10.1 16.3 22.8 12.7 18.3 13.8 15.3 11.1 12.2 8.9 10.3 9.9 24.8 11.4 11.0 14.4 18.1 13.5 12.7 22.9 12.2 14.2 11.9 16.3 16.3 11.6 10.4 10.5 11.3 10.7 14.2 15.8 14.2 7.7 21.0 17.2 14.5 12.7 10.3 12.3 10.4 19.8 6.9 24.3 20.7 25.4 16.4 30.6 6.0 15.7 8.4 16.7 28.6 18.1 28.4 15.1 17.9 33.5 12.4 15.5 16.3 14.5 18.1 15.9 15.4 26.7 18.6 9.9 13.2 23.8 34.3 12.7 22.2 19.4 22.2 13.7 21.1 28.0 11.9 22.1 12.7 21.1 14.4 13.4 7.3 22.0 13.0 16.7 22.9 14.9 23.9 14.5 11.4 11.6 6.4 27.8 24.0 16.5 31.5 38.5 13.0 15.4 9.5 10.7 8.4 3.0 11.6 14.2 13.6 10.5 11.0 11.7 11.3 9.9 12.2 11.8 1.4 15.8 10.8 7.4 14.2 7.7 11.3 14.9 11.6 15.0 14.1 11.8 14.0 10.1 15.3 12.2 53.6 69.5 32.8 58.3 55.6 25.5 29.7 22.9 66.9 108.1 27.9 17.7 41.8 28.2 54.3 49.0 30.8 10.0 23.3 37.9 45.9 31.1 41.3 62.7 24.3 30.8 22.3 21.2 20.9 25.9 13.8 23.0 29.0 21.9 38.7 24.5 27.3 52.1 17.5 27.6 24.0 31.8 19.4 25.8 86.5 85.2 58.7 79.8 24.5 28.6 76.5 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 36.0;SuSa: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Uncertain Uncertain "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 36.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.5 0.3 0.3 9.0 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.9 0.3 0.4 2.2 1.8 0.1 0.2 0.1 49.4 0.0 1.6 0.9 0.5 0.0 0.4 0.5 1.4 0.0 6.2 0.3 1.6 0.0 3.2 1.4 0.5 0.1 0.0 0.2 0.2 0.1 11.2 0.0 1.9 1.4 0.1 1.5 2.0 5.7 0.0 1.0 33.8 8.4 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 0.0 2.6 0.0 2.2 2.9 5.3 3.2 0.0 8.1 3.4 0.0 0.0 5.4 13.3 2.1 3.3 39.4 0.9 0.0 1.0 39.7 2.7 1.6 10.4 0.5 1.6 20.6 35.4 13.5 0.6 1.6 0.0 2.1 32.1 0.0 1.9 6.0 0.5 5.8 0.4 0.3 11.5 0.0 6.1 0.7 4.1 2.6 19.6 0.0 2.3 1.8 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.8" "Group enriched" "Detected in many" 5 "Distal tubular cells: 111.0;Proximal tubular cells: 39.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 14 "pons and medulla: 9.2" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.7" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.7" "Cell line enhanced" "Detected in many" "HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7" "Region enriched" "Detected in single" 12 "pons and medulla: 1.4" "Region enriched" "Detected in single" 10 "pons and medulla: 2.9" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 6.5 14.5 0.2 4.8 0.2 0.0 11.2 0.3 0.6 7.3 10.0 0.2 7.9 0.0 5.0 15.4 3.0 12.2 0.5 0.2 0.2 0.0 25.4 0.4 2.6 3.5 0.2 0.2 6.2 0.2 0.3 0.2 1.3 9.2 8.2 7.2 0.2 0.2 8.9 27.8 8.2 6.1 8.1 14.3 3.7 3.2 2.7 0.2 1.6 0.9 0.2 1.1 11.4 6.7 0.2 0.9 0.0 0.0 7.7 1.6 0.2 6.9 2.4 0.0 7.5 0.0 0.0 0.4 2.5 4.3 5.2 6.0 3.6 2.7 4.8 7.0 1.9 0.2 4.8 19.7 0.0 3.1 0.0 12.4 0.3 2.8 0.1 0.5 0.4 0.2 4.1 0.2 0.6 7.0 0.0 9.8 8.4 0.0 0.0 1.9 1.2 0.0 1.1 0.3 5.0 0.7 2.5 4.6 0.0 24.4 4.8 19.7 0.0 13.6 0.0 0.0 1.4 0.2 1.9 0.8 0.0 4.7 14.0 2.4 0.0 0.1 0.1 0.0 9.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 7.7 0.0 0.6 0.4 0.2 0.2 0.2 0.3 0.6 0.2 0.0 0.2 0.2 9.2 0.2 0.0 0.0 0.0 7.5 8.0 0.0 0.3 0.0 0.0 0.0 12.2 0.0 0.4 111.0 0.0 15.9 2.2 3.0 0.0 0.0 4.6 2.7 4.0 0.0 0.0 0.2 0.0 15.5 0.0 0.0 2.1 0.6 0.5 3.3 0.0 11.2 0.0 0.1 10.4 0.0 39.0 0.0 0.0 7.3 0.4 0.2 10.8 0.2 0.9 15.7 2.6 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594390 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 9.0 15.0 11.4 13.5 23.1 12.3 7.0 24.0 28.4 7.5 8.5 8.3 3.8 7.7 8.2 5.7 8.4 6.7 11.0 10.8 12.9 7.8 8.1 7.2 13.5 17.0 6.1 19.8 8.3 8.2 12.7 7.0 8.6 17.9 6.8 8.6 16.1 9.3 7.2 13.6 7.3 12.1 10.5 10.4 24.0 8.4 6.4 6.8 17.6 8.4 2.7 13.4 16.8 6.9 0.8 5.9 3.8 5.1 5.8 6.4 1.8 6.4 5.4 10.0 8.0 5.7 6.5 10.0 5.6 5.0 6.0 6.2 6.9 5.7 4.1 6.4 8.2 7.3 6.0 7.1 5.5 4.9 13.7 6.1 4.8 4.9 3.2 5.1 9.1 17.8 5.8 5.2 5.7 5.1 5.1 8.4 23.3 4.4 34.2 4.4 7.8 13.8 8.1 9.4 3.6 5.3 6.0 7.0 26.7 2.9 19.8 6.6 8.6 6.4 5.2 5.1 10.7 2.4 7.3 7.9 7.0 8.9 5.5 3.8 24.3 14.1 2.8 5.7 8.7 6.0 2.0 1.8 3.8 5.5 3.9 6.4 0.8 3.1 3.7 1.9 0.2 4.3 4.9 2.0 5.8 5.1 5.9 1.6 1.8 11.4 23.1 24.0 28.4 12.9 7.8 6.1 19.8 17.9 6.8 6.0 9.6 10.0 4.7 7.1 46.8 10.5 2.5 0.0 10.3 5.2 7.9 7.2 3.3 3.9 12.8 10.1 1.7 0.0 1.3 6.6 7.2 4.6 0.0 3.2 9.0 31.8 5.2 14.7 37.8 5.4 8.6 17.7 10.1 4.6 5.4 9.2 3.8 3.4 11.3 2.2 13.8 6.5 9.0 9.7 11.2 5.4 7.9 39.8 3.5 5.4 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 24.9;Syncytiotrophoblasts: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.0 21.9 22.1 17.6 12.3 15.5 14.2 13.3 17.3 22.3 20.6 19.5 28.6 19.8 18.8 16.6 18.5 24.5 47.0 22.4 19.6 17.3 28.5 17.2 16.3 21.1 24.6 17.6 22.2 15.0 22.4 16.9 26.0 16.5 24.1 30.8 23.6 11.6 15.6 19.2 19.9 17.0 16.1 30.6 12.2 17.2 18.6 22.6 17.3 22.6 15.9 12.6 16.1 16.4 22.3 19.7 15.3 20.5 11.8 15.4 16.2 13.7 21.0 11.5 21.3 26.7 15.5 32.2 17.9 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 20.8 7.5 0.0 0.0 0.0 0.0 0.0 0.0 20.1 10.3 12.2 0.0 32.4 18.3 15.6 0.0 0.0 0.0 0.0 13.7 24.9 0.0 0.0 7.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.2 0.0 0.0 12.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 41.6 0.0 0.0 0.0 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCNJ13 "Kir1.4, Kir7.1, LCA16" ENSG00000115474 "Potassium voltage-gated channel subfamily J member 13" O60928 2 232766464-232776568 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cataract, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 22.9;intestine: 49.5;retina: 70.3" "Group enriched" "Detected in some" 14 "Melanocytes: 20.3;Muller glia cells: 44.0" "Cancer enriched" "Detected in some" 5 "melanoma: 5.9" "Region enriched" "Detected in some" 7 "pons and medulla: 22.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051609 Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA051609: " "unprognostic (4.29e-2)" "unprognostic (2.00e-1)" "unprognostic (2.69e-1)" "unprognostic (9.03e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-2)" "unprognostic (2.26e-1)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.41e-1)" "unprognostic (4.90e-2)" "unprognostic (1.86e-2)" "unprognostic (2.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.5 0.0 0.7 0.1 0.3 0.4 0.9 0.2 10.1 7.0 1.3 4.3 0.2 0.3 0.2 0.1 1.6 0.2 3.2 0.5 1.9 0.3 0.2 0.0 0.4 0.4 0.3 0.4 8.5 0.3 0.0 22.9 0.3 0.0 70.3 0.3 1.6 0.2 1.8 49.5 0.0 0.6 0.2 1.1 0.5 0.1 0.0 3.8 0.0 0.0 0.3 0.3 1.1 0.8 5.4 1.1 1.1 2.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.0 0.0 0.5 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 1.0 3.1 0.2 0.3 0.0 0.1 0.0 4.6 0.3 1.3 0.1 0.8 0.8 0.4 0.0 5.4 1.1 0.9 1.0 0.2 1.2 0.8 1.8 0.7 0.4 1.1 2.1 1.1 0.8 1.1 1.0 0.8 2.7 0.1 0.5 0.7 0.4 0.9 3.2 0.5 0.4 0.4 22.9 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.4 0.0 1.0 0.0 1.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 44.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45190338-45240769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 60.5;Kupffer cells: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9" "Cell line enhanced" "Detected in many" "THP-1: 83.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nuclear membrane,Mitochondria" No No "Nuclear membrane, Mitochondria" "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favorable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 13.4 18.0 51.3 17.1 50.0 14.4 12.9 9.9 41.3 15.3 11.6 52.8 10.3 9.6 8.3 28.4 14.2 10.0 10.7 6.6 50.2 39.9 5.9 12.7 12.5 16.6 48.2 36.8 6.7 8.2 10.2 5.6 7.9 28.9 9.5 7.6 4.9 8.6 18.1 15.6 34.2 12.9 10.3 29.3 15.4 8.5 10.1 50.0 6.5 5.2 6.7 14.3 14.1 9.6 1.8 9.8 6.5 12.9 1.5 2.2 2.6 12.4 8.1 5.0 9.9 17.2 8.1 5.0 6.9 6.9 7.4 6.4 7.4 6.8 8.3 10.3 10.9 5.9 14.0 7.6 30.6 2.8 8.9 12.0 0.0 10.0 8.5 6.9 22.2 5.1 4.6 15.5 7.1 12.0 5.6 6.9 6.1 2.9 13.8 4.4 14.3 9.8 20.7 4.9 9.0 6.8 12.1 3.4 27.4 11.1 7.6 4.2 7.4 10.9 15.0 18.9 10.1 7.3 83.1 9.3 7.6 13.5 10.3 3.9 11.8 7.9 8.0 8.9 33.9 7.8 0.9 9.1 6.5 2.0 11.1 1.3 1.8 0.8 2.2 9.8 1.6 0.8 1.4 2.2 1.5 12.9 8.2 1.5 2.6 51.3 50.0 9.9 41.3 50.2 39.9 48.2 36.8 28.9 50.0 6.0 9.1 9.0 15.2 46.9 4.4 9.9 7.6 5.3 4.5 17.4 5.9 1.5 0.0 16.3 2.3 10.3 12.9 0.0 17.8 4.7 23.4 14.4 2.3 19.8 60.5 4.8 10.3 20.9 61.7 6.1 10.0 44.0 42.2 22.6 10.8 5.5 15.6 11.6 13.8 11.2 4.7 0.0 16.9 7.5 4.7 50.1 2.3 10.7 10.2 23.7 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981318 "Disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 27.5;seminal vesicle: 39.0" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.2;neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 20.4;SH-SY5Y: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 2.1 3.2 3.3 0.6 4.4 0.6 2.9 1.2 8.3 2.7 1.8 1.6 27.5 1.5 3.7 4.1 1.4 4.9 2.5 1.9 3.1 2.0 8.0 1.5 4.7 0.3 1.6 3.8 2.6 12.9 6.5 3.6 4.6 3.7 3.1 1.5 2.0 4.4 39.0 1.4 2.6 1.8 2.9 3.3 1.2 3.0 2.9 1.2 3.1 2.2 0.1 0.4 3.8 4.4 0.3 0.1 1.5 0.1 0.3 0.2 0.0 5.1 9.7 8.6 15.0 0.1 0.0 5.0 5.2 4.7 3.0 3.9 9.0 3.1 0.0 3.2 7.9 9.3 1.0 5.3 1.5 3.7 2.4 3.3 2.4 10.4 2.3 1.3 3.7 3.5 1.3 2.4 1.1 1.6 2.9 5.0 3.4 1.9 0.1 3.4 4.8 2.6 3.6 8.1 3.7 20.4 7.2 4.4 0.0 1.5 3.1 11.4 19.5 2.8 5.2 2.3 5.2 4.3 2.3 3.2 3.1 3.2 0.0 4.9 0.7 0.0 0.2 4.1 1.5 7.2 1.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.5 0.3 0.1 0.1 0.0 0.0 3.3 4.4 1.2 8.3 3.1 2.0 1.6 3.8 3.7 1.2 0.0 2.1 0.0 2.1 0.5 13.5 2.2 0.0 9.4 3.4 7.0 53.0 2.1 0.0 2.3 0.3 4.5 0.1 0.0 2.8 1.9 2.1 3.0 16.1 0.5 0.4 3.2 10.4 1.8 1.0 0.0 1.4 0.2 1.7 0.0 2.0 7.7 4.7 0.6 2.5 6.9 26.7 6.5 1.6 0.0 7.7 0.6 1.3 1.0 1.5 1.4 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 7.2 8.7 11.9 5.7 19.7 11.7 9.0 33.8 15.7 9.1 6.8 2.9 6.5 3.6 10.4 6.5 5.7 6.1 7.8 6.0 10.4 8.7 6.1 8.0 5.9 6.9 10.9 9.3 13.3 5.4 9.8 19.7 15.3 12.4 9.1 4.5 2.6 5.0 6.5 4.1 4.3 5.3 7.5 8.4 7.4 4.7 12.5 10.4 6.2 9.6 3.6 6.4 9.0 6.6 5.5 6.3 3.1 4.2 8.2 7.1 3.2 4.9 2.1 13.1 14.9 5.3 8.6 7.3 8.3 6.9 7.3 8.7 3.4 1.6 1.9 6.9 6.1 6.4 2.5 10.0 4.9 10.0 6.2 7.6 20.6 4.8 7.8 6.9 16.5 7.7 6.2 3.6 6.4 7.1 5.2 6.8 5.4 28.3 1.6 8.5 3.9 7.9 10.1 8.5 1.7 3.1 7.3 9.6 4.7 4.8 10.3 11.1 10.3 5.4 1.8 6.2 9.4 4.3 15.0 5.5 11.2 4.7 10.7 5.9 6.6 8.7 9.7 6.9 12.2 4.5 0.3 4.2 3.1 3.9 3.0 4.3 5.5 5.7 4.9 5.9 4.4 7.1 6.0 0.3 8.2 2.8 6.3 6.5 3.2 11.9 19.7 33.8 15.7 10.4 8.7 10.9 9.3 12.4 10.4 8.9 4.6 9.0 4.2 9.3 14.8 20.8 2.5 12.0 7.9 7.0 2.0 36.3 10.0 5.7 45.2 7.1 0.7 0.0 4.7 25.6 16.5 1.6 12.7 3.9 10.7 9.5 5.2 8.0 7.3 18.2 11.8 5.6 3.3 7.2 2.3 8.9 3.2 0.0 13.8 12.4 7.8 19.4 10.3 18.1 18.9 3.9 8.9 7.4 3.3 1.6 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Group enriched" "Detected in many" 17 "Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "RH-30: 12.3;SH-SY5Y: 31.1" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.1 3.0 7.5 3.3 2.2 2.6 1.1 0.6 1.0 1.2 0.5 2.1 2.7 0.5 2.2 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.2 3.5 0.1 0.1 0.0 1.8 1.5 1.7 1.3 0.8 1.0 0.9 1.3 0.4 2.3 0.3 0.3 0.7 12.3 1.6 1.8 1.0 8.5 31.1 0.7 0.8 4.9 1.0 0.9 1.4 3.5 2.4 1.8 2.8 0.9 1.6 2.0 1.0 0.3 0.8 1.6 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 0.0 2.6 0.0 0.8 0.3 91.9 2.8 0.0 0.0 2.3 1.8 123.7 0.2 1.7 0.2 3.4 1.7 0.0 0.0 0.2 0.4 2.8 0.3 1.1 0.0 1.4 3.2 0.0 2.5 0.0 1.3 7.2 0.0 3.3 1.8 0.0 7.6 1.0 0.0 5.3 1.3 171.7 6.5 1.4 0.7 0.2 0.3 0.2 0.0 0.0 0.0 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 15.5;Horizontal cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.5 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.6 6.2 12.9 1.4 8.0 4.1 2.8 2.1 3.8 4.7 1.5 7.1 3.6 1.2 4.1 5.2 1.2 12.9 2.6 15.9 13.5 3.8 1.6 1.7 4.3 0.9 3.3 1.6 10.8 0.3 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.0 2.7 1.2 14.2 9.1 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 0.0 0.0 0.0 1.2 0.5 15.5 3.1 2.5 1.4 1.2 0.0 5.9 0.3 0.0 7.7 2.5 3.9 0.0 0.0 1.2 3.3 1.3 0.9 6.9 0.0 2.8 39.7 2.9 9.8 2.7 3.6 1.7 1.1 3.3 2.8 0.2 6.4 8.3 0.0 4.2 0.7 5.9 6.5 2.3 0.2 1.1 0.3 1.0 2.2 0.1 0.5 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49767608-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 17.0 20.2 18.2 9.6 18.0 7.6 20.7 21.0 22.3 15.4 22.0 10.8 16.2 15.9 18.4 14.3 13.6 13.4 15.2 47.1 16.0 14.3 29.7 41.7 12.6 13.1 17.6 16.8 22.9 43.2 16.2 15.5 11.1 17.6 16.9 16.1 18.5 16.2 18.8 40.7 14.9 22.5 20.7 13.5 10.2 20.3 21.7 18.3 15.0 24.8 13.1 9.5 23.9 13.0 13.1 7.0 15.0 7.0 12.5 19.9 8.7 8.5 7.2 13.6 6.6 19.6 17.2 14.3 9.0 17.2 11.4 11.6 4.2 11.7 17.2 12.7 16.1 6.6 7.7 8.3 8.2 9.7 11.8 9.4 5.3 5.4 9.8 14.3 11.3 4.7 17.7 14.2 5.2 10.3 14.1 10.4 14.6 6.8 12.9 9.0 10.1 11.6 4.9 10.0 9.9 21.2 9.2 14.6 10.3 5.2 18.3 16.9 13.4 15.1 28.0 9.8 10.9 10.7 4.3 8.8 10.6 8.4 8.3 4.6 17.7 11.4 10.1 5.9 5.9 5.5 8.8 7.0 15.0 9.2 4.5 11.5 13.0 14.0 14.5 7.0 13.1 19.9 13.3 6.8 12.5 4.4 5.4 13.3 8.7 18.2 18.0 21.0 22.3 16.0 14.3 17.6 16.8 17.6 18.3 38.7 44.9 30.4 46.5 43.5 61.9 8.0 63.7 8.1 29.6 45.4 47.1 79.2 91.2 47.8 50.9 38.7 75.6 0.0 75.6 56.4 54.1 49.6 30.0 84.4 29.0 62.0 54.9 39.9 21.1 13.6 75.4 27.9 37.1 35.1 73.9 61.3 50.5 92.2 72.9 135.2 91.2 64.7 53.4 224.0 88.8 58.1 68.9 41.5 79.2 42.7 KLHL11 FLJ10572 ENSG00000178502 "Kelch like family member 11" Q9NVR0 17 41853545-41865431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 8 "Early spermatids: 91.3;Late spermatids: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023021, HPA052403, HPA054269" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432" "unprognostic (9.90e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-1)" "unprognostic (2.07e-1)" "unprognostic (1.84e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-2)" "unprognostic (1.50e-1)" "unprognostic (1.83e-2)" "unprognostic (3.25e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-3)" "unprognostic (4.05e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-2)" "unprognostic (5.07e-2)" 4.0 4.6 7.0 3.5 10.6 15.5 5.1 10.4 13.3 4.7 6.3 6.4 3.4 3.0 6.0 3.3 4.2 6.1 3.2 7.1 5.8 5.5 4.5 3.6 4.4 4.4 5.9 9.3 7.0 5.4 9.2 7.7 4.0 10.9 5.4 3.8 5.1 4.7 6.0 12.2 5.0 5.2 4.2 3.9 4.6 4.8 25.0 5.9 5.7 8.4 2.8 5.4 6.1 4.0 3.7 2.0 0.3 1.3 1.2 3.1 1.0 2.8 7.6 4.2 8.9 3.6 2.3 6.6 2.9 3.0 3.4 3.7 6.0 1.8 9.0 3.2 3.5 3.1 8.8 11.1 4.1 6.2 4.5 5.6 3.4 10.0 4.6 2.7 4.2 3.9 2.5 1.8 4.6 7.6 2.7 3.4 5.9 3.5 9.5 3.6 2.8 7.0 1.9 3.2 1.5 1.8 6.3 9.8 5.7 1.2 6.9 10.3 4.5 5.7 18.0 2.1 4.2 9.8 1.6 4.7 4.7 6.8 4.7 4.8 5.8 5.0 7.8 5.1 3.2 4.7 0.0 1.3 0.0 1.4 0.2 3.1 2.4 2.0 1.1 2.0 3.7 1.7 1.3 0.3 1.2 1.2 0.3 1.2 1.0 7.0 10.6 10.4 13.3 5.8 5.5 5.9 9.3 10.9 5.9 0.0 0.3 0.0 1.0 0.5 2.7 0.1 0.0 0.0 2.3 0.0 3.9 0.4 0.0 0.3 91.3 0.6 0.3 0.0 0.2 0.3 0.4 0.6 0.0 0.0 0.2 7.9 0.0 0.0 0.0 33.4 0.3 1.1 1.7 1.0 0.3 2.3 0.5 0.0 0.0 0.0 3.4 6.5 0.8 2.6 2.0 0.3 0.3 1.0 0.2 0.9 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976482-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 29.1;skin 1: 77.5;tongue: 90.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 6.7;HaCaT: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" NA NA 960000 "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 2.1 0.3 5.4 0.3 4.3 0.4 5.6 0.5 11.3 5.4 0.3 0.0 0.0 0.5 0.7 0.3 29.1 7.8 3.3 0.2 4.8 0.5 2.6 0.2 1.6 0.3 0.3 3.5 1.0 0.2 0.2 0.1 0.5 4.2 0.3 0.2 0.0 7.4 0.3 0.6 77.5 0.3 0.4 0.3 0.5 0.4 0.3 0.0 0.0 0.4 90.2 15.3 0.2 9.0 1.1 0.4 1.3 0.8 2.1 1.0 0.6 2.7 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 6.7 0.0 1.0 0.0 0.1 26.6 0.0 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 1.3 0.8 0.4 0.4 0.4 0.7 0.6 0.6 0.4 0.4 1.1 1.0 0.9 0.9 2.1 0.4 0.4 0.7 0.6 5.4 4.3 0.5 11.3 4.8 0.5 0.3 3.5 4.2 0.0 6.0 0.6 0.0 0.1 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.0 0.0 0.0 1.8 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.7 74.6 47.5 43.1 23.0 40.0 47.7 52.2 46.8 68.5 53.9 130.2 26.1 56.5 35.7 48.7 48.3 31.0 85.7 48.1 104.1 34.7 52.3 62.4 60.2 40.7 23.7 70.6 41.1 32.4 21.2 78.6 77.1 29.2 45.1 31.5 70.5 38.7 52.9 47.6 65.4 21.2 45.2 29.9 47.2 40.6 84.0 32.9 28.1 62.7 41.8 38.8 35.7 19.2 30.2 59.2 41.5 27.3 37.5 74.9 46.5 38.9 63.2 47.4 54.7 81.0 31.9 34.2 54.9 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 119.1 66.6 108.8 81.6 111.6 93.4 119.7 66.2 52.2 73.9 41.8 64.8 98.4 34.9 106.8 32.0 100.4 53.1 46.7 102.8 118.0 87.0 86.2 75.0 80.5 109.7 76.3 118.8 122.8 99.2 31.1 89.8 89.3 57.3 151.5 71.7 76.6 115.8 60.4 114.2 42.9 82.7 97.0 78.3 276.1 166.5 125.5 132.3 92.4 98.1 114.9 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell type enriched" "Detected in some" 9 "Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 9.1" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Group enriched" "Detected in some" 5 "granulocytes: 4.6;Melanocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HMC-1: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.9 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRTAP25-1 KAP25.1 ENSG00000232263 "Keratin associated protein 25-1" Q3LHN0 21 30289145-30289514 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031438 Uncertain Approved "Nuclear membrane,Plasma membrane,Cytosol" NA NA "Nuclear membrane" "Plasma membrane, Cytosol" "HPA031438: AB_10610000" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LBR "DHCR14B, TDRD18" ENSG00000143815 "Lamin B receptor" Q14739 1 225401502-225428925 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "DNA-binding, Oxidoreductase, Receptor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 88.7" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049840, HPA062236" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "HPA049840: AB_2680908, HPA062236: AB_2684721" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (2.14e-3)" "unprognostic (1.32e-2)" "unprognostic (7.96e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.60e-2)" "unprognostic (1.11e-2)" "unprognostic (3.43e-2)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (6.42e-2)" "unprognostic (2.08e-1)" "unprognostic (5.45e-1)" "unprognostic (8.32e-2)" "unprognostic (2.78e-1)" 16.7 4.2 5.6 22.9 7.8 37.0 14.6 5.5 7.2 23.4 37.7 14.5 10.8 16.8 31.4 19.5 17.2 21.8 11.1 7.2 6.5 6.1 15.4 18.9 12.3 31.0 9.9 4.2 14.3 11.8 2.4 5.0 11.2 9.4 19.6 19.7 6.2 8.2 16.6 6.8 7.3 20.4 32.8 9.9 25.4 21.5 8.0 8.9 88.7 8.7 6.9 28.1 28.8 16.2 14.1 13.1 70.9 15.0 12.2 19.9 20.2 25.1 9.9 33.5 14.9 14.1 8.8 16.9 6.6 8.4 13.9 14.9 19.8 43.4 51.9 14.8 6.9 8.3 19.2 23.9 7.0 21.0 30.2 24.8 12.9 9.6 16.9 8.7 56.1 22.9 7.6 4.5 12.6 11.2 7.2 17.6 25.7 39.1 35.3 9.3 3.5 51.4 31.7 30.2 24.7 3.4 34.7 30.5 48.3 15.9 11.8 9.0 11.9 11.3 8.4 5.5 15.2 11.5 37.0 11.5 3.8 20.0 10.7 23.8 12.7 17.3 58.0 5.2 25.4 13.0 22.2 15.0 21.1 15.3 10.1 17.1 13.8 14.6 16.2 13.1 14.1 14.7 17.4 70.9 12.2 7.8 6.6 19.9 20.2 5.6 7.8 5.5 7.2 6.5 6.1 9.9 4.2 9.4 8.9 26.8 31.3 74.4 22.1 24.0 4.2 5.1 50.9 28.1 45.5 29.6 5.9 27.8 5.0 20.9 0.7 42.7 17.2 163.5 17.2 18.7 25.9 27.1 9.3 64.4 38.4 11.1 25.9 44.2 84.0 2.3 31.4 51.1 25.3 15.4 30.9 12.0 18.1 21.0 30.4 22.5 9.8 38.8 33.0 14.0 27.7 31.0 9.3 46.3 62.8 28.9 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192" "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 8.3 7.8 11.3 5.7 11.9 5.1 6.6 21.9 10.4 7.0 9.2 6.9 4.7 14.2 6.3 5.1 7.3 4.6 7.1 3.9 10.3 9.8 9.6 7.2 7.5 8.0 14.8 6.5 7.6 6.4 8.4 11.3 8.7 8.9 5.9 8.8 5.0 7.0 5.3 7.9 8.6 22.3 5.8 16.2 12.6 9.1 12.2 15.3 17.1 8.1 2.7 5.7 6.5 5.4 4.4 3.8 8.2 4.6 2.4 3.2 1.5 4.8 3.2 13.0 4.0 6.9 10.8 3.3 6.0 5.9 5.2 6.8 1.6 6.5 9.4 3.2 4.0 8.0 2.2 6.2 2.5 7.3 2.6 3.9 7.5 5.7 3.9 4.4 6.0 6.1 5.9 3.0 3.5 7.3 7.6 7.0 6.1 4.5 15.0 7.0 1.3 5.8 12.3 4.5 4.3 4.7 5.8 8.0 5.2 8.4 2.6 9.7 9.3 4.3 2.2 4.2 5.1 3.9 5.8 4.7 8.2 4.1 5.1 9.4 12.2 4.6 7.9 6.7 8.1 6.5 8.2 4.5 4.9 2.9 4.6 2.4 4.4 2.0 1.8 3.8 3.0 2.3 2.7 2.2 2.4 3.6 2.6 3.2 1.5 11.3 11.9 21.9 10.4 10.3 9.8 14.8 6.5 8.9 15.3 11.9 10.4 17.9 3.8 21.2 18.3 8.1 40.8 17.4 6.8 7.0 39.3 7.3 8.3 9.7 26.0 20.2 18.1 0.0 9.7 7.4 8.7 8.5 18.5 11.9 13.9 19.1 34.0 9.2 11.7 15.2 13.6 22.6 3.3 8.2 17.8 9.8 10.0 14.1 7.1 14.0 20.9 19.4 6.1 40.8 15.6 16.7 8.2 6.9 14.9 4.2 LEMD2 "dJ482C21.1, NET25" ENSG00000161904 "LEM domain containing 2" Q8NC56 6 33771202-33789136 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017340 Supported Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA017340: AB_2296925" "unprognostic (9.01e-2)" "unprognostic (7.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.12e-2)" "unprognostic (2.98e-1)" "unprognostic (8.29e-3)" "unprognostic (6.53e-2)" "unprognostic (5.98e-2)" "unprognostic (4.42e-2)" "unprognostic (7.03e-2)" "unprognostic (1.67e-3)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.82e-2)" "unprognostic (7.12e-2)" 18.7 24.1 23.9 22.9 30.4 37.8 23.5 49.0 26.0 25.2 22.0 31.1 17.9 21.8 24.3 28.7 23.6 22.3 20.7 19.6 24.0 18.3 22.5 22.8 23.9 28.3 32.2 17.3 28.1 26.9 31.6 28.5 29.2 25.5 24.9 21.2 28.9 23.5 24.1 17.1 34.9 25.8 25.9 21.8 34.4 21.0 20.0 27.7 18.7 28.0 15.6 27.8 18.3 27.2 5.4 6.9 6.8 4.5 3.0 7.2 2.5 12.7 14.7 25.0 24.2 14.3 15.5 18.8 14.0 21.9 18.1 19.2 11.1 13.8 12.0 19.8 20.1 51.0 22.4 14.5 18.9 12.8 12.5 13.4 4.5 14.8 14.4 30.0 9.0 15.8 16.7 36.1 19.2 33.1 30.0 19.3 16.0 12.6 14.1 15.7 10.9 16.9 22.7 14.3 19.2 8.5 11.1 10.3 10.0 19.3 18.3 17.8 14.2 8.4 26.9 18.2 26.5 18.2 25.2 8.9 25.4 9.9 13.5 16.4 18.3 14.5 8.5 10.0 14.5 30.3 3.8 4.1 6.8 5.9 3.7 7.2 5.2 6.3 5.6 3.9 5.4 5.0 6.0 3.3 3.0 4.5 6.9 6.3 2.5 23.9 30.4 49.0 26.0 24.0 18.3 32.2 17.3 25.5 27.7 3.0 7.0 8.2 11.4 9.6 17.6 9.0 5.1 2.7 2.3 8.7 17.7 22.1 1.7 7.6 19.6 15.7 15.2 23.3 5.8 29.7 12.2 11.1 12.7 6.8 15.3 41.3 5.2 12.3 13.2 30.2 9.8 11.5 11.8 5.4 16.0 14.5 11.1 17.5 15.2 6.0 12.3 19.4 15.9 17.6 7.2 8.9 24.9 11.7 14.3 11.0 LEMD3 MAN1 ENSG00000174106 "LEM domain containing 3" Q9Y2U8 12 65169571-65248327 "Disease related genes, Plasma proteins, Predicted membrane proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025078, HPA076986" Uncertain Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA025078: AB_10601908, HPA076986: AB_2686821" "unprognostic (2.10e-2)" "unprognostic (6.83e-3)" "unprognostic (1.63e-3)" "unprognostic (1.76e-3)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (1.68e-3)" "unprognostic (7.22e-2)" "unprognostic (3.06e-2)" "unprognostic (4.16e-2)" "unprognostic (8.89e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.30e-4)" "unprognostic (4.37e-2)" "unprognostic (3.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.72e-1)" 13.7 11.9 21.9 15.3 27.3 24.8 15.3 36.0 26.3 13.3 14.4 10.9 11.4 13.4 18.0 13.1 14.5 14.3 10.0 11.1 19.4 12.5 14.2 13.3 13.9 17.2 15.8 16.9 17.8 16.4 25.7 15.2 10.4 16.9 14.0 14.6 12.1 14.8 11.9 14.9 13.3 14.8 12.1 15.8 16.2 13.5 28.6 19.6 23.2 15.3 8.4 16.7 13.1 15.8 4.8 5.0 3.1 2.1 3.8 5.3 1.6 11.6 6.6 10.7 10.6 7.5 8.8 7.3 13.7 7.4 6.9 6.0 8.2 7.6 32.0 8.8 8.4 5.3 15.9 11.4 9.8 10.0 7.6 13.2 13.0 6.3 6.3 5.8 19.7 9.5 6.3 10.6 8.2 11.1 9.8 8.1 9.0 17.0 15.3 9.6 6.9 10.3 10.3 14.6 5.3 6.8 24.3 10.5 15.9 8.7 13.0 11.1 6.9 13.7 14.0 8.2 10.7 14.0 15.7 11.0 8.4 9.1 7.9 9.4 10.9 10.3 19.7 7.1 9.7 10.3 2.3 1.8 3.1 3.9 1.6 5.0 4.5 5.2 5.2 2.4 4.8 5.0 5.3 2.1 3.8 2.1 5.0 4.1 1.6 21.9 27.3 36.0 26.3 19.4 12.5 15.8 16.9 16.9 19.6 35.7 15.2 15.9 16.0 28.5 19.5 14.6 5.1 21.4 13.6 10.4 17.7 6.6 0.0 9.2 1.5 14.3 13.1 23.3 11.2 3.6 13.1 17.1 21.9 11.9 5.6 15.9 14.3 8.6 17.7 2.4 14.7 10.8 16.9 10.0 11.9 19.1 11.6 14.2 11.7 4.5 19.5 6.5 17.9 47.2 39.4 34.3 12.0 15.4 11.2 19.0 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LMNB1 ENSG00000113368 "Lamin B1" P20700 5 126776623-126837020 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 93.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 61.8;Extravillous trophoblasts: 58.3;granulocytes: 89.2;Late spermatids: 58.6;monocytes: 77.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 23.4;pons and medulla: 6.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005269, HPA050524, CAB079757" Supported Supported "Nuclear membrane" NA NA 3300000 "Nuclear membrane" "CAB005269: AB_648156, CAB079757: AB_2665863, HPA050524: AB_2681156" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "unprognostic (4.96e-3)" "unprognostic (3.70e-2)" "unprognostic (1.61e-1)" "unprognostic (8.65e-3)" "prognostic unfavorable (3.08e-6)" "unprognostic (2.06e-2)" "unprognostic (6.62e-3)" "unprognostic (5.28e-2)" "unprognostic (2.13e-3)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.33e-2)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" 3.9 2.0 2.5 36.8 3.5 21.1 7.0 23.4 2.5 3.1 10.6 0.5 3.9 8.2 2.2 3.2 15.8 2.4 4.3 3.3 3.0 2.7 2.4 5.0 9.7 25.4 2.1 1.7 2.9 2.9 1.0 3.4 5.2 6.3 1.9 9.9 1.7 4.1 5.7 1.8 6.2 11.1 2.6 8.8 15.3 5.7 2.5 2.3 93.1 2.0 9.3 20.3 4.1 5.1 3.8 13.2 8.5 12.2 1.9 10.5 4.9 25.3 8.4 26.3 25.1 0.6 1.9 34.1 11.9 3.5 13.2 14.3 21.9 21.2 44.1 20.7 4.1 6.3 14.2 17.9 8.1 14.6 30.9 22.0 28.3 10.0 12.8 0.2 33.6 19.1 0.5 0.1 6.9 3.2 2.5 10.8 18.1 16.4 17.2 9.2 20.9 60.8 66.7 19.8 10.4 11.9 29.1 52.0 17.8 7.2 11.6 30.5 16.1 19.2 8.3 7.2 9.5 15.1 38.9 9.1 9.9 26.9 7.3 25.4 11.4 8.7 38.7 5.0 47.8 14.6 1.2 12.2 4.0 1.9 5.0 1.5 3.8 4.0 2.5 13.2 2.9 2.9 2.6 8.5 1.9 1.2 4.0 10.5 4.9 2.5 3.5 23.4 2.5 3.0 2.7 2.1 1.7 6.3 2.3 0.0 7.0 22.9 2.4 4.4 6.1 0.8 7.6 2.7 4.5 0.0 7.9 14.6 1.7 1.9 61.8 3.8 2.3 0.0 0.7 58.3 2.9 1.0 89.2 2.4 18.5 4.8 5.8 1.8 18.2 58.6 2.0 12.5 1.7 77.5 13.5 2.8 0.9 10.5 0.4 1.7 16.5 0.0 4.2 2.8 8.1 4.6 3.9 20.8 25.7 0.4 LMNB2 LMN2 ENSG00000176619 "Lamin B2" Q03252 19 2427638-2456996 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 144.2;Extravillous trophoblasts: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022593, HPA047863, HPA062477" Enhanced Supported "Nuclear membrane" NA NA 97000 "Nuclear membrane" "CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776" "unprognostic (3.92e-2)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (9.65e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.53e-3)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.96e-1)" "unprognostic (3.09e-3)" "prognostic unfavorable (9.53e-5)" "prognostic unfavorable (9.34e-5)" "prognostic favorable (3.98e-4)" "unprognostic (4.03e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-2)" 5.6 5.0 4.6 11.5 6.0 11.8 8.6 8.9 5.9 3.7 8.2 4.3 5.1 8.7 10.1 3.6 7.9 5.1 5.9 5.4 4.3 5.0 4.2 4.4 5.7 9.3 5.3 5.4 7.0 5.1 2.3 5.4 11.6 5.2 5.0 4.8 4.5 5.3 4.1 10.1 7.7 9.6 4.1 3.4 6.0 7.5 7.4 4.4 18.4 5.4 12.4 8.7 4.1 11.3 1.6 7.3 1.6 4.0 1.6 3.5 1.2 45.8 29.5 21.4 27.8 4.7 7.4 28.6 31.0 15.2 31.3 23.8 38.9 19.7 21.4 12.8 14.4 18.1 48.3 19.0 22.0 16.1 26.0 22.7 17.0 10.4 30.3 5.7 23.7 17.3 6.6 5.6 16.8 13.3 5.8 16.0 20.0 29.5 13.8 14.7 26.7 27.0 13.1 40.8 24.9 25.9 38.2 27.2 17.9 8.9 23.2 31.7 18.4 25.9 17.3 10.3 12.4 17.4 24.5 22.1 30.2 31.6 46.4 46.2 12.3 10.4 21.6 24.5 22.7 38.8 0.0 1.4 1.6 2.3 1.3 3.5 0.9 2.5 2.2 1.7 1.6 2.6 2.9 0.1 1.6 4.0 7.3 0.7 1.2 4.6 6.0 8.9 5.9 4.3 5.0 5.3 5.4 5.2 4.4 3.0 3.4 6.7 10.1 18.3 9.0 5.0 2.5 4.0 4.5 5.2 7.9 16.3 8.3 7.1 144.2 13.1 10.5 23.3 10.0 66.7 11.3 12.7 4.6 2.5 17.9 12.7 5.8 5.5 6.7 16.6 8.6 7.8 1.7 15.4 13.1 8.2 9.3 8.6 7.4 4.3 7.7 12.9 11.9 6.5 13.8 17.6 11.6 7.5 16.6 17.7 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 77.7;Erythroid cells: 70.0;Spermatocytes: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.8 12.1 11.1 27.6 24.9 14.3 18.8 20.3 8.4 7.2 8.0 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.1 2.3 23.2 12.9 2.2 3.8 12.3 5.6 1.9 13.0 17.5 9.9 13.7 13.6 20.1 27.0 19.4 7.7 10.7 20.9 19.1 21.6 14.6 9.3 9.2 12.8 7.2 11.6 13.9 8.3 3.4 17.9 15.1 5.0 19.1 31.7 8.4 14.9 7.5 10.7 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 3.0 6.2 3.0 4.9 13.9 3.6 2.8 10.2 2.7 7.9 3.5 2.0 8.3 1.7 11.3 77.7 8.4 10.5 70.0 19.7 27.5 7.5 7.5 13.9 5.6 18.9 1.6 4.6 6.2 11.1 26.3 6.9 12.4 10.1 14.4 8.4 4.5 10.8 0.0 3.2 6.2 5.0 6.5 7.1 63.9 10.0 13.0 6.4 6.4 12.4 5.9 MAD1L1 "HsMAD1, MAD1, PIG9, TP53I9, TXBP181" ENSG00000002822 "Mitotic arrest deficient 1 like 1" Q9Y6D9 7 1815793-2233243 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 225.4;Late spermatids: 498.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003635, CAB015338" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB015338: AB_627901, HPA003635: AB_1853472" "unprognostic (1.85e-1)" "unprognostic (3.76e-2)" "unprognostic (4.26e-3)" "unprognostic (8.32e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" "unprognostic (2.70e-2)" "unprognostic (1.18e-2)" "unprognostic (4.78e-2)" "unprognostic (5.76e-2)" "unprognostic (1.89e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (5.18e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (4.57e-1)" 11.8 7.6 11.4 17.3 29.7 19.1 9.0 15.7 15.0 10.0 9.3 12.1 6.1 8.8 10.4 8.5 12.3 9.2 10.9 11.4 12.3 10.0 7.9 17.6 13.3 23.2 14.8 13.3 10.3 10.7 7.8 10.7 9.3 10.5 9.4 6.8 12.0 10.3 8.3 16.8 17.4 9.8 10.3 11.9 21.2 9.8 15.4 11.0 25.9 10.5 7.2 19.1 11.3 11.3 25.4 21.9 25.8 21.6 6.7 46.8 18.2 17.0 6.8 8.5 12.9 6.0 5.2 11.2 12.6 7.9 13.6 11.0 13.4 10.3 10.6 4.8 7.5 19.8 13.6 7.9 9.2 7.8 5.4 8.0 11.8 10.4 20.8 7.9 8.1 23.3 6.6 7.6 14.8 7.6 3.0 6.7 6.1 13.5 8.2 7.2 17.1 3.4 32.0 14.0 2.8 8.1 18.3 9.1 7.9 7.5 9.8 5.9 16.2 10.0 10.2 28.9 6.5 7.8 28.0 8.3 9.8 27.6 27.8 12.6 12.9 12.0 13.0 8.6 25.7 33.4 25.8 12.1 8.6 27.9 21.6 26.0 19.7 27.2 27.1 21.9 25.4 37.7 26.2 3.4 6.7 19.6 8.1 46.8 18.2 11.4 29.7 15.7 15.0 12.3 10.0 14.8 13.3 10.5 11.0 3.0 7.2 29.6 12.2 15.7 6.9 7.5 0.0 6.7 9.1 7.0 9.8 13.5 13.3 10.9 225.4 10.8 7.0 0.0 9.9 13.5 13.2 7.9 40.5 28.0 35.1 22.3 31.2 4.3 18.6 498.1 11.5 30.9 35.4 29.7 7.7 17.4 12.6 6.0 9.9 8.6 11.6 19.4 9.8 28.6 33.1 18.7 20.5 41.5 6.5 9.5 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235126-46286297 "Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: AB_2674152" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favorable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 19.4 16.7 14.2 21.5 25.3 19.5 19.0 26.6 29.2 18.3 17.2 27.7 19.3 15.4 24.8 18.0 18.1 21.1 16.3 17.9 14.4 13.2 15.5 13.3 18.2 21.9 16.5 14.6 23.7 17.5 25.7 20.6 18.2 18.2 17.7 17.6 21.3 22.1 21.4 52.9 18.2 19.9 19.5 15.1 20.7 18.7 15.7 15.7 31.8 19.6 15.7 26.0 21.1 16.4 4.8 4.8 3.8 4.9 3.0 6.9 4.1 16.0 15.8 18.6 20.0 15.2 19.0 16.9 17.7 21.7 16.8 13.7 14.4 9.6 22.9 14.6 18.7 18.1 9.6 24.5 14.9 14.8 23.5 22.2 37.5 15.1 11.2 13.7 17.0 21.2 14.8 13.0 22.9 15.9 11.5 17.8 13.9 44.7 17.5 19.3 9.2 18.2 11.5 31.9 17.5 13.2 23.8 11.7 20.7 8.2 14.9 15.7 16.7 22.6 15.0 17.3 14.7 20.4 17.8 22.5 17.6 13.4 14.6 13.2 31.9 35.3 14.2 15.9 16.5 22.8 1.5 4.7 3.8 6.1 4.9 6.5 2.9 3.7 6.9 4.8 4.8 3.3 3.4 2.9 3.0 2.7 4.2 4.4 4.1 14.2 25.3 26.6 29.2 14.4 13.2 16.5 14.6 18.2 15.7 8.9 17.6 16.7 6.1 6.3 21.7 3.6 15.3 10.7 12.5 10.4 19.6 9.8 1.7 9.7 2.5 7.8 12.3 0.0 12.4 9.8 8.9 11.6 8.1 15.3 13.5 15.9 11.5 13.5 20.6 3.6 17.0 12.4 10.1 21.6 18.4 8.9 12.8 7.0 13.4 5.2 21.0 19.4 6.6 18.9 13.4 9.2 7.8 8.5 14.5 5.5 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.9 12.3 3.5 9.0 6.0 4.3 9.8 12.0 5.9 5.9 6.8 6.5 31.4 2.3 6.4 7.5 10.9 12.2 3.2 17.3 1.6 14.6 11.1 4.9 10.5 6.7 10.1 15.5 7.2 6.5 10.2 6.6 4.2 9.1 6.7 5.2 6.8 4.8 4.4 14.0 4.4 71.8 11.7 10.2 14.8 5.4 1.7 10.8 8.7 8.0 9.3 11.1 2.8 8.4 12.5 3.8 22.1 29.5 9.8 4.7 8.3 5.9 9.5 3.2 1.4 3.5 13.7 39.7 7.5 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 35.7 29.0 29.6 60.0 27.8 6.7 4.6 28.1 29.4 21.6 43.6 7.9 55.4 3.3 85.0 10.1 33.1 37.5 0.0 39.9 70.0 33.4 67.6 32.3 2.9 65.2 14.3 27.1 38.6 37.6 12.2 33.6 46.5 40.5 72.1 34.1 9.8 74.5 42.1 21.2 17.3 9.4 90.5 37.6 14.3 16.0 23.5 70.0 69.2 41.7 89.7 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860520 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Ciliated cells: 21.4;Hofbauer cells: 31.6;Syncytiotrophoblasts: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 14.6 22.0 17.9 10.0 22.2 15.2 18.4 22.0 32.0 19.1 13.7 19.7 11.4 8.2 18.6 20.0 13.4 15.3 13.3 8.9 20.1 18.8 16.0 15.8 15.5 11.9 22.9 14.0 18.1 12.8 16.3 14.4 20.1 25.8 18.9 18.0 13.5 11.8 16.5 4.1 15.3 11.4 16.7 32.0 11.8 14.6 18.8 16.1 10.5 17.2 7.7 12.6 17.8 14.1 3.4 4.2 5.7 8.0 3.4 6.2 2.9 6.6 6.2 12.1 12.8 18.0 17.1 10.0 21.3 10.8 16.3 19.1 5.4 10.5 5.0 4.1 23.0 11.3 6.2 10.3 12.7 14.6 15.3 14.4 16.3 8.8 5.8 22.6 3.3 13.7 12.9 11.1 14.5 10.3 16.0 12.8 12.2 9.9 4.2 16.1 7.2 7.1 4.0 4.4 10.8 11.9 3.5 7.1 3.5 18.2 5.1 10.0 11.1 10.4 10.1 8.5 11.3 11.3 8.1 13.4 10.6 8.2 17.8 6.2 23.1 9.8 8.6 12.2 7.4 8.4 5.7 3.6 3.1 4.9 7.1 4.1 3.1 3.4 5.2 4.0 3.4 2.3 4.4 3.1 3.4 8.0 4.2 6.2 2.9 17.9 22.2 22.0 32.0 20.1 18.8 22.9 14.0 25.8 16.1 20.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 21.4 6.8 14.0 0.0 16.7 16.6 10.4 0.0 0.0 0.0 0.0 7.3 13.3 0.0 0.0 1.1 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.8 0.0 0.0 7.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MLX, MAX dimerization protein" Q9UH92 17 42567068-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 21.3 19.2 10.4 12.6 11.9 8.3 22.5 10.3 14.3 12.3 32.2 10.8 15.4 27.5 11.0 15.1 18.8 10.5 19.2 38.1 9.8 9.8 23.5 34.7 19.0 18.6 11.3 6.6 10.4 36.8 8.5 13.0 13.7 9.4 13.4 23.1 11.6 18.5 14.8 43.3 15.6 42.5 12.1 10.2 18.7 20.6 7.4 8.9 20.3 23.5 24.9 19.7 16.5 13.1 14.6 26.3 34.7 33.5 12.8 18.2 23.0 15.8 18.3 14.4 14.6 22.0 25.4 10.0 23.8 21.1 25.7 23.3 16.5 16.5 19.1 16.8 20.2 23.4 24.0 26.2 15.4 22.6 15.1 24.6 19.7 13.2 18.3 25.9 26.4 28.5 22.0 17.2 20.6 18.9 17.4 18.9 23.1 21.5 17.1 29.3 21.0 37.0 13.0 10.2 39.3 16.6 16.8 29.9 20.4 20.8 19.6 22.5 11.2 10.6 13.7 26.7 20.0 28.1 31.3 13.4 22.9 14.8 25.0 35.1 17.4 19.7 18.0 25.7 16.9 26.9 14.2 25.0 34.7 14.3 30.8 15.8 14.6 14.8 14.3 26.3 11.8 13.1 13.1 32.3 12.8 33.5 14.1 18.2 23.0 10.4 11.9 10.3 14.3 9.8 9.8 11.3 6.6 9.4 8.9 62.5 76.9 37.4 23.4 37.3 27.5 22.9 40.8 30.8 50.0 26.2 23.6 33.1 51.4 35.7 17.8 23.2 101.9 0.0 60.3 38.8 28.7 21.1 44.1 46.0 60.8 23.8 24.8 23.4 50.2 21.2 32.5 61.4 30.4 50.5 40.2 12.3 61.7 61.4 29.4 44.4 24.5 51.8 33.9 8.4 38.4 43.5 36.8 35.8 48.8 32.5 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enriched" "Detected in single" 78 "HEL: 41.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 41.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013409 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2" "Region enriched" "Detected in some" 5 "cerebellum: 16.6" "Low region specificity" "Detected in all" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 10.8 1.7 0.8 7.6 1.2 0.0 26.6 7.8 1.5 61.9 39.5 1.2 13.9 4.8 49.2 22.3 28.2 28.0 30.6 6.2 0.7 0.4 4.2 2.1 4.8 5.6 1.1 1.3 25.6 0.9 0.4 1.1 5.9 1.8 29.6 4.8 5.8 2.9 25.5 3.1 4.0 10.1 41.1 1.0 8.2 14.2 13.1 0.6 0.1 3.8 6.4 2.7 42.2 19.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.8 12.0 0.5 15.1 38.1 14.3 9.5 0.0 0.6 0.0 0.3 11.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.1 0.0 3.3 0.0 0.0 8.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 18.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 7.8 1.5 0.7 0.4 1.1 1.3 1.8 0.6 0.0 0.0 0.0 0.2 4.4 0.0 0.6 2.5 0.0 0.0 10.4 0.0 0.6 0.0 0.0 3.6 0.6 0.0 0.0 0.0 0.6 34.7 0.3 0.0 3.4 0.9 0.0 0.0 5.5 0.0 5.2 61.2 0.0 6.8 0.0 0.0 2.8 0.1 0.0 94.7 0.6 0.2 51.8 90.4 1.0 0.5 3.3 0.9 0.0 0.0 0.2 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.0 8.9 21.2 7.5 24.0 17.3 6.8 9.7 11.9 16.6 17.3 11.6 9.8 14.1 11.9 13.0 7.3 9.9 13.1 11.3 17.7 15.5 18.0 11.6 17.5 13.2 10.2 12.8 10.4 18.8 14.0 9.7 6.8 14.7 13.7 12.3 14.0 12.5 11.5 6.1 14.0 9.3 11.6 20.8 4.7 12.2 11.2 16.7 11.4 9.0 17.9 12.6 14.1 13.1 9.3 17.4 15.5 13.7 11.2 5.6 6.3 11.8 8.7 13.8 11.7 17.6 8.1 12.2 11.8 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 26.8 23.2 38.7 45.3 19.6 13.8 73.8 40.8 34.8 34.2 52.4 13.7 85.5 116.0 57.8 11.2 35.8 23.6 46.7 38.9 90.2 43.7 47.0 17.4 59.4 70.3 1.6 30.5 34.4 33.2 8.5 43.1 29.4 47.2 88.4 32.3 32.0 49.2 49.1 40.3 89.3 18.4 38.8 36.4 71.7 37.5 25.6 46.9 31.0 46.9 40.3 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" No No Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavorable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 15.1 28.5 23.0 19.0 27.5 16.0 19.9 16.4 32.0 13.4 16.4 17.6 28.3 18.1 18.0 23.1 18.1 19.3 17.2 53.5 22.5 22.1 36.6 19.9 16.5 21.3 23.6 26.2 16.3 29.9 17.3 16.7 15.5 23.7 28.3 16.0 15.3 16.9 24.7 39.2 14.1 15.5 17.0 19.4 17.4 25.7 21.9 17.2 14.8 28.4 19.8 19.7 15.3 16.5 25.1 30.8 33.4 26.7 23.5 24.3 22.8 32.4 32.8 17.8 18.6 10.8 12.6 20.5 21.1 15.9 29.5 22.8 24.7 19.6 41.2 62.9 16.2 27.3 16.1 28.0 24.9 24.7 32.7 32.5 29.8 13.7 42.6 20.7 39.0 28.9 11.5 22.5 21.8 22.8 13.5 18.5 22.2 44.1 14.9 23.1 27.8 36.1 22.5 21.5 36.9 34.3 26.3 29.7 34.4 22.8 15.6 23.9 37.2 15.9 13.4 42.0 13.6 41.8 29.1 15.7 25.1 32.0 25.0 44.6 32.8 69.1 45.9 23.9 24.5 23.0 24.9 21.8 33.4 22.4 26.7 23.4 23.6 22.4 22.6 30.8 25.1 24.3 24.0 3.5 23.5 18.8 29.0 21.4 22.8 23.0 27.5 16.4 32.0 22.5 22.1 23.6 26.2 23.7 17.2 44.7 28.1 29.0 30.7 29.8 41.5 148.1 33.1 41.5 36.4 45.4 11.8 68.7 126.0 75.4 4.7 33.0 13.5 0.0 86.9 68.6 37.0 43.2 22.0 38.1 75.9 47.7 21.2 24.5 28.2 7.0 30.2 38.1 38.8 71.3 27.2 49.9 70.7 17.5 37.1 149.9 53.1 25.8 28.4 27.1 87.3 28.4 35.6 32.4 38.2 27.8 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MX1 "IFI-78K, MxA" ENSG00000157601 "MX dynamin like GTPase 1" P20591 21 41420304-41459214 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 59.4;Extravillous trophoblasts: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 120.2;BJ hTERT+ SV40 Large T+ RasG12V: 108.2;Karpas-707: 27.8;SK-MEL-30: 36.3" "Low region specificity" "Detected in all" "HPA030917, HPA030918, HPA049724" Approved Approved Supported "Nuclear membrane,Cytosol" No NA "Nuclear membrane, Cytosol" "HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862" "unprognostic (3.62e-1)" "unprognostic (6.84e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (2.27e-1)" "unprognostic (1.35e-3)" "unprognostic (5.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (6.88e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.95e-2)" "unprognostic (8.10e-2)" "unprognostic (3.24e-1)" "unprognostic (1.81e-1)" 19.3 7.5 8.6 19.8 22.5 25.7 11.6 3.1 15.5 14.4 12.8 9.4 4.7 14.7 13.2 19.3 19.2 12.4 19.0 8.1 12.4 16.2 20.8 11.9 28.4 17.3 14.3 11.4 16.3 7.2 7.5 16.2 9.7 20.5 7.2 5.4 15.9 54.0 8.4 3.7 5.7 15.4 11.3 13.1 34.5 16.2 5.2 4.8 33.7 16.9 14.5 20.7 15.6 11.5 22.8 25.0 36.5 27.0 9.2 29.5 17.0 2.4 0.0 0.1 0.2 0.1 1.0 0.0 0.1 3.7 120.2 108.2 0.8 5.0 0.0 1.0 0.4 1.2 0.3 0.1 0.1 2.3 0.7 0.1 0.2 0.4 0.3 1.2 0.1 0.1 1.1 0.3 7.2 0.2 0.0 0.4 0.5 0.0 27.8 0.0 0.2 2.0 0.4 0.4 0.0 1.2 2.0 0.1 3.8 0.5 1.5 0.2 0.1 0.1 0.2 36.3 0.0 1.6 0.9 0.2 0.1 0.1 0.0 0.1 6.1 5.7 0.2 0.1 0.4 0.3 13.7 24.0 14.0 10.9 27.0 14.6 22.8 16.0 12.7 16.9 20.1 14.5 10.7 36.5 9.2 22.0 25.0 29.5 17.0 8.6 22.5 3.1 15.5 12.4 16.2 14.3 11.4 20.5 4.8 29.8 25.9 23.1 15.8 5.7 3.4 3.6 12.7 26.8 20.5 22.7 0.0 1.9 16.6 32.5 0.6 59.4 10.1 0.0 48.6 73.8 14.8 6.8 1.1 5.4 46.7 1.6 0.0 16.5 13.3 1.0 10.0 24.5 18.6 17.2 6.7 6.8 30.1 1.5 15.6 3.8 2.2 0.0 18.2 0.3 0.7 3.0 3.4 19.1 2.9 30.8 NANP "C20orf147, dJ694B14.3, HDHD4, MGC26833" ENSG00000170191 "N-acetylneuraminic acid phosphatase" Q8TBE9 20 25612935-25624175 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050342 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA050342: AB_2681098" "unprognostic (8.72e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (6.01e-2)" "unprognostic (5.59e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.01e-6)" "unprognostic (3.20e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-3)" "unprognostic (1.24e-1)" "unprognostic (3.46e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-1)" "unprognostic (1.71e-2)" "unprognostic (9.42e-2)" 10.0 14.0 6.3 6.0 7.4 6.9 7.2 13.3 8.2 6.3 6.4 4.1 4.3 7.1 6.9 5.7 9.5 6.2 6.2 6.8 4.3 4.8 11.6 12.5 6.7 4.4 4.2 3.3 12.0 7.4 8.0 8.6 6.0 6.5 5.6 6.2 7.1 7.8 6.1 9.2 4.9 7.6 6.9 5.6 7.1 6.2 6.6 3.7 18.2 9.0 6.0 6.8 7.4 6.8 1.7 6.4 1.7 4.5 4.9 4.2 2.3 11.1 6.5 5.3 7.7 8.6 9.2 7.8 5.7 11.2 7.6 9.8 5.9 7.7 4.0 6.5 10.8 9.0 7.1 8.1 8.2 14.8 1.4 4.8 10.0 3.1 15.7 7.2 7.6 3.0 8.0 4.1 8.5 10.9 4.2 6.4 13.8 8.4 7.2 9.2 6.1 15.0 3.8 3.9 9.7 10.2 7.5 11.2 4.9 4.4 6.0 10.2 4.2 6.3 10.2 6.7 5.6 4.4 6.5 5.4 12.1 9.0 11.1 8.0 3.8 3.5 10.0 3.4 17.7 7.2 0.4 4.5 1.7 2.8 4.5 4.2 1.4 2.0 2.1 6.4 1.7 1.8 3.1 0.3 4.9 2.4 1.4 1.7 2.3 6.3 7.4 13.3 8.2 4.3 4.8 4.2 3.3 6.5 3.7 3.0 1.0 1.5 3.4 5.3 4.6 3.1 5.1 0.0 2.3 7.0 0.0 3.4 11.6 4.4 0.3 4.5 1.3 0.0 3.7 1.6 4.6 2.4 5.7 4.9 3.9 6.4 2.9 4.3 2.5 0.0 2.8 3.7 5.0 1.0 2.6 5.6 4.4 2.0 2.5 7.1 6.8 0.0 3.9 2.6 10.7 4.4 1.6 1.5 2.5 2.3 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213008 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;ovary: 29.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 47.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.8;THP-1: 20.9;U-138 MG: 16.0;WM-115: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 6.2 8.5 17.8 2.4 14.2 1.5 7.1 14.7 25.2 2.8 2.1 9.7 2.6 1.2 4.1 5.8 3.8 3.6 8.6 3.7 14.2 7.5 1.4 2.3 3.8 1.6 7.8 13.0 29.6 1.4 2.2 9.3 4.3 7.1 4.5 2.0 12.3 2.2 5.1 2.6 4.1 1.3 4.6 10.6 12.7 1.6 5.0 8.3 0.0 1.7 0.0 1.4 3.9 2.3 0.3 0.1 3.8 0.2 0.1 0.0 0.0 1.8 4.4 0.3 0.1 4.6 9.5 0.1 13.4 10.5 5.5 2.9 1.2 0.3 0.1 1.0 10.7 3.8 1.4 3.9 2.0 9.8 0.0 0.0 0.0 1.8 0.1 3.6 0.0 0.1 3.5 0.0 23.8 6.0 4.9 8.2 0.0 0.0 0.0 13.5 0.1 0.1 6.0 1.5 0.1 1.2 0.6 1.1 0.0 0.9 0.0 0.4 0.0 0.9 0.1 1.9 0.5 0.0 20.9 7.1 16.0 4.5 6.8 9.1 0.7 0.0 0.4 4.8 0.2 19.8 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.1 0.2 0.1 0.0 0.0 17.8 14.2 14.7 20.5 14.2 7.5 7.8 13.0 7.1 8.3 17.9 7.7 0.0 7.4 3.2 3.1 2.1 0.0 16.0 13.6 0.0 0.0 0.1 0.0 1.7 7.6 3.5 0.0 0.0 1.3 0.1 8.7 1.8 10.5 0.0 5.4 47.7 15.7 2.5 0.0 3.6 22.2 1.3 11.8 0.0 0.0 19.9 11.8 0.0 7.1 0.0 2.1 0.0 2.8 0.2 0.5 1.3 0.2 0.0 0.0 2.8 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.5 7.3 8.1 5.6 21.3 23.4 8.4 10.3 11.3 8.0 8.1 7.3 8.0 7.1 2.3 15.6 8.3 6.7 8.8 12.9 9.6 7.0 5.6 27.1 6.5 20.4 21.9 7.0 13.8 15.4 10.3 10.6 17.8 16.6 16.5 10.1 21.0 8.2 12.2 6.8 5.8 15.8 7.0 9.0 7.0 6.2 14.3 8.4 16.6 7.5 4.8 7.8 8.7 7.2 12.9 10.6 5.1 6.4 14.3 10.2 6.3 7.2 7.4 12.2 10.3 10.1 18.1 8.2 9.1 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 17.9 14.4 12.9 8.3 6.5 15.6 26.3 22.9 25.4 13.6 17.4 27.5 9.8 0.0 9.6 29.5 10.5 11.9 0.0 12.1 11.2 8.0 7.9 37.0 7.8 7.7 12.7 7.0 7.4 9.5 46.9 10.6 8.2 5.0 19.0 13.5 15.2 8.1 9.3 15.6 7.7 22.9 0.0 11.7 30.4 16.6 9.8 8.7 11.8 11.0 5.8 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" NA NA "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: AB_2686189, HPA070882: AB_2686320" "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favorable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavorable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 20.0 10.6 14.4 14.7 5.3 5.4 17.0 13.8 10.3 21.6 17.5 15.6 13.5 39.6 9.0 6.1 17.5 24.2 24.3 14.3 30.6 9.8 17.5 19.3 15.5 13.2 5.0 30.9 11.0 3.2 5.7 21.3 12.7 6.3 13.0 14.8 22.0 5.7 11.8 7.2 15.1 12.3 34.3 17.0 16.9 17.1 23.3 21.6 10.1 13.8 8.7 11.1 12.3 24.0 11.8 16.0 18.6 16.4 7.6 11.3 11.3 15.5 24.7 6.3 15.6 28.2 9.4 23.5 14.1 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 6.0 4.6 3.7 6.1 9.0 4.1 7.6 2.5 2.7 2.3 5.2 2.0 8.2 0.0 5.9 1.7 4.8 3.3 0.0 7.7 16.4 5.9 5.0 7.0 5.9 10.3 3.2 0.0 4.3 9.1 1.7 2.6 6.7 6.8 2.8 8.4 4.1 6.1 2.9 3.2 4.5 3.2 6.5 4.7 9.3 13.1 7.4 5.7 4.1 15.1 5.4 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Cell line enhanced" "Detected in many" "Hep G2: 22.4;TIME: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: AB_2673271" "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.6 6.9 4.8 6.0 6.2 2.4 1.1 0.9 0.8 3.0 1.5 0.0 3.1 2.0 1.6 6.1 10.0 6.2 0.4 0.2 6.7 1.6 1.1 22.4 7.2 5.9 1.2 8.6 3.5 0.4 7.2 0.9 11.7 0.9 0.0 0.9 3.6 5.2 0.6 0.4 6.6 1.5 4.4 6.8 1.7 0.5 5.7 6.8 6.3 0.0 2.5 5.2 16.7 11.5 1.6 1.9 31.9 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.8 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 56.6 50.9 0.8 2.4 38.0 0.7 20.3 5.1 25.4 12.5 27.9 27.5 12.0 8.3 3.0 0.8 8.3 65.2 0.0 3.1 3.0 11.6 3.5 8.1 32.7 3.9 35.0 19.4 29.4 6.7 0.0 0.6 3.8 20.3 0.0 29.8 14.7 3.5 45.6 0.0 12.9 0.9 6.5 4.6 0.0 0.7 43.0 36.3 0.9 40.2 7.4 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 2.7 1.3 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 1121.0;granulocytes: 643.7;Smooth muscle cells: 682.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 18.2;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 13 "monocytes: 24.4" "Cell line enhanced" "Detected in many" "HeLa: 25.8;MCF7: 29.4;SK-BR-3: 28.0;SK-MEL-30: 48.6" "Group enriched" "Detected in many" 5 "amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 69.1 111.3 4.0 58.1 12.9 5.7 25.0 5.4 10.9 32.3 23.3 21.1 46.0 5.6 49.8 33.9 28.1 63.3 99.9 76.7 4.8 5.0 17.9 12.1 50.1 8.3 7.5 5.9 177.3 16.1 28.9 51.8 7.6 13.1 88.3 13.8 43.7 66.8 203.2 32.3 23.4 24.3 98.4 6.8 5.1 32.8 11.8 6.4 11.9 34.7 35.8 14.9 71.4 54.5 0.4 1.8 0.2 24.4 0.1 0.2 0.7 1.9 9.7 1.9 3.4 1.4 0.4 7.4 1.8 3.6 1.5 2.1 9.5 1.8 2.0 0.8 3.2 1.4 1.0 5.8 0.8 0.8 0.1 2.0 2.7 25.8 2.6 1.4 1.0 9.1 0.3 1.1 1.4 0.1 1.0 0.4 2.1 2.6 0.5 0.1 29.4 0.7 2.8 5.3 3.0 1.0 0.9 0.3 4.8 0.0 0.7 1.6 4.8 6.0 28.0 48.6 1.3 1.7 3.0 0.0 1.4 4.7 0.9 1.5 16.5 7.8 4.2 1.0 0.8 8.1 0.1 0.6 0.0 0.1 18.2 0.1 0.4 0.0 0.0 1.8 0.4 0.2 0.0 0.2 0.1 24.4 0.1 0.1 0.7 4.0 12.9 5.4 10.9 4.8 5.0 7.5 5.9 13.1 6.4 223.4 1121.0 24.4 132.4 396.0 36.6 7.8 15.3 111.1 143.3 82.0 117.8 62.1 5.0 12.1 16.2 91.9 82.8 0.0 11.1 32.1 293.0 212.1 643.7 7.4 47.6 15.9 331.5 135.7 50.1 4.5 28.1 257.6 352.6 8.2 251.3 24.1 5.1 265.7 22.3 0.7 70.9 122.9 682.6 1.5 12.4 413.3 92.5 20.2 184.5 44.7 NRM NRM29 ENSG00000137404 Nurim Q8IXM6 6 30688047-30691420 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA072545, HPA073982" Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA072545: AB_2686532, HPA073982: AB_2686649" "unprognostic (2.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.71e-1)" "unprognostic (2.32e-2)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (1.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (3.52e-8)" "unprognostic (3.95e-2)" "unprognostic (1.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" 14.2 5.6 1.4 6.5 2.4 10.0 11.4 2.2 2.5 16.2 6.6 2.9 5.8 2.6 15.3 5.3 11.4 7.7 7.4 7.5 1.5 1.4 7.3 3.0 8.1 15.7 2.1 1.5 13.7 5.7 3.6 1.7 11.3 2.4 10.4 4.2 5.4 4.2 7.0 4.5 9.0 6.0 7.4 2.4 9.6 4.2 9.7 2.2 23.3 5.0 14.4 11.9 9.9 9.2 4.2 3.7 1.6 3.8 0.8 1.6 1.0 3.8 3.7 6.9 4.8 1.1 3.8 0.8 1.9 3.9 6.2 5.7 3.9 2.7 6.5 1.4 4.0 2.8 6.0 3.8 6.5 1.8 9.0 2.0 4.0 5.3 5.1 1.4 3.1 6.1 2.3 2.4 6.0 2.3 2.1 4.8 5.4 3.5 6.0 4.2 3.4 4.8 3.3 1.4 4.3 2.2 11.7 4.6 7.9 2.7 2.0 2.6 2.2 2.2 2.8 1.2 2.2 4.5 3.0 1.9 5.7 3.1 3.2 3.5 2.2 4.0 2.3 0.9 8.3 7.3 0.9 3.8 0.2 1.0 1.1 0.8 4.2 1.1 1.6 3.3 4.1 0.5 0.6 1.6 0.8 0.4 3.7 0.8 1.0 1.4 2.4 2.2 2.5 1.5 1.4 2.1 1.5 2.4 2.2 3.0 1.3 16.4 5.8 8.8 0.2 1.6 10.2 0.0 6.8 1.8 2.0 15.7 3.3 9.9 8.4 11.7 0.2 0.0 5.0 23.5 13.6 1.2 12.7 0.8 15.3 3.2 1.2 1.8 21.2 44.7 5.2 14.9 3.3 27.9 1.9 1.1 5.2 0.0 5.6 0.6 1.5 6.5 9.2 4.5 1.7 5.5 4.2 8.6 3.0 2.6 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-138 MG: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 11000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 6.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 48.6 0.9 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 0.0 0.0 0.0 5.9 0.5 58.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 85.5 0.7 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.9 1.6 0.0 1.8 0.0 103.3 3.1 0.2 0.0 0.0 0.0 8.9 0.0 0.0 25.8 0.0 2.7 51.8 37.7 8.8 1.9 0.1 0.1 0.0 0.0 0.1 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.6 12.9 6.5 25.6 16.2 10.4 20.7 13.5 8.0 8.0 8.1 18.5 15.7 21.2 16.7 14.6 7.4 11.9 14.5 12.8 11.7 9.1 5.1 13.5 14.3 16.1 9.4 8.5 15.5 19.3 9.5 9.0 16.5 15.9 5.1 14.4 10.6 15.0 14.1 13.1 10.2 10.4 25.1 4.7 15.4 11.5 9.2 60.2 9.9 15.7 10.7 13.3 23.6 10.5 17.5 13.5 13.6 16.3 12.9 12.5 9.4 10.1 8.1 6.3 12.8 18.5 8.9 16.3 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 62.5 31.4 15.2 36.7 8.9 13.8 35.3 43.3 45.5 60.3 22.7 25.5 27.4 34.9 42.5 19.0 27.0 24.4 0.0 31.7 28.2 26.6 34.7 19.7 42.0 28.9 6.4 16.1 17.8 11.6 7.6 23.6 17.1 10.1 22.6 15.4 21.8 28.5 25.8 25.1 47.3 15.3 25.8 26.7 29.8 21.7 8.3 31.5 7.2 22.2 26.3 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.1 22.1 26.4 19.1 7.8 10.0 28.6 18.8 10.9 28.3 23.7 22.2 14.6 31.5 18.4 9.0 12.6 19.8 29.6 13.9 37.9 29.5 22.0 35.9 15.9 18.7 4.9 31.6 12.2 5.3 6.6 22.6 14.8 9.9 16.9 18.3 42.8 22.7 17.7 20.8 26.0 27.6 29.0 6.6 21.7 26.6 31.8 18.9 12.2 18.3 15.6 16.0 20.8 15.7 11.3 21.5 23.5 15.3 10.3 15.5 15.8 18.0 22.9 9.9 19.8 38.2 11.9 23.1 18.2 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 11.9 15.3 27.4 14.6 15.3 20.5 11.3 12.7 20.1 14.8 8.7 17.7 24.8 10.0 15.4 26.7 16.1 8.4 0.0 15.4 25.3 16.3 13.0 15.1 6.7 15.5 12.7 8.2 17.8 11.1 7.1 35.9 19.8 18.6 27.9 11.3 22.6 17.1 7.0 20.5 5.8 31.5 12.9 14.6 52.6 42.8 15.4 11.8 25.9 13.0 10.0 NUP133 FLJ10814 ENSG00000069248 "Nucleoporin 133" Q8WUM0 1 229440260-229508341 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059767 Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA059767: AB_2684123" "unprognostic (2.05e-2)" "unprognostic (3.54e-1)" "unprognostic (5.75e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.17e-1)" "unprognostic (3.02e-2)" "unprognostic (2.20e-2)" "unprognostic (5.72e-2)" "unprognostic (2.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.48e-1)" "unprognostic (8.31e-2)" "unprognostic (2.22e-1)" "unprognostic (7.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.30e-2)" 20.6 20.0 17.4 16.3 21.6 16.2 25.4 29.8 24.0 19.6 17.7 27.2 15.5 13.2 23.0 18.4 18.5 22.2 13.5 22.7 17.6 17.0 19.5 15.6 19.8 27.8 20.9 20.3 27.3 17.8 33.3 23.3 23.0 20.6 19.1 18.3 15.5 17.8 21.2 28.6 21.8 16.2 20.9 19.4 19.1 17.1 19.4 20.9 38.0 21.7 18.0 22.8 20.2 17.9 9.0 10.5 7.5 13.6 7.6 10.9 7.3 14.3 11.6 18.2 9.4 13.1 14.1 35.5 11.9 12.2 17.8 16.2 13.7 14.2 20.9 10.4 11.8 7.9 19.1 25.1 12.6 19.1 12.6 31.2 12.6 12.0 10.3 10.5 25.5 10.3 11.0 9.5 12.8 15.3 12.4 14.8 18.0 28.4 10.1 13.9 6.5 18.8 10.9 27.2 20.2 10.6 18.4 18.9 20.5 10.1 12.7 15.6 19.4 17.8 11.2 13.0 9.3 17.4 20.3 12.9 8.1 9.9 14.0 17.7 9.7 12.0 22.5 9.2 14.9 16.8 7.5 8.2 6.1 8.8 8.2 10.9 9.0 9.3 9.7 10.5 7.1 9.6 10.0 2.9 7.6 13.6 6.0 8.6 7.3 17.4 21.6 29.8 23.4 17.6 17.0 20.9 20.3 20.6 20.9 8.9 17.6 3.7 5.2 8.0 16.0 17.3 7.6 9.4 10.3 14.0 7.9 18.2 5.0 7.2 1.1 8.7 2.9 0.0 7.4 11.1 10.6 5.8 7.0 9.5 8.5 15.9 9.8 12.3 12.3 1.9 11.5 7.1 6.8 9.0 7.1 11.6 6.2 6.5 11.3 6.8 11.9 0.0 9.9 12.3 16.7 9.4 15.3 7.0 9.5 5.5 NUP153 HNUP153 ENSG00000124789 "Nucleoporin 153" P49790 6 17615035-17706834 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027896, HPA027897, HPA027898, HPA027899" Supported Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: " "unprognostic (2.49e-1)" "unprognostic (5.37e-1)" "unprognostic (3.17e-2)" "unprognostic (6.20e-3)" "unprognostic (3.36e-1)" "unprognostic (7.64e-3)" "unprognostic (2.53e-2)" "unprognostic (6.49e-2)" "unprognostic (1.95e-2)" "unprognostic (7.16e-3)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.60e-2)" "unprognostic (3.66e-1)" "unprognostic (5.40e-2)" "unprognostic (8.69e-2)" 20.2 14.0 13.8 22.2 15.3 37.5 19.0 24.7 14.9 17.8 15.2 14.4 18.9 9.8 19.7 16.0 21.6 17.8 15.6 15.1 12.3 10.2 13.4 22.9 17.7 21.6 12.2 10.5 21.0 15.1 23.3 17.3 29.2 12.6 15.1 13.4 12.4 16.3 19.9 30.7 19.9 16.3 16.0 11.0 18.7 15.0 26.8 13.8 34.4 15.9 18.9 26.4 18.4 21.1 3.9 3.5 6.5 3.3 5.5 7.6 2.2 19.2 9.7 21.4 18.6 9.5 11.2 20.8 15.1 14.4 23.1 24.8 16.1 9.0 36.6 25.3 13.7 19.2 14.1 25.0 14.9 37.5 19.2 18.6 19.6 10.7 16.6 7.1 28.3 18.3 11.8 12.1 24.1 17.5 8.8 13.6 12.4 45.4 11.8 15.5 10.4 20.9 17.2 16.6 7.4 10.5 27.7 27.4 34.4 10.2 19.1 23.7 13.7 12.9 21.4 12.9 35.4 13.8 10.3 12.4 23.5 13.3 11.0 23.5 15.0 21.5 37.0 5.8 13.1 27.6 2.4 2.5 5.5 5.9 2.4 7.6 3.6 7.1 6.8 3.5 3.9 4.4 4.3 6.5 5.5 3.3 2.0 3.1 2.2 13.8 15.3 24.7 14.9 12.3 10.2 12.2 10.5 12.6 13.8 17.9 21.0 16.6 35.4 67.9 13.1 10.9 10.2 17.4 11.4 15.7 15.7 17.8 1.7 7.7 20.7 23.4 10.7 0.0 5.2 18.0 24.9 29.7 3.5 24.5 15.1 15.9 20.1 12.9 17.1 16.4 16.1 16.8 20.3 6.4 12.1 8.0 12.4 3.5 13.8 9.1 12.5 12.9 23.6 29.1 20.3 69.4 20.0 20.2 14.6 28.0 NUP155 "KIAA0791, N155" ENSG00000113569 "Nucleoporin 155" O75694 5 37288137-37371181 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "lymphoid tissue: 20.4;testis: 70.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 50.6;Late spermatids: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037775 Enhanced Enhanced "Nuclear membrane" "Intracellular and membrane" NA NA "Nuclear membrane" "HPA037775: AB_10671885" "unprognostic (1.10e-2)" "unprognostic (7.94e-2)" "unprognostic (1.28e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (2.18e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "unprognostic (9.49e-2)" "unprognostic (1.49e-2)" "unprognostic (6.80e-2)" "unprognostic (2.27e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" 6.8 5.3 3.9 6.5 5.9 11.2 7.3 6.9 7.5 6.4 5.1 5.9 3.4 4.4 9.7 3.7 6.9 5.0 3.7 4.7 3.9 4.1 4.4 5.3 5.1 8.1 3.8 4.2 7.9 5.5 8.1 7.0 8.4 5.2 5.5 6.3 5.9 6.0 5.9 6.1 8.1 5.0 5.9 3.9 7.2 4.9 70.1 2.5 20.4 5.4 4.8 9.8 5.8 6.0 7.3 4.9 7.1 7.1 7.7 10.0 4.4 13.8 11.0 12.0 17.7 3.7 5.5 43.1 11.2 5.9 15.4 11.3 16.2 11.4 15.7 5.2 7.2 16.7 11.3 20.2 11.0 24.2 10.3 11.4 12.2 40.1 7.5 4.7 20.3 8.6 4.0 4.6 23.7 12.0 4.2 8.1 7.1 22.1 8.4 10.2 6.8 10.8 5.5 11.3 8.5 10.0 13.1 37.8 12.5 3.5 13.3 14.5 10.0 25.8 11.1 6.5 8.9 13.7 8.1 7.0 18.6 15.6 14.0 17.0 9.6 16.0 21.1 8.7 18.4 14.0 7.1 3.4 5.8 6.1 7.1 10.0 7.3 5.7 5.3 4.9 5.8 5.8 6.5 1.3 7.7 5.0 3.4 4.1 4.4 3.9 5.9 6.9 7.5 3.9 4.1 3.8 4.2 5.2 2.5 3.0 5.0 11.5 5.6 9.3 6.5 7.3 2.5 12.0 11.4 3.5 5.9 11.9 0.0 5.9 50.6 7.4 3.8 0.0 5.2 17.5 5.8 6.6 4.7 7.9 6.8 4.8 1.2 13.5 8.8 71.9 10.3 7.4 0.0 4.6 9.7 3.5 5.5 3.5 9.6 3.1 13.1 0.0 6.1 27.7 19.6 10.2 6.3 8.7 10.3 4.4 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 131.7;Late spermatids: 308.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 8.8 10.9 9.1 13.7 21.4 4.1 15.3 18.9 12.6 9.2 8.6 5.6 5.8 7.3 9.6 9.0 11.7 10.6 9.1 7.9 11.1 6.8 11.9 16.4 9.5 9.3 11.5 5.1 13.1 17.2 8.9 13.1 9.0 8.8 9.3 10.7 7.3 9.7 9.6 9.1 10.9 7.1 10.5 7.6 7.8 9.3 25.8 9.7 19.1 10.3 12.6 12.7 8.0 10.2 8.9 3.8 1.7 6.8 5.9 10.5 5.0 10.0 10.8 16.8 9.9 6.1 5.9 12.2 12.1 9.8 18.3 17.6 19.8 12.2 17.1 11.4 6.4 21.7 8.7 23.1 13.4 29.7 15.3 15.3 16.1 9.0 21.0 4.6 11.6 10.9 4.3 7.1 15.6 14.9 4.1 10.7 10.3 14.5 12.7 13.9 11.7 13.4 13.9 28.6 15.8 33.4 16.5 13.3 12.1 16.9 12.3 14.9 10.4 11.2 13.1 12.7 13.0 8.5 8.1 5.7 14.4 10.2 11.6 13.5 8.5 18.4 18.2 9.8 8.5 19.3 0.0 4.8 1.7 6.1 6.3 10.5 8.9 7.8 7.5 3.8 7.9 9.6 8.4 0.1 5.9 6.8 3.6 7.7 5.0 9.1 21.4 18.9 12.6 11.1 6.8 11.5 5.1 8.8 9.7 8.9 5.0 11.1 14.4 23.1 10.8 4.1 10.2 8.1 14.8 15.7 17.7 18.4 10.0 10.8 131.7 9.3 3.1 23.3 11.1 17.4 12.4 7.0 8.1 11.9 7.4 6.4 3.5 11.6 6.2 308.3 8.9 3.7 20.3 4.6 6.6 10.8 9.6 7.0 7.8 10.1 17.1 12.9 13.2 34.7 19.4 24.0 7.9 8.9 7.4 9.7 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163841-45188015 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047162 Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA047162: AB_2679963" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favorable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 9.0 12.0 8.0 12.3 9.3 26.4 12.8 11.3 11.4 8.7 13.2 6.6 15.8 9.0 9.1 11.0 18.1 10.4 8.0 5.3 7.4 8.6 10.8 13.6 10.4 17.6 7.1 8.4 9.9 11.7 8.2 16.1 12.9 16.8 11.9 9.6 8.2 11.3 15.0 6.5 10.8 18.1 6.2 6.3 19.3 13.4 20.0 7.5 41.3 12.2 5.5 19.5 10.7 15.3 8.2 10.3 37.6 16.2 11.8 12.5 12.3 24.3 11.7 22.4 14.5 10.5 11.0 23.9 20.4 13.6 15.8 16.1 25.3 10.9 26.7 9.6 13.4 11.8 17.2 27.5 16.6 22.9 14.2 29.2 23.4 18.3 15.4 11.0 61.7 24.9 13.3 11.5 20.2 15.4 7.6 17.4 23.6 24.2 28.2 16.2 16.3 27.9 16.0 16.8 16.2 12.1 29.7 13.6 18.7 12.3 23.7 14.0 13.6 20.3 12.6 24.0 17.9 7.8 16.4 15.8 33.6 30.2 17.3 17.1 19.7 15.9 39.3 12.6 16.0 23.3 19.7 15.7 31.0 8.8 16.2 12.0 8.2 10.6 10.0 10.3 7.4 12.5 8.5 37.6 11.8 9.2 5.7 10.1 12.3 8.0 9.3 11.3 11.4 7.4 8.6 7.1 8.4 16.8 7.5 8.9 24.7 25.2 40.1 76.0 14.5 9.0 22.9 33.5 18.2 31.4 11.8 20.7 11.6 16.5 34.0 19.0 21.4 70.0 18.1 32.1 18.9 47.3 32.5 32.4 24.1 12.7 16.7 35.0 41.1 58.5 13.6 24.9 23.6 23.4 22.0 9.7 22.7 31.6 13.1 17.4 16.3 25.8 14.7 31.2 39.5 78.2 47.4 37.1 22.2 77.6 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.1 25.7 15.8 29.1 18.5 19.8 16.1 28.3 21.7 18.2 17.1 21.0 13.4 20.0 24.1 13.7 21.5 22.1 20.9 16.9 14.3 15.1 16.8 27.5 16.2 29.0 15.2 14.2 26.6 18.6 14.0 21.3 24.1 17.4 19.8 17.7 16.2 18.8 20.2 27.1 18.8 20.2 23.3 14.2 26.0 16.4 70.9 17.6 45.5 16.8 17.3 29.6 18.9 19.4 10.7 21.1 6.2 22.3 13.7 16.9 12.5 32.0 30.5 22.6 19.2 7.1 8.1 21.1 24.3 16.7 25.6 25.6 20.6 18.9 36.1 13.4 15.5 17.2 19.1 27.5 16.8 24.8 52.2 29.3 29.0 15.3 19.0 8.6 26.6 28.9 8.3 11.6 16.9 14.1 11.4 18.8 21.7 35.4 35.3 17.5 15.5 48.0 20.3 21.4 29.0 27.2 43.4 26.4 30.7 12.3 24.9 25.3 18.0 23.2 26.5 12.1 16.9 21.5 13.6 14.6 40.3 23.7 13.0 39.4 25.6 69.7 33.2 16.6 23.2 30.0 6.2 20.7 4.2 12.0 22.3 16.9 10.6 12.0 13.2 21.1 10.7 8.2 10.5 3.3 13.7 11.8 18.3 10.7 12.5 15.8 18.5 28.3 21.7 14.3 15.1 15.2 14.2 17.4 17.6 23.8 21.9 40.6 17.0 30.3 10.8 12.6 20.4 24.1 19.4 8.7 5.9 23.7 8.3 21.3 98.8 27.0 16.6 23.3 14.1 38.8 21.5 15.3 22.0 11.0 44.5 60.4 20.7 30.1 34.9 254.9 23.0 47.7 20.3 90.2 22.7 18.3 20.1 23.4 21.5 13.6 15.4 19.4 12.2 71.6 37.3 28.0 18.2 26.6 27.6 12.9 PAPD7 "LAK-1, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Poly(A) RNA polymerase D7, non-canonical" Q5XG87 5 6713007-6757048 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.5 7.9 9.6 13.9 11.1 25.8 16.3 22.7 12.3 15.1 16.6 10.6 14.8 9.5 13.2 8.0 12.2 11.3 11.4 8.6 10.7 7.3 9.7 19.9 13.2 14.1 14.8 5.8 18.5 13.3 13.2 12.2 10.0 9.0 11.6 8.3 10.2 17.0 10.6 10.4 16.7 13.1 13.9 7.9 14.8 10.1 11.1 11.7 25.4 11.3 11.3 11.6 12.5 34.9 1.9 3.8 0.7 0.7 0.5 2.3 0.8 16.5 11.2 13.8 17.0 10.0 9.0 19.9 11.3 14.1 14.1 16.0 11.6 9.3 12.1 8.7 13.8 15.8 12.3 11.3 8.7 13.0 13.6 7.2 6.2 35.5 6.3 6.2 9.3 9.4 6.1 7.6 15.7 10.1 10.4 8.2 9.1 8.3 16.1 11.4 9.1 12.6 12.2 7.5 5.1 8.8 11.5 11.8 3.1 5.6 9.5 13.8 10.5 26.9 13.1 7.7 7.8 7.9 5.1 7.2 16.9 17.8 14.7 15.7 15.4 6.3 10.7 11.0 8.7 10.4 0.0 0.7 0.7 2.1 0.4 2.3 1.9 1.7 1.6 1.2 1.5 1.9 1.7 0.4 0.5 0.6 3.8 1.8 0.8 9.6 11.1 22.7 12.3 10.7 7.3 14.8 5.8 9.0 11.7 6.0 20.8 6.7 8.4 29.1 16.5 0.0 7.6 4.0 9.1 0.0 35.3 4.5 0.0 0.0 9.6 8.2 7.3 0.0 0.0 3.5 14.1 9.6 4.7 13.2 5.8 14.3 4.7 16.0 5.7 2.8 6.1 7.6 3.3 0.0 8.1 7.8 0.0 6.2 8.5 0.0 24.9 0.0 14.7 6.3 4.9 22.6 4.7 6.9 7.6 8.7 PCM1 PTC4 ENSG00000078674 "Pericentriolar material 1" Q15154 8 17922840-18029944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 451.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023370, HPA023374, CAB058695" Enhanced Enhanced "Nuclear membrane,Centrosome,Cytosol" NA NA Centrosome "Nuclear membrane, Cytosol" "CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073" "unprognostic (1.52e-2)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (3.35e-2)" "unprognostic (9.52e-2)" "unprognostic (1.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.74e-3)" "unprognostic (1.09e-1)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "unprognostic (2.83e-1)" "unprognostic (1.76e-2)" "unprognostic (2.16e-1)" "unprognostic (4.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.45e-1)" 19.6 19.0 26.2 26.7 40.4 25.1 25.1 29.2 29.0 25.0 21.1 21.6 22.8 12.4 23.3 27.3 16.4 26.4 17.8 23.0 22.9 18.4 18.8 22.0 19.1 21.1 24.5 24.9 29.1 27.0 42.0 35.8 19.8 26.4 20.2 16.3 16.2 19.4 25.3 63.1 17.6 18.3 26.7 27.2 20.8 17.9 80.0 28.0 40.2 28.2 19.1 20.4 27.0 22.6 11.5 14.9 19.9 7.5 11.2 13.0 4.3 20.6 22.1 34.0 45.0 19.2 20.0 17.6 17.5 21.5 18.7 21.1 14.9 12.4 27.1 12.1 17.4 16.1 15.0 21.7 16.1 31.9 8.9 8.4 46.6 15.6 30.3 21.4 20.4 12.0 17.4 17.2 21.7 24.1 16.4 21.4 28.4 31.4 21.1 22.8 10.3 43.6 33.7 28.0 17.3 6.4 26.3 30.4 9.7 15.5 28.8 26.0 19.6 18.7 10.3 26.8 15.2 16.2 29.7 19.1 17.1 14.0 20.8 14.7 9.0 19.9 24.3 14.4 22.5 17.4 19.9 6.0 14.4 11.5 3.8 12.0 11.1 10.4 13.0 5.9 11.5 11.6 11.6 6.4 11.2 7.5 14.9 10.3 4.3 26.2 40.4 29.2 29.0 22.9 18.4 24.5 24.9 26.4 28.0 119.1 118.7 34.0 55.5 30.0 182.6 220.7 38.2 392.1 177.5 82.0 329.9 42.5 24.9 61.5 377.1 62.9 27.3 70.0 51.3 30.8 46.8 39.6 133.4 45.3 37.2 122.3 68.3 61.4 51.5 176.2 85.4 63.1 52.3 59.5 45.1 137.5 50.9 39.3 91.9 20.6 207.3 122.9 58.7 451.7 165.6 33.4 50.6 87.1 43.7 42.1 PHF11 "BCAP, IGER, NY-REN-34" ENSG00000136147 "PHD finger protein 11" Q9UIL8 13 49495610-49528987 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016566, HPA016708" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA016566: AB_2669387, HPA016708: AB_1855286" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.98e-6)" "unprognostic (3.49e-3)" "unprognostic (6.29e-2)" "unprognostic (5.50e-2)" "unprognostic (6.91e-2)" "unprognostic (3.05e-2)" "unprognostic (1.64e-1)" "unprognostic (2.37e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (4.46e-7)" "unprognostic (9.81e-2)" "unprognostic (5.36e-3)" "unprognostic (1.05e-1)" "prognostic favorable (3.46e-4)" 25.2 32.3 16.8 37.8 23.7 23.3 27.6 6.1 18.8 18.9 20.6 18.0 13.7 17.8 22.0 21.5 19.4 17.2 22.9 19.5 15.2 17.9 22.4 17.1 20.7 38.0 23.3 12.5 19.2 23.1 10.1 13.6 20.8 18.0 21.4 16.2 12.7 27.1 20.5 11.3 19.2 23.1 32.1 22.9 31.3 20.0 9.7 22.2 37.1 25.7 17.8 28.1 25.8 20.3 21.4 20.7 26.2 27.0 14.4 39.3 21.7 5.4 2.2 0.8 0.0 11.4 21.9 7.0 13.2 15.2 19.1 20.3 0.0 13.2 13.3 3.7 14.9 12.7 3.8 4.9 4.6 11.4 26.9 4.1 6.5 4.5 5.8 14.2 4.7 10.3 13.1 7.3 7.7 4.3 7.8 12.2 11.0 1.3 5.9 14.3 4.4 15.0 11.2 2.6 3.6 1.5 14.6 0.0 4.0 17.3 10.1 0.4 0.1 3.5 7.5 0.2 1.1 4.4 10.9 10.8 4.7 1.8 6.6 3.7 4.2 2.1 8.2 9.6 6.8 7.0 13.9 22.3 15.2 23.7 27.0 27.4 21.4 30.3 27.9 20.7 19.3 25.0 27.4 26.2 14.4 24.4 18.0 39.3 21.7 16.8 23.7 6.1 18.8 15.2 17.9 23.3 12.5 18.0 22.2 14.9 26.6 29.9 32.1 20.0 4.6 15.9 17.8 75.0 39.8 34.9 0.0 21.7 29.9 37.6 24.6 32.1 14.7 0.0 36.8 38.1 24.5 26.5 22.1 21.2 37.5 11.1 4.1 28.8 37.5 36.9 29.7 37.9 11.8 57.7 13.3 15.1 36.6 8.6 29.7 21.9 4.2 45.3 27.0 9.1 2.8 17.7 17.6 41.7 11.2 29.2 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 349.5;Late spermatids: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.7 7.8 13.7 20.3 10.0 11.5 12.8 11.2 10.7 11.3 9.9 22.8 7.4 16.4 10.2 14.9 13.9 6.1 12.6 15.6 13.8 7.4 5.4 30.5 15.0 8.4 10.0 14.6 11.9 9.0 22.0 11.9 18.4 13.4 12.3 11.7 12.5 10.6 12.9 5.8 14.7 8.5 6.8 6.5 9.8 10.8 20.3 9.7 9.0 6.8 12.5 10.2 20.0 23.2 10.2 13.0 18.3 10.9 17.2 25.1 5.7 13.0 11.4 9.8 11.6 12.0 18.5 10.7 12.8 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 35.7 39.9 77.0 65.2 30.9 75.5 47.0 30.6 57.6 40.9 36.6 92.3 85.9 31.5 25.8 349.5 40.9 11.8 0.0 17.4 39.0 36.8 47.3 136.5 15.3 46.9 108.1 34.5 39.3 53.1 510.4 33.1 60.9 37.1 31.5 24.9 44.2 20.8 25.7 50.2 19.5 75.2 19.4 39.6 55.4 46.4 24.7 18.7 82.0 29.0 53.3 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535006-154550435 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" NA NA "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536" "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 20.2 18.1 23.3 14.9 30.9 17.5 25.2 29.3 28.6 22.7 19.5 24.7 16.7 15.6 24.4 19.3 24.4 22.8 16.0 16.2 22.9 22.2 26.0 34.9 17.1 20.4 28.9 24.3 23.9 14.2 28.2 21.9 17.8 29.4 18.4 22.7 13.3 19.4 23.3 23.0 16.5 22.1 29.2 32.5 19.1 16.8 13.3 25.9 22.0 24.8 22.3 31.5 18.3 16.5 25.2 25.2 23.2 30.9 34.0 28.8 23.7 23.9 19.6 25.4 27.1 30.1 26.1 21.4 30.8 37.8 42.2 34.5 23.1 21.2 26.1 15.8 36.6 27.8 17.7 33.1 41.2 46.9 26.3 16.5 31.4 15.6 22.3 30.8 31.2 26.4 28.0 38.3 49.8 39.2 25.4 36.1 28.9 32.0 33.6 36.6 17.1 23.9 14.9 19.2 19.1 21.4 23.8 13.2 15.8 29.2 15.4 14.8 16.7 18.8 20.3 29.4 25.1 19.5 21.9 23.2 25.2 28.6 22.2 27.4 17.6 22.8 32.9 23.7 15.1 33.5 23.2 19.4 15.2 23.7 22.5 28.2 25.2 24.8 25.6 25.2 19.2 26.6 24.8 5.2 34.0 30.9 24.8 28.8 23.7 23.3 30.9 29.3 28.6 22.9 22.2 28.9 24.3 29.4 25.9 23.8 14.9 29.0 28.9 14.4 27.4 22.1 12.7 37.5 14.8 21.0 11.8 43.2 13.3 39.6 14.7 21.9 18.7 0.0 30.4 31.8 28.3 15.4 45.0 25.5 30.6 58.8 26.0 17.2 20.6 1.3 25.9 20.4 13.5 38.7 14.1 29.8 28.6 20.9 32.9 29.0 19.5 19.4 21.7 22.8 29.6 15.2 37.1 28.8 19.1 20.2 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 19.4 15.2 14.5 16.0 17.7 35.0 14.4 25.9 22.0 13.1 16.6 16.0 14.2 19.5 17.9 14.8 15.8 15.8 14.9 11.8 11.7 10.0 14.0 16.6 13.3 18.7 10.8 12.7 18.6 23.3 14.9 20.6 15.4 13.4 18.6 11.4 20.2 17.4 11.7 18.4 17.0 19.1 12.1 12.7 19.0 16.3 17.3 13.5 24.5 19.5 15.2 22.3 15.8 14.5 3.7 4.3 3.7 3.6 4.5 5.2 2.6 17.1 12.6 15.7 35.3 8.5 7.0 13.1 12.3 10.5 12.3 10.7 22.2 10.9 23.7 4.0 10.6 13.7 13.2 15.6 11.9 13.8 20.5 31.1 17.7 12.6 14.7 8.7 36.6 22.6 9.2 8.5 16.3 15.0 8.0 9.1 13.8 48.4 17.8 12.0 13.2 21.8 23.3 16.5 9.6 15.3 20.0 12.3 20.0 6.2 15.1 22.5 19.8 10.8 20.8 11.0 11.0 17.3 19.3 12.8 22.1 13.6 17.4 24.6 21.4 19.8 34.4 12.9 23.5 21.8 0.1 2.3 3.7 5.2 1.4 3.0 3.0 3.3 3.8 2.6 3.7 3.0 4.3 2.6 4.5 3.6 4.3 1.7 2.6 14.5 17.7 25.9 22.0 11.7 10.0 10.8 12.7 13.4 13.5 35.7 28.2 12.7 8.8 22.3 31.1 4.4 25.5 17.4 20.5 17.4 92.3 14.5 5.0 10.8 6.8 14.2 16.9 23.3 14.7 10.9 16.5 15.7 16.1 20.3 13.8 38.1 17.2 17.8 15.8 4.2 13.8 18.3 18.6 7.2 19.6 18.3 17.2 10.5 16.6 5.4 23.8 12.9 15.9 14.2 11.8 27.0 16.2 18.1 19.0 18.4 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" 7 75416787-75486271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 5.5 5.5 6.5 9.9 8.4 11.0 4.5 11.2 7.4 5.9 5.1 5.8 6.5 4.5 7.0 7.5 6.6 5.9 6.0 5.3 6.8 6.9 6.3 5.0 10.3 4.3 4.4 8.4 7.5 7.7 10.1 6.6 5.4 5.4 5.2 9.3 6.5 5.3 5.7 5.5 6.2 6.2 4.6 6.7 5.3 4.6 6.3 13.1 7.0 7.3 12.0 6.6 5.0 3.5 3.4 3.9 1.6 2.7 3.8 1.7 15.8 13.3 18.4 35.2 6.9 7.8 12.1 11.6 10.7 9.5 9.2 15.9 10.3 28.1 4.8 12.6 14.9 14.4 15.6 14.3 15.7 18.9 21.6 13.9 15.3 10.6 9.2 36.8 19.8 6.6 9.1 14.4 10.8 14.0 9.6 11.7 38.9 15.8 15.3 16.0 22.4 18.7 14.6 12.3 15.1 20.2 12.3 14.4 5.2 21.7 20.6 27.0 13.4 21.4 9.4 17.4 18.6 13.1 10.6 23.1 12.5 16.8 23.9 16.9 19.8 34.8 15.0 18.9 21.2 0.6 1.2 1.3 3.8 1.6 3.3 2.6 2.9 1.1 0.9 3.5 1.5 1.9 3.9 2.7 1.0 3.4 0.5 1.7 32.8 22.1 15.2 8.3 16.0 29.4 10.1 30.6 21.4 28.4 12.2 64.8 11.5 5.0 11.7 1.5 15.8 11.4 0.0 14.9 8.4 12.0 18.1 7.0 12.3 10.2 23.8 27.5 12.9 17.3 2.9 16.7 15.5 6.8 7.2 13.8 20.6 15.0 3.5 14.5 8.6 28.6 12.9 12.1 14.0 12.3 16.2 14.2 20.1 16.9 19.0 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 38.3;Late spermatids: 28.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049817 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA049817: AB_2680896" "unprognostic (2.23e-1)" "prognostic favorable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favorable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 4.0 3.0 4.7 3.4 5.6 6.6 4.5 6.0 5.3 4.7 4.6 2.4 5.8 5.2 3.8 2.8 2.1 3.8 4.7 3.5 4.4 2.2 3.6 3.1 3.5 5.8 4.7 2.0 3.1 1.7 4.5 3.7 4.3 5.1 14.2 5.3 3.0 7.0 4.0 2.5 3.9 9.5 3.9 3.6 4.0 3.9 4.2 3.5 5.7 3.3 3.0 4.8 1.1 1.9 8.1 13.0 16.7 8.6 3.4 1.9 2.9 4.5 2.1 2.7 4.7 3.6 1.2 0.8 2.6 4.6 1.1 3.0 1.3 2.0 4.9 4.6 5.4 4.4 2.7 2.0 2.4 3.6 2.9 5.4 7.2 2.5 1.0 1.3 2.1 2.9 9.4 9.2 2.5 4.2 10.0 5.7 3.0 4.0 1.8 9.5 2.0 1.5 3.0 6.8 12.3 2.5 11.8 4.2 14.4 4.5 3.1 5.0 6.6 0.9 16.4 6.7 2.4 2.1 8.7 1.3 9.7 9.2 1.4 3.3 5.7 2.4 1.5 3.5 2.5 3.9 4.0 3.3 4.2 4.8 2.7 3.8 3.0 1.6 3.5 3.4 1.1 3.0 2.6 3.0 6.4 6.3 4.1 6.0 2.5 4.0 0.0 5.2 11.8 5.7 0.0 1.1 38.3 3.0 4.5 0.0 1.9 3.1 6.0 4.2 5.7 1.7 2.6 3.2 12.5 1.8 4.1 28.3 5.8 3.0 10.1 0.0 2.7 4.6 1.6 4.0 7.4 3.5 5.2 12.9 3.2 22.1 4.1 6.0 8.7 2.2 5.6 8.4 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 366.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Cell line enhanced" "Detected in many" "WM-115: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" NA NA 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: AB_2678461" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.96e-4)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.6 20.3 4.6 7.2 37.9 23.2 4.1 40.8 58.9 19.8 20.2 6.7 19.1 4.5 9.5 79.5 44.9 57.4 5.1 55.6 37.2 3.7 4.4 0.0 2.3 21.0 46.6 8.0 1.8 21.0 80.2 84.7 66.2 29.2 17.0 3.3 2.4 16.0 22.8 5.5 3.1 4.9 3.8 10.8 30.2 3.8 12.4 4.1 9.9 4.4 5.5 0.8 11.6 16.2 58.0 6.7 3.3 4.2 25.5 32.3 14.8 18.0 33.2 7.4 14.9 15.0 26.0 5.9 116.2 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 74.5 42.1 34.0 181.6 366.5 230.5 189.4 33.1 26.8 70.5 31.4 110.0 6.3 10.0 50.5 4.7 46.7 2.0 0.0 12.7 5.7 171.5 79.9 168.6 29.7 58.0 42.9 28.7 42.4 184.5 8.0 132.6 109.3 160.3 13.6 4.9 133.0 16.9 2.9 159.8 69.9 78.9 12.9 124.6 28.3 4.3 248.5 12.0 52.2 6.9 105.0 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 58.8" "Group enriched" "Detected in many" 45 "Early spermatids: 1437.9;Late spermatids: 5492.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.3;REH: 12.6" "Not detected" "Not detected" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 1.2 1.1 1.7 1.8 2.6 1.6 1.1 7.8 2.8 2.1 2.0 2.6 2.9 1.8 1.8 1.2 0.9 2.2 1.0 1.0 1.9 2.0 1.8 0.5 1.3 2.6 1.7 2.3 3.1 0.7 0.9 1.2 0.9 3.5 1.2 1.0 4.0 0.8 1.4 2.2 1.3 2.1 1.2 2.4 3.5 1.1 58.8 1.6 1.0 0.7 0.0 1.5 0.9 1.6 3.1 5.0 6.2 3.0 1.1 2.2 1.1 1.1 1.4 4.6 8.6 3.4 2.4 3.1 1.5 0.6 1.1 0.9 1.4 4.2 0.2 0.8 0.8 0.6 3.7 3.6 0.2 0.6 2.1 1.9 3.4 3.4 0.9 0.5 6.4 0.3 1.6 0.4 1.8 0.7 2.6 0.8 2.5 4.1 2.8 0.9 0.9 4.1 12.3 7.1 0.9 0.9 12.6 4.7 0.1 1.3 1.0 2.2 1.9 1.4 0.6 0.5 5.7 7.0 5.4 0.5 0.8 1.4 0.9 0.9 1.5 2.0 1.9 1.3 7.0 1.1 6.2 2.2 6.2 1.1 3.0 0.4 3.1 2.2 0.7 1.4 1.1 1.0 1.8 1.3 1.1 2.5 5.0 1.2 1.1 1.7 2.6 7.8 2.8 1.9 2.0 1.7 2.3 3.5 1.6 0.0 1.4 0.0 1.1 0.9 3.3 5.5 0.0 1.4 2.3 0.0 3.9 0.7 0.0 0.4 1437.9 0.6 1.0 0.0 0.2 1.6 1.8 0.7 15.0 0.0 2.4 3.2 2.4 3.7 4.3 5492.6 23.6 4.3 0.0 1.0 1.1 7.8 0.5 0.0 18.4 0.8 4.6 19.4 1.9 76.2 19.6 0.3 0.6 1.0 1.6 0.3 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 46.6" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 4.0;Club cells: 1.2;granulocytes: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 5.3" "Lineage enriched" "Detected in single" 28 "dendritic cells: 5.3" "Cell line enhanced" "Detected in many" "RH-30: 6.7;THP-1: 13.2" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.7 0.1 0.7 1.2 4.5 1.2 0.5 0.6 1.6 1.5 5.5 0.3 0.1 1.7 4.7 2.4 2.2 1.6 3.6 13.8 0.5 0.7 0.3 0.2 0.6 0.7 0.6 0.8 0.7 0.3 0.4 1.5 0.4 0.4 2.0 3.2 1.6 0.7 3.1 46.6 0.2 1.6 10.6 0.2 0.4 2.4 3.8 0.2 0.5 0.5 14.4 0.8 5.1 1.4 0.1 5.3 0.0 0.0 0.0 0.0 0.4 1.0 0.0 2.7 2.7 0.3 0.0 0.8 2.2 2.0 1.2 1.1 1.7 0.3 0.3 1.7 0.2 0.8 0.0 0.4 1.1 1.9 1.0 0.4 5.6 2.2 4.1 0.0 0.5 4.0 0.1 0.7 1.9 0.1 0.8 0.6 1.8 2.0 0.4 2.2 0.0 1.8 1.4 0.7 3.5 0.5 1.5 6.7 0.7 0.3 0.5 1.3 3.5 1.4 0.5 1.5 3.5 0.9 13.2 0.0 0.9 1.7 0.0 0.7 3.7 1.1 0.4 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.7 4.5 0.6 1.6 0.5 0.7 0.6 0.8 0.4 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Cell type enhanced" "Detected in some" 21 "Cholangiocytes: 7.6;Early spermatids: 25.8;Late spermatids: 5.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: AB_2681766" "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.2 2.5 4.8 5.4 2.6 2.4 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.4 1.3 0.5 6.3 1.1 2.1 1.8 3.8 0.6 1.7 5.8 1.4 0.9 3.0 2.1 1.0 1.9 0.1 3.3 2.1 2.0 3.5 1.3 0.6 3.8 3.4 0.8 1.9 1.6 5.2 7.6 3.9 0.2 0.9 2.3 4.4 4.4 1.1 0.6 2.6 4.9 2.0 2.7 2.1 1.4 5.1 6.8 2.6 1.8 1.7 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 0.0 0.0 0.0 0.3 0.1 0.5 1.6 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.7 25.8 0.6 0.3 0.0 0.0 0.9 0.2 0.3 0.0 0.8 0.2 1.6 0.0 0.0 0.3 5.8 0.9 0.0 1.7 1.0 0.5 1.5 0.5 0.0 0.7 0.4 1.8 0.0 0.6 2.1 1.1 0.3 0.3 0.0 0.4 0.3 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Nuclear membrane" "Nucleoli fibrillar center" "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 44.2 45.4 42.3 36.7 42.5 29.6 43.5 30.9 53.1 43.6 40.5 32.0 45.3 47.8 46.8 32.4 36.2 30.4 39.8 32.2 39.5 45.9 46.0 92.3 35.7 53.0 44.7 33.4 37.5 88.1 18.5 48.6 51.0 39.9 33.8 19.1 23.3 68.8 40.5 52.2 31.6 43.4 32.0 38.4 32.2 60.6 28.3 31.9 38.8 56.1 28.7 32.4 31.4 47.5 54.5 59.6 114.0 58.1 33.2 57.2 64.1 17.3 47.7 6.9 17.9 47.0 27.0 9.1 51.7 27.4 12.7 17.9 8.4 11.4 50.2 26.8 30.6 7.3 13.0 4.2 16.2 5.3 18.5 28.0 7.3 14.0 14.5 25.2 6.4 20.3 26.2 16.2 8.6 6.3 16.6 17.7 14.2 3.2 65.4 11.7 26.7 11.2 5.8 8.4 24.9 31.0 15.3 14.8 9.7 12.1 13.0 12.7 18.5 13.6 29.6 12.5 5.6 11.1 5.4 34.3 22.8 15.1 22.1 7.4 58.2 19.4 17.4 33.0 12.0 24.5 86.2 58.1 76.4 57.2 30.5 48.1 54.5 52.0 49.8 33.8 49.9 35.3 47.6 114.0 33.2 29.6 59.6 55.8 64.1 42.3 42.5 30.9 53.1 39.5 45.9 44.7 33.4 39.9 31.9 119.1 107.6 134.8 132.5 110.7 54.7 56.9 175.8 84.3 81.9 172.7 15.7 168.6 116.0 298.8 157.9 238.6 301.1 23.3 264.4 410.9 312.7 240.5 140.7 234.8 161.0 54.0 187.1 255.9 127.0 499.8 284.2 161.6 384.6 285.9 338.7 137.5 343.3 280.5 236.2 262.8 46.9 226.4 277.1 222.3 127.0 119.2 227.2 151.3 250.8 152.9 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.8 7.7 0.2 1.9 0.0 0.9 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.1 0.0 3.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.1 0.0 0.4 2.1 0.0 0.0 6.8 0.0 1.3 5.0 0.2 0.0 0.0 0.0 9.5 20.6 0.1 0.0 0.0 1.6 3.0 0.6 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 3.0 1.0 0.0 0.0 0.7 0.5 1.7 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 1.6 0.0 2.4 0.4 0.0 0.0 0.1 12.7 0.0 0.0 0.0 4.1 3.1 0.0 6.8 0.0 0.1 3.3 0.3 0.0 3.5 0.0 0.5 6.5 3.6 18.2 9.7 0.5 0.1 0.0 0.0 0.0 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538116 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 10 "neutrophil: 55.1" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.1" "Cell line enhanced" "Detected in all" "OE19: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" NA NA Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: AB_2679738" "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favorable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favorable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 19.7 14.6 23.2 14.8 24.3 17.9 19.1 27.1 27.2 17.1 20.7 14.0 54.7 12.5 15.9 16.7 33.7 17.5 13.7 21.4 24.7 19.6 30.6 14.2 15.1 14.6 23.1 13.7 18.8 10.4 19.8 15.3 28.8 19.6 24.3 17.4 9.8 17.6 44.8 24.3 47.5 13.4 22.7 20.6 19.3 17.4 8.5 23.1 15.4 15.7 23.4 16.4 24.3 26.3 2.5 5.5 55.1 4.5 4.3 3.2 1.2 18.4 12.4 11.1 12.5 12.8 20.1 14.7 22.3 12.1 11.4 12.3 13.8 18.3 23.5 16.3 20.4 16.3 10.6 15.3 16.7 14.4 23.3 14.8 12.4 11.5 10.2 10.4 36.4 14.4 14.0 16.8 16.0 16.0 15.4 19.3 20.7 17.7 21.7 18.1 14.6 21.8 16.0 8.6 74.7 12.7 29.5 19.8 17.2 15.8 25.7 14.9 12.2 19.3 16.9 9.9 17.8 10.5 16.9 23.0 34.1 26.2 23.6 26.5 13.4 13.3 25.4 14.8 17.3 12.8 3.1 2.8 4.3 3.2 2.9 2.7 2.5 2.7 2.6 2.4 2.4 2.3 2.9 55.1 4.3 4.5 5.5 1.7 1.2 23.2 24.3 27.1 27.2 24.7 19.6 23.1 13.7 19.6 23.1 53.6 33.1 41.7 69.2 138.9 39.0 58.4 94.3 28.1 45.5 455.4 27.5 88.3 104.5 97.1 10.8 89.6 83.8 93.5 79.0 356.6 77.0 126.4 39.3 76.9 61.7 49.3 71.2 62.0 61.6 4.2 67.3 70.3 55.6 119.0 76.9 41.2 124.5 79.5 82.0 81.7 31.3 64.7 79.6 48.8 70.5 212.0 37.3 67.5 84.5 98.4 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 240.1;monocytes: 755.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.9 0.0 0.1 0.0 3.4 5.3 0.3 0.5 0.9 0.5 0.4 0.0 13.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 37.9 1.0 0.0 0.0 0.2 10.7 0.0 0.0 4.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 0.0 44.2 0.0 0.4 0.2 0.0 0.0 0.4 55.7 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 0.0 1.0 0.5 11.4 10.3 2.1 136.4 91.7 14.7 9.1 10.4 0.0 2.1 0.0 55.5 0.2 4.2 4.9 0.0 240.1 7.5 28.8 73.7 1.1 137.8 18.7 1.6 110.7 51.5 4.0 0.4 7.8 6.3 60.8 755.6 26.2 3.3 79.4 4.0 10.6 0.0 2.3 6.5 86.3 0.0 4.9 5.1 1.9 3.2 6.6 3.8 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.5 4.5 1.5 0.5 3.4 4.0 1.8 2.9 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 0.0 1.7 5.8 0.0 4.3 1.1 2.2 0.0 1.6 0.0 0.0 4.5 0.3 0.3 0.0 0.3 2.6 0.0 0.4 0.0 1.6 2.8 0.0 0.0 0.4 0.8 0.5 0.0 3.6 0.0 0.9 1.4 0.3 2.0 0.0 5.5 2.8 2.5 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 8.9 1.3 0.0 5.2 0.2 20.8 1.4 5.1 0.0 2.3 0.0 13.7 8.7 0.0 6.3 76.6 2.8 2.8 0.0 1.2 2.7 2.6 5.1 0.0 1.3 1.6 0.0 5.2 3.1 1.2 31.1 2.6 0.0 1.7 1.8 3.3 5.6 3.6 3.5 2.8 0.7 24.1 0.0 2.2 27.1 24.0 0.0 2.1 0.0 4.5 6.1 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719481-108785811 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane" "Nucleoplasm, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.3 14.4 17.0 18.6 35.5 24.4 23.1 22.2 19.8 17.1 12.8 25.5 13.3 19.9 21.5 17.0 19.1 14.8 20.2 12.9 12.5 18.9 19.5 17.7 19.2 15.1 17.0 32.4 24.1 48.5 37.5 18.8 16.5 21.8 15.8 14.3 20.0 31.6 37.5 17.3 17.4 23.2 17.8 16.3 20.9 20.6 15.9 26.6 28.7 18.0 17.5 20.5 19.7 5.6 5.1 8.3 6.3 4.2 8.7 2.3 18.4 11.3 16.3 14.7 19.0 17.0 15.8 16.6 13.2 13.8 12.1 28.1 8.9 29.1 12.9 17.3 17.0 15.6 27.8 17.3 20.1 17.7 13.5 30.3 14.0 19.8 11.1 35.3 10.2 14.3 13.2 21.5 16.8 13.6 21.0 12.7 32.4 16.1 18.2 10.2 15.6 14.4 20.5 9.3 13.6 14.8 25.0 14.0 12.2 23.1 23.7 10.9 14.7 12.7 16.1 10.2 8.1 16.3 25.0 14.4 19.1 10.1 18.5 13.4 19.8 26.4 11.2 16.0 11.1 8.3 5.3 5.1 7.6 3.4 8.7 5.5 6.3 6.9 4.2 5.6 6.2 6.7 8.3 4.2 6.3 5.1 5.1 2.3 14.4 18.6 23.1 22.2 12.9 12.5 15.1 17.0 16.5 15.9 71.5 71.1 34.9 25.8 49.5 43.3 85.9 33.1 57.6 70.5 55.8 68.7 22.7 1.7 31.3 59.8 43.8 25.7 0.0 44.1 15.0 32.3 38.2 83.1 49.9 41.1 30.2 102.2 27.0 44.0 22.0 35.6 64.2 45.5 49.5 50.9 18.7 36.5 25.9 52.6 15.4 37.7 45.3 62.9 74.1 59.2 59.2 34.0 44.5 31.5 31.5 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.2 30.6 20.0 20.9 10.8 8.9 24.3 50.5 27.6 51.0 26.7 37.1 19.2 31.4 40.8 37.0 24.6 54.3 36.3 39.8 30.8 25.4 56.3 26.6 29.9 28.9 13.5 42.9 20.0 8.6 19.0 36.3 32.2 16.8 26.7 11.8 34.1 22.4 29.0 49.9 25.0 34.9 21.8 53.1 36.4 30.7 19.7 33.1 19.9 33.4 18.2 12.1 35.9 31.8 18.5 19.2 18.7 17.3 41.2 39.1 37.5 21.5 41.5 16.7 22.2 29.9 27.3 30.5 22.5 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 3.0 24.7 28.1 17.5 20.5 15.2 17.4 22.9 9.4 9.1 8.7 13.7 15.1 3.3 34.2 259.8 12.7 10.1 0.0 17.4 28.1 9.3 32.2 5.8 17.9 14.0 14.3 24.0 11.6 13.4 1320.8 13.8 17.1 11.8 10.0 13.9 7.8 29.0 6.5 11.3 11.2 24.4 0.0 9.0 18.0 19.2 27.0 19.8 23.8 10.9 19.2 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037739 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;pancreas: 26.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 31.4;Horizontal cells: 35.0;Intestinal endocrine cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 110000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.2 4.6 6.7 2.9 13.5 16.8 3.1 27.5 22.9 2.7 5.3 2.2 0.0 5.9 3.7 1.0 2.5 5.8 2.7 9.9 6.5 6.3 3.9 0.7 3.4 3.4 4.3 16.4 3.3 26.0 4.5 8.0 3.3 15.8 2.6 5.6 2.6 9.0 3.5 0.8 2.7 5.5 2.3 4.3 3.2 15.4 2.3 3.1 1.6 2.1 0.3 3.0 1.6 2.2 0.5 3.0 7.2 6.3 2.9 5.2 2.0 4.5 5.7 1.1 4.7 0.0 0.0 9.4 6.1 2.9 0.8 0.7 12.5 2.0 1.7 1.7 0.8 8.0 6.3 3.7 11.5 0.2 0.0 4.0 2.1 8.0 5.6 1.1 0.4 2.3 0.3 10.0 3.2 8.3 4.3 0.1 2.1 11.8 0.8 0.0 5.1 1.7 1.1 6.8 2.2 5.5 7.6 4.0 4.4 3.5 2.3 12.7 30.9 8.9 9.2 4.0 4.6 4.6 1.3 1.4 5.4 8.6 0.9 5.2 0.0 0.0 0.7 0.3 3.9 8.7 1.5 2.3 3.3 5.2 4.7 2.0 0.5 1.7 3.7 1.8 0.4 0.3 1.9 7.2 2.9 6.3 3.0 1.6 2.0 6.7 13.5 27.5 22.9 6.5 6.3 4.3 16.4 15.8 3.1 6.0 4.5 1.3 5.8 1.8 13.0 14.2 7.6 4.0 2.3 12.2 31.4 5.9 8.3 5.3 3.4 1.4 6.8 0.0 10.5 4.8 2.9 11.6 5.8 0.4 2.9 35.0 46.3 2.5 13.9 5.4 1.7 3.9 3.3 1.0 20.7 2.0 11.4 21.0 1.4 0.6 4.7 0.0 2.8 0.4 3.0 0.4 2.9 4.3 12.1 9.6 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622456-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA024391: AB_2671554, HPA053049: AB_2682025" "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 16.2 13.7 36.6 9.8 19.8 38.0 15.0 21.8 36.8 14.5 13.3 7.9 11.9 11.0 15.5 11.9 15.0 11.0 12.2 22.7 31.1 17.0 15.2 18.3 13.5 10.5 16.5 22.5 18.4 14.6 21.5 15.2 13.3 17.0 14.2 10.1 7.6 12.9 11.4 35.9 13.2 13.2 13.4 12.2 11.7 12.0 28.2 17.0 21.6 15.7 10.3 10.9 16.4 14.1 7.1 7.6 25.5 9.7 8.5 8.4 6.6 13.3 11.9 14.8 12.9 16.5 18.8 8.4 10.2 20.9 10.8 13.5 8.3 15.2 9.8 17.2 15.0 27.4 17.9 18.2 9.5 20.5 7.4 15.9 16.7 12.4 11.4 20.3 5.9 9.5 17.5 19.7 10.7 29.5 22.7 14.6 15.5 19.8 16.0 13.1 8.7 15.1 8.8 14.6 12.7 6.2 7.7 7.1 9.9 10.0 10.5 14.3 14.9 10.6 12.2 22.6 18.1 13.9 10.9 17.2 10.4 14.6 16.3 8.9 15.9 13.7 9.8 16.4 10.4 11.6 22.3 8.0 14.7 7.8 7.6 7.8 7.1 6.5 7.9 7.6 6.2 8.0 7.4 25.5 8.5 9.7 3.9 8.4 6.6 36.6 19.8 21.8 36.8 31.1 17.0 16.5 22.5 17.0 17.0 181.7 102.5 28.4 53.1 78.5 76.8 142.2 12.7 147.2 72.8 17.4 64.8 22.9 8.3 41.1 35.1 49.4 36.0 140.2 42.8 21.5 70.2 73.7 24.4 38.4 20.5 82.6 42.4 33.2 36.1 39.4 71.7 44.0 40.5 35.1 29.8 34.2 55.5 30.8 68.9 23.0 54.0 45.3 68.0 171.7 121.8 80.4 50.6 41.5 24.7 56.8 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein, X-linked 2" Q9Y388 X 130401969-130413343 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 19.4 16.7 22.3 16.7 20.0 17.1 25.0 22.7 22.9 25.1 19.9 18.9 19.1 17.0 29.4 29.5 18.7 19.8 18.8 17.8 21.0 18.7 17.7 21.1 16.9 21.2 18.6 22.1 28.2 21.9 17.9 24.4 17.3 21.0 23.0 20.0 16.3 20.5 23.7 21.0 21.4 15.9 23.0 18.9 21.1 18.4 10.8 19.0 26.4 23.0 17.9 26.7 27.2 20.2 12.6 10.5 11.0 9.5 9.4 19.3 5.4 14.0 14.7 14.7 15.2 14.7 27.6 15.0 13.2 13.5 15.0 16.4 10.9 17.2 13.5 31.7 10.0 19.8 15.2 23.5 12.2 21.9 12.3 20.9 12.1 13.5 11.4 13.3 18.7 14.4 20.0 17.4 16.8 23.4 21.8 16.8 16.8 10.5 11.8 16.7 24.4 21.4 23.3 11.1 24.6 23.9 16.6 14.6 18.2 15.2 11.2 17.2 20.6 8.3 17.7 23.2 12.5 11.5 13.8 10.9 12.1 9.9 28.2 27.4 15.7 17.0 19.2 14.8 30.5 15.3 11.0 9.4 10.8 11.1 9.5 11.1 12.4 13.8 14.0 7.8 12.6 15.1 14.2 8.0 9.4 9.4 10.5 19.3 5.4 22.3 20.0 22.7 22.9 21.0 18.7 18.6 22.1 21.0 19.0 17.9 14.7 30.6 27.8 28.5 21.4 20.3 25.5 29.4 45.5 10.4 9.8 28.5 13.3 28.8 2.9 30.2 14.2 0.0 30.8 34.2 26.7 22.1 34.6 23.6 30.5 15.9 39.0 35.0 46.7 3.5 30.0 32.5 27.0 31.5 21.9 19.8 26.5 17.5 41.4 32.3 10.4 32.3 30.7 16.5 47.3 26.0 21.6 32.0 27.7 20.3 RCC1 CHC1 ENSG00000180198 "Regulator of chromosome condensation 1" P18754 1 28505943-28539300 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 12 "Early spermatids: 181.3;Late spermatids: 634.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015413, HPA027573, HPA027574" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236" "unprognostic (6.23e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.91e-5)" "unprognostic (3.93e-2)" "unprognostic (2.03e-3)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.43e-11)" "unprognostic (1.04e-2)" "unprognostic (2.78e-1)" "unprognostic (3.02e-1)" "unprognostic (6.23e-2)" 12.3 11.2 7.5 21.1 10.9 32.0 13.9 5.8 10.4 11.6 17.9 5.0 8.0 17.5 12.1 10.1 30.1 12.6 8.6 6.9 8.0 4.6 9.5 23.0 15.3 22.7 14.8 4.0 16.3 21.0 4.7 12.4 17.0 9.8 10.2 19.0 6.0 20.6 7.8 13.6 11.7 14.7 12.7 17.7 23.0 11.8 46.7 10.2 34.2 47.9 28.4 34.2 16.4 16.7 8.4 16.0 4.6 8.7 6.2 11.5 6.9 48.3 21.0 18.2 21.5 13.0 16.9 20.4 19.0 11.6 30.9 24.2 20.8 38.9 62.1 11.7 18.2 12.8 29.1 59.4 30.2 24.3 25.1 35.4 54.8 25.6 27.4 9.8 59.7 32.9 21.3 20.1 29.7 24.5 18.6 21.0 37.5 40.8 19.2 12.5 26.2 47.6 21.7 39.2 22.3 20.5 47.2 32.2 30.3 11.5 22.7 29.3 14.9 20.6 32.7 15.8 10.3 13.8 18.7 16.1 15.9 31.5 19.5 36.8 11.7 16.5 47.5 15.5 88.4 17.1 4.6 8.7 3.2 6.2 8.7 11.5 8.4 9.2 9.6 16.0 7.7 8.3 9.1 1.9 6.2 6.2 9.1 8.4 6.9 7.5 10.9 5.8 10.4 8.0 4.6 14.8 4.0 9.8 10.2 0.0 9.3 16.4 8.8 32.5 0.8 4.0 7.6 9.4 9.1 7.0 2.0 18.6 3.3 28.4 181.3 8.7 7.4 23.3 20.5 31.6 11.8 10.1 1.1 5.3 18.6 12.7 5.2 4.3 10.5 634.1 15.8 9.7 13.5 16.2 15.5 0.2 34.0 3.5 9.9 3.5 0.3 6.5 13.3 11.4 18.1 29.5 20.5 12.9 23.4 16.3 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.6 20.6 9.0 14.7 23.3 13.0 13.0 9.5 12.9 11.3 13.3 9.7 14.3 14.6 13.4 15.4 11.6 26.0 11.6 14.2 11.0 15.6 11.1 5.9 12.6 17.2 16.0 10.1 15.3 19.8 19.6 12.4 12.6 12.6 12.1 10.8 12.1 14.5 8.9 11.5 14.8 14.8 5.7 12.5 5.1 8.1 14.1 14.9 12.9 21.4 16.3 11.2 10.2 8.3 14.4 17.4 23.7 7.9 15.3 12.3 7.6 12.1 9.0 25.1 29.8 13.0 11.2 6.5 9.3 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 23.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 29.6 0.0 17.6 6.6 15.5 0.0 0.0 0.0 0.0 21.8 13.6 0.0 0.0 7.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 12.6 0.0 0.0 25.9 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Cell line enhanced" "Detected in many" "K-562: 24.4;U-266/70: 25.2" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.4 3.6 5.7 2.5 2.3 4.8 1.9 4.3 4.8 4.8 5.3 2.7 5.6 3.9 6.9 3.6 3.3 3.2 4.3 1.9 5.0 4.1 3.1 6.5 5.4 3.7 0.5 9.6 9.5 2.2 0.8 5.6 7.3 2.1 1.6 0.0 24.4 17.5 11.7 8.3 1.5 7.2 3.1 2.5 3.7 7.8 10.8 7.0 1.4 2.2 5.1 5.7 4.0 5.5 1.4 1.7 9.3 8.2 0.8 3.5 3.2 4.7 5.1 25.2 17.0 1.5 7.4 12.4 3.4 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.3 2.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.1 4.8 4.3 3.3 10.1 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 6.9 7.0 11.3 6.1 5.8 6.6 4.6 8.9 4.3 6.9 3.2 2.3 9.9 9.4 10.1 5.7 10.1 8.1 10.2 3.7 4.3 5.2 11.1 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 6.0 11.2 5.4 4.2 11.8 15.8 5.3 2.5 6.7 4.5 7.0 9.8 3.5 3.3 3.0 16.3 6.2 3.0 23.3 4.0 1.2 5.4 5.4 11.6 7.6 4.7 15.9 4.6 8.0 11.3 9.1 6.1 5.6 5.0 1.8 5.6 4.1 3.0 6.5 9.9 3.7 7.4 0.0 3.6 6.6 5.8 15.4 1.4 6.4 6.2 5.1 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 1.6;Early spermatids: 1.9;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.8;MOLT-4: 13.2;NTERA-2: 4.0;RPMI-8226: 2.9;SuSa: 7.7" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 13.2 0.2 4.0 0.2 0.0 0.1 0.1 2.9 0.0 0.0 0.1 0.8 0.2 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2-like and GRIP domain containing 2" P0DJD1 2 87755955-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;testis: 12.3" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 5.7;Early spermatids: 4.3;Late spermatids: 2.3;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "T-reg: 11.3" "Lineage enriched" "Detected in single" 12 "T-cells: 11.3" "Cell line enhanced" "Detected in some" "BEWO: 10.7;JURKAT: 5.2;MOLT-4: 12.2;NTERA-2: 5.3;SuSa: 15.5;THP-1: 4.9" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 0.7 2.1 0.1 0.6 0.2 7.1 0.8 1.3 0.3 4.6 0.8 1.2 1.1 0.0 0.3 2.4 0.0 0.5 0.0 0.2 0.4 0.8 1.2 1.3 0.1 1.7 6.3 0.1 2.7 7.5 0.6 0.1 0.8 0.1 0.6 0.6 1.8 0.0 0.1 0.9 1.7 12.3 0.9 1.6 0.3 0.9 0.9 0.0 0.5 0.1 0.0 11.3 0.4 0.0 0.0 0.6 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.1 2.5 0.2 0.0 0.1 0.0 5.2 3.7 0.3 0.0 0.4 12.2 0.0 5.3 2.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.7 4.3 0.1 0.0 15.5 0.0 4.9 0.1 0.8 0.1 0.0 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.4 0.9 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.0 0.0 0.0 11.3 0.4 0.0 0.6 0.0 0.0 0.1 0.2 5.7 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.1 4.3 0.0 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.4 0.0 0.8 0.0 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2-like and GRIP domain containing 3" A6NKT7 2 106391290-106468376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 14.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 3.3;MOLT-4: 10.3;RPMI-8226: 3.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.3 0.0 0.5 0.4 0.4 0.3 0.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.4 1.4 0.7 0.1 0.1 0.6 0.2 0.2 0.7 0.7 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.4 0.7 0.1 11.6 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 1.2 0.2 0.4 0.5 0.5 0.4 0.3 0.5 0.1 0.4 0.5 0.4 0.3 0.5 0.0 0.0 0.1 0.4 1.4 0.3 1.2 0.1 0.7 0.3 0.1 3.3 0.3 0.6 0.3 0.1 0.1 0.1 0.3 1.1 0.4 0.4 0.3 0.7 0.6 0.0 0.5 0.2 10.3 0.1 0.4 0.0 0.1 0.0 0.1 3.3 0.1 0.6 0.5 0.1 0.4 0.0 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.6 0.5 0.7 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.5 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.2 1.2 0.2 0.0 1.4 0.0 0.0 0.1 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 2.1 0.0 0.0 0.0 0.0 0.0 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.8;Early spermatids: 7.2;Late spermatids: 2.1;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.4" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2-like and GRIP domain containing 5" Q99666 2 109792758-109857695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 15.0;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 10.7;PC-3: 11.2" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 4.9 5.0 5.2 2.5 11.7 11.4 9.4 8.2 6.3 6.4 5.2 7.5 6.0 12.3 6.8 6.1 2.6 4.0 3.4 4.4 4.7 4.8 5.3 5.1 5.6 3.0 5.1 4.9 6.0 11.9 3.8 15.1 4.9 5.6 6.4 2.0 8.3 8.5 4.9 7.4 5.2 5.8 6.9 4.9 3.7 8.7 15.7 3.7 1.0 6.8 3.2 2.6 6.3 15.3 6.9 4.3 9.2 3.5 2.8 6.7 0.9 8.5 4.8 1.7 1.9 0.4 0.1 1.6 4.3 1.4 1.7 2.4 9.2 1.0 0.6 5.4 0.7 1.5 3.5 1.4 0.3 0.3 1.9 10.7 3.8 3.7 0.2 0.2 0.6 0.5 0.7 2.3 0.9 0.6 0.5 0.9 1.6 2.3 2.2 0.7 2.3 0.4 1.3 2.4 0.1 11.2 3.7 5.9 0.0 0.5 3.1 5.8 3.2 5.1 0.0 1.4 0.3 0.1 0.9 5.9 1.8 6.5 0.4 2.4 4.1 0.3 0.6 3.3 0.1 0.7 6.8 3.5 4.1 4.1 1.6 6.7 4.0 3.8 4.0 2.3 6.9 4.9 3.7 9.2 2.8 3.0 4.3 2.9 0.9 5.2 11.7 8.2 6.3 4.7 4.8 5.1 4.9 5.6 3.7 3.0 7.3 0.9 3.6 3.1 15.0 12.2 0.0 4.0 5.7 12.2 15.7 2.0 0.0 1.0 2.4 2.7 1.6 0.0 0.9 1.6 3.1 5.2 0.0 0.8 1.6 3.2 5.1 2.5 2.8 0.9 2.3 2.2 1.7 1.0 0.9 1.9 1.4 1.7 1.1 0.3 16.7 0.0 4.7 2.7 2.3 2.9 3.7 5.7 0.6 4.2 RGPD6 RGP6 ENSG00000183054 "RANBP2-like and GRIP domain containing 6" Q99666 2 110513812-110577185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 11.3;Ciliated cells: 4.0;Club cells: 14.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 5.6 4.1 3.2 2.4 4.9 6.9 5.5 5.6 8.1 4.5 3.8 2.1 4.9 10.1 2.3 3.8 3.4 4.7 3.8 4.4 3.3 4.7 5.1 2.8 3.4 6.4 6.9 8.5 9.5 5.3 6.0 3.5 3.3 4.4 5.2 6.2 4.1 3.5 2.6 3.2 4.0 19.9 7.5 2.4 3.8 3.7 5.7 3.8 8.1 2.6 2.9 4.1 0.3 13.9 3.5 16.7 12.6 5.0 6.2 1.7 10.2 9.3 8.3 5.9 11.3 5.2 0.3 7.5 8.7 10.6 6.2 10.3 5.6 11.0 3.3 5.8 14.7 1.2 7.8 6.3 1.9 1.9 5.5 5.7 10.7 10.9 10.0 5.3 5.1 6.3 3.4 6.9 4.0 4.4 0.4 11.2 2.6 4.4 2.1 8.4 0.1 8.2 7.4 23.7 4.2 5.2 1.1 9.7 13.5 0.6 5.6 7.8 9.1 12.3 2.3 10.9 7.7 0.3 0.3 7.3 0.8 4.0 6.8 2.6 3.2 2.4 1.3 4.1 2.5 3.1 2.7 1.7 5.7 3.1 2.5 8.1 2.9 1.6 3.8 0.9 0.3 8.9 11.3 0.0 0.2 0.8 0.0 0.8 0.0 4.0 14.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2-like and GRIP domain containing 8" O14715 2 112370092-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Cardiomyocytes: 6.9;Ciliated cells: 10.7;Early spermatids: 19.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.6;hTEC/SVTERT24-B: 12.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 2.4 0.9 0.5 1.3 0.9 6.2 2.3 2.6 2.7 1.7 1.5 0.4 1.9 2.1 1.1 1.6 1.4 1.7 0.6 0.8 1.3 2.8 2.4 0.9 0.6 2.2 2.3 2.0 2.8 2.0 1.4 1.0 1.3 1.6 1.5 2.4 1.3 1.5 0.8 1.3 1.2 14.0 2.1 1.4 1.9 1.5 2.9 2.1 3.1 2.4 1.4 5.1 1.2 6.2 3.0 4.6 2.8 1.4 3.1 0.1 2.9 2.2 2.3 1.7 5.4 0.4 0.0 1.9 3.4 1.9 2.7 11.0 1.5 2.4 7.7 3.6 14.6 3.8 2.9 1.7 0.1 0.2 0.5 2.1 12.4 3.1 4.7 2.0 2.3 7.4 0.4 3.4 2.3 6.7 0.8 2.8 0.8 3.3 0.0 0.7 0.0 1.0 2.8 2.9 0.6 7.2 0.1 1.6 3.1 0.7 3.2 8.7 1.5 2.2 4.9 4.3 0.1 0.0 0.0 0.4 1.8 0.3 3.1 1.3 1.3 3.5 1.0 5.1 1.7 2.3 2.9 1.4 2.9 3.2 2.2 1.0 1.4 2.4 2.1 1.3 1.2 8.9 2.2 0.0 0.2 0.3 0.7 6.9 0.0 10.7 3.4 0.0 2.0 0.1 0.0 0.4 19.2 0.0 0.0 0.0 1.0 0.1 0.4 0.0 4.7 0.0 0.4 0.0 0.0 0.6 0.6 6.2 0.3 1.1 0.0 3.6 0.0 0.2 1.0 0.0 0.0 0.1 0.6 0.0 0.5 4.3 1.1 0.0 0.3 0.0 0.0 0.1 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330242-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 31.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.7;non-classical monocyte: 19.1" "Lineage enriched" "Detected in many" 6 "monocytes: 19.1" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;PC-3: 20.1;U-2197: 29.3" "Group enriched" "Detected in many" 6 "amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6" "Group enriched" "Detected in many" 6 "amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.9 5.1 11.1 7.1 22.7 3.9 3.4 13.0 13.5 5.9 5.2 1.5 2.4 8.0 4.2 2.3 15.8 5.8 8.7 3.3 9.7 2.3 2.3 2.7 3.8 5.4 1.4 5.8 4.8 6.6 1.5 5.0 4.5 2.2 4.7 3.6 2.5 4.8 3.5 10.3 31.5 5.8 2.8 0.8 4.6 11.1 2.8 2.5 0.0 1.5 8.7 8.6 3.4 7.0 0.1 3.3 0.0 19.1 0.0 1.5 2.0 1.6 4.5 1.3 2.8 1.6 8.8 1.0 10.1 9.2 7.8 3.8 2.8 5.1 0.3 5.1 7.3 3.2 10.7 0.0 13.6 1.0 0.5 0.0 0.4 4.3 2.4 3.0 0.1 4.7 8.5 26.7 7.9 4.7 9.7 1.6 0.3 0.2 0.1 3.4 0.3 0.1 11.5 0.6 2.1 20.1 0.1 3.9 0.0 2.3 1.7 10.0 2.7 2.6 1.3 13.8 0.4 0.9 0.8 4.4 12.5 7.4 29.3 2.5 0.2 0.5 0.0 17.4 2.7 5.0 0.0 4.3 0.0 0.2 9.7 1.5 0.1 1.0 0.3 3.3 0.0 1.1 0.5 0.0 0.0 19.1 0.0 0.1 2.0 11.1 22.7 13.0 13.5 9.7 2.3 1.4 5.8 2.2 2.5 0.0 0.3 0.0 7.8 11.8 3.3 0.8 2.5 1.4 1.2 0.0 0.0 0.6 0.0 2.4 0.3 2.9 8.6 0.0 6.1 4.3 5.1 1.9 4.6 0.0 4.3 0.0 2.9 4.9 9.5 1.0 4.0 4.2 1.7 1.0 5.2 0.5 6.7 7.0 1.8 0.0 0.9 0.0 1.4 1.6 0.9 13.2 0.2 1.3 6.6 6.3 RNF6 DKFZp686P0776 ENSG00000127870 "Ring finger protein 6" Q9Y252 13 26132115-26222493 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 129.7;Spermatocytes: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039343, HPA040048" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA039343: AB_2676456, HPA040048: AB_10672969" "unprognostic (3.22e-1)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.45e-1)" "unprognostic (1.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "unprognostic (7.63e-2)" "unprognostic (6.13e-2)" "unprognostic (1.39e-1)" "unprognostic (4.21e-2)" "unprognostic (2.70e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" 16.4 19.8 22.3 15.9 27.5 25.1 24.2 26.6 28.9 13.1 16.4 8.1 20.3 15.5 13.0 13.0 20.9 13.4 12.5 17.9 20.4 17.3 16.9 17.5 14.5 18.4 15.8 22.6 10.9 14.2 17.9 26.3 23.3 16.8 15.2 17.2 8.1 16.1 13.5 24.8 15.5 21.0 14.3 16.7 16.6 15.1 28.7 14.5 23.6 16.1 14.4 20.7 14.1 19.5 13.5 12.5 24.6 15.0 13.3 13.2 9.2 12.8 11.3 4.3 6.3 15.0 11.8 9.6 22.1 18.0 14.3 10.2 14.1 16.6 23.0 11.1 21.0 12.8 17.3 12.0 17.9 23.9 22.1 7.5 25.1 9.5 12.1 23.4 26.2 26.5 11.1 34.9 16.1 34.4 14.0 14.3 10.1 9.7 0.0 22.1 11.5 14.6 15.3 3.5 23.1 7.9 11.7 16.7 9.1 17.6 17.0 7.8 4.8 11.8 21.7 20.9 10.5 8.3 25.8 18.7 12.4 7.5 16.5 15.7 5.9 5.5 13.8 11.3 15.0 16.1 24.6 10.1 23.7 11.9 13.1 12.8 13.5 13.0 13.2 12.5 9.4 13.2 11.2 7.1 13.3 15.0 6.5 13.1 9.2 22.3 27.5 26.6 28.9 20.4 17.3 15.8 22.6 16.8 14.5 20.8 16.6 13.3 10.0 27.1 20.3 12.6 5.1 29.4 19.4 7.0 23.6 18.0 28.2 13.6 81.3 20.2 17.0 0.0 13.5 17.4 11.7 18.2 25.5 10.2 15.6 28.6 10.9 11.6 23.5 129.7 13.6 19.6 13.5 10.0 13.4 21.8 19.3 14.7 10.6 16.1 37.7 25.8 16.0 94.2 31.6 25.5 35.2 20.3 10.9 20.3 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 4.5 6.5 9.5 6.4 14.3 6.8 5.4 9.5 19.1 5.0 4.5 3.5 3.1 3.3 5.9 4.6 4.1 6.1 3.7 3.7 7.1 7.9 4.4 3.8 8.5 7.2 4.6 12.0 7.6 4.6 5.7 4.6 2.7 4.8 5.5 5.0 12.4 3.7 3.3 4.2 6.6 4.0 4.0 4.0 5.0 4.4 5.2 5.1 34.4 5.3 2.1 6.2 4.2 4.5 2.9 3.1 1.5 1.7 2.5 2.6 1.3 3.7 2.9 3.9 3.7 2.2 5.3 6.5 2.3 4.9 2.5 3.6 3.7 3.6 6.7 1.8 2.3 3.0 6.3 5.0 2.6 5.2 4.7 1.8 4.4 5.3 3.2 3.0 4.7 3.4 2.0 2.3 3.9 2.6 4.3 3.6 12.2 6.2 7.9 3.8 4.0 14.9 3.2 3.8 7.2 3.2 9.4 6.2 5.8 1.7 5.1 4.0 2.5 5.5 3.1 2.9 4.4 7.6 2.1 3.7 2.3 4.3 3.8 4.0 4.4 8.3 6.4 2.8 3.8 3.4 0.8 1.2 0.2 1.1 1.7 1.2 2.0 1.9 1.3 0.8 2.9 2.6 1.8 1.5 2.5 0.6 3.1 2.6 1.3 9.5 14.3 9.5 17.0 7.1 7.9 4.6 12.0 4.8 5.1 65.5 23.3 13.0 7.7 2.5 39.5 3.9 17.8 9.4 12.5 17.4 188.5 5.6 1.7 3.0 9.2 6.8 5.0 0.0 1.8 4.3 5.4 6.4 4.7 7.6 3.5 15.9 12.6 13.5 5.6 4.1 8.9 3.2 3.3 1.8 7.1 32.7 2.2 6.6 5.6 1.9 114.6 0.0 3.8 27.2 20.4 3.8 2.2 8.7 8.6 3.7 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Melanocytes: 843.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Cell line enhanced" "Detected in many" "HHSteC: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.5 22.6 24.1 12.5 90.5 78.0 10.6 15.0 53.8 21.9 28.8 9.0 30.7 0.0 24.2 20.1 40.3 6.1 13.0 17.3 27.1 2.6 11.1 22.0 20.1 7.2 100.5 5.6 35.8 53.2 23.4 22.0 66.1 34.2 52.4 15.3 10.8 12.9 49.6 3.8 12.3 6.6 15.1 57.5 6.5 6.0 7.3 2.8 34.8 15.3 10.6 19.1 16.0 6.9 73.8 27.9 6.3 15.3 45.0 21.1 9.1 24.9 9.6 3.9 5.2 8.8 53.8 0.0 18.9 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 196.5 114.3 99.6 291.9 300.9 9.9 48.4 58.6 61.6 77.3 195.4 15.7 224.5 190.6 334.0 5.9 318.0 108.1 46.7 256.7 631.9 182.6 258.8 390.0 80.9 683.1 14.3 107.7 330.8 517.6 7.7 216.6 535.9 843.5 212.0 105.0 74.6 227.0 96.2 150.3 153.5 9.7 97.0 282.9 12.5 6.5 151.4 403.9 126.8 84.4 372.9 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA 7400000 "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 65.5 43.6 18.7 23.3 17.3 36.4 42.6 11.2 15.5 44.4 38.5 23.0 38.8 20.7 41.8 57.9 40.3 27.3 33.2 30.8 18.7 18.4 56.5 68.2 44.7 41.1 24.7 12.6 55.7 70.9 21.2 41.7 46.0 18.4 44.4 28.0 28.5 43.5 36.2 51.9 23.3 33.3 39.7 31.5 38.4 29.5 28.2 19.7 33.2 74.6 39.3 32.1 49.8 37.8 29.1 44.3 32.6 48.4 34.3 45.9 46.3 23.7 51.3 37.9 58.6 48.1 60.0 29.1 38.0 44.3 31.2 37.4 54.9 59.0 11.8 25.0 46.7 36.9 51.9 52.5 31.9 34.0 29.0 38.8 34.5 58.5 51.6 41.7 25.9 39.1 41.3 40.1 21.5 34.9 50.9 44.1 15.5 34.2 31.8 42.1 55.7 10.6 56.4 40.3 36.1 22.1 13.3 49.0 38.5 70.2 66.7 18.6 41.8 31.6 35.4 85.5 59.4 34.5 60.3 30.0 31.7 23.8 27.0 46.2 31.2 59.2 16.7 34.4 45.7 24.7 20.7 43.8 24.1 28.4 47.3 28.5 29.1 35.4 30.4 43.8 26.6 30.2 30.9 32.6 34.3 48.4 44.3 45.9 46.3 18.7 17.3 11.2 15.5 18.7 18.4 24.7 12.6 18.4 19.7 83.4 82.6 129.4 146.5 95.1 26.0 57.2 214.0 68.3 101.2 122.1 21.6 264.5 202.2 211.7 36.2 236.3 103.8 23.3 215.7 493.0 216.8 157.8 217.7 143.3 324.9 19.1 151.1 167.6 353.0 67.9 277.3 291.4 150.1 267.9 172.8 64.3 169.6 103.7 156.3 255.0 33.2 168.1 121.7 176.8 142.9 104.8 255.7 159.2 214.9 195.4 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139477-59158836 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 132.6" "Cell type enhanced" "Detected in all" 5 "Glandular cells: 405.9;Muller glia cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 5.9 18.4 30.1 18.6 29.7 11.3 16.0 14.9 25.2 12.2 18.7 24.4 27.8 27.5 9.1 58.0 10.7 9.2 11.1 7.2 27.7 33.9 19.0 66.8 13.0 22.0 41.8 21.3 7.0 96.8 14.6 46.6 8.1 27.1 48.8 16.4 10.0 132.6 34.1 4.3 7.9 21.1 6.6 51.3 23.6 28.4 6.4 25.3 7.3 35.9 8.6 23.4 18.9 5.9 33.6 50.0 10.6 17.6 17.3 34.4 32.6 8.8 10.7 5.8 9.0 3.6 0.6 7.4 8.0 6.9 9.9 6.0 7.5 4.8 20.3 12.7 4.8 7.3 9.5 9.1 6.0 5.7 59.5 12.5 6.5 7.4 22.9 10.8 21.5 9.9 2.0 14.4 6.1 16.6 2.1 3.2 8.7 7.5 64.1 3.5 10.4 8.8 8.6 5.9 14.7 6.6 8.0 5.7 129.8 6.4 7.4 27.1 10.8 4.8 19.5 27.1 3.3 8.8 15.8 2.6 12.0 5.0 4.2 9.6 65.4 48.1 19.9 12.0 14.6 14.7 10.6 13.1 9.4 25.9 15.5 33.1 33.6 27.3 25.2 13.5 17.4 14.3 19.5 2.0 17.3 17.6 50.0 34.4 32.6 30.1 29.7 14.9 25.2 27.7 33.9 41.8 21.3 27.1 25.3 26.8 96.0 46.9 40.1 29.0 63.6 51.8 132.5 95.0 89.9 57.6 47.1 59.9 74.6 117.2 35.1 52.2 73.8 23.3 229.6 80.5 24.9 405.9 46.2 201.1 102.0 47.7 325.7 35.6 28.2 14.8 11.5 58.2 243.0 32.5 93.2 440.4 146.8 74.8 21.5 86.0 65.5 6.5 40.9 97.2 84.1 39.6 125.2 74.3 75.9 57.4 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 175.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 10.9 7.3 8.3 11.0 10.0 5.5 10.4 38.0 11.5 10.6 8.0 4.5 10.8 6.0 14.1 9.2 8.5 9.8 6.7 7.2 7.2 4.2 8.4 6.5 7.1 9.0 7.6 5.9 18.8 8.7 11.4 19.7 6.6 8.5 8.3 7.4 7.3 10.2 13.7 11.4 13.9 8.2 11.0 10.3 8.8 8.5 10.7 8.7 8.4 12.5 7.2 8.0 10.7 11.5 6.7 4.8 4.4 2.4 3.4 4.3 1.2 3.0 2.3 11.7 6.8 5.4 5.8 5.6 3.6 2.9 4.5 5.8 5.3 2.1 10.6 4.5 2.7 3.5 5.2 7.1 5.1 5.9 4.7 8.1 10.7 5.3 4.4 4.0 22.4 6.7 4.0 5.9 4.2 6.2 4.4 4.8 7.6 14.8 6.0 3.8 2.7 14.4 8.3 7.8 5.0 4.1 10.4 18.1 3.6 6.1 3.0 9.6 6.7 6.4 5.9 4.0 8.4 3.1 10.8 5.3 2.9 5.4 5.6 4.2 4.9 7.0 12.7 3.0 9.6 4.4 1.6 2.3 4.4 4.3 2.4 3.7 3.9 3.6 2.9 2.7 6.7 4.1 3.3 0.1 3.4 2.4 4.8 3.3 1.2 8.3 10.0 38.0 11.5 7.2 4.2 7.6 5.9 8.5 8.7 26.8 18.9 20.8 15.3 18.8 113.2 15.9 17.8 12.0 23.9 21.0 198.3 12.7 6.6 15.4 8.3 19.7 10.0 0.0 11.1 5.8 14.4 13.4 12.7 14.8 10.2 89.0 18.5 14.1 21.8 5.1 46.9 15.5 13.5 15.4 14.3 57.4 13.0 10.5 32.2 4.5 175.4 71.1 21.7 76.9 67.5 17.2 5.5 20.3 15.0 9.6 SIPA1L2 KIAA1389 ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232561558 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 54.1;Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.8;NTERA-2: 27.1;WM-115: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Nuclear bodies" "Nuclear membrane, Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 4.1 1.1 3.6 2.9 3.3 2.1 3.4 0.3 7.6 3.2 8.9 1.6 1.9 1.0 8.7 1.2 4.4 16.2 3.1 3.9 1.6 2.4 6.5 0.8 6.5 6.7 1.4 3.9 3.2 10.0 2.9 10.5 3.3 2.3 2.5 3.3 3.3 3.7 3.0 4.5 2.0 3.4 3.4 1.1 4.7 5.7 0.0 1.2 4.3 1.2 2.0 2.4 0.2 0.0 3.6 33.8 0.2 0.2 0.0 14.6 0.6 1.2 1.5 1.1 1.4 0.0 2.8 6.8 12.7 1.4 0.8 6.9 1.1 1.4 0.0 6.4 0.0 3.3 0.0 3.1 0.4 3.6 1.9 4.7 0.3 3.0 0.0 7.8 12.4 0.0 0.0 0.8 1.5 3.6 0.3 27.1 0.1 5.4 0.0 0.0 1.7 4.3 5.3 1.8 5.9 11.3 0.3 4.6 8.1 0.7 0.4 2.7 4.0 0.0 8.7 1.4 3.2 0.0 0.0 5.0 3.1 22.9 0.0 0.6 0.0 0.2 1.2 2.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 4.3 2.0 0.9 1.2 0.0 0.2 6.0 2.6 0.5 7.6 7.8 24.4 54.1 12.7 5.3 5.7 3.5 49.1 4.0 0.0 5.3 9.5 18.6 16.4 0.0 0.5 6.1 12.6 14.3 1.1 3.0 8.9 4.8 6.9 1.3 12.9 7.6 0.9 11.0 13.5 5.4 30.2 10.8 1.2 35.1 1.8 0.2 35.3 0.0 19.8 3.4 26.0 6.5 12.4 1.0 21.2 15.9 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005161-45009430 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.3;skeletal muscle: 21.0" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 2.2;Exocrine glandular cells: 1.9;Melanocytes: 1.7;Pancreatic endocrine cells: 1.2;Smooth muscle cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9;LHCN-M2: 22.0;RH-30: 15.1;SCLC-21H: 25.8;U-2197: 16.7;U-698: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA056958 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA056958: AB_2683287" "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 5.8 0.2 0.2 0.2 0.4 0.1 3.4 0.5 0.4 13.3 0.4 0.2 0.0 0.1 1.1 0.8 0.8 0.1 0.1 0.8 0.1 0.0 0.4 0.1 0.3 0.2 0.9 1.8 0.3 4.6 5.7 13.5 0.3 1.4 5.2 0.1 9.3 23.3 1.3 21.0 0.3 0.1 0.4 0.8 0.1 7.4 1.1 0.0 3.9 0.7 4.0 0.8 1.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 6.3 23.9 0.0 0.1 1.1 0.4 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 2.2 3.9 0.2 0.0 1.2 0.0 7.7 0.0 0.0 0.0 2.1 1.1 0.0 4.9 0.0 0.1 0.7 0.2 0.1 0.0 22.0 0.8 0.0 1.3 0.2 0.0 4.8 0.0 15.1 0.0 0.0 1.2 25.8 0.2 3.3 0.1 0.0 0.2 0.1 1.9 0.3 0.4 1.3 16.7 0.0 0.5 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.1 0.0 0.9 1.8 1.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.6 0.0 0.0 0.0 0.1 SLA "hSLAP, SLA1, SLAP, SLAP-1" ENSG00000155926 "Src like adaptor" Q13239 8 133036724-133103054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 61.6;lymphoid tissue: 152.5" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 59.4;Kupffer cells: 193.1;Macrophages: 141.0;T-cells: 117.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 14.1;JURKAT: 59.1;Karpas-707: 37.9;U-266/84: 21.3;U-937: 14.9" "Group enriched" "Detected in many" 5 "amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6" "Low region specificity" "Detected in all" "HPA012296, HPA074192" Enhanced Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA012296: AB_1856946, HPA074192: AB_2686673" "unprognostic (1.19e-2)" "unprognostic (6.29e-3)" "unprognostic (2.73e-3)" "unprognostic (6.07e-3)" "unprognostic (1.66e-2)" "unprognostic (1.10e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (9.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.66e-1)" "unprognostic (3.05e-2)" "unprognostic (8.60e-2)" "unprognostic (1.65e-1)" 6.8 3.6 2.5 21.3 2.7 24.0 2.6 1.6 3.3 2.7 2.2 1.5 1.7 1.6 2.1 1.6 2.4 3.2 5.3 2.6 2.8 1.7 3.2 3.5 11.2 18.2 2.5 2.7 1.7 1.4 0.0 1.4 3.4 2.0 2.1 1.7 1.5 4.0 1.4 1.6 1.3 8.4 2.8 4.1 33.3 2.5 1.6 1.4 152.5 9.2 2.1 18.3 4.3 1.6 11.2 18.4 61.6 31.7 29.2 27.5 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 1.7 14.1 0.2 0.0 0.1 0.0 0.0 0.0 59.1 0.0 37.9 0.0 0.0 10.0 2.4 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.0 0.1 0.0 0.0 2.0 21.3 0.0 0.2 14.9 0.0 0.1 24.3 45.0 21.2 28.1 26.7 9.5 19.5 21.1 18.4 11.2 18.6 18.9 61.6 29.2 31.7 1.4 27.5 29.6 2.5 2.7 1.6 3.3 2.8 1.7 2.5 2.7 2.0 1.4 8.9 25.0 32.9 0.3 1.9 7.0 2.0 2.5 9.4 19.4 0.0 0.0 0.4 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.7 2.3 0.1 34.8 1.7 59.4 0.0 0.0 11.1 193.1 0.9 0.3 141.0 5.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.5 0.9 0.0 0.0 2.4 0.1 117.6 0.0 0.1 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.5 5.8 0.1 0.1 2.6 8.3 11.5 48.2 29.7 34.3 38.9 2.7 30.2 0.1 38.0 34.0 29.7 4.1 4.1 69.9 14.4 20.7 0.2 22.0 42.9 50.4 44.2 32.3 27.2 17.1 10.3 23.0 10.6 45.1 18.6 0.4 0.1 6.8 29.7 3.1 0.3 31.8 0.4 4.8 47.0 0.1 0.5 7.6 18.1 0.5 0.7 0.3 46.4 41.3 0.6 4.8 6.0 27.2 32.2 68.4 1.1 1.0 50.3 22.1 0.3 1.0 33.5 20.4 0.6 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 8.9 12.7 14.3 34.8 5.8 9.7 4.8 7.6 14.7 14.8 54.1 3.9 56.0 0.0 116.4 3.0 22.8 93.3 0.0 16.0 1393.3 24.4 12.4 75.9 0.8 262.7 120.8 20.1 17.2 103.7 2.7 2.8 101.0 13.5 232.6 23.8 21.4 199.4 84.2 3.5 3.8 7.4 0.0 14.7 1.6 7.1 5.8 626.2 40.6 16.6 118.3 SLC2A13 HMIT ENSG00000151229 "Solute carrier family 2 member 13" Q96QE2 12 39755021-40106089 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;parathyroid gland: 43.0" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 87.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006584, HPA061679" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA006584: AB_1849755, HPA061679: " "unprognostic (1.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-1)" "unprognostic (3.31e-1)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-2)" "unprognostic (2.12e-3)" "unprognostic (4.07e-2)" "unprognostic (6.34e-2)" "unprognostic (1.24e-2)" "unprognostic (9.16e-2)" 3.8 7.2 9.8 3.3 18.0 1.2 3.0 4.0 27.7 13.0 7.4 2.8 0.3 6.0 5.9 5.3 3.7 2.9 4.0 4.9 8.2 14.1 10.7 6.2 3.7 1.9 14.9 11.0 3.1 5.0 43.0 11.1 4.6 4.8 3.0 6.8 2.4 4.2 2.6 1.2 2.1 8.3 4.7 2.7 2.3 5.6 2.0 4.1 0.6 2.2 0.9 1.4 3.9 3.9 2.0 0.1 1.5 0.5 0.6 0.9 0.0 0.6 3.6 2.6 1.2 18.5 7.7 5.3 5.8 4.1 2.6 3.4 0.0 1.7 2.2 4.3 4.6 3.6 0.3 1.8 1.8 2.2 1.9 5.4 1.7 9.1 1.3 2.9 4.9 2.9 3.8 1.7 1.2 2.2 1.5 1.2 2.2 0.7 5.7 5.9 0.6 0.7 4.1 2.9 0.0 2.5 0.0 4.0 1.2 4.8 2.2 3.3 3.4 2.3 4.5 1.5 4.1 2.5 4.3 1.1 3.5 1.3 12.4 3.4 4.5 0.1 1.4 6.4 2.8 2.2 0.0 0.5 1.5 0.4 0.2 0.3 0.1 0.4 0.9 0.0 2.0 0.2 0.5 0.8 0.6 0.1 0.1 0.1 0.0 9.8 18.0 4.0 19.8 8.2 14.1 14.9 11.0 4.8 4.1 8.9 17.1 4.7 1.7 3.7 4.3 3.5 10.2 5.3 2.3 8.7 0.0 5.0 0.0 4.3 2.5 5.2 35.1 0.0 10.9 2.1 7.1 2.7 10.3 8.5 7.2 87.4 19.5 8.0 7.9 2.1 21.3 7.4 15.1 6.4 21.3 2.0 8.7 29.4 7.1 6.4 1.3 6.5 6.1 0.9 1.9 4.5 3.1 4.4 11.1 1.4 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.7 5.0 7.8 6.5 8.1 9.2 8.1 16.2 7.0 8.4 9.4 6.6 1.9 7.3 22.1 5.2 8.3 5.1 16.1 5.7 15.1 4.0 11.7 7.5 5.6 5.2 10.8 13.9 1.8 11.0 15.9 8.6 11.3 6.6 8.8 6.6 10.6 3.0 15.8 3.2 5.9 8.1 3.6 3.9 4.4 7.9 14.3 10.1 5.1 4.6 18.1 10.0 3.4 11.2 18.9 11.3 2.7 5.8 12.5 12.7 9.2 5.2 10.8 5.6 18.7 10.4 3.0 5.9 19.4 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 11.9 1.0 11.2 14.5 66.6 17.0 10.5 5.1 1.4 2.3 10.4 19.6 24.9 3.3 4.9 6.3 10.5 4.0 0.0 6.5 30.2 12.4 11.5 10.4 20.8 12.3 28.6 3.5 7.4 5.3 3.8 2.6 9.5 15.1 4.6 6.9 7.1 7.9 3.5 3.9 6.6 13.9 0.0 10.3 11.3 17.0 34.5 54.5 6.9 7.4 14.0 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 48.0;Pancreatic endocrine cells: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1;neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 35.5;Karpas-707: 60.7;RPTEC TERT1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA047117: AB_2679940, HPA060198: AB_2684220" "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.33e-6)" "prognostic unfavorable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 3.5 3.1 26.0 4.1 22.7 24.2 3.4 10.1 29.0 9.6 6.7 23.5 17.6 9.5 10.2 6.9 6.1 4.7 14.0 2.9 28.8 16.2 3.8 4.4 2.1 4.0 25.1 16.5 9.2 28.9 8.7 6.0 5.7 20.7 8.1 1.4 6.5 10.6 10.2 2.5 7.8 7.1 3.9 25.9 2.9 7.4 3.9 24.1 0.3 3.9 3.4 2.6 5.3 5.2 0.1 2.1 3.5 0.9 0.2 0.2 15.3 3.2 35.5 2.5 1.8 1.7 2.6 4.5 4.6 8.9 3.4 2.3 14.6 8.9 0.0 1.5 4.2 5.5 6.5 2.0 2.2 1.4 0.0 1.1 6.2 1.1 14.8 10.9 1.2 2.5 9.8 4.0 7.1 3.0 4.1 6.0 5.0 1.3 60.7 2.0 1.0 2.3 3.5 3.1 3.1 4.9 2.0 3.1 8.4 28.0 2.4 0.5 2.1 8.6 1.0 15.9 1.3 0.1 1.5 7.1 3.9 3.7 0.7 3.6 2.8 0.4 0.0 3.2 1.5 3.0 0.0 0.9 0.1 0.0 0.4 0.0 0.1 0.2 0.2 2.1 0.0 0.0 0.0 3.5 0.2 0.1 1.0 0.0 15.3 26.0 22.7 10.1 17.6 28.8 16.2 25.1 16.5 20.7 24.1 0.0 0.3 1.5 9.5 11.2 0.5 1.4 12.7 1.4 4.5 10.4 0.0 0.3 0.0 48.0 3.1 5.6 2.1 23.3 26.4 0.6 9.5 12.1 5.7 2.0 16.2 0.0 5.8 14.1 3.4 5.6 13.6 10.4 8.5 36.9 2.1 28.2 84.5 0.8 12.7 1.4 1.3 0.0 8.1 4.2 4.9 9.3 0.2 0.0 2.9 8.8 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 32.0 15.8 20.0 14.8 10.3 7.6 26.1 17.1 12.7 25.2 21.1 45.8 16.5 20.9 15.2 17.1 14.4 18.2 25.5 22.6 17.5 27.7 24.7 23.5 17.0 36.3 8.8 26.2 15.0 8.8 15.2 28.3 11.3 9.3 14.5 20.9 29.2 17.0 14.1 17.3 27.4 13.2 30.7 13.7 21.1 29.1 15.2 22.7 10.7 15.2 27.8 15.6 16.8 20.6 7.5 11.6 14.0 11.5 11.2 21.6 21.0 14.1 20.0 14.8 16.6 28.1 19.5 15.0 15.3 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 3.0 9.9 10.2 9.1 13.4 20.0 3.2 5.1 6.7 6.8 7.0 11.8 19.8 8.3 8.1 17.4 7.4 7.1 0.0 10.5 21.1 10.3 8.6 5.8 13.5 12.1 14.3 12.6 9.8 9.4 32.6 13.6 6.5 15.1 5.4 12.5 7.8 11.0 9.1 17.3 5.6 15.1 0.0 8.0 24.0 22.0 18.1 13.0 12.8 12.1 7.9 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046627, HPA073243" Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA046627: AB_10961152, HPA073243: AB_2686585" "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 6.8 5.8 7.6 9.5 15.4 12.7 7.6 20.1 19.4 8.0 6.6 10.9 8.7 9.5 9.9 10.1 6.6 14.5 9.2 6.3 10.1 8.0 8.6 11.5 8.0 10.8 7.7 10.1 11.2 17.8 13.4 13.3 6.7 10.4 9.1 7.2 11.8 10.8 8.5 7.2 13.5 7.8 8.0 8.2 11.7 8.1 20.0 10.2 11.2 10.0 5.7 10.2 9.4 7.1 3.4 1.7 3.7 1.6 2.3 2.6 0.6 6.1 7.2 7.4 10.3 4.8 9.4 13.7 8.0 5.4 8.5 6.8 16.5 5.7 9.5 5.8 6.3 5.9 20.0 9.0 10.4 5.1 13.3 14.1 6.4 18.3 7.8 4.3 13.5 7.7 7.4 8.7 7.3 7.0 7.4 7.5 7.9 13.1 7.1 5.9 13.8 7.8 15.2 15.4 9.8 9.5 12.8 7.5 13.5 4.9 11.2 21.5 15.0 8.1 13.4 4.3 6.7 13.7 7.9 10.6 8.8 8.0 15.7 11.4 4.4 5.1 7.7 6.1 6.3 5.1 0.0 1.6 1.3 2.6 1.3 1.2 2.0 1.1 1.1 0.6 3.4 0.9 0.7 3.7 2.3 0.5 1.7 0.9 0.6 7.6 15.4 20.1 19.4 10.1 8.0 7.7 10.1 10.4 10.2 6.0 7.0 2.9 1.9 4.7 7.5 3.2 2.5 17.4 3.4 3.5 2.0 2.4 0.0 5.9 2.6 3.6 3.6 23.3 3.8 1.7 2.7 2.2 1.1 6.4 2.8 3.2 5.1 5.5 1.6 1.5 4.6 2.8 0.0 1.0 5.2 4.8 5.3 6.0 4.6 4.2 11.5 0.0 2.3 8.6 8.8 5.9 1.1 3.2 5.6 2.8 SNUPN "RNUT1, SNURPORTIN-1, Snurportin1" ENSG00000169371 "Snurportin 1" O95149 15 75598083-75626469 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005004 Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "CAB005004: AB_425829" "unprognostic (2.37e-2)" "unprognostic (1.54e-1)" "unprognostic (2.36e-2)" "unprognostic (8.73e-2)" "unprognostic (2.25e-1)" "unprognostic (1.18e-1)" "unprognostic (4.76e-2)" "unprognostic (6.74e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.99e-3)" "unprognostic (9.07e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-1)" "unprognostic (2.14e-2)" 17.3 17.5 18.7 13.9 21.7 11.8 22.8 16.1 26.8 20.6 17.0 16.0 21.1 13.6 25.6 20.5 14.2 23.2 19.6 17.2 18.2 17.8 19.4 20.6 15.2 17.1 18.3 21.1 26.2 15.2 17.2 14.2 14.8 19.6 16.9 16.9 17.6 18.3 26.8 29.8 15.8 15.9 23.5 14.0 18.5 15.7 31.1 13.6 25.4 23.3 17.0 19.2 16.0 21.0 17.2 20.6 5.0 17.4 14.2 29.4 17.0 11.3 15.3 14.0 9.8 19.5 21.9 10.6 11.9 17.2 20.1 21.9 11.3 28.1 21.1 16.4 15.0 16.9 13.3 27.4 16.3 15.8 12.1 24.7 25.0 14.1 7.2 18.8 17.1 17.5 20.3 16.7 15.0 18.8 18.2 18.9 16.6 15.9 13.7 20.3 3.9 16.4 16.8 18.3 18.1 8.7 21.2 10.8 20.5 17.8 6.0 12.9 8.9 5.2 17.4 29.1 17.6 14.6 31.5 12.7 16.3 15.1 8.9 10.3 9.9 18.3 31.1 17.7 26.1 21.4 3.8 17.4 5.0 21.9 16.0 26.1 15.4 22.7 20.7 20.6 17.2 29.4 24.9 3.3 14.2 16.1 20.3 17.4 17.0 18.7 21.7 16.1 26.8 18.2 17.8 18.3 21.1 19.6 13.6 11.9 12.6 9.2 9.3 11.7 15.6 11.8 15.3 13.4 11.4 8.7 11.8 24.4 46.4 19.1 104.2 9.8 12.3 0.0 16.8 31.0 18.3 8.7 12.7 14.4 22.1 12.7 15.5 15.4 19.6 35.9 29.1 20.5 18.6 21.6 11.2 17.6 14.2 14.0 27.6 22.6 18.6 19.4 6.9 40.8 14.0 9.5 10.0 13.8 15.8 5.1 SPANXN4 "CT11.9, SPANX-N4" ENSG00000189326 "SPANX family member N4" Q5MJ08 X 143025918-143034702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 23.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 233.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0" "HPA045730, HPA059094" Uncertain Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nuclear membrane" "HPA045730: AB_10961036, HPA059094: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 4.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 172.0;Peritubular cells: 251.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.0;hTERT-RPE1: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.3 0.7 2.0 0.0 13.0 7.4 0.1 3.8 5.3 0.5 1.5 0.0 4.7 0.0 0.8 5.2 3.0 1.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.6 0.4 1.7 0.4 46.8 0.2 0.0 0.0 0.0 4.0 0.8 0.2 1.1 4.4 0.2 1.2 0.1 5.3 1.4 1.2 4.0 0.2 3.8 1.4 0.3 3.7 2.1 0.4 0.1 1.4 1.8 1.0 1.8 0.9 0.1 0.5 0.0 2.8 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 3.0 2.7 20.9 16.5 12.0 1.7 79.0 7.6 6.7 19.4 17.4 0.0 63.3 5.0 8.5 3.3 8.3 8.4 0.0 6.5 5.6 56.4 10.8 0.0 0.0 12.1 6.4 4.7 8.6 0.0 3.1 172.0 7.9 18.6 32.5 9.1 35.9 2.4 7.0 251.4 2.2 2.6 38.8 42.9 0.3 0.9 6.1 23.2 1.0 5.8 17.1 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.8;U-87 MG: 33.8" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.6 7.5 1.2 3.6 1.6 4.2 0.8 5.1 3.4 2.1 1.4 2.6 4.3 1.9 0.7 3.6 11.8 1.3 1.8 3.2 1.6 3.5 1.4 0.6 2.6 1.5 1.8 0.8 1.8 2.5 1.4 14.8 5.2 9.6 3.7 0.3 1.6 2.3 4.0 3.7 0.6 7.3 0.9 2.8 17.0 0.0 0.8 1.9 1.7 1.3 50.8 8.0 1.5 4.2 1.0 1.5 1.4 0.6 13.8 10.5 3.5 8.1 13.5 1.3 0.8 0.9 33.8 0.7 12.3 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 0.0 3.2 0.0 11.2 3.8 4.5 2.2 5.1 2.7 3.4 1.8 3.9 0.4 0.0 3.1 0.0 0.5 1.8 0.0 3.2 1.6 2.4 9.7 15.0 0.2 0.6 7.9 50.6 1.3 0.8 0.0 1.7 1.7 3.3 0.0 2.4 0.8 18.8 0.3 1.4 0.4 1.8 0.0 2.3 1.7 3.3 2.4 0.6 2.2 1.5 12.9 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Group enriched" "Detected in some" 4 "Horizontal cells: 36.5;Late spermatids: 9.9" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.4;hTEC/SVTERT24-B: 10.3;hTERT-RPE1: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 2.7 4.3 0.6 0.4 0.2 0.1 3.8 5.8 4.8 8.4 0.0 3.1 0.7 0.2 5.0 0.1 0.7 1.9 0.5 5.8 2.3 0.4 0.3 2.2 2.1 0.3 0.1 2.7 1.5 0.1 10.3 0.9 19.0 0.0 0.9 0.4 0.2 5.0 1.2 1.7 0.2 2.1 0.0 0.3 6.3 0.2 0.1 0.4 0.0 5.9 3.7 0.4 0.2 0.0 0.7 0.7 0.1 0.7 2.8 2.2 0.3 0.2 0.3 0.2 0.3 3.1 0.2 0.0 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 0.0 0.0 0.0 0.0 0.7 3.6 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 5.7 0.5 0.0 0.0 0.3 0.0 0.3 0.1 0.0 4.9 0.6 36.5 0.0 0.6 0.0 9.9 0.3 0.0 0.0 1.0 0.0 1.7 0.2 0.0 1.8 2.1 2.9 0.0 0.5 5.2 1.0 0.5 0.7 0.0 0.0 0.0 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 123.8;Late spermatids: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079007" Uncertain Supported Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079007: , HPA069176: AB_2686098" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 15.9 14.5 16.0 15.4 13.4 8.8 27.0 12.5 18.7 13.1 18.8 15.3 8.8 6.1 18.1 15.4 9.6 19.4 14.5 16.4 15.5 11.4 12.2 12.0 18.3 11.9 12.7 12.4 16.0 10.7 11.9 16.3 18.0 17.9 10.2 10.2 9.8 5.2 15.7 6.3 6.1 10.7 23.5 24.8 12.3 11.7 23.2 12.3 9.7 12.6 6.9 9.4 13.5 22.2 2.6 1.6 4.6 2.4 1.4 3.1 0.9 4.7 9.5 13.8 10.8 12.8 29.1 1.4 20.2 16.2 24.9 16.5 2.6 3.3 6.1 3.2 22.1 7.8 1.3 12.6 3.3 26.0 9.3 4.3 3.2 8.3 7.4 13.9 4.7 8.0 10.8 4.1 12.1 9.7 22.0 12.2 6.5 12.8 5.7 21.2 2.8 6.6 4.8 9.2 1.3 13.1 7.0 9.0 3.2 13.7 1.0 13.2 13.0 10.2 0.9 8.5 12.5 3.2 3.1 16.4 14.3 10.1 15.8 8.8 4.2 3.4 4.0 16.5 5.2 11.2 4.6 2.2 2.8 2.4 2.4 2.4 2.6 2.7 2.7 1.5 1.7 2.9 3.1 3.0 1.4 1.2 1.6 1.9 0.9 16.0 13.4 12.5 18.7 15.5 11.4 12.7 12.4 17.9 12.3 20.8 11.3 2.2 1.0 3.1 5.0 13.4 12.7 44.2 11.4 27.9 0.0 1.5 8.3 17.7 123.8 18.3 0.0 23.3 6.4 6.3 25.2 1.9 1.1 13.9 9.6 0.0 6.4 16.5 8.6 61.1 25.9 9.0 13.5 10.0 0.2 8.6 10.4 0.0 23.0 10.0 32.5 12.9 24.7 34.6 27.0 1.3 0.7 7.5 0.2 0.4 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 377.4;Cone photoreceptor cells: 371.1;Rod photoreceptor cells: 377.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 49.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 10.8 16.3 5.3 14.1 8.3 23.4 22.6 11.5 10.7 10.7 19.9 4.9 27.8 23.8 14.2 16.4 12.8 6.8 21.1 9.4 6.2 6.0 25.0 6.4 26.5 15.1 8.7 10.2 12.0 14.8 16.7 21.2 33.6 6.8 12.6 22.9 54.7 16.0 19.8 7.3 11.4 19.7 11.4 7.2 14.5 19.5 11.4 6.2 2.1 12.8 9.3 6.4 11.4 12.2 0.9 2.7 28.1 2.5 0.2 1.4 0.9 12.0 7.1 0.2 3.4 6.2 3.6 9.9 6.5 11.2 15.0 18.7 32.4 11.4 3.4 12.6 4.7 25.7 13.7 18.9 6.7 18.4 3.0 4.0 3.7 5.0 10.0 16.7 12.5 36.6 6.6 14.5 11.6 14.2 9.5 12.0 4.9 32.5 7.1 6.5 7.0 0.1 9.2 18.5 17.6 5.9 4.4 12.6 5.6 28.3 28.8 8.2 12.8 2.8 14.3 49.3 25.5 15.8 8.6 16.7 6.5 14.3 8.9 5.6 8.4 14.6 6.9 9.0 8.3 8.7 14.3 2.5 28.1 1.0 0.7 1.1 0.3 1.4 0.6 2.7 0.9 1.3 0.4 25.7 0.2 0.4 0.4 0.0 0.9 5.3 8.3 11.5 10.7 6.2 6.0 8.7 10.2 6.8 6.2 62.5 29.9 7.8 63.8 45.1 377.4 8.7 28.1 9.4 13.6 10.4 371.1 7.2 14.9 34.0 4.0 29.2 50.3 0.0 22.1 13.8 11.8 83.7 55.6 4.9 14.2 68.3 25.2 21.5 19.0 4.7 3.4 26.8 35.4 12.6 26.9 39.3 38.9 29.4 7.1 51.2 377.2 6.5 14.1 3.9 10.4 52.6 33.9 10.7 21.7 72.9 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860152 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.8;liver: 26.2;vagina: 15.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 47.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "pons and medulla: 3.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 9.8 0.1 0.1 0.3 0.1 1.1 0.1 0.4 13.1 8.9 0.5 0.1 19.8 0.4 3.7 0.4 0.1 1.2 0.1 0.1 0.0 1.5 26.2 2.0 0.1 0.3 0.3 0.2 0.1 0.0 0.4 0.1 3.3 1.0 0.1 0.3 4.7 0.3 0.1 10.9 37.8 0.5 0.3 0.1 1.3 0.4 0.1 0.6 0.2 0.1 1.0 0.4 15.8 0.6 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 38.0 0.0 0.0 17.2 14.3 0.0 0.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.6 0.2 0.1 1.7 0.3 0.3 0.2 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.3 0.3 3.3 0.1 0.0 0.0 0.0 1.0 10.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.2 0.1 0.0 0.0 47.0 0.2 0.0 0.0 1.8 1.0 0.0 0.3 0.0 1.7 0.0 0.2 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.3 0.0 0.0 0.1 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin-like modifier 1" P63165 2 202206180-202238608 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 27.1 37.8 44.4 21.6 37.9 41.8 31.6 47.7 49.2 26.9 29.7 19.9 27.2 26.2 24.7 33.4 26.9 24.7 26.6 28.3 38.0 39.6 43.5 62.6 24.6 28.7 34.6 40.6 23.4 29.8 26.6 28.7 30.4 32.3 28.8 31.2 21.6 35.6 24.5 42.4 21.6 33.2 27.6 29.6 25.1 26.4 28.7 27.1 32.2 38.4 28.1 33.6 26.9 23.1 74.8 63.0 77.0 63.7 65.8 89.0 94.0 33.7 17.1 62.4 33.1 34.8 37.2 27.9 35.9 45.4 44.8 59.5 36.8 43.0 23.1 33.4 41.4 41.9 24.7 51.1 49.9 70.5 21.6 39.2 42.7 33.6 43.2 25.2 48.1 40.7 28.6 48.3 35.1 26.8 42.2 41.7 46.2 39.3 37.6 47.9 28.7 60.5 80.0 75.0 34.8 36.4 39.2 35.0 40.7 54.3 28.1 43.4 47.4 29.3 28.5 48.0 70.7 25.6 46.1 29.2 33.1 33.4 30.3 31.7 32.8 64.7 58.6 36.9 34.3 29.0 56.6 63.7 77.0 51.1 62.6 53.5 74.8 63.7 59.8 63.0 58.4 60.2 62.8 73.6 65.8 62.8 52.9 89.0 94.0 44.4 37.9 47.7 49.2 38.0 39.6 34.6 40.6 32.3 27.1 104.2 49.5 141.2 176.9 375.0 93.7 54.1 96.8 83.0 78.5 179.7 60.9 228.3 407.8 216.2 44.0 153.6 150.3 46.7 152.2 246.7 239.6 215.1 91.1 181.0 182.5 82.6 136.7 118.4 134.8 20.6 120.3 156.9 200.8 294.0 123.6 118.9 175.8 178.5 120.2 378.6 73.5 109.9 205.0 172.2 119.7 371.1 175.4 191.9 139.7 207.2 SUN1 "FLJ12407, KIAA0810, UNC84A" ENSG00000164828 "Sad1 and UNC84 domain containing 1" O94901 7 816615-896435 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 286.8;Late spermatids: 435.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008346, HPA008461" Enhanced Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA008346: AB_1080462, HPA008461: AB_1080461" "unprognostic (2.70e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.25e-1)" "unprognostic (2.57e-3)" "unprognostic (1.82e-1)" "unprognostic (1.67e-1)" "unprognostic (4.57e-2)" "unprognostic (3.32e-2)" "unprognostic (1.69e-1)" "unprognostic (8.10e-2)" "unprognostic (1.08e-2)" "unprognostic (1.47e-2)" "unprognostic (4.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.33e-2)" 29.8 14.5 18.2 17.2 23.6 4.0 26.0 49.6 28.9 31.1 22.5 23.6 18.9 18.1 47.1 22.6 24.2 28.5 20.0 40.8 16.6 14.9 19.4 13.4 19.6 11.6 15.9 21.3 39.6 22.4 37.5 26.8 25.3 18.0 18.8 16.8 27.6 19.5 19.7 56.7 46.1 17.9 33.6 15.3 17.6 23.9 36.4 15.4 11.8 20.1 31.0 17.8 20.3 25.3 8.0 8.1 7.6 10.2 6.7 13.2 6.5 38.7 10.5 12.7 20.6 14.0 20.1 12.4 9.8 16.5 18.3 18.8 8.9 43.8 9.3 10.2 13.4 36.1 48.9 10.3 17.4 17.9 3.9 10.4 3.0 15.4 8.4 18.0 4.6 7.7 10.0 20.8 14.6 24.4 17.1 13.3 5.9 12.5 7.0 18.3 13.4 3.0 7.6 17.6 13.4 12.2 6.6 7.0 8.7 18.7 12.5 24.5 15.9 12.4 25.5 9.4 21.4 20.2 4.7 10.0 16.9 15.4 17.5 16.1 6.5 7.5 5.7 11.6 3.8 23.2 7.6 10.2 2.6 4.7 8.8 5.0 8.0 9.2 5.3 8.1 6.8 13.2 8.2 0.6 6.7 6.3 1.6 7.7 6.5 18.2 23.6 49.6 28.9 16.6 14.9 15.9 21.3 18.0 15.4 41.7 34.2 14.9 83.2 94.7 70.8 83.7 30.6 73.6 47.8 38.4 82.5 26.8 23.2 36.0 286.8 74.1 41.1 23.3 20.1 19.4 40.9 82.0 16.2 36.5 14.8 106.5 39.1 67.5 19.0 435.0 52.9 19.2 40.5 3.6 39.1 23.8 40.3 52.6 40.0 19.3 66.7 64.7 64.5 30.9 48.0 74.9 32.2 15.0 33.0 105.6 SUN2 UNC84B ENSG00000100242 "Sad1 and UNC84 domain containing 2" Q9UH99 22 38734725-38794143 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001209 Supported Supported "Nuclear membrane" NA Yes "Nuclear membrane" "HPA001209: AB_1080465" "unprognostic (9.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" "unprognostic (5.09e-2)" "unprognostic (1.36e-1)" "unprognostic (5.57e-2)" "unprognostic (1.94e-2)" "unprognostic (2.37e-2)" "unprognostic (3.14e-2)" "unprognostic (1.25e-3)" "unprognostic (8.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (8.10e-2)" "unprognostic (2.33e-2)" 59.3 22.9 28.7 41.7 58.7 84.6 66.9 17.6 43.8 33.7 33.6 57.5 24.2 29.0 47.3 23.3 41.4 42.5 25.3 32.3 37.8 19.3 24.4 47.1 37.7 56.8 73.6 25.4 44.8 44.1 10.5 14.8 22.7 42.5 31.2 16.3 14.9 39.1 35.0 48.6 31.0 31.6 35.3 37.1 46.3 35.2 30.2 68.0 42.6 26.9 20.1 36.0 47.0 35.9 6.4 6.0 14.0 13.9 13.3 25.5 11.8 25.1 11.7 11.7 13.0 35.7 8.9 15.3 17.3 20.3 20.6 17.5 10.5 28.5 7.9 21.2 24.5 12.7 18.8 3.9 12.8 8.5 27.5 15.8 5.1 12.6 9.4 21.7 17.4 54.3 7.5 10.9 9.8 9.2 13.9 16.3 16.0 6.5 45.0 11.1 8.0 9.6 15.1 1.1 17.8 7.6 16.1 16.4 23.8 5.1 12.3 10.4 3.8 19.3 21.5 10.1 5.7 14.4 32.7 27.3 15.0 13.1 13.1 22.4 33.3 10.4 8.4 27.8 21.0 25.0 14.0 7.4 9.7 25.5 8.8 16.5 6.3 16.2 20.6 6.0 6.4 17.1 20.1 8.0 13.3 13.9 3.7 11.0 11.8 28.7 58.7 17.6 43.8 37.8 19.3 73.6 25.4 42.5 68.0 20.8 22.2 33.6 23.8 16.1 8.4 2.2 35.7 2.7 17.0 31.4 7.9 11.6 3.3 30.6 1.7 29.2 45.1 23.3 41.2 49.9 28.2 22.7 25.3 93.6 23.5 20.6 17.9 30.1 39.8 2.0 56.7 37.5 16.9 3.6 25.6 21.7 45.2 31.3 61.5 16.3 12.4 51.8 34.0 0.9 0.7 15.1 12.4 112.3 17.8 18.0 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 182.4;Bipolar cells: 303.5;Ciliated cells: 222.1;Cone photoreceptor cells: 188.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 33.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.8" "Cell line enhanced" "Detected in many" "U-266/70: 19.2" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 12.7 11.5 18.2 9.1 30.2 41.7 9.0 62.0 25.0 16.8 7.3 9.8 12.4 2.7 15.2 18.4 6.2 12.9 7.9 22.7 21.0 17.5 18.4 11.2 16.1 13.7 13.2 15.1 27.7 10.6 37.3 37.0 4.7 19.7 10.1 6.3 10.5 3.6 12.5 22.0 16.9 5.3 19.1 9.7 15.5 9.0 8.3 11.6 9.0 20.6 9.5 12.1 10.0 12.3 3.2 0.8 33.8 1.5 4.7 6.4 1.4 0.1 4.0 2.8 3.2 4.0 8.8 1.1 9.0 4.7 2.3 4.3 0.9 0.1 8.4 0.5 4.9 7.7 0.2 1.0 2.3 2.4 10.1 2.8 3.5 2.7 2.7 9.2 0.6 1.6 5.6 0.5 5.1 10.5 6.5 4.5 4.4 0.0 9.7 6.3 0.4 1.4 0.1 0.6 0.7 1.5 1.9 5.6 2.4 9.0 0.1 1.7 2.7 1.5 0.6 6.2 2.6 0.5 0.3 6.0 10.9 14.7 3.8 4.9 19.2 8.2 13.5 6.0 2.0 3.1 3.0 1.1 33.8 6.4 0.7 4.1 2.9 4.2 6.1 0.8 3.2 4.0 5.1 1.1 4.7 1.5 0.7 5.1 1.4 18.2 30.2 62.0 25.0 21.0 17.5 13.2 15.1 19.7 11.6 154.9 182.4 21.6 6.0 11.3 303.5 110.2 2.5 222.1 95.5 41.8 188.5 0.8 3.3 20.2 8.3 87.0 0.0 0.0 6.6 5.4 44.0 3.0 14.0 19.5 7.2 130.3 2.9 65.7 9.2 9.0 30.8 11.2 15.1 1.0 6.7 24.3 4.5 0.0 37.4 14.1 150.7 25.8 40.0 2.9 5.8 8.4 1.0 49.8 0.2 1.6 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 579.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Cell line enhanced" "Detected in many" "Daudi: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.7 6.0 8.9 2.8 8.9 2.6 11.8 1.2 1.2 2.0 3.6 2.0 3.7 44.5 1.9 1.2 2.2 8.6 5.8 2.3 2.5 6.7 2.3 0.2 4.4 0.5 1.7 0.7 0.2 3.7 8.4 2.6 2.4 2.0 4.6 5.7 0.2 3.6 1.5 9.9 4.7 0.2 4.0 5.7 1.8 5.6 8.4 1.4 13.5 8.5 8.2 6.1 14.1 3.3 3.8 3.8 3.9 0.1 4.0 3.3 5.3 1.1 3.7 4.9 2.1 16.9 0.9 0.0 4.7 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 285.9 119.8 37.9 110.7 98.9 26.4 222.5 107.0 271.7 293.5 191.9 172.8 136.2 16.6 78.5 6.5 155.5 34.5 0.0 48.5 56.0 55.6 45.4 24.4 28.8 14.9 6.4 44.4 68.7 4.7 8.1 93.5 7.9 45.5 4.6 57.4 99.5 65.8 10.5 50.2 64.2 579.2 109.9 65.5 13.6 7.8 76.5 187.3 96.2 67.0 63.0 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;bone marrow: 10.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 43.7;Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 109.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;ASC TERT1: 19.8;Karpas-707: 22.3;REH: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA055227: AB_2682747, HPA077140: AB_2686826" "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 12.2 2.4 1.2 2.7 1.3 10.0 6.5 0.3 1.2 2.1 1.0 0.6 1.2 0.6 1.1 2.0 1.2 2.8 1.6 1.1 0.4 1.0 2.7 4.0 1.6 3.0 0.1 0.0 0.5 2.1 0.6 1.6 1.9 0.4 1.1 2.8 1.5 1.2 2.6 2.7 0.9 1.6 1.7 4.3 1.6 2.8 3.4 2.6 5.4 5.1 0.9 3.7 2.2 0.6 0.1 0.3 0.5 25.2 19.8 7.6 2.8 4.9 2.7 2.1 4.0 0.7 3.2 0.5 1.3 0.8 0.1 0.6 2.1 1.2 10.6 0.4 2.2 0.5 1.1 3.3 3.3 5.5 5.5 0.7 3.4 2.0 0.2 4.7 1.0 0.1 22.3 2.0 0.7 1.9 3.7 0.1 0.1 1.3 17.6 12.3 6.8 0.3 0.3 0.5 2.7 0.1 0.0 1.3 0.3 1.1 4.9 4.2 2.0 1.2 2.6 0.3 2.7 5.4 3.0 3.9 7.5 14.7 5.4 5.1 0.4 2.2 4.0 2.8 3.4 2.9 2.3 2.1 3.3 3.7 3.0 2.4 0.9 4.1 2.6 2.3 2.2 8.9 19.4 15.7 0.2 2.1 4.2 43.7 0.0 12.0 1.2 0.0 58.9 1.4 0.0 0.0 2.9 11.7 2.1 0.0 0.3 13.8 7.1 0.8 11.5 4.5 3.9 6.4 1.2 3.1 18.0 1.5 12.0 13.3 5.0 1.0 4.1 5.2 0.5 5.8 0.4 0.3 109.0 6.5 9.2 0.5 0.9 0.9 1.6 8.5 1.6 0.2 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818504-8016627 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 11.2 11.2 10.6 13.5 13.9 13.1 9.5 24.5 13.0 10.7 10.0 11.1 12.7 6.4 11.7 6.0 7.9 8.3 8.2 11.5 11.5 12.1 9.3 8.2 8.6 12.0 12.8 8.4 16.1 9.5 16.1 15.9 9.9 11.6 9.6 8.1 9.6 7.6 13.3 20.8 10.6 9.6 9.5 12.4 11.4 8.1 15.8 14.2 17.4 9.7 7.3 9.9 10.0 14.4 8.8 4.7 7.7 8.6 8.3 10.8 5.0 7.0 6.6 7.5 3.9 8.5 6.0 10.4 8.4 3.3 6.3 7.3 14.1 5.3 12.1 6.5 4.9 2.6 7.7 8.2 7.3 8.0 9.7 9.0 10.3 4.6 8.9 7.4 6.9 9.5 4.0 7.3 8.9 4.4 4.0 6.0 13.3 11.5 12.6 7.2 13.3 15.6 4.9 5.7 10.3 3.9 12.7 7.1 8.1 3.7 4.4 4.0 5.7 9.1 6.6 8.2 7.7 12.1 7.3 7.4 5.8 10.1 15.2 8.2 7.5 8.9 13.3 5.6 7.9 5.2 7.3 5.6 7.7 9.3 5.0 10.8 7.6 8.4 9.0 4.7 8.8 10.5 9.0 2.2 8.3 8.6 4.6 6.9 5.0 10.6 13.9 24.5 13.0 11.5 12.1 12.8 8.4 11.6 14.2 26.8 28.5 29.8 19.4 28.4 28.0 36.6 10.2 24.1 9.1 26.2 33.4 22.7 0.0 15.2 30.9 22.2 17.1 0.0 12.7 30.6 16.8 12.5 20.9 11.9 17.4 25.4 18.0 13.5 17.5 17.0 25.3 21.9 23.6 16.2 12.1 29.9 12.3 2.9 26.9 3.4 40.5 25.8 28.4 48.9 42.1 37.6 16.7 30.9 11.5 17.3 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26755351 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favorable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.51e-1)" 6.1 13.9 8.6 5.4 10.2 2.8 6.8 11.5 11.2 11.8 8.8 8.7 7.7 3.1 22.4 11.0 4.8 11.9 11.8 10.7 6.6 9.0 24.9 4.6 6.6 3.5 9.3 7.7 13.9 7.7 21.9 23.4 6.1 14.8 8.7 5.1 8.4 5.8 10.4 5.7 4.2 3.8 13.5 8.6 4.4 6.9 10.0 7.1 33.3 12.1 2.9 4.2 8.3 7.0 4.1 2.4 2.3 0.9 6.6 8.7 1.8 1.4 1.3 4.6 2.8 6.8 10.5 1.4 5.9 4.6 2.7 3.0 2.1 3.4 3.2 5.3 8.3 8.8 0.6 2.5 3.3 2.6 1.0 1.3 0.7 3.7 0.7 3.6 1.6 0.7 5.1 2.5 5.4 3.1 11.2 3.7 4.2 2.5 0.0 40.9 0.0 3.4 1.9 2.1 1.7 4.9 2.5 4.7 0.3 10.5 1.3 4.6 1.9 2.8 0.6 2.8 3.7 1.2 0.7 3.3 3.5 1.0 2.6 1.4 0.8 1.7 1.4 12.2 0.9 3.6 1.6 0.9 2.3 8.1 0.9 8.7 3.2 6.2 8.3 1.4 4.1 4.9 5.1 0.1 6.6 0.8 2.4 3.0 1.8 8.6 10.2 11.5 11.2 6.6 9.0 9.3 7.7 14.8 7.1 3.0 2.6 4.7 4.8 3.2 7.5 5.3 2.5 18.7 0.0 19.2 13.7 3.6 5.0 4.8 4.8 5.7 0.4 0.0 2.8 1.7 6.2 2.5 9.2 1.8 1.6 4.8 9.1 6.7 1.6 1.9 8.3 2.3 10.1 1.0 1.9 8.2 2.1 0.0 8.5 11.3 19.4 0.0 4.7 22.0 5.7 4.0 1.6 17.5 1.3 1.6 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084144-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 1.7;skin 1: 3.8;tongue: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "SK-BR-3: 10.7" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN, adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Cytotrophoblasts: 8.3;Hofbauer cells: 7.9;monocytes: 15.4;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Supported "Nuclear membrane,Nuclear speckles,Golgi apparatus" NA NA "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: AB_2685008" "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favorable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favorable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavorable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 8.5 6.7 8.0 11.9 8.5 17.3 21.3 11.9 9.8 6.0 9.9 9.0 7.3 14.9 7.9 8.6 8.8 8.0 6.6 4.9 8.8 4.7 9.8 13.3 12.5 13.5 12.5 6.3 6.8 11.1 5.3 9.2 7.7 9.8 10.1 6.5 4.8 9.1 9.3 12.4 15.8 12.4 9.8 8.5 17.0 9.7 9.1 9.8 12.2 12.6 7.5 9.0 7.2 7.0 3.0 2.7 7.6 2.9 0.7 1.8 1.2 8.9 13.1 5.1 8.3 3.5 5.9 10.2 8.0 4.5 8.0 7.3 8.5 6.3 6.4 4.5 5.3 7.9 11.6 5.3 6.7 3.8 3.9 17.4 5.3 7.3 12.1 5.3 5.7 11.1 3.0 8.7 3.6 4.2 5.9 12.7 8.7 6.5 6.3 5.1 7.8 10.7 13.3 5.6 7.1 11.3 6.8 6.7 7.0 3.1 5.7 6.8 8.0 9.4 10.4 10.9 10.4 7.1 10.3 8.0 10.8 6.2 8.2 7.6 8.5 5.9 4.8 7.9 4.9 5.3 4.2 2.4 7.6 1.8 2.9 1.1 2.5 1.2 1.4 2.7 3.0 0.8 0.8 4.3 0.7 1.9 2.7 1.6 1.2 8.0 8.5 11.9 9.8 8.8 4.7 12.5 6.3 9.8 9.8 8.9 5.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.3 1.8 0.0 8.3 0.0 4.1 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 5.8 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 5.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560656-68694482 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 59.1;Horizontal cells: 33.4;Leydig cells: 23.9" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 15.3;HAP1: 17.4;K-562: 9.7;NTERA-2: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: AB_2683391" "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 4.4 1.6 3.3 4.3 2.6 1.6 3.1 4.4 4.3 5.1 2.4 5.8 3.2 1.2 6.0 3.4 2.4 2.9 3.5 2.4 3.5 2.3 1.8 1.5 1.6 1.7 2.5 2.6 6.1 1.6 7.4 2.2 5.8 2.9 3.2 2.0 8.1 15.9 4.8 4.0 2.2 1.8 6.5 3.6 1.7 2.2 1.4 5.9 1.2 3.2 3.2 1.8 5.1 5.4 1.3 1.1 1.0 0.0 0.9 2.3 0.2 0.6 0.7 6.9 7.8 0.7 0.6 15.3 0.4 0.8 0.6 1.1 4.6 0.2 0.0 0.2 0.7 0.1 0.0 17.4 0.0 0.7 0.2 2.8 1.8 0.0 4.1 1.0 1.6 0.9 0.9 0.1 0.4 0.0 1.4 0.1 2.9 9.7 1.2 0.6 0.5 2.7 1.2 10.2 0.0 0.9 2.7 2.2 0.2 0.3 0.7 1.9 3.1 0.3 0.4 1.4 7.2 0.9 1.2 0.2 0.6 1.4 0.0 0.5 0.5 0.5 2.7 0.1 0.0 0.1 0.0 0.0 1.0 1.5 0.0 2.0 1.3 0.8 1.3 0.2 0.5 1.4 1.1 0.0 0.9 0.0 1.1 2.3 0.2 3.3 2.6 4.4 2.6 3.5 2.3 2.5 2.6 2.9 5.9 3.0 3.8 0.0 1.9 1.0 2.2 4.5 2.5 1.4 4.5 0.0 9.8 16.6 0.0 1.4 0.4 3.3 0.0 0.0 0.3 59.1 11.8 2.1 0.0 2.1 3.3 33.4 13.2 7.4 0.0 0.6 23.9 0.1 1.7 0.0 0.0 17.3 0.9 0.0 19.4 0.8 10.8 6.5 3.8 0.5 0.7 1.0 23.3 1.7 0.4 0.3 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA Nucleoplasm "Nuclear membrane, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.6 12.0 3.2 5.5 2.9 3.6 7.2 6.1 5.4 7.4 7.0 6.1 6.2 9.0 5.8 3.4 4.0 7.3 2.8 5.6 1.1 8.4 17.7 10.5 9.1 7.1 8.9 10.0 6.6 3.4 7.0 6.5 6.0 3.3 3.9 6.0 49.9 9.2 4.0 13.6 10.7 6.7 4.7 7.2 12.1 8.9 6.5 4.8 3.9 5.5 7.3 6.1 7.0 9.0 9.5 1.5 10.4 6.8 2.5 12.2 9.6 7.2 6.1 13.4 7.6 6.8 13.1 6.4 10.4 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 14.9 22.6 29.8 17.2 16.9 31.2 10.0 38.2 18.7 10.3 24.4 13.7 26.0 54.7 21.0 23.7 22.4 23.1 0.0 33.0 27.5 22.8 23.6 20.8 30.8 24.2 12.7 21.4 15.4 10.5 35.5 38.6 16.3 38.8 28.9 19.4 37.0 21.8 17.6 30.4 35.1 21.3 38.8 25.9 123.0 55.1 14.3 24.7 22.4 21.5 10.6 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 16.6;Spermatogonia: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.4 2.6 2.3 6.0 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.1 0.3 1.0 1.0 0.2 1.0 1.4 2.3 0.1 0.2 1.8 2.3 0.4 1.4 4.7 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.1 0.3 2.3 1.4 3.1 0.0 3.4 2.9 1.9 1.3 1.3 1.1 4.2 1.0 4.0 0.1 1.3 6.7 4.2 1.7 2.6 1.1 0.2 4.3 1.4 0.0 0.2 1.1 1.6 1.0 6.4 4.1 1.3 0.1 1.8 0.7 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 0.0 0.6 0.0 0.2 1.3 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 2.2 0.0 1.0 0.0 0.5 0.3 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.8 1.8 0.0 0.9 1.7 1.0 0.3 1.0 0.6 0.0 0.4 0.5 3.8 0.0 0.8 16.6 5.3 1.4 0.7 0.0 0.4 0.1 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60913874-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 40.2 21.2 7.7 22.4 11.5 10.4 45.4 13.4 17.4 39.7 28.8 17.0 17.7 12.0 43.1 25.9 38.0 30.0 32.0 32.7 9.9 8.3 27.0 31.7 30.0 26.0 16.5 9.5 42.6 28.5 23.2 18.9 36.2 12.4 38.5 11.8 44.1 43.4 27.5 41.9 28.4 19.2 38.0 10.5 28.8 25.1 16.6 12.1 21.5 36.9 35.2 33.0 35.6 44.7 25.5 83.1 9.5 13.7 19.9 36.2 21.9 24.5 21.7 14.0 23.3 35.5 16.4 11.7 23.1 20.8 24.5 21.3 19.3 26.1 28.3 43.0 25.5 14.7 32.2 14.5 9.9 14.9 22.0 19.3 20.0 10.2 4.2 10.5 40.5 17.9 11.1 12.6 19.0 9.5 8.7 29.6 22.9 10.3 74.5 17.4 44.5 29.8 17.4 24.0 12.5 22.2 29.7 27.3 40.6 12.0 12.6 5.7 10.1 18.3 44.4 21.9 9.8 24.9 7.4 30.3 31.6 15.2 39.8 20.9 25.6 18.8 15.2 28.1 17.5 36.5 6.2 13.7 9.5 35.8 12.1 36.2 22.3 20.8 30.3 40.8 25.5 19.0 24.3 1.5 19.9 8.8 83.1 15.5 21.9 7.7 11.5 13.4 17.4 9.9 8.3 16.5 9.5 12.4 12.1 65.5 21.0 47.9 39.3 45.1 12.5 30.7 20.4 22.7 22.7 24.4 0.0 104.3 21.6 63.3 20.4 85.0 6.5 0.0 69.7 95.5 55.6 29.5 49.7 16.6 62.1 28.6 6.9 50.3 19.6 7.5 82.8 53.7 49.0 53.3 10.1 27.1 44.7 19.5 91.6 13.3 33.9 38.8 64.8 6.0 6.8 44.3 44.5 56.6 16.5 34.5 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.2 0.0 0.1 0.0 0.2 3.5 5.6 3.1 11.5 3.4 6.5 0.1 1.6 12.6 1.3 2.8 3.7 9.0 0.0 24.7 6.3 0.0 0.0 0.7 0.1 0.0 3.7 9.7 28.5 3.4 11.9 10.9 9.5 0.0 8.4 7.8 0.0 22.2 0.2 0.8 3.8 3.0 0.6 0.0 2.9 0.4 0.0 0.0 19.5 7.5 0.0 0.5 0.7 2.4 0.4 3.5 0.3 6.9 3.4 0.5 2.0 0.3 4.3 27.8 9.4 6.9 4.7 22.1 2.6 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 11.9 22.9 42.2 7.7 65.9 0.0 1.4 0.0 60.2 19.4 21.0 2.0 21.8 0.0 6.1 0.0 5.7 0.0 0.0 3.3 12.7 5.5 5.3 97.2 3.9 4.2 3.2 1.2 0.6 8.7 0.0 0.6 15.0 5.0 0.0 0.6 0.0 12.8 9.1 0.0 0.3 0.4 0.0 1.9 0.0 0.2 169.9 21.6 15.8 3.1 23.5 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA057160: AB_2683356" "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.1 3.5 4.8 17.0 8.9 8.2 8.2 6.0 5.0 7.5 2.8 13.4 2.5 5.1 8.6 8.8 5.5 3.2 6.5 2.2 6.2 7.5 5.2 9.0 2.8 9.8 2.7 9.7 12.6 7.9 4.5 3.0 3.6 3.1 5.4 5.2 20.9 4.4 10.9 6.9 11.2 2.2 3.9 17.2 4.8 2.1 7.2 4.8 3.2 9.6 8.5 5.7 3.6 5.4 1.8 16.0 7.5 4.1 9.3 2.1 10.7 6.3 14.2 3.7 4.9 9.0 6.0 7.5 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 11.9 9.9 12.9 8.5 5.6 24.5 8.7 5.1 4.0 5.7 14.0 3.9 21.7 1.7 7.4 4.4 8.2 12.4 0.0 10.0 9.3 12.7 8.2 6.9 23.8 13.5 44.5 15.5 8.6 15.3 3.2 11.5 11.0 18.6 4.6 8.1 43.7 8.0 14.4 15.2 6.7 25.4 12.9 9.5 22.3 10.2 6.8 15.8 13.1 7.0 5.4 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.5 6.6 15.5 2.8 1.9 5.9 9.1 2.8 10.9 7.7 19.3 7.1 13.5 11.6 3.1 5.3 16.2 7.3 7.2 3.7 8.9 18.3 9.5 10.0 9.8 5.1 11.5 9.9 3.4 3.3 14.6 2.4 2.3 4.3 6.4 12.1 3.9 4.3 9.2 10.0 8.4 6.7 6.0 9.8 21.2 11.3 11.1 3.9 4.3 15.9 11.9 7.2 17.6 7.9 2.4 5.4 7.3 3.9 13.0 11.3 14.3 17.1 6.6 5.5 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 3.0 1.3 1.9 1.7 6.3 14.7 10.6 2.5 2.7 2.3 0.0 25.5 2.8 1.7 2.0 1.1 4.5 0.7 0.0 0.8 1.8 2.3 1.4 4.6 1.5 3.0 9.5 6.4 4.3 3.7 1.3 3.7 2.5 3.3 0.0 3.6 4.8 1.3 0.0 4.2 1.9 16.3 0.0 3.8 4.7 5.3 4.8 0.7 1.0 4.0 1.7 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.3 48.1 5.9 20.1 11.8 14.2 11.2 7.4 17.1 16.2 12.7 14.6 6.2 17.4 44.9 14.9 16.1 19.9 8.5 22.2 10.9 20.4 8.1 4.6 16.7 23.9 29.8 7.8 14.9 13.4 22.7 10.4 17.4 16.3 19.5 16.7 14.0 74.6 10.0 49.0 11.7 21.9 10.6 25.3 36.9 11.1 9.2 46.0 39.4 35.1 10.7 16.3 7.8 32.1 18.0 7.4 27.9 22.8 11.4 20.4 7.8 22.2 16.4 44.5 44.3 10.3 19.7 35.1 15.6 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 62.5 59.8 25.2 116.9 45.7 27.8 62.3 178.3 58.9 89.9 144.8 11.8 101.4 51.4 137.3 396.4 66.1 62.3 0.0 143.8 66.1 80.7 116.5 28.8 417.5 85.9 25.4 113.0 63.3 78.3 488.1 74.8 50.9 91.1 31.5 72.5 72.5 99.5 66.6 64.0 180.1 27.1 45.3 59.3 30.7 14.9 47.2 80.9 37.9 73.4 104.8 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" NA NA "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.5 9.2 12.6 15.5 7.3 7.5 9.3 8.8 8.9 8.0 10.8 10.2 17.4 14.2 6.6 5.6 14.9 14.4 14.7 10.2 14.3 17.5 8.4 7.4 15.6 6.7 13.0 15.5 7.5 8.3 10.5 15.9 16.0 4.9 6.1 14.8 23.9 16.8 9.7 12.4 29.5 9.4 18.7 8.6 8.2 15.9 14.1 23.5 8.0 12.3 11.3 17.4 20.0 32.1 12.6 10.3 10.4 10.4 4.8 14.6 5.7 15.2 21.0 22.3 32.6 29.6 23.7 18.0 22.4 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 3.0 10.5 8.2 3.0 4.1 13.0 6.9 7.6 8.1 11.4 8.7 3.9 6.6 1.7 5.0 22.4 9.0 7.0 0.0 7.9 7.4 8.1 5.0 9.3 8.2 7.0 4.8 13.3 7.4 11.3 4.9 6.1 7.5 6.8 4.6 10.2 19.3 6.0 11.2 4.9 3.9 13.9 0.0 5.8 12.6 15.1 4.6 5.5 11.5 8.1 3.8 TMEM221 ENSG00000188051 "Transmembrane protein 221" A6NGB7 19 17435509-17448567 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.4" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;PC-3: 11.3;REH: 6.3" "HPA041580, HPA062945" Supported Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700, HPA062945: " "unprognostic (3.60e-2)" "unprognostic (7.86e-2)" "unprognostic (4.51e-4)" "unprognostic (2.09e-2)" "unprognostic (2.61e-2)" "unprognostic (9.14e-3)" "unprognostic (3.19e-1)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (9.47e-4)" "unprognostic (2.37e-2)" "unprognostic (6.67e-2)" "unprognostic (2.76e-1)" "unprognostic (2.42e-2)" "unprognostic (1.23e-1)" 1.0 6.1 5.4 0.7 2.9 0.5 1.6 1.3 7.0 0.9 0.8 1.1 0.0 0.4 1.2 3.1 0.9 6.2 1.5 1.2 6.0 2.1 0.7 0.4 0.7 0.6 1.2 2.5 11.4 5.4 10.2 2.5 0.5 3.3 3.8 0.4 6.5 3.3 4.6 0.6 1.2 0.6 0.6 3.1 0.5 0.6 2.4 1.8 0.0 1.4 1.1 0.4 0.9 3.3 0.0 1.6 0.0 0.1 0.0 0.7 0.1 0.8 2.5 1.0 7.4 0.0 0.0 0.2 0.3 0.0 0.1 0.4 0.1 0.2 0.2 1.5 0.0 0.6 0.3 2.2 0.1 0.0 0.1 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.1 0.1 0.0 0.1 0.2 0.3 1.6 0.6 11.3 6.3 0.2 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.1 0.7 0.3 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.4 2.9 1.3 7.0 6.0 2.1 1.2 2.5 3.3 1.8 0.0 0.3 0.0 0.1 0.0 0.9 0.3 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 1.6 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 51.3 0.1 0.0 1.1 0.0 22.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.3 13.2 7.9 10.8 6.3 7.3 10.8 8.3 7.3 9.4 7.9 11.5 18.9 11.6 20.5 5.9 12.4 23.5 9.5 10.2 5.4 18.3 17.8 8.6 14.8 13.7 11.7 10.5 10.2 7.8 10.4 6.2 7.8 11.1 7.2 15.4 13.0 8.7 6.9 22.4 10.5 23.4 15.6 16.1 16.0 13.1 9.6 25.8 14.5 9.8 13.5 17.9 8.7 17.7 21.9 8.4 26.4 9.9 7.5 11.3 13.6 10.3 9.8 17.9 14.2 13.2 13.4 9.5 11.7 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 11.9 3.5 22.6 13.7 11.9 18.5 16.8 40.8 36.1 13.6 19.2 11.8 41.9 53.0 32.8 1.9 17.5 26.1 0.0 38.3 35.7 20.6 16.0 19.6 34.8 32.6 6.4 19.8 31.3 19.6 2.6 30.2 16.6 18.6 16.2 29.2 14.8 31.4 14.0 24.8 47.6 17.3 19.4 9.6 6.3 21.2 12.2 11.9 29.9 38.6 14.5 TMEM47 "BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9" ENSG00000147027 "Transmembrane protein 47" Q9BQJ4 X 34627064-34657288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 68.7;Muller glia cells: 146.8;Peritubular cells: 87.4;Sertoli cells: 90.5;Smooth muscle cells: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 27.5;fHDF/TERT166: 84.5;RPTEC TERT1: 20.8;U-2197: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046658 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA046658: AB_2679742" "unprognostic (1.50e-1)" "unprognostic (1.44e-1)" "unprognostic (5.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "unprognostic (3.82e-2)" "unprognostic (6.74e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.67e-2)" "unprognostic (4.23e-2)" "unprognostic (1.36e-1)" "prognostic favorable (4.05e-6)" "unprognostic (2.69e-2)" "unprognostic (7.19e-2)" "unprognostic (2.76e-1)" "unprognostic (9.94e-2)" 19.7 11.3 22.3 4.3 28.3 0.0 19.0 8.1 18.5 26.7 13.7 15.0 7.6 4.5 24.8 18.7 19.2 19.5 15.4 18.4 24.1 17.2 15.0 12.8 11.7 2.9 10.5 9.5 15.3 5.9 2.0 4.5 0.6 14.0 18.4 8.1 19.0 17.1 26.0 11.8 3.6 6.3 29.9 6.9 3.7 8.5 7.0 15.7 0.3 10.9 4.8 2.1 21.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 5.3 11.2 8.5 0.0 27.5 0.0 5.4 4.7 0.0 0.0 0.0 2.3 84.5 0.0 0.0 3.5 0.9 8.1 0.0 2.4 0.0 3.5 0.0 6.4 0.0 0.0 7.6 0.0 2.2 2.4 9.8 6.1 0.0 0.0 0.0 10.2 0.2 0.0 0.0 1.5 0.1 0.0 0.0 6.3 0.0 20.8 8.0 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.2 11.1 1.1 18.5 1.1 0.0 0.0 0.0 4.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 28.3 8.1 12.4 24.1 17.2 10.5 9.5 14.0 15.7 17.9 1.1 0.0 11.6 7.2 6.6 24.4 10.2 1.4 2.3 15.7 5.9 0.0 6.6 0.8 0.4 30.5 0.0 0.0 4.4 0.1 42.9 11.2 2.3 12.9 0.1 28.6 0.0 39.3 0.6 1.1 68.7 2.1 62.4 0.0 0.0 146.8 3.3 0.0 87.4 11.5 6.1 90.5 67.4 0.3 1.9 4.5 0.1 0.0 0.0 10.9 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515512-98550379 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 130.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847, HPA070805" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: " "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavorable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 10.8 9.5 8.1 25.0 9.5 36.8 12.7 19.1 11.0 16.9 22.9 10.7 8.7 15.9 18.4 17.1 23.0 15.4 10.3 9.6 8.5 8.3 15.8 20.5 13.8 34.0 9.0 11.2 34.7 21.6 9.9 9.9 13.6 7.6 15.6 17.6 12.5 14.0 9.7 9.4 11.7 22.6 10.7 9.4 29.1 16.8 11.4 10.3 130.9 13.2 12.2 35.4 13.0 17.9 14.1 10.9 18.1 33.1 9.7 15.6 13.3 30.8 20.4 50.3 25.5 4.2 5.6 29.8 25.4 13.5 34.5 25.1 22.2 15.5 53.9 15.6 14.7 12.6 19.8 42.1 19.1 31.7 37.7 26.1 46.1 18.6 14.6 3.8 53.2 30.8 3.1 6.3 20.3 10.9 12.0 19.6 33.6 38.9 20.9 21.4 19.4 86.8 42.0 30.2 28.6 19.1 72.9 33.3 37.3 12.2 28.8 39.8 23.8 43.5 27.3 13.7 20.6 30.8 25.6 10.5 20.0 17.5 13.6 25.9 22.8 38.8 60.3 5.7 30.9 26.5 18.1 14.4 6.1 9.5 25.0 10.2 10.9 11.1 10.8 10.9 14.1 15.6 11.7 1.1 9.7 33.1 6.1 13.3 13.3 8.1 9.5 19.1 11.0 8.5 8.3 9.0 11.2 7.6 10.3 29.8 18.0 45.4 21.4 24.6 20.8 7.1 25.5 36.1 48.9 29.6 11.8 16.5 26.6 16.3 26.8 36.0 27.6 70.0 27.6 75.5 19.0 17.7 27.8 45.0 32.2 9.5 27.5 32.5 64.7 21.9 26.4 40.1 16.9 34.3 51.4 24.2 21.6 31.5 38.2 27.8 47.9 19.4 15.6 38.6 53.5 20.5 9.8 33.1 42.9 16.3 TMX4 "DJ971N18.2, KIAA1162, PDIA14, TXNDC13" ENSG00000125827 "Thioredoxin related transmembrane protein 4" Q9H1E5 20 7977348-8019829 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 607.5;Late spermatids: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000399, HPA015752" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA000399: AB_1858471, HPA015752: AB_1858470" "unprognostic (3.93e-2)" "unprognostic (5.96e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-3)" "unprognostic (5.14e-2)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" "unprognostic (3.66e-1)" "unprognostic (2.96e-1)" "unprognostic (5.80e-3)" "unprognostic (3.16e-1)" "prognostic favorable (2.60e-5)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" 11.2 24.6 15.4 10.6 20.8 15.7 12.2 19.9 30.5 27.5 17.6 11.7 34.2 8.0 18.0 21.6 10.0 18.6 13.3 35.0 15.5 30.9 18.5 17.3 11.6 14.7 15.6 16.2 23.0 11.0 23.9 40.9 7.6 21.8 16.7 8.2 14.7 24.2 31.4 21.7 6.5 10.2 19.2 10.7 9.9 13.7 48.2 7.2 8.5 16.3 8.8 8.7 14.8 11.2 10.1 9.9 51.2 8.0 11.5 17.8 13.5 4.2 6.4 6.4 7.2 14.3 15.9 1.9 11.1 15.4 7.1 5.1 4.3 10.7 11.5 8.8 11.1 10.4 3.9 4.6 6.8 7.4 5.8 5.1 5.7 2.8 7.0 13.5 21.0 8.5 9.6 8.7 6.1 14.4 17.1 8.1 8.7 7.0 29.6 7.8 2.9 0.6 13.2 5.1 6.5 7.1 6.6 22.9 12.0 10.1 2.5 12.8 15.7 18.4 0.8 10.9 4.2 7.8 10.3 10.7 19.1 5.3 7.1 10.8 29.9 8.3 23.1 9.2 10.5 13.3 22.6 8.0 23.3 12.2 4.7 12.0 10.1 12.5 17.8 9.9 8.1 7.6 10.2 51.2 11.5 5.0 3.3 15.9 13.5 15.4 20.8 19.9 30.5 15.5 30.9 15.6 16.2 21.8 7.2 32.8 26.9 44.7 51.6 14.5 52.6 198.1 50.9 28.1 23.9 55.8 55.0 16.8 18.3 23.8 607.5 41.3 21.6 0.0 28.7 5.3 46.6 47.3 59.9 47.0 23.0 87.4 53.6 33.7 36.0 1164.8 71.4 37.5 43.9 7.2 21.4 79.0 22.5 19.8 52.6 20.7 90.7 32.3 28.1 158.4 45.1 13.7 6.9 66.0 23.9 26.3 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 128.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.5 27.4 0.2 0.1 1.8 7.9 9.2 1.6 7.0 4.4 1.5 0.3 24.9 0.0 20.5 8.0 23.4 17.7 1.9 0.0 2.1 0.9 0.1 2.5 19.1 0.1 3.4 1.2 3.4 3.0 0.2 1.4 0.0 1.7 2.3 1.3 2.5 6.0 0.6 0.5 0.0 1.9 1.6 3.2 2.2 1.1 3.1 4.0 14.0 128.9 0.2 0.3 25.2 8.8 0.3 1.0 14.2 8.1 4.7 0.9 2.4 5.1 5.0 5.4 0.4 0.1 6.7 5.6 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 0.0 33.8 0.5 27.9 25.1 0.6 12.5 40.8 25.4 30.7 26.2 0.0 0.8 0.0 129.0 29.4 40.9 0.4 0.0 39.8 58.7 62.7 91.7 33.4 6.4 46.3 0.0 16.6 22.1 116.0 36.8 7.8 125.1 28.7 414.8 0.0 8.0 86.0 6.5 2.1 5.5 0.4 19.4 41.0 1.1 2.8 29.2 4.0 2.5 0.2 83.4 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNKS "PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555914-9782346 "Enzymes, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 9.1 13.4 17.8 8.7 19.6 14.6 14.0 26.5 22.3 18.1 8.9 17.0 12.5 8.5 14.9 25.3 7.7 11.9 8.9 9.5 18.6 17.9 9.0 9.1 10.3 12.9 28.7 17.2 19.2 10.2 23.9 20.0 11.0 20.1 11.5 10.0 10.9 9.4 11.7 22.1 15.6 9.8 11.0 21.0 8.7 10.1 26.3 21.8 15.6 13.7 4.4 11.7 10.8 13.6 6.8 3.6 7.4 2.8 2.9 4.8 1.2 6.1 8.1 20.8 12.5 13.2 17.7 7.7 9.5 10.8 7.7 8.8 4.8 4.9 13.2 3.9 9.3 10.4 6.5 11.8 8.9 11.2 3.4 6.1 9.2 7.4 10.8 11.9 4.7 5.7 12.5 10.8 8.0 15.8 12.6 10.4 10.3 8.6 14.1 14.2 4.0 11.9 7.2 13.6 6.7 4.7 9.6 12.9 3.8 9.3 12.5 21.2 15.6 7.4 7.1 13.4 13.2 4.7 7.1 13.9 12.7 7.8 8.6 7.0 4.9 7.9 9.4 13.7 6.7 12.2 4.8 2.3 1.8 4.4 2.2 2.4 4.2 3.5 4.2 2.8 6.8 4.2 4.8 7.4 2.9 2.8 3.6 1.7 1.2 17.8 19.6 26.5 22.3 18.6 17.9 28.7 17.2 20.1 21.8 14.9 9.4 11.0 11.2 10.2 32.0 14.3 17.8 26.8 9.1 8.7 13.7 9.0 1.7 9.8 118.1 10.9 9.0 0.0 7.4 7.7 14.9 11.9 9.3 15.8 6.2 39.7 13.3 20.9 9.4 58.4 15.5 7.3 11.8 1.8 13.5 18.4 11.2 13.1 17.0 6.0 36.2 0.0 9.9 30.7 13.5 13.6 10.3 11.5 11.7 10.2 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.7 19.4 16.2 13.6 13.7 16.3 41.9 15.5 14.6 8.6 9.2 8.0 19.2 14.9 15.3 22.7 19.2 24.4 9.3 18.5 7.3 6.5 5.9 9.4 16.6 12.9 11.9 31.0 34.9 16.4 21.9 17.1 19.9 12.5 9.6 13.5 13.4 8.4 10.9 36.1 7.3 38.0 1.4 14.3 14.9 8.1 8.0 11.0 7.0 27.8 7.1 16.9 12.0 31.9 11.5 7.6 33.3 32.2 24.0 24.9 35.1 14.8 11.1 12.1 12.5 14.1 14.0 22.1 29.0 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 8.9 31.9 1.4 3.1 8.2 56.8 6.2 15.3 6.7 11.4 14.0 2.0 12.8 1.7 4.5 12.0 10.7 16.9 0.0 5.5 3.6 11.3 4.6 13.9 22.9 9.5 47.7 30.1 29.4 40.0 12.0 17.0 11.9 5.0 3.6 27.0 23.8 8.0 5.8 18.7 4.2 3.7 19.4 11.9 0.5 2.0 7.8 8.4 6.4 21.8 2.6 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812944-129824134 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 19.8 26.8 17.8 21.9 19.3 28.0 37.5 19.9 28.4 18.8 19.0 15.5 17.8 15.2 22.5 19.6 15.0 17.4 22.7 18.0 18.4 19.7 20.9 47.1 19.3 34.4 16.1 14.3 20.4 18.8 15.2 15.9 28.9 15.6 20.8 21.3 14.9 18.9 24.7 15.8 17.8 21.0 24.0 15.9 23.1 18.1 11.7 11.3 32.8 22.6 11.9 18.2 21.0 16.1 17.3 24.1 53.3 28.8 24.9 24.0 27.2 13.3 20.1 14.9 17.1 22.6 22.0 19.8 31.3 38.8 28.0 24.1 13.0 19.7 16.5 18.5 40.4 19.2 31.6 14.2 20.7 23.1 26.1 13.6 14.7 21.1 12.9 28.6 32.4 27.4 29.8 21.1 26.4 19.2 25.8 30.0 26.7 26.1 13.3 30.7 33.5 23.1 31.5 22.3 15.7 23.0 12.1 23.5 16.7 22.9 17.2 11.2 19.9 32.4 12.7 17.1 17.5 25.4 25.5 26.5 27.8 15.9 20.6 23.9 15.3 33.8 15.1 20.6 18.8 22.2 30.0 28.8 53.3 24.0 26.4 20.1 17.3 20.6 21.6 24.1 12.9 17.7 18.3 28.2 24.9 21.3 22.1 22.4 27.2 17.8 19.3 19.9 28.4 18.4 19.7 16.1 14.3 15.6 11.3 8.9 10.2 22.0 14.3 15.7 10.7 7.8 20.4 13.4 19.4 14.0 2.0 42.7 13.3 38.6 0.4 17.7 12.1 0.0 43.7 54.7 23.7 18.0 21.9 21.2 41.6 20.6 18.5 14.1 12.3 1.0 11.8 30.3 13.5 56.9 17.9 18.9 34.7 21.5 14.5 14.0 7.9 32.3 13.4 5.9 9.1 16.2 44.6 26.7 15.3 16.9 TOR1AIP1 "FLJ13142, LAP1B" ENSG00000143337 "Torsin 1A interacting protein 1" Q5JTV8 1 179882042-179925000 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 252.7;Late spermatids: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047151, HPA050546, HPA070991" Enhanced Enhanced "Nuclear membrane" NA NA 17000 "Nuclear membrane" "HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: " "unprognostic (1.41e-1)" "unprognostic (3.95e-3)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (9.00e-2)" "unprognostic (6.33e-2)" "unprognostic (7.04e-2)" "unprognostic (8.62e-2)" "unprognostic (1.93e-1)" "unprognostic (9.10e-2)" "unprognostic (4.40e-2)" "unprognostic (4.41e-2)" "unprognostic (2.87e-1)" "unprognostic (7.75e-2)" "unprognostic (4.02e-2)" 29.3 26.4 27.1 25.1 28.1 52.2 25.4 28.6 30.5 33.2 40.0 24.6 38.2 11.6 33.6 33.0 30.1 27.6 27.2 29.3 28.3 20.8 27.2 27.1 25.5 28.2 31.7 23.6 42.5 24.6 31.1 30.5 20.3 27.3 33.6 17.0 27.0 21.9 42.9 44.7 17.8 21.6 46.9 26.1 27.8 30.9 23.5 32.2 24.9 34.5 28.8 21.8 40.7 30.5 19.0 27.9 61.0 35.9 21.4 29.4 29.9 13.2 13.3 9.2 11.8 41.8 28.1 17.8 18.0 21.4 16.9 17.4 10.4 25.1 3.4 20.0 18.3 11.9 23.3 8.6 14.4 19.8 22.5 8.7 9.5 12.6 10.1 19.2 32.0 29.4 22.6 11.3 20.6 19.4 18.9 15.0 14.5 13.7 17.6 17.6 11.8 13.1 10.0 13.2 17.2 5.2 8.1 14.5 9.1 16.3 25.9 7.9 10.9 22.2 21.4 29.9 14.3 16.7 33.1 15.4 23.8 10.0 15.6 21.0 20.0 26.1 7.0 8.9 17.8 35.8 45.8 26.4 61.0 24.9 29.1 29.4 17.7 23.0 24.9 27.9 19.0 23.8 24.4 41.0 21.4 35.9 20.2 24.2 29.9 27.1 28.1 28.6 30.5 28.3 20.8 31.7 23.6 27.3 32.2 29.8 29.7 21.3 56.6 38.5 11.5 22.2 17.8 25.4 25.0 19.2 15.7 14.9 11.6 16.7 252.7 29.5 10.5 0.0 21.9 20.2 28.2 41.1 34.7 27.6 24.0 6.4 19.4 31.9 46.0 162.0 44.0 27.6 13.5 20.8 9.9 36.5 21.9 11.5 55.2 15.6 12.9 25.8 37.5 11.2 19.5 32.9 15.2 37.1 8.1 46.4 TPR ENSG00000047410 "Translocated promoter region, nuclear basket protein" P12270 1 186311652-186375693 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 640.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019661, HPA019663, HPA024336" Enhanced Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217" "unprognostic (4.51e-2)" "unprognostic (9.87e-3)" "unprognostic (2.48e-1)" "unprognostic (7.56e-2)" "unprognostic (9.88e-3)" "prognostic favorable (4.71e-4)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.71e-1)" "unprognostic (3.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-2)" "unprognostic (3.63e-2)" "unprognostic (1.31e-3)" "unprognostic (3.75e-1)" "unprognostic (4.19e-2)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" 21.5 17.3 14.3 26.7 21.3 21.6 19.0 24.4 17.1 21.7 24.2 7.3 27.1 12.9 20.8 23.5 18.5 16.9 16.8 28.3 13.8 10.5 18.7 20.6 17.9 20.4 14.1 16.6 24.7 17.8 44.2 29.1 29.7 15.1 22.2 17.7 9.1 20.2 30.1 33.1 20.5 21.1 21.2 16.4 26.1 18.8 35.0 17.8 39.5 21.7 19.7 21.4 25.1 19.1 19.1 19.8 50.3 15.2 10.7 16.9 5.2 21.6 18.7 28.1 16.3 22.6 20.2 29.6 24.9 16.7 17.6 16.4 28.2 18.5 25.4 19.3 16.9 12.1 28.4 21.1 17.0 21.8 19.0 23.1 33.8 30.3 19.7 12.1 36.0 22.2 15.4 10.3 26.5 20.6 16.3 20.7 14.6 40.7 22.9 18.7 18.7 17.9 9.6 30.9 19.8 6.5 21.2 22.0 22.0 14.4 26.1 15.3 24.3 29.0 19.3 15.6 40.1 21.4 23.0 29.1 17.6 16.8 19.4 30.1 25.1 29.3 23.2 11.3 18.4 15.7 29.5 12.0 21.9 15.8 10.0 13.3 15.2 13.8 12.7 6.8 19.1 16.9 11.7 50.3 10.7 15.2 19.8 15.3 5.2 14.3 21.3 24.4 17.1 13.8 10.5 14.1 16.6 15.1 17.8 202.5 98.3 78.9 89.1 89.9 87.4 160.6 35.7 133.8 120.6 55.8 74.6 117.3 19.9 88.2 106.7 100.9 41.3 23.3 65.3 89.1 87.0 62.9 77.5 34.3 63.0 93.8 65.1 57.1 60.2 23.6 116.2 74.5 52.3 147.9 49.2 93.4 74.7 52.6 110.3 23.7 104.0 129.4 82.9 640.0 239.5 86.7 126.1 97.0 64.6 75.6 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Group enriched" "Detected in some" 167 "Early spermatids: 407.9;Late spermatids: 161.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.3" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: AB_2677410" "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.8 29.5 26.3 25.0 21.5 22.7 23.3 23.8 19.3 32.4 29.5 27.4 15.6 26.7 8.9 22.7 22.0 18.6 31.6 27.7 21.5 31.1 40.1 19.1 44.8 64.4 27.5 54.8 31.4 21.1 24.6 23.0 29.6 20.7 30.4 33.2 16.7 39.0 22.5 39.6 38.8 37.2 20.5 16.7 63.9 23.7 17.6 55.0 31.8 34.7 40.3 29.3 11.8 35.2 43.4 23.7 17.2 32.7 14.3 28.6 35.1 13.0 29.0 17.3 65.0 43.9 26.8 41.8 26.2 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 17.9 41.8 50.0 60.5 77.4 32.4 73.1 63.7 25.4 52.4 62.8 33.4 96.1 305.1 118.9 207.4 51.7 39.3 23.3 108.6 136.0 58.6 137.6 10.5 80.8 109.4 42.9 54.1 37.4 48.3 186.2 38.9 65.4 89.4 102.8 78.3 48.2 121.8 56.1 42.5 211.1 37.3 45.3 91.2 74.9 65.0 96.0 80.9 50.7 65.4 100.5 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.5 6.1 5.5 17.7 2.9 2.1 9.9 5.0 3.4 4.9 7.0 12.1 2.3 12.9 5.5 5.2 8.6 6.5 19.9 2.8 6.7 6.6 6.4 11.4 5.9 10.1 11.8 10.3 7.2 4.8 8.3 3.9 8.4 4.6 6.1 11.3 19.0 5.1 2.1 8.1 7.9 6.7 2.5 6.2 4.3 4.8 8.8 7.7 6.6 7.9 6.6 6.7 12.6 6.6 16.9 5.9 12.7 13.5 3.7 2.4 9.0 3.8 5.5 7.7 11.9 8.2 1.3 14.4 6.0 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 14.9 4.6 1.5 2.5 0.9 9.5 14.6 5.1 4.0 10.3 0.0 19.6 5.6 1.7 5.1 8.0 4.5 3.5 0.0 5.0 3.0 3.5 8.1 1.1 5.1 12.9 4.8 9.1 17.8 11.7 11.0 5.2 8.2 0.0 10.8 3.4 5.6 7.9 2.9 2.5 3.8 11.3 12.9 3.4 13.7 11.9 2.5 4.1 2.6 3.7 5.4 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 20.5;Glandular cells: 61.9;monocytes: 13.6;Urothelial cells: 21.4" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Group enriched" "Detected in some" 5 "Hep G2: 18.7;RT4: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 2.9 0.0 0.0 0.0 0.1 0.0 31.3 0.1 0.0 0.1 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 0.0 0.0 0.5 20.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.0 6.4 0.9 0.3 6.3 0.0 13.6 3.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.4 0.1 0.0 2.8 21.4 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 146.3;Late spermatids: 145.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.5 26.4 16.8 15.4 11.1 16.7 43.9 14.7 12.2 25.8 24.9 16.5 14.9 33.7 21.1 10.9 27.6 14.5 27.3 15.7 38.5 22.0 35.6 35.4 16.0 28.7 15.2 37.4 17.4 10.6 12.2 21.9 17.8 13.1 15.4 16.8 28.7 15.5 19.4 16.4 33.5 25.5 24.1 37.9 28.0 30.5 38.3 26.4 18.8 17.7 18.8 23.8 17.1 20.4 33.4 21.9 25.1 19.1 13.4 26.6 22.3 21.9 30.5 30.1 55.4 39.0 16.5 26.1 19.0 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 14.9 25.5 32.0 48.3 53.3 16.3 3.9 17.8 48.2 22.7 14.0 13.7 61.4 33.2 24.4 146.3 25.4 10.5 0.0 40.8 58.4 26.5 24.1 31.1 16.6 54.8 9.5 15.4 8.6 38.6 145.5 24.7 35.4 21.9 38.7 19.4 20.6 29.1 17.8 20.8 29.8 10.3 12.9 16.5 115.2 106.7 46.0 66.6 27.7 22.5 46.3 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 39.4 35.3 47.9 35.9 21.7 29.2 35.3 43.7 28.2 46.0 39.4 46.9 29.7 57.9 30.6 29.9 46.8 33.5 73.0 30.3 67.7 35.3 26.9 57.0 36.3 29.3 15.7 57.4 39.0 16.4 22.7 36.3 39.6 34.9 37.5 29.2 65.7 33.8 42.3 20.8 47.7 25.2 55.7 47.2 27.1 42.8 54.7 35.2 20.9 30.0 38.3 20.4 42.5 35.9 21.3 50.4 29.4 28.4 25.0 43.2 49.1 35.1 42.9 27.5 45.3 84.0 26.8 49.3 38.9 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 38.7 36.3 31.8 27.6 46.2 69.7 57.0 43.3 46.8 28.4 29.6 90.3 46.3 11.6 24.4 3.2 40.7 19.3 70.0 22.5 42.3 40.9 34.4 40.5 48.0 49.4 68.3 43.4 42.4 46.3 8.0 31.1 53.2 35.4 49.5 31.2 34.0 26.3 17.5 29.0 20.8 102.5 19.4 43.7 64.6 88.2 49.7 25.2 42.9 37.6 38.3 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359703-69390796 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Spermatocytes: 352.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA072532: AB_2686530" "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 10.0 13.4 10.7 12.9 11.7 33.1 15.6 21.2 16.0 9.4 10.3 8.2 5.6 11.4 10.6 13.6 12.7 10.8 7.3 10.2 10.2 11.4 13.0 12.6 8.8 17.6 13.8 8.1 10.7 19.2 6.0 14.7 9.2 11.5 9.6 12.1 12.1 12.1 9.0 12.5 9.5 11.2 9.7 11.7 12.1 10.3 51.6 10.9 22.6 12.2 13.4 16.7 10.1 9.8 13.5 10.7 14.7 15.1 12.8 23.1 13.0 17.3 8.9 17.5 10.8 4.1 6.6 14.1 10.5 11.3 18.7 15.6 10.3 5.2 35.4 10.3 5.7 9.5 13.5 13.9 10.7 18.4 17.3 15.2 20.3 7.1 12.5 5.7 29.4 18.0 4.8 13.7 9.9 14.8 9.5 10.6 29.4 17.1 43.3 9.1 8.7 41.3 32.2 24.5 11.7 12.3 22.0 16.5 17.2 10.4 15.8 19.5 13.3 10.9 10.6 17.1 11.5 20.3 17.4 6.2 7.7 7.8 21.3 12.8 11.5 14.0 38.6 8.3 14.1 13.4 5.2 7.8 14.7 13.5 11.0 15.1 13.2 18.9 14.1 10.7 13.5 23.1 19.5 4.0 12.8 15.1 8.9 18.3 13.0 10.7 11.7 21.2 16.0 10.2 11.4 13.8 8.1 11.5 10.9 6.0 19.6 31.4 31.2 26.4 23.3 22.2 15.3 24.1 25.0 10.4 11.8 38.5 39.7 23.6 5.4 14.6 15.1 46.7 33.9 48.2 16.2 30.4 18.5 16.6 33.0 17.5 16.9 9.8 10.0 12.0 17.3 24.0 11.8 56.9 25.2 21.7 26.2 17.5 22.6 28.7 21.9 19.4 14.6 352.0 74.5 28.0 19.7 33.1 35.3 31.0 YTHDF3 FLJ31657 ENSG00000185728 "YTH N6-methyladenosine RNA binding protein 3" Q7Z739 8 63168553-63212786 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048703 Approved "Nuclear membrane,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nuclear membrane, Cytosol" "HPA048703: " "unprognostic (1.06e-2)" "unprognostic (9.89e-3)" "unprognostic (6.65e-3)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (7.87e-2)" "unprognostic (9.57e-2)" "unprognostic (2.07e-1)" "unprognostic (6.14e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (1.35e-3)" "unprognostic (1.11e-1)" 21.7 17.5 12.2 12.8 15.2 53.2 16.0 16.7 17.3 19.4 20.2 14.3 16.8 14.2 24.3 13.6 17.7 17.6 17.6 26.9 11.9 11.4 18.8 26.8 16.8 12.4 14.2 10.6 25.1 15.6 16.6 19.3 29.0 16.8 21.2 15.6 12.9 18.1 18.8 28.0 12.7 24.7 19.4 14.4 18.1 15.9 13.3 14.2 20.1 17.2 15.9 14.1 21.0 15.9 8.2 16.9 21.2 24.9 9.7 11.0 10.1 16.3 22.2 21.3 16.0 28.6 24.6 14.7 29.8 25.0 18.9 22.5 18.8 16.4 17.3 6.5 29.0 21.4 15.6 28.1 19.8 28.1 14.0 13.3 32.2 16.8 12.7 26.0 9.1 15.9 32.5 15.3 20.2 28.4 19.4 15.9 10.8 18.8 15.9 28.4 11.3 17.5 8.5 29.7 21.5 16.4 13.3 16.3 8.5 17.8 29.0 8.8 15.6 21.1 19.1 21.6 19.1 25.6 11.6 28.6 17.6 17.1 15.7 15.9 19.1 17.2 25.9 18.0 12.9 21.2 20.6 16.6 17.4 8.9 19.4 9.8 7.4 9.0 10.5 16.9 8.2 11.0 10.5 21.2 9.7 24.9 5.1 9.4 10.1 12.2 15.2 16.7 17.3 11.9 11.4 14.2 10.6 16.8 14.2 29.8 42.7 14.7 18.8 34.5 15.4 42.4 22.9 28.1 25.0 19.2 5.9 17.0 6.6 14.3 5.1 22.5 31.0 0.0 14.3 22.2 31.9 23.9 22.0 57.7 27.0 19.1 39.1 32.5 51.9 4.7 22.2 36.1 16.9 17.2 28.6 14.5 18.6 28.1 24.8 23.7 12.7 12.9 21.7 10.8 21.7 27.5 22.1 20.0 23.5 30.7 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150329789-150332721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.4;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.8;K-562: 17.5" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 0.4 37.4 0.4 2.6 0.4 1.7 0.8 0.3 0.2 1.1 1.4 1.6 2.0 0.2 1.2 1.9 0.4 0.4 0.3 0.6 1.8 5.6 1.5 3.9 0.3 3.1 3.2 11.3 2.5 0.0 1.5 1.5 1.1 0.9 0.1 2.2 2.1 0.6 0.1 2.3 1.7 0.3 1.8 3.7 1.3 0.8 3.6 1.0 2.8 1.0 2.8 3.5 2.4 4.5 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 6.3 4.7 2.6 2.3 0.0 0.0 1.8 0.0 0.0 0.3 40.8 3.3 3.1 6.7 10.7 1.3 0.0 4.8 0.9 2.4 0.0 0.0 0.1 0.2 9.1 17.5 6.8 0.0 2.0 7.7 1.9 3.0 1.8 0.0 0.0 0.3 5.7 2.1 9.0 8.6 5.0 6.9 1.9 0.3 1.4 0.6 2.1 0.1 0.0 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.7 0.7 3.2 2.2 2.4 3.4 0.7 3.6 3.5 2.9 2.8 2.8 0.2 1.0 2.2 2.4 0.0 1.0 0.0 0.3 0.2 1.0 0.6 5.1 0.0 2.3 1.8 7.9 1.3 5.0 2.1 0.0 0.0 0.9 0.0 11.0 0.7 0.6 0.3 1.1 2.6 0.5 0.0 4.6 0.0 1.6 0.0 2.6 0.0 0.0 3.6 2.0 1.4 19.3 0.0 1.1 0.7 0.5 0.0 0.2 0.5 0.9 0.1 1.6 0.0 2.3 0.5 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.3 4.1 5.5 4.4 8.8 13.3 4.4 4.4 7.3 4.7 4.5 2.6 6.2 2.7 6.5 10.1 2.8 6.1 3.8 3.9 7.5 2.4 2.3 2.2 5.6 2.4 7.8 4.3 2.2 5.4 10.2 4.7 8.2 9.6 3.2 3.1 5.1 3.3 12.0 3.6 3.2 2.4 2.1 5.1 1.5 2.2 7.7 4.8 5.8 4.2 7.9 7.0 8.0 14.1 8.4 4.2 10.7 3.3 5.2 9.3 5.4 7.3 5.8 3.8 1.9 2.9 4.4 1.6 12.9 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 17.9 6.2 7.2 4.6 6.6 13.6 12.8 7.6 10.7 10.3 15.7 2.0 3.3 1.7 6.1 2.9 5.5 3.8 0.0 4.9 3.2 6.1 8.3 1.1 8.3 3.7 23.8 12.6 8.0 7.9 2.7 14.4 4.6 11.8 6.4 6.5 30.0 6.0 0.0 11.3 9.1 8.1 6.5 6.1 6.5 4.5 8.8 2.9 4.5 7.6 5.2 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Suprabasal keratinocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.3;GAMG: 15.7;U-698: 11.6" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.1 0.1 4.6 0.7 2.3 0.1 10.3 0.1 0.2 0.0 0.0 1.6 0.0 1.6 1.5 0.1 15.7 0.0 4.4 1.8 0.6 1.8 0.0 6.1 0.0 0.0 0.0 2.3 6.0 0.2 0.2 2.7 2.7 0.0 0.0 0.3 2.5 0.5 2.0 0.5 0.4 0.0 2.9 0.2 0.4 3.0 2.8 2.0 2.4 2.1 0.5 0.3 3.0 0.1 1.0 0.2 0.5 0.4 1.5 0.3 0.1 0.9 1.1 0.0 1.7 11.6 0.2 1.9 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.1 0.0 0.0 0.7 0.0 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093361-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Basal keratinocytes: 42.1;Suprabasal keratinocytes: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "basophil: 7.1" "Lineage enriched" "Detected in single" 23 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "HSkMC: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane, Golgi apparatus" "HPA038836: AB_2676229, HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favorable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 6.9 8.1 7.7 3.5 12.6 4.6 4.8 21.4 12.0 7.1 7.3 8.7 6.8 2.6 7.9 4.2 5.2 6.0 7.6 6.8 9.3 4.8 5.6 6.4 6.3 2.0 9.2 5.2 11.5 5.5 8.4 13.2 4.1 9.9 5.8 6.1 5.8 4.9 5.6 18.4 9.3 4.5 10.8 11.1 2.7 5.1 12.0 11.0 0.2 13.3 4.0 2.2 7.9 4.2 0.0 0.0 7.1 0.2 0.0 0.3 0.0 4.3 2.6 10.4 0.0 4.8 11.2 2.0 1.7 11.4 3.1 5.1 3.3 4.1 0.0 6.5 5.1 7.7 4.2 2.0 6.1 6.1 16.3 1.4 6.9 3.3 1.2 5.5 0.0 3.3 18.0 5.9 5.3 8.8 6.1 4.2 0.0 0.6 1.0 6.3 0.6 0.0 0.0 1.6 0.1 9.3 0.0 3.6 0.4 3.4 8.9 4.7 8.5 4.0 0.2 7.5 2.1 2.5 2.5 7.0 6.8 3.3 3.5 3.7 0.4 0.0 0.0 4.1 1.2 7.9 7.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 12.6 21.4 12.0 9.3 4.8 9.2 5.2 9.9 11.0 32.8 7.5 0.5 3.4 42.1 8.0 13.0 5.1 0.0 1.2 5.2 3.9 1.2 0.0 5.7 8.5 12.8 7.0 0.0 3.1 0.4 10.8 10.3 0.0 6.4 8.8 14.3 8.5 13.5 5.9 9.3 8.9 4.6 21.9 2.8 8.2 5.2 3.1 14.4 7.8 5.1 2.7 0.0 3.5 1.7 0.8 58.2 0.7 0.0 6.8 6.7 ZC3H13 "DKFZp434D1812, KIAA0853" ENSG00000123200 "Zinc finger CCCH-type containing 13" Q5T200 13 45954465-46052759 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039340, HPA040140, HPA047806" Uncertain Approved "Nuclear membrane,Actin filaments" NA NA "Nuclear membrane, Actin filaments" "HPA039340: AB_2676454, HPA040140: AB_2676858, HPA047806: AB_2680161" "unprognostic (1.50e-1)" "unprognostic (6.28e-3)" "unprognostic (1.25e-1)" "unprognostic (2.22e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.77e-1)" "unprognostic (1.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.69e-4)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.45e-1)" "unprognostic (9.21e-3)" 16.4 11.7 17.7 13.9 30.3 15.4 17.3 17.8 26.9 18.9 15.4 19.0 14.2 9.4 20.6 16.9 13.5 13.4 12.4 11.9 20.3 15.9 14.3 67.5 13.5 15.9 23.0 23.2 20.5 10.5 22.2 18.3 17.0 24.5 17.5 13.8 7.6 14.3 16.9 19.8 14.7 13.3 20.8 24.9 16.9 12.7 11.9 25.7 25.2 19.3 10.6 14.2 21.0 12.3 18.4 20.3 28.4 15.2 13.0 19.4 8.0 6.7 8.5 20.2 8.4 14.7 15.3 10.0 12.1 9.7 10.4 7.1 12.4 11.8 18.5 8.1 12.0 6.8 12.1 13.1 10.1 16.2 16.3 15.2 21.6 8.0 10.8 8.8 26.6 11.9 11.6 8.2 10.6 12.3 9.0 10.3 10.4 11.5 5.7 10.1 9.2 13.4 12.9 19.8 12.1 5.6 14.0 13.3 5.6 7.9 9.6 5.6 12.5 11.0 7.5 64.7 13.8 5.7 11.8 18.2 8.8 8.1 7.9 10.6 5.6 6.8 18.7 10.0 14.6 11.4 19.9 13.3 22.9 19.4 15.2 18.7 13.6 15.5 13.1 10.4 18.4 15.7 12.7 28.4 13.0 14.4 20.3 16.0 8.0 17.7 30.3 17.8 26.9 20.3 15.9 23.0 23.2 24.5 25.7 199.5 190.7 89.3 56.4 36.1 81.4 159.8 91.7 120.5 122.8 52.4 41.2 76.6 23.2 57.3 3.5 66.9 33.2 46.7 42.3 65.9 68.7 53.3 119.7 190.6 57.8 81.0 53.4 77.3 82.1 6.0 71.1 51.0 27.0 89.2 29.4 78.7 44.7 37.7 76.7 14.6 66.7 51.8 55.2 139.4 101.3 44.3 67.2 69.8 32.8 47.4 ZC3HC1 NIPA ENSG00000091732 "Zinc finger C3HC-type containing 1" Q86WB0 7 130018286-130051451 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019089, HPA024023" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA019089: AB_1858976, HPA024023: AB_1858977" "unprognostic (7.14e-3)" "unprognostic (4.07e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.89e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (5.11e-2)" "unprognostic (2.60e-2)" "unprognostic (1.53e-1)" 11.0 13.8 8.1 10.0 10.3 4.9 14.2 9.5 12.6 9.5 9.2 9.9 5.9 6.0 14.5 11.0 7.9 9.4 7.5 16.3 8.2 8.9 13.2 14.8 6.9 13.6 7.3 8.4 10.7 10.6 10.5 9.6 10.0 10.5 9.0 8.4 9.6 10.5 8.4 33.0 7.1 7.8 12.9 5.5 13.7 9.0 24.6 6.6 15.4 8.3 11.9 11.5 8.5 9.6 23.1 20.2 17.4 17.7 17.4 23.8 15.8 7.0 12.0 14.9 16.8 8.5 7.8 10.3 9.2 11.0 17.4 18.1 14.1 12.1 16.3 6.7 11.7 23.8 6.5 19.5 13.9 17.2 10.6 16.7 11.3 10.9 13.7 13.7 13.0 11.6 9.4 10.5 18.1 11.8 9.9 19.0 14.0 33.9 5.7 17.6 12.4 15.3 25.1 30.4 12.4 13.7 14.5 11.5 14.2 17.6 4.8 9.6 17.2 13.3 19.3 14.7 22.3 8.4 13.8 8.7 11.9 5.8 10.4 15.4 11.1 16.7 21.2 18.8 16.7 20.2 17.4 16.2 14.5 17.0 17.7 19.5 23.1 18.2 18.2 20.2 20.6 23.8 18.8 1.3 17.4 16.3 11.9 18.5 15.8 8.1 10.3 9.5 12.6 8.2 8.9 7.3 8.4 10.5 6.6 6.0 2.9 5.1 4.3 1.3 5.8 12.1 7.6 10.7 3.4 7.0 0.0 16.1 14.9 10.7 2.6 6.5 2.1 0.0 8.4 13.7 4.8 2.2 4.6 8.5 7.8 6.4 3.5 11.6 3.2 4.3 8.1 4.1 1.7 15.4 4.1 7.2 7.8 7.0 6.0 17.0 5.6 0.0 5.1 31.6 18.8 1.5 6.2 5.7 4.2 1.4 ZCCHC14 "BDG29, MGC14139" ENSG00000140948 "Zinc finger CCHC-type containing 14" Q8WYQ9 16 87406246-87492045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 48.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014122 Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA014122: " "unprognostic (2.04e-2)" "unprognostic (2.84e-1)" "unprognostic (4.62e-2)" "unprognostic (2.67e-1)" "unprognostic (3.99e-1)" "unprognostic (6.74e-2)" "unprognostic (7.44e-2)" "unprognostic (1.69e-1)" "unprognostic (1.46e-1)" "unprognostic (6.41e-2)" "unprognostic (1.20e-1)" "unprognostic (2.88e-2)" "prognostic favorable (1.47e-14)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (7.13e-2)" "unprognostic (2.83e-2)" 4.9 5.3 3.3 2.2 3.7 0.6 3.9 9.3 4.5 5.2 3.6 6.3 5.0 2.9 3.5 4.0 4.6 4.2 3.1 2.5 4.6 9.0 4.0 1.6 2.1 7.8 5.7 8.5 4.2 3.1 2.6 3.5 3.3 3.3 3.4 5.4 6.3 3.4 1.8 1.8 3.6 16.8 5.3 1.3 4.2 3.7 0.3 0.3 0.8 1.8 1.0 2.6 0.3 6.9 5.2 8.6 11.3 11.5 7.8 5.2 3.5 5.0 4.2 2.1 11.3 6.0 3.8 4.7 6.7 10.6 11.3 8.1 2.7 5.4 1.1 10.5 3.7 7.6 11.0 5.0 0.9 1.9 6.8 5.6 8.0 5.0 6.3 5.8 2.2 8.7 1.1 3.7 7.6 0.1 4.6 6.4 4.2 4.8 9.8 4.7 1.6 7.6 3.9 19.5 24.7 25.7 3.5 14.2 5.6 8.4 8.1 4.7 10.4 7.8 9.4 5.8 2.4 1.3 11.4 4.6 6.0 6.7 0.0 0.4 0.3 1.1 0.1 2.6 0.3 1.1 1.7 0.3 0.3 2.0 1.0 0.8 1.0 1.8 0.2 1.8 0.3 11.9 9.8 1.9 2.2 16.3 20.0 8.1 15.3 12.0 18.2 5.2 5.9 2.8 3.3 6.4 19.8 11.2 16.3 0.0 7.0 1.6 8.8 2.9 1.1 26.4 4.7 22.3 20.2 14.1 8.1 31.5 10.3 5.6 6.8 0.0 15.8 7.5 7.3 5.8 9.6 8.4 14.8 19.4 26.4 48.6 19.0 15.3 3.1 4.3 14.2 2.0 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.7 25.5 17.0 21.0 27.3 18.7 17.8 23.9 31.9 27.6 26.5 19.8 19.5 19.2 27.6 34.9 24.2 25.6 21.4 33.8 24.7 19.0 24.8 12.2 17.9 18.8 21.9 14.4 17.9 20.9 22.4 32.3 23.3 30.0 28.3 17.8 9.7 14.6 35.0 20.7 21.8 19.8 13.9 19.8 22.2 15.0 17.3 17.6 23.4 10.1 8.3 11.8 14.6 15.1 12.9 17.7 19.9 14.2 17.3 17.4 16.2 11.2 27.9 14.0 22.6 11.8 20.1 22.5 9.1 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 17.9 17.2 14.5 15.7 4.6 15.1 9.7 15.3 6.7 27.3 12.2 3.9 35.3 21.6 31.3 20.3 9.2 12.9 0.0 28.4 55.1 10.0 16.3 6.9 15.8 21.8 12.7 6.9 8.0 7.3 5.7 8.1 7.5 3.3 24.4 16.7 10.4 30.7 10.5 3.5 17.8 10.6 6.5 4.9 16.1 12.7 3.8 31.7 7.5 17.9 14.1 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: AB_2732568, HPA060470: AB_2684290" "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.7 2.8 3.4 4.3 7.0 9.0 1.6 1.2 7.4 5.8 4.1 5.8 0.2 0.0 0.9 8.8 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.7 1.3 5.0 1.5 0.0 3.2 9.2 0.0 0.0 6.8 0.0 11.4 0.0 7.8 0.0 1.5 9.6 5.7 2.2 3.4 4.2 0.1 8.7 0.0 0.5 5.4 8.4 1.6 5.1 0.4 2.5 4.4 4.4 5.7 5.0 3.4 11.3 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 0.0 8.3 1.9 2.5 0.9 19.2 3.5 2.5 8.1 3.4 5.2 21.6 6.8 8.3 4.5 4.8 4.2 0.0 0.0 1.2 5.4 4.5 1.7 5.8 0.5 3.7 31.8 2.9 2.5 1.9 1.3 5.5 3.5 5.0 1.0 0.3 9.4 1.4 0.0 7.1 4.5 10.4 19.4 4.2 10.8 6.3 0.5 1.1 4.9 1.0 0.9 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.7;salivary gland: 23.4" "Group enriched" "Detected in many" 31 "Early spermatids: 319.1;Late spermatids: 835.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favorable (1.03e-4)" 1.9 1.1 1.2 1.9 1.0 2.8 2.1 1.9 1.4 1.6 3.9 3.5 4.1 2.3 1.7 1.7 1.8 1.5 1.5 1.7 3.4 1.9 2.8 3.0 1.8 3.1 3.9 0.5 0.8 2.2 2.3 4.0 23.4 1.2 1.1 2.2 4.2 1.8 2.1 5.2 2.6 2.8 2.4 3.4 3.1 1.8 10.6 12.6 10.0 14.7 9.9 12.3 6.3 3.6 2.8 7.9 10.4 3.0 1.9 19.9 3.8 2.3 4.0 4.1 4.2 3.3 7.4 4.5 3.0 2.7 4.0 9.4 3.0 5.7 0.4 2.6 6.5 3.3 8.9 2.9 11.6 7.5 2.3 2.4 3.9 3.8 1.9 5.7 8.7 9.1 5.2 5.0 3.2 11.9 7.5 20.5 7.1 6.5 12.6 6.4 5.2 3.8 11.0 12.4 12.6 5.6 4.4 3.8 9.9 3.2 18.6 6.5 3.0 4.5 3.3 6.8 4.5 5.5 10.9 1.2 11.9 6.3 6.2 8.8 10.0 7.0 9.9 10.1 10.6 9.1 8.5 12.6 6.7 12.3 11.8 2.0 9.9 14.7 9.9 6.7 6.3 14.9 9.9 3.7 3.6 3.2 3.3 4.4 5.1 4.0 7.9 3.5 3.9 3.1 1.7 4.3 319.1 8.8 6.6 0.0 4.3 5.7 2.7 4.0 10.5 0.8 7.2 0.0 7.5 2.5 18.7 835.8 11.2 14.2 6.8 5.4 5.6 2.1 3.7 10.7 11.3 4.9 5.2 6.5 3.3 7.4 12.8 1.4 1.1 4.3 8.0 5.7 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 18.5;Late spermatids: 41.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: AB_2683225" "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.4 10.7 4.8 11.3 4.6 3.9 5.9 6.2 2.5 3.3 3.9 3.4 7.0 4.1 6.1 4.0 4.8 8.3 2.2 6.9 1.3 8.6 8.3 2.9 11.8 6.6 8.9 7.0 7.7 3.7 8.6 4.6 1.7 2.5 2.5 8.1 7.4 9.2 2.1 14.6 6.6 8.7 8.2 3.6 8.2 8.9 5.6 7.5 2.6 2.3 9.9 8.5 9.4 5.6 4.4 3.2 7.4 12.2 6.1 6.7 6.2 7.6 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 0.0 0.6 1.7 1.3 1.6 5.9 3.3 2.5 1.4 1.2 0.0 2.0 1.4 1.7 3.5 18.5 2.2 8.5 0.0 4.3 1.6 2.5 1.7 4.6 1.0 2.8 7.9 2.4 2.5 4.1 41.1 6.1 2.3 0.0 3.6 5.3 4.6 4.9 3.5 6.7 2.3 5.2 19.4 4.4 8.9 3.8 1.8 1.1 0.0 5.2 1.3 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA054045: AB_2682354" "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.53e-7)" 13.5 13.3 12.4 13.6 17.7 6.9 14.4 29.2 20.2 13.6 11.0 10.8 17.7 14.8 14.9 20.3 10.0 13.5 11.6 9.0 16.4 7.8 12.7 13.3 14.6 17.1 20.3 11.0 18.6 13.1 16.6 25.0 12.1 15.4 15.0 18.1 11.6 13.8 13.9 6.6 20.2 19.4 15.0 12.3 23.6 13.1 5.4 15.8 14.9 18.0 8.7 18.3 12.1 11.3 11.6 6.5 25.0 8.1 10.0 14.5 6.7 6.1 10.2 11.0 9.0 10.9 11.5 9.0 7.7 11.5 5.4 12.4 5.0 4.9 7.4 8.6 10.1 4.1 6.9 6.0 6.6 7.2 7.5 12.2 14.1 16.9 5.2 5.8 10.1 16.6 14.2 12.0 6.6 9.9 17.1 9.6 7.4 4.3 9.0 8.9 1.6 8.9 12.3 4.7 3.3 7.1 5.3 11.9 4.5 8.1 19.6 5.6 12.9 10.6 4.6 3.5 11.4 4.5 13.3 10.0 11.9 7.7 5.3 5.4 12.1 11.3 4.2 6.4 7.9 5.5 25.0 6.1 14.1 13.3 4.1 14.5 11.2 11.2 13.1 6.5 11.6 14.1 10.9 4.5 10.0 8.1 5.8 12.5 6.7 12.4 17.7 29.2 20.2 16.4 7.8 20.3 11.0 15.4 15.8 20.8 13.4 27.2 6.3 4.9 25.7 4.0 22.9 5.3 7.9 24.4 17.7 10.3 1.7 6.4 11.3 9.5 18.0 0.0 4.6 6.2 10.0 8.4 20.7 5.3 6.6 25.4 9.2 12.9 8.8 2.9 15.0 11.5 5.0 19.0 8.8 17.8 6.3 17.5 13.1 1.4 21.3 12.9 6.4 3.7 3.7 5.9 6.9 29.4 8.5 8.0 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87264196 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: AB_2681190" "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 11.8 10.2 15.2 16.7 16.8 31.1 14.5 31.1 19.7 15.0 13.9 10.3 11.4 11.2 16.4 15.1 11.1 11.1 9.8 11.6 13.6 9.0 9.8 10.8 9.7 14.8 18.2 9.8 20.6 12.5 14.6 20.7 12.3 15.3 14.0 10.2 12.0 15.0 11.2 9.3 14.0 15.7 12.3 18.6 12.2 11.6 8.7 19.6 25.6 14.1 5.7 16.5 22.6 22.9 16.7 10.4 35.8 7.6 4.3 8.3 3.0 6.3 3.8 12.8 11.2 7.3 6.7 13.3 4.9 6.4 5.9 8.2 6.4 4.5 9.8 7.3 6.5 8.4 6.6 7.9 7.5 12.9 22.2 6.0 13.2 4.9 5.1 5.5 10.6 6.0 6.6 7.4 5.8 7.6 9.5 5.4 10.6 9.6 15.1 6.4 3.5 6.1 9.5 6.4 2.2 3.5 12.9 12.7 3.7 5.2 13.8 9.6 13.5 6.3 4.2 4.8 7.7 4.2 12.8 6.1 7.9 5.5 5.8 7.8 14.0 9.1 6.7 8.7 9.2 5.7 18.0 7.6 7.9 6.9 2.2 6.5 16.6 7.4 7.5 3.2 16.7 8.3 7.1 35.8 4.3 2.3 10.4 7.1 3.0 15.2 16.8 31.1 19.7 13.6 9.0 18.2 9.8 15.3 19.6 56.6 56.6 44.4 25.9 58.7 160.5 61.0 40.8 32.1 48.9 24.4 115.8 19.3 8.3 84.7 16.4 40.7 47.6 0.0 33.2 25.7 35.7 37.4 27.8 15.3 23.3 176.4 45.4 36.2 26.5 6.4 55.5 39.5 30.4 44.1 44.3 74.5 51.7 42.1 62.2 11.6 93.9 32.3 37.3 48.7 29.8 44.9 177.1 57.3 40.7 34.6 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.1 5.2 3.6 5.4 4.1 3.6 3.9 3.3 4.2 3.4 3.1 4.6 2.1 6.5 3.2 2.8 4.9 5.3 4.6 4.6 1.6 5.6 35.6 4.5 4.0 2.2 3.3 7.5 5.3 2.7 5.8 4.8 2.2 3.9 2.4 5.6 6.3 4.2 3.7 3.3 6.7 4.1 2.8 4.4 7.9 7.2 4.5 4.1 2.4 8.3 7.3 5.7 3.7 6.0 2.6 2.9 3.0 5.5 4.2 10.3 2.3 3.6 5.7 6.2 6.2 3.3 5.2 3.6 3.2 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 0.0 1.7 5.1 4.5 8.0 35.6 5.6 2.5 2.7 3.4 0.0 23.6 4.1 0.0 4.0 0.9 4.2 9.2 0.0 3.6 3.2 4.6 5.2 1.1 2.9 2.5 31.8 7.5 5.5 1.8 0.7 11.8 3.6 3.3 1.8 5.0 16.4 3.2 7.4 13.8 1.4 57.5 6.5 7.8 10.7 13.8 11.7 5.6 8.7 5.6 4.1 ZNF383 FLJ35863 ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 9.1 7.5 9.3 10.4 12.1 6.9 10.7 20.4 10.8 9.1 8.2 12.6 10.4 7.5 11.6 7.8 8.9 8.2 6.1 9.6 8.7 6.9 9.3 7.4 7.2 11.3 14.2 6.5 12.9 9.2 9.4 11.0 6.5 11.8 9.6 7.4 8.7 8.5 8.7 14.0 11.8 9.5 10.8 13.7 10.8 8.4 10.5 12.1 13.2 11.4 5.7 11.9 10.2 9.4 11.4 4.0 6.3 5.4 5.7 11.6 4.8 3.8 8.7 6.1 9.2 7.6 7.8 4.0 5.2 7.2 5.3 8.0 4.0 4.6 5.2 8.0 5.0 4.9 3.8 5.0 7.0 7.8 7.2 5.4 7.8 6.5 3.2 8.5 9.0 8.6 10.0 6.0 5.1 10.0 6.9 4.8 7.4 4.0 2.7 6.8 1.6 7.7 4.1 5.4 7.5 3.0 5.6 10.9 4.6 4.6 10.8 7.3 5.4 8.4 5.0 7.3 8.2 5.9 5.3 3.0 7.0 4.7 4.8 5.0 8.5 8.0 10.0 1.0 4.3 6.3 3.6 4.1 6.3 7.6 4.7 10.7 9.8 7.2 9.2 4.0 11.4 11.6 9.1 5.0 5.7 5.4 3.8 7.0 4.8 9.3 12.1 20.4 10.8 8.7 6.9 14.2 6.5 11.8 12.1 3.0 4.1 6.5 3.7 2.4 8.3 11.7 2.5 2.7 2.3 1.8 13.7 3.4 1.7 3.0 7.3 4.2 4.1 0.0 3.1 3.6 2.9 3.9 5.7 2.1 3.1 14.3 2.4 6.2 5.0 2.5 6.1 4.8 8.5 4.6 4.5 7.3 2.6 3.5 7.1 3.7 9.5 12.9 5.1 4.8 5.3 2.9 4.1 7.2 5.0 3.3 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345949-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 8.7" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 4.7 3.1 2.8 5.5 6.0 1.5 5.1 8.3 3.8 6.6 3.4 1.0 2.9 1.9 5.5 5.5 3.8 5.5 2.0 3.9 2.6 2.5 8.1 5.2 3.4 3.6 2.7 2.4 17.1 4.8 4.3 5.2 3.1 7.1 6.2 3.9 4.3 3.0 6.8 8.0 3.6 2.6 8.7 5.0 4.7 2.7 3.5 3.4 3.9 5.8 2.5 3.1 8.5 4.6 5.7 1.3 5.0 1.0 1.0 3.4 0.9 0.4 0.1 2.8 3.7 1.8 1.0 0.4 3.8 1.1 3.5 2.8 2.7 0.9 3.3 1.2 2.1 1.3 0.8 2.3 1.9 3.3 0.1 0.5 0.2 4.1 2.5 1.4 0.1 3.2 1.6 2.1 1.5 0.5 0.3 0.4 2.4 4.7 0.4 3.1 2.5 3.8 0.6 2.3 0.5 1.6 0.2 4.2 0.1 1.4 2.2 0.2 0.7 0.0 0.2 0.0 3.5 3.8 2.6 0.1 4.5 2.2 5.6 2.3 3.5 8.7 0.1 0.2 0.1 1.8 1.0 0.7 5.0 2.0 1.0 1.3 5.7 1.3 1.2 1.3 1.3 3.4 2.1 1.7 1.0 0.9 1.2 0.1 0.9 2.8 6.0 8.3 3.8 2.6 2.5 2.7 2.4 7.1 3.4 0.0 1.6 0.5 0.7 0.3 1.4 2.4 2.5 2.7 0.0 1.8 5.9 0.4 1.7 0.8 1.0 2.1 0.0 0.0 0.8 0.2 1.7 0.7 2.3 0.9 1.2 0.0 1.2 3.7 2.2 0.4 0.6 0.8 3.3 2.8 0.6 2.0 0.3 0.0 0.4 3.8 1.5 0.0 1.5 1.0 1.9 0.5 0.3 0.0 0.2 0.4 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.1 5.1 6.7 4.3 3.5 4.3 0.0 3.4 5.5 6.1 6.7 1.6 3.2 3.6 3.0 2.7 4.3 6.8 4.9 5.1 6.5 5.8 2.1 3.1 4.1 3.3 5.4 2.5 5.6 4.8 3.9 6.7 7.1 4.5 5.3 4.0 3.3 14.6 6.5 4.2 3.7 1.2 5.6 4.7 2.5 3.1 8.2 2.6 3.2 4.8 4.7 4.2 6.0 1.7 3.4 5.3 0.4 2.0 5.7 5.5 5.3 2.8 2.4 5.5 2.7 2.1 3.6 2.1 4.3 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 0.0 1.0 0.0 0.5 0.1 4.2 1.7 0.0 6.7 7.9 1.8 0.0 0.9 1.7 1.1 0.5 0.9 0.8 0.0 0.4 0.9 0.7 0.4 2.3 0.2 0.7 4.8 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.9 3.1 0.7 0.9 1.4 1.3 3.5 0.0 1.0 0.5 0.8 0.1 0.6 1.3 0.5 0.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.6 6.0 8.1 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.9 2.2 4.1 2.2 0.2 3.3 0.2 3.0 0.5 7.3 0.1 0.8 1.1 9.3 0.0 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 8.7 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 3.0 8.0 18.2 11.4 8.4 11.1 9.0 10.2 12.0 4.5 26.2 9.8 14.9 26.6 6.8 0.8 9.0 0.0 0.0 8.4 19.4 10.3 16.3 6.9 6.4 9.3 12.7 2.4 19.0 3.1 1.5 17.3 6.3 5.0 3.6 0.7 14.2 7.6 0.0 14.5 21.3 7.9 12.9 9.2 7.2 15.8 11.0 36.3 10.1 0.1 13.4 ZNF665 FLJ14345 ENSG00000197497 "Zinc finger protein 665" Q9H7R5 19 53159213-53193386 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023437 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA023437: AB_2671205" "unprognostic (8.01e-2)" "unprognostic (2.44e-1)" "unprognostic (1.73e-1)" "unprognostic (8.04e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (1.26e-1)" "unprognostic (3.27e-2)" "unprognostic (5.81e-4)" "unprognostic (2.26e-1)" "unprognostic (1.04e-2)" "unprognostic (2.45e-1)" "unprognostic (9.27e-2)" 4.3 3.8 4.2 4.3 6.7 2.3 5.1 10.7 6.2 5.3 4.0 5.7 2.6 1.6 6.4 5.2 3.2 6.7 2.9 2.6 5.2 2.6 2.6 1.1 3.6 4.2 5.5 3.2 11.5 2.7 7.7 4.8 2.9 4.8 6.0 2.6 6.0 2.9 4.0 1.4 3.3 2.6 5.5 6.5 3.9 2.9 3.4 7.0 7.2 5.8 1.5 3.2 5.4 4.1 5.4 1.6 1.5 1.1 4.9 2.2 0.5 1.1 0.2 1.2 3.8 1.2 2.2 2.8 2.8 1.7 2.7 3.8 0.5 1.0 2.0 2.0 2.0 1.8 0.4 0.7 0.2 4.4 0.0 0.1 0.1 0.7 0.1 2.7 0.5 1.0 2.6 0.0 2.4 0.0 0.8 0.2 0.1 0.4 0.6 0.1 0.4 5.4 1.6 2.2 0.0 0.6 0.1 0.1 0.8 0.5 5.3 0.5 2.4 0.2 0.4 0.1 2.8 1.5 1.1 0.7 1.8 2.2 1.7 1.0 0.3 4.6 4.9 0.1 1.4 2.6 1.5 0.5 1.1 0.8 0.3 1.0 2.7 1.0 2.2 0.9 5.4 1.8 1.9 1.4 4.9 1.1 1.6 0.7 0.5 4.2 6.7 10.7 6.2 5.2 2.6 5.5 3.2 4.8 7.0 17.9 9.6 1.7 2.9 1.0 5.7 0.8 2.5 8.1 6.8 5.2 0.0 2.0 3.3 1.1 1.5 2.5 0.3 0.0 0.6 2.1 1.9 2.1 4.7 0.4 1.1 11.1 2.4 1.8 1.0 0.8 2.0 1.1 1.7 2.8 0.3 6.8 0.4 0.0 2.8 0.3 3.7 0.0 2.1 1.9 7.0 0.5 0.7 3.8 0.7 2.0 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435329-57445485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 23.5" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005" "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 5.8 5.6 7.2 7.6 8.0 5.0 8.4 12.4 10.7 6.3 8.1 5.2 7.5 6.6 6.3 5.1 7.4 7.9 8.3 5.1 6.4 6.0 5.3 12.4 5.4 7.5 9.0 7.7 8.2 7.0 11.4 7.2 6.3 6.0 6.2 4.5 8.5 12.8 10.8 6.2 9.7 7.1 5.9 5.3 6.7 5.5 6.2 6.8 7.8 6.7 12.1 8.0 6.0 6.1 2.9 3.2 0.2 2.7 1.9 4.1 2.8 2.7 6.4 5.7 5.8 1.5 1.5 2.3 1.7 1.4 2.8 5.1 2.6 2.0 5.3 1.5 1.6 1.9 2.0 5.4 4.3 4.2 2.3 23.5 4.7 6.7 3.0 1.8 5.2 3.1 1.8 4.8 3.6 7.7 2.8 1.5 5.7 4.5 6.3 2.1 1.1 6.4 1.8 5.4 2.0 8.9 6.7 8.2 3.9 1.3 6.5 5.6 4.6 3.2 1.9 1.3 4.7 2.8 1.7 1.6 5.2 3.8 1.6 4.7 4.8 6.2 5.5 2.9 2.2 3.1 0.1 1.2 0.2 2.1 2.7 3.4 2.7 3.5 3.1 3.2 2.9 4.1 3.0 0.2 1.9 1.2 1.6 2.6 2.8 7.2 8.0 12.4 10.7 6.4 6.0 9.0 7.7 6.0 6.8 3.0 0.6 0.8 0.6 2.2 0.8 0.4 5.1 2.7 3.4 0.0 0.0 0.9 3.3 0.9 0.6 1.6 1.3 0.0 0.3 0.7 0.8 0.7 0.0 2.9 0.8 3.2 2.9 1.3 0.3 0.0 0.6 1.0 21.9 1.0 0.7 0.4 0.8 0.0 0.0 3.1 0.9 6.5 1.2 0.7 1.7 2.8 0.7 2.1 0.9 0.9